
<html lang="en"     class="pb-page"  data-request-id="690d78a4-96f6-43cd-9477-aebec705ca67"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;article:article:10.1021/acs.jmedchem.9b00412;ctype:string:Journal Content;wgroup:string:ACHS website Group;website:website:acspubs;issue:issue:10.1021/jmcmar.2019.62.issue-10;pageGroup:string:Publication Pages;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="citation_journal_title" content="Journal of Medicinal Chemistry" /></meta><meta name="dc.Title" content="Leveraging a Low-Affinity Diazaspiro Orthosteric Fragment to Reduce Dopamine D3 Receptor (D3R) Ligand Promiscuity across Highly Conserved Aminergic G-Protein-Coupled Receptors (GPCRs)" /></meta><meta name="dc.Creator" content="Sean W.  Reilly" /></meta><meta name="dc.Creator" content="Aladdin A.  Riad" /></meta><meta name="dc.Creator" content="Chia-Ju  Hsieh" /></meta><meta name="dc.Creator" content="Kristoffer  Sahlholm" /></meta><meta name="dc.Creator" content="Daniel A.  Jacome" /></meta><meta name="dc.Creator" content="Suzy  Griffin" /></meta><meta name="dc.Creator" content="Michelle  Taylor" /></meta><meta name="dc.Creator" content="Chi-Chang  Weng" /></meta><meta name="dc.Creator" content="Kuiying  Xu" /></meta><meta name="dc.Creator" content="Nathan  Kirschner" /></meta><meta name="dc.Creator" content="Robert R.  Luedtke" /></meta><meta name="dc.Creator" content="Christopher  Parry" /></meta><meta name="dc.Creator" content="Shipra  Malhotra" /></meta><meta name="dc.Creator" content="John  Karanicolas" /></meta><meta name="dc.Creator" content="Robert H.  Mach" /></meta><meta name="dc.Description" content="Previously, we reported a 3-(2-methoxyphenyl)-9-(3-((4-methyl-5-phenyl-4H-1,2,4-triazol-3-yl)thio)propyl)-3,9-diazaspiro[5.5]undecane (1) compound with excellent dopamine D3 receptor (D3R) affinity..." /></meta><meta name="Description" content="Previously, we reported a 3-(2-methoxyphenyl)-9-(3-((4-methyl-5-phenyl-4H-1,2,4-triazol-3-yl)thio)propyl)-3,9-diazaspiro[5.5]undecane (1) compound with excellent dopamine D3 receptor (D3R) affinity..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="April 25, 2019" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/acs.jmedchem.9b00412" /></meta><meta name="dc.Language" content="en" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="Copyright © 2019 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Facs.jmedchem.9b00412" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Facs.jmedchem.9b00412" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Facs.jmedchem.9b00412" /></link>
        
    
    

<title>Leveraging a Low-Affinity Diazaspiro Orthosteric Fragment to Reduce Dopamine D3 Receptor (D3R) Ligand Promiscuity across Highly Conserved Aminergic G-Protein-Coupled Receptors (GPCRs) | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/acs.jmedchem.9b00412" /></meta><meta property="og:title" content="Leveraging a Low-Affinity Diazaspiro Orthosteric Fragment to Reduce Dopamine D3 Receptor (D3R) Ligand Promiscuity across Highly Conserved Aminergic G-Protein-Coupled Receptors (GPCRs)" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-10/acs.jmedchem.9b00412/20190516/images/large/jm-2019-004124_0014.jpeg" /></meta><meta property="og:description" content="Previously, we reported a 3-(2-methoxyphenyl)-9-(3-((4-methyl-5-phenyl-4H-1,2,4-triazol-3-yl)thio)propyl)-3,9-diazaspiro[5.5]undecane (1) compound with excellent dopamine D3 receptor (D3R) affinity (D3R Ki = 12.0 nM) and selectivity (D2R/D3R ratio = 905). Herein, we present derivatives of 1 with comparable D3R affinity (32, D3R Ki = 3.2 nM, D2R/D3R ratio = 60) and selectivity (30, D3R Ki = 21.0 nM, D2R/D3R ratio = 934). Fragmentation of 1 revealed orthosteric fragment 5a to express an unusually low D3R affinity (Ki = 2.7 μM). Compared to piperazine congener 31, which retains a high-affinity orthosteric fragment (5d, D3R Ki = 23.9 nM), 1 was found to be more selective for the D3R among D1- and D2-like receptors and exhibited negligible off-target interactions at serotoninergic and adrenergic G-protein-coupled receptors (GPCRs), common off-target sites for piperazine-containing D3R scaffolds. This study provides a unique rationale for implementing weakly potent orthosteric fragments into D3R ligand systems to minimize drug promiscuity at other aminergic GPCR sites." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/acs.jmedchem.9b00412"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/acs.jmedchem.9b00412">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Facs.jmedchem.9b00412&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Facs.jmedchem.9b00412&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/acs.jmedchem.9b00412&amp;href=/doi/10.1021/acs.jmedchem.9b00412" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2019</span><span class="cit-fg-volume">, 62</span><span class="cit-fg-issue">, 10</span><span class="cit-fg-pageRange">, 5132-5147</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/62/10" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/acs.jmedchem.9b00349" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/acs.jmedchem.9b00462" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Leveraging a Low-Affinity Diazaspiro Orthosteric Fragment to Reduce Dopamine D<sub>3</sub> Receptor (D<sub>3</sub>R) Ligand Promiscuity across Highly Conserved Aminergic G-Protein-Coupled Receptors (GPCRs)</span></h1><ul class="loa"><li><span><span class="hlFld-ContribAuthor">Sean W. Reilly</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Sean W. Reilly</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Radiology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania 19104, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Sean+W.++Reilly">Sean W. Reilly</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-1656-1895" title="Orcid link">http://orcid.org/0000-0002-1656-1895</a></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Aladdin A. Riad</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Aladdin A. Riad</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Radiology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania 19104, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Aladdin+A.++Riad">Aladdin A. Riad</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Chia-Ju Hsieh</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Chia-Ju Hsieh</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Radiology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania 19104, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Chia-Ju++Hsieh">Chia-Ju Hsieh</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-2833-7727" title="Orcid link">http://orcid.org/0000-0002-2833-7727</a></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Kristoffer Sahlholm</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Kristoffer Sahlholm</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Radiology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania 19104, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Kristoffer++Sahlholm">Kristoffer Sahlholm</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Daniel A. Jacome</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Daniel A. Jacome</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Systems Pharmacology and Translational Therapeutics, University of Pennsylvania, 421 Curie Boulevard, Philadelphia, Pennsylvania 19104, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Daniel+A.++Jacome">Daniel A. Jacome</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Suzy Griffin</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Suzy Griffin</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Pharmacology and Neuroscience, University of North Texas Health Science Center, 3500 Camp Bowie Boulevard, Fort Worth, Texas 76107, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Suzy++Griffin">Suzy Griffin</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Michelle Taylor</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Michelle Taylor</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Pharmacology and Neuroscience, University of North Texas Health Science Center, 3500 Camp Bowie Boulevard, Fort Worth, Texas 76107, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Michelle++Taylor">Michelle Taylor</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Chi-Chang Weng</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Chi-Chang Weng</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Radiology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania 19104, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Chi-Chang++Weng">Chi-Chang Weng</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Kuiying Xu</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Kuiying Xu</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Radiology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania 19104, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Kuiying++Xu">Kuiying Xu</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Nathan Kirschner</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Nathan Kirschner</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Radiology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania 19104, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Nathan++Kirschner">Nathan Kirschner</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Robert R. Luedtke</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Robert R. Luedtke</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Pharmacology and Neuroscience, University of North Texas Health Science Center, 3500 Camp Bowie Boulevard, Fort Worth, Texas 76107, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Robert+R.++Luedtke">Robert R. Luedtke</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Christopher Parry</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Christopher Parry</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Program in Molecular Therapeutics, Fox Chase Cancer Center, 333 Cottman Avenue, Philadelphia, Pennsylvania 19111, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Christopher++Parry">Christopher Parry</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Shipra Malhotra</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Shipra Malhotra</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Program in Molecular Therapeutics, Fox Chase Cancer Center, 333 Cottman Avenue, Philadelphia, Pennsylvania 19111, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Shipra++Malhotra">Shipra Malhotra</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">John Karanicolas</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">John Karanicolas</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Program in Molecular Therapeutics, Fox Chase Cancer Center, 333 Cottman Avenue, Philadelphia, Pennsylvania 19111, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=John++Karanicolas">John Karanicolas</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0003-0300-726X" title="Orcid link">http://orcid.org/0000-0003-0300-726X</a></div></div></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor">Robert H. Mach</span><strong>*</strong><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Robert H. Mach</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Radiology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania 19104, United States</div></div><span class="conrtib-corresp"><strong>*</strong>E-mail: <a href="/cdn-cgi/l/email-protection#7e0c131f1d163e0e1b1010131b1a171d17101b500b0e1b1010501b1a0b"><span class="__cf_email__" data-cfemail="b0c2ddd1d3d8f0c0d5dededdd5d4d9d3d9ded59ec5c0d5dede9ed5d4c5">[email protected]</span></a>. Phone: (215) 746-8233.</span><span class="conrtib-corresp"></span><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Robert+H.++Mach">Robert H. Mach</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-7645-2869" title="Orcid link">http://orcid.org/0000-0002-7645-2869</a></div></div></span></li><span class="comma-separator"></span></ul><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.9b00412&amp;href=/doi/10.1021%2Facs.jmedchem.9b00412" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2019</span></span><span class="cit-volume">, 62</span><span class="cit-issue">, 10</span><span class="cit-pageRange">, 5132–5147</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">April 25, 2019</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>12 March 2019</li><li><span class="item_label"><b>Published</b> online</span>25 April 2019</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 23 May 2019</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/acs.jmedchem.9b00412" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.9b00412</a></div><div class="article_header-article-copyright"><strong>Copyright © 2019 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D5132%26pageCount%3D16%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DSean%2BW.%2BReilly%252C%2BAladdin%2BA.%2BRiad%252C%2BChia-Ju%2BHsieh%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D62%26issueNum%3D10%26contentID%3Dacs.jmedchem.9b00412%26title%3DLeveraging%2Ba%2BLow-Affinity%2BDiazaspiro%2BOrthosteric%2BFragment%2Bto%2BReduce%2BDopamine%2BD3%2BReceptor%2B%2528D3R%2529%2BLigand%2BPromiscuity%2Bacross%2BHighly%2BConserved%2BAminergic%2BG-Protein-Coupled%2BReceptors%2B%2528GPCRs%2529%26numPages%3D16%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D5147%26publicationDate%3DMay%2B2019">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/acs.jmedchem.9b00412"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">919</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">4</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/acs.jmedchem.9b00412" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Leveraging a Low-Affinity Diazaspiro Orthosteric Fragment to Reduce Dopamine D3 Receptor (D3R) Ligand Promiscuity across Highly Conserved Aminergic G-Protein-Coupled Receptors (GPCRs)&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Sean&quot;,&quot;last_name&quot;:&quot;W. Reilly&quot;},{&quot;first_name&quot;:&quot;Aladdin&quot;,&quot;last_name&quot;:&quot;A. Riad&quot;},{&quot;first_name&quot;:&quot;Chia-Ju&quot;,&quot;last_name&quot;:&quot;Hsieh&quot;},{&quot;first_name&quot;:&quot;Kristoffer&quot;,&quot;last_name&quot;:&quot;Sahlholm&quot;},{&quot;first_name&quot;:&quot;Daniel&quot;,&quot;last_name&quot;:&quot;A. Jacome&quot;},{&quot;first_name&quot;:&quot;Suzy&quot;,&quot;last_name&quot;:&quot;Griffin&quot;},{&quot;first_name&quot;:&quot;Michelle&quot;,&quot;last_name&quot;:&quot;Taylor&quot;},{&quot;first_name&quot;:&quot;Chi-Chang&quot;,&quot;last_name&quot;:&quot;Weng&quot;},{&quot;first_name&quot;:&quot;Kuiying&quot;,&quot;last_name&quot;:&quot;Xu&quot;},{&quot;first_name&quot;:&quot;Nathan&quot;,&quot;last_name&quot;:&quot;Kirschner&quot;},{&quot;first_name&quot;:&quot;Robert&quot;,&quot;last_name&quot;:&quot;R. Luedtke&quot;},{&quot;first_name&quot;:&quot;Christopher&quot;,&quot;last_name&quot;:&quot;Parry&quot;},{&quot;first_name&quot;:&quot;Shipra&quot;,&quot;last_name&quot;:&quot;Malhotra&quot;},{&quot;first_name&quot;:&quot;John&quot;,&quot;last_name&quot;:&quot;Karanicolas&quot;},{&quot;first_name&quot;:&quot;Robert&quot;,&quot;last_name&quot;:&quot;H. Mach&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2019&quot;,&quot;month&quot;:&quot;04&quot;,&quot;day&quot;:&quot;25&quot;,&quot;issue&quot;:&quot;10&quot;,&quot;volume&quot;:&quot;62&quot;,&quot;pages&quot;:&quot;5132-5147&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/acs.jmedchem.9b00412&quot;},&quot;abstract&quot;:&quot;Previously, we reported a 3-(2-methoxyphenyl)-9-(3-((4-methyl-5-phenyl-4H-1,2,4-triazol-3-yl)thio)propyl)-3,9-diazaspiro[5.5]undecane (1) compound with excellent dopamine D3 receptor (D3R) affinity (D3R Ki = 12.0 nM) and selectivity (D2R/D3R ratio = 905). Herein, we present derivatives of 1 with comparable D3R affinity (32, D3R Ki = 3.2 nM, D2R/D3R ratio = 60) and selectivity (30, D3R Ki = 21.0 nM, D2R/D3R ratio = 934). Fragmentation of 1 revealed orthosteric fragment 5a to express an unusually low D3R affinity (Ki = 2.7 μM). Compared to piperazine congener 31, which retains a high-affinity orthosteric fragment (5d, D3R Ki = 23.9 nM), 1 was found to be more selective for the D3R among D1- and D2-like receptors and exhibited negligible off-target interactions at serotoninergic and adrenergic G-protein-coupled receptors (GPCRs), common off-target sites for piperazine-containing D3R scaffolds. This study provides a unique rationale for implementing weakly potent orthosteric fragments into D3R ligand systems to m&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.9b00412&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.9b00412" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.9b00412&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.9b00412" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.9b00412&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.9b00412" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.9b00412&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.9b00412&amp;href=/doi/10.1021/acs.jmedchem.9b00412" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/acs.jmedchem.9b00412" /></input><a href="/doi/pdf/10.1021/acs.jmedchem.9b00412" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (3 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.9b00412&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Facs.jmedchem.9b00412%26sid%3Dliteratum%253Aachs%26pmid%3D31021617%26genre%3Darticle%26aulast%3DReilly%26date%3D2019%26atitle%3DLeveraging%2Ba%2BLow-Affinity%2BDiazaspiro%2BOrthosteric%2BFragment%2Bto%2BReduce%2BDopamine%2BD3%2BReceptor%2B%2528D3R%2529%2BLigand%2BPromiscuity%2Bacross%2BHighly%2BConserved%2BAminergic%2BG-Protein-Coupled%2BReceptors%2B%2528GPCRs%2529%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D62%26issue%3D10%26spage%3D5132%26epage%3D5147%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (2)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=292366" title="Ligands">Ligands</a>,</li><li><a href="/action/doSearch?ConceptID=291602" title="Organic synthesis">Organic synthesis</a>,</li><li><a href="/action/doSearch?ConceptID=291711" title="Selectivity">Selectivity</a>,</li><li><a href="/action/doSearch?ConceptID=291352" title="Screening assays">Screening assays</a>,</li><li><a href="/action/doSearch?ConceptID=292186" title="Receptors">Receptors</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/62/10" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-10/jmcmar.2019.62.issue-10/20190523/jmcmar.2019.62.issue-10.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="_i1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-10/acs.jmedchem.9b00412/20190516/images/medium/jm-2019-004124_0014.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-10/acs.jmedchem.9b00412/20190516/images/large/jm-2019-004124_0014.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00412&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">Previously, we reported a 3-(2-methoxyphenyl)-9-(3-((4-methyl-5-phenyl-4<i>H</i>-1,2,4-triazol-3-yl)thio)propyl)-3,9-diazaspiro[5.5]undecane (<b>1</b>) compound with excellent dopamine D<sub>3</sub> receptor (D<sub>3</sub>R) affinity (D<sub>3</sub>R <i>K</i><sub>i</sub> = 12.0 nM) and selectivity (D<sub>2</sub>R/D<sub>3</sub>R ratio = 905). Herein, we present derivatives of <b>1</b> with comparable D<sub>3</sub>R affinity (<b>32</b>, D<sub>3</sub>R <i>K</i><sub>i</sub> = 3.2 nM, D<sub>2</sub>R/D<sub>3</sub>R ratio = 60) and selectivity (<b>30</b>, D<sub>3</sub>R <i>K</i><sub>i</sub> = 21.0 nM, D<sub>2</sub>R/D<sub>3</sub>R ratio = 934). Fragmentation of <b>1</b> revealed orthosteric fragment <b>5a</b> to express an unusually low D<sub>3</sub>R affinity (<i>K</i><sub>i</sub> = 2.7 μM). Compared to piperazine congener <b>31</b>, which retains a high-affinity orthosteric fragment (<b>5d</b>, D<sub>3</sub>R <i>K</i><sub>i</sub> = 23.9 nM), <b>1</b> was found to be more selective for the D<sub>3</sub>R among D<sub>1</sub>- and D<sub>2</sub>-like receptors and exhibited negligible off-target interactions at serotoninergic and adrenergic G-protein-coupled receptors (GPCRs), common off-target sites for piperazine-containing D<sub>3</sub>R scaffolds. This study provides a unique rationale for implementing weakly potent orthosteric fragments into D<sub>3</sub>R ligand systems to minimize drug promiscuity at other aminergic GPCR sites.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_64263" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_64263" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">The dopamine (DA) D<sub>3</sub> receptor (D<sub>3</sub>R) is a G-protein-coupled receptor (GPCR), viewed as a pharmacotherapeutic target for numerous neurological and psychiatric disorders as well as drug addiction.<a onclick="showRef(event, 'ref1 ref2'); return false;" href="javascript:void(0);" class="ref ref1 ref2">(1,2)</a> Targeting this D<sub>2</sub>-like receptor is a strategy for schizophrenia drug development due to the unwanted extrapyramidal side-effects elicited with many typical antipsychotics.<a onclick="showRef(event, 'ref3'); return false;" href="javascript:void(0);" class="ref ref3">(3)</a> The appeal of D<sub>3</sub>R for drug addiction therapeutics stems from the high expression of this protein in the mesolimbic pathway, a region of the brain implicated in reward and motivation.<a onclick="showRef(event, 'ref4'); return false;" href="javascript:void(0);" class="ref ref4">(4)</a> Human postmortem studies showing an enhanced expression of the D<sub>3</sub>R in drug exposed brains have further validated the clinical importance of this receptor for substance abuse disorders.<a onclick="showRef(event, 'ref5'); return false;" href="javascript:void(0);" class="ref ref5">(5)</a> Selective engagement of this receptor is also of considerable interest for positron-emission tomography (PET) imaging applications to further our understanding and elucidate the complex molecular mechanisms of drug addiction.<a onclick="showRef(event, 'ref6 ref7 ref8 ref9'); return false;" href="javascript:void(0);" class="ref ref6 ref7 ref8 ref9">(6−9)</a></div><div class="NLM_p">The development of high-affinity D<sub>3</sub>R selective ligands begins with a fragment-based approach in which the binding profiles of amino core synthons are examined at the orthosteric binding site (OBS) of the receptor. This region contains a highly conserved Asp110 [3.32] residue which forms a salt bridge interaction with the protonated nitrogen of the amino core in the ligand scaffold affording receptor recognintion.<a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">(10)</a> Due to the high degree of homology between the D<sub>3</sub>R and the dopamine D<sub>2</sub> receptor (D<sub>2</sub>R) in this domain, the ligand must then extend into a secondary binding pocket (SBP) containing residues unique to each receptor to confer D<sub>3</sub>R selectivity.<a onclick="showRef(event, 'ref10 ref11 ref12'); return false;" href="javascript:void(0);" class="ref ref10 ref11 ref12">(10−12)</a> However, the Asp110 [3.32] that forms the critical receptor–ligand interaction is also greatly conserved across other aminergic GPCRs.<a onclick="showRef(event, 'ref13'); return false;" href="javascript:void(0);" class="ref ref13">(13)</a> Thus, synthesizing D<sub>3</sub>R selective compounds that concomitantly engage the Asp110 [3.32] residue and exhibit minimal off-target interactions continues to be problematic. As such, there has been no clinically viable D<sub>3</sub>R selective therapeutic or PET imaging agent reported to date, preventing us from exploring the therapeutic potential of this receptor.</div><div class="NLM_p">Recently, we reported a new class of D<sub>3</sub>R selective compounds containing spirodiamine systems as an alternative to the piperazine amino core (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>).<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a> In this study, we synthesized and evaluated analogs and fragments of <b>1</b> to identify the structural determinants responsible for ligand affinity and selectivity at the D<sub>3</sub>R. Compared to the excellent binding profile of aryl piperazine orthosteric fragment <b>5d</b> (<i>K</i><sub>i</sub> = 23.9 nM) of ligand <b>31</b>, we found sython <b>5a</b> of <b>1</b> to bind with lower affinity (<i>K</i><sub>i</sub> > 2 μM). Computational ligand docking studies were performed to elucidate the binding mode of <b>1</b>, and other select compounds, within the D<sub>3</sub>R crystal structure (3PBL). Finally, the pharmacological behavior of <b>1</b> and <b>31</b> was screened across all D<sub>1</sub> (D<sub>1</sub>R and D<sub>5</sub>R)- and D<sub>2</sub> (D<sub>2</sub>R, D<sub>3</sub>R and D<sub>4</sub>R)-like receptors, and select aminergic GPCRs, revealing <b>1</b> to be a more selective ligand for the D<sub>3</sub>R with less off-target interactions. These results provide rationale for utilizing primary pharmacophores (PP) with limited affinity for the highly conserved orthosteric binding pocket (OBP) of the receptor to develop selective D<sub>3</sub>R ligands with minimized off-target interactions.</div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-10/acs.jmedchem.9b00412/20190516/images/medium/jm-2019-004124_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-10/acs.jmedchem.9b00412/20190516/images/large/jm-2019-004124_0001.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Lead compounds identified with diazaspiro amino systems.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-10/acs.jmedchem.9b00412/20190516/images/large/jm-2019-004124_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00412&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i3">Results and Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_86650" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_86650" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec2_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i4" class="anchor-spacer"></div><h3 class="article-section__title" id="_i4"> Chemistry</h3><div class="NLM_p">Synthesis of arylated diazaspiro and piperazine systems was achieved in excellent yields following our previously reported palladium (Pd) C–N cross-coupling reports outlined in <a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>.<a onclick="showRef(event, 'ref15 ref16'); return false;" href="javascript:void(0);" class="ref ref15 ref16">(15,16)</a> Unsaturated diazaspiro[5.5]undec-1-ene motif <b>4a</b>, a presumed cross-coupling β-hydride elimination side-product, was able to be obtained, albeit in low yields (<10%). Following removal of the BOC protecting groups from <b>4b</b>, <b>4c</b>, and <b>4e</b> with trifluoroacetic acid (TFA) and basification, the corresponding free-amine intermediates <b>4b′</b>, <b>4c′</b>, and <b>4e′</b> were <i>N</i>-alkylated with 1-bromobutane at room temperature (rt) in acetone to afford desired synthons <b>5a</b>–<b>c</b>. Similarly, <i>S</i>-alkylation of commercially available 4-methyl-5-phenyl-4<i>H</i>-1,2,4-triazole-3-thiol with the appropriate alkylating reagent yielded <b>6a</b>,<b>b</b> in good yields. The formation of 1,2,4-triazole fragments <b>6c</b>–<b>e</b> and <b>6g</b> was readily accessed by reacting <b>6b</b> with the desired amine in the presence of Cs<sub>2</sub>CO<sub>3</sub> under refluxing conditions. BOC-deprotection with TFA, followed by base neutralization, afforded the final free-amine fragments <b>6f</b> and <b>6h</b>.</div><figure id="sch1" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-10/acs.jmedchem.9b00412/20190516/images/medium/jm-2019-004124_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-10/acs.jmedchem.9b00412/20190516/images/large/jm-2019-004124_0005.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthesis of Fragmented Synthons<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-10/acs.jmedchem.9b00412/20190516/images/large/jm-2019-004124_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00412&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (i) Pd<sub>2</sub>(dba)<sub>3</sub>, RuPhos, aryl halide, diazaspiro reagent, NaO<i>t</i>-Bu, dioxane, 100 °C, 20 min; (ii) TFA, CH<sub>2</sub>Cl<sub>2</sub>, rt, 3 h; (iii) 1-bromobutane, K<sub>2</sub>CO<sub>3</sub>, acetone, rt, 12 h; (iv) alkylating reagent, K<sub>2</sub>CO<sub>3</sub>, acetone, rt, 12 h; (v) amine, Cs<sub>2</sub>CO<sub>3</sub>, acetonitrile (ACN), 70 °C, 8 h.</p></p></figure><div class="NLM_p"><a class="ref internalNav" href="#sch2" aria-label="Scheme 2">Scheme 2</a> briefly illustrates the general synthesis, disclosed in our previous report,<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a> used to obtain ligands <b>1</b>–<b>3</b> and <b>7</b>–<b>34</b>. Aryl amide scaffolds <b>35</b>–<b>37</b> were prepared by reacting <b>4b′</b> with 2-(4-bromobutyl)isoindoline-1,3-dione, to afford precursor <b>E</b> in a modest yield of 64%. Next, <b>E</b> was treated with hydrazine in refluxing EtOH to afford free-amine intermediate <b>F</b> in an excellent yield (97%). Finally, benzamide compounds <b>35</b>–<b>36</b> were synthesized by coupling <b>F</b> with the respective benzoic acid in the presence of 1-hydroxybenzotriazole (HOBt) hydrate and 1-ethyl-3-(3′-dimethylaminopropyl)carbodiimide (EDC) in dichloromethane at room temperature. Following our 2011 report,<a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a> synthon <b>4b′</b> was <i>N</i>-alkylated with intermediate <b>G</b> to afford the aripiprazole analog <b>37</b> in a modest yield (62%).</div><figure id="sch2" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-10/acs.jmedchem.9b00412/20190516/images/medium/jm-2019-004124_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-10/acs.jmedchem.9b00412/20190516/images/large/jm-2019-004124_0006.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. General Synthesis of Compounds <b>1</b>–<b>3</b> and <b>7</b>-<b>37</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-10/acs.jmedchem.9b00412/20190516/images/large/jm-2019-004124_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00412&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (i) (A) TFA, CH<sub>2</sub>Cl<sub>2</sub>, rt, 3 h; (ii) (B) alkylating reagent, K<sub>2</sub>CO<sub>3</sub>, acetone, rt, 12 h; (iii) (<b>C</b>, <b>D</b>) TEA, EtOH, 75 °C, 12 h; (iv) <b>4b′</b>, 2-(4-bromobutyl)isoindoline-1,3-dione, KI and Cs<sub>2</sub>CO<sub>3</sub>, ACN, 75 °C for 3 h; (v) (E), hydrazine, EtOH, 75 °C for 2 h; (vi) (F), benzoic acid, HOBt, EDC, CH<sub>2</sub>Cl<sub>2</sub>, rt, 2 h; (vii) (G), KI, and K<sub>2</sub>CO<sub>3</sub>, ACN, 90 °C for 12 h.</p></p></figure></div><div id="sec2_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i7" class="anchor-spacer"></div><h3 class="article-section__title" id="_i7"> Radioligand Binding Profiles of Compound <b>1</b> Analogs and Fragments</h3><div class="NLM_p">Structural modifications were made to <b>1</b> in attempts to further enhance D<sub>3</sub>R binding affinity and probe the structural determinants of this ligand template responsible for receptor selectivity. Compounds and synthons of select ligands were then evaluated in radioligand binding assays using [<sup>125</sup>I]-<i>N</i>-benzyl-5-iodo-2,3-dimethoxy[3.3.1]azabicyclononan-3-β-ylbenzamide ([<sup>125</sup>I]IABN) with human embryonic kidney 293 (HEK) cells stably expressing human D<sub>3</sub>R and D<sub>2L</sub> (<a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Tables <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>–<a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a>). Values of <i>c</i> log <i>P</i> and topological polar surface area (tPSA) are also included in <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Tables <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>–<a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a> to provide an estimate of lipophilicity and cell permeability, respectively, for each full-length ligand.</div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. D<sub>3</sub>R/D<sub>2</sub>R Binding Profiles of <b>1</b> Analogs with Modifications to the 1,2,4-Triazole System<a class="ref internalNav" href="#t1fn1" aria-label="a">a</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-10/acs.jmedchem.9b00412/20190516/images/medium/jm-2019-004124_0007.gif" alt="" id="fx1" /></img><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="char" char="±" /></col><col align="char" char="±" /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="2" align="center" char="±"><i>K</i><sub>i</sub> ± SEM (nM)<a class="ref internalNav" href="#t1fn2" aria-label="b">b</a></th><th class="colsep0 rowsep0" align="center" char="."> </th><th class="colsep0 rowsep0" align="center" char="."> </th><th class="colsep0 rowsep0" align="center" char="."> </th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compound</th><th class="colsep0 rowsep0" align="center">R<sub>1</sub></th><th class="colsep0 rowsep0" align="center">R<sub>2</sub></th><th class="colsep0 rowsep0" align="center">Y</th><th class="colsep0 rowsep0" align="center" char="±">D<sub>3</sub>R<a class="ref internalNav" href="#t1fn3" aria-label="c">c</a></th><th class="colsep0 rowsep0" align="center" char="±">D<sub>2</sub>R<a class="ref internalNav" href="#t1fn4" aria-label="d">d</a></th><th class="colsep0 rowsep0" align="center" char=".">D<sub>2</sub>/D<sub>3</sub> ratio<a class="ref internalNav" href="#t1fn5" aria-label="e">e</a></th><th class="colsep0 rowsep0" align="center" char="."><i>c</i>log <i>P</i><a class="ref internalNav" href="#t1fn6" aria-label="f">f</a></th><th class="colsep0 rowsep0" align="center" char=".">tPSA<a class="ref internalNav" href="#t1fn6" aria-label="f">f</a></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>1</b><a class="ref internalNav" href="#t1fn7" aria-label="g">g</a></td><td class="colsep0 rowsep0" align="left">phenyl</td><td class="colsep0 rowsep0" align="left">CH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">N</td><td class="colsep0 rowsep0" align="char" char="±">12.0 ± 2.8</td><td class="colsep0 rowsep0" align="char" char="±">10 895 ± 2069</td><td class="colsep0 rowsep0" align="char" char=".">905</td><td class="colsep0 rowsep0" align="char" char=".">4.88</td><td class="colsep0 rowsep0" align="char" char=".">43.67</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>7</b></td><td class="colsep0 rowsep0" align="left">4-<i>N</i>,<i>N</i>-dimethylaniline</td><td class="colsep0 rowsep0" align="left">CH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">N</td><td class="colsep0 rowsep0" align="char" char="±">138 ± 17.1</td><td class="colsep0 rowsep0" align="char" char="±">12 137 ± 2713</td><td class="colsep0 rowsep0" align="char" char=".">88</td><td class="colsep0 rowsep0" align="char" char=".">5.21</td><td class="colsep0 rowsep0" align="char" char=".">46.91</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>8</b></td><td class="colsep0 rowsep0" align="left">2-methoxyphenyl</td><td class="colsep0 rowsep0" align="left">CH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">N</td><td class="colsep0 rowsep0" align="char" char="±">63.0 ± 7.5</td><td class="colsep0 rowsep0" align="char" char="±">2112 ± 269</td><td class="colsep0 rowsep0" align="char" char=".">33.5</td><td class="colsep0 rowsep0" align="char" char=".">4.37</td><td class="colsep0 rowsep0" align="char" char=".">52.90</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>9</b></td><td class="colsep0 rowsep0" align="left">pyrimidin-3-yl</td><td class="colsep0 rowsep0" align="left">CH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">N</td><td class="colsep0 rowsep0" align="char" char="±">213 ± 21.4</td><td class="colsep0 rowsep0" align="char" char="±">48 584 ± 10 378</td><td class="colsep0 rowsep0" align="char" char=".">229</td><td class="colsep0 rowsep0" align="char" char=".">3.69</td><td class="colsep0 rowsep0" align="char" char=".">56.03</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>10</b></td><td class="colsep0 rowsep0" align="left">4-(thiophen-3-yl)phenyl</td><td class="colsep0 rowsep0" align="left">CH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">N</td><td class="colsep0 rowsep0" align="char" char="±">101 ± 32.3</td><td class="colsep0 rowsep0" align="char" char="±">3250 ± 782</td><td class="colsep0 rowsep0" align="char" char=".">32.2</td><td class="colsep0 rowsep0" align="char" char=".">6.41</td><td class="colsep0 rowsep0" align="char" char=".">43.67</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>11</b></td><td class="colsep0 rowsep0" align="left">4-(1,3-oxazol-2-yl)-phenyl</td><td class="colsep0 rowsep0" align="left">CH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">N</td><td class="colsep0 rowsep0" align="char" char="±">25.4 ± 2.7</td><td class="colsep0 rowsep0" align="char" char="±">1574 ± 396</td><td class="colsep0 rowsep0" align="char" char=".">62.1</td><td class="colsep0 rowsep0" align="char" char=".">4.66</td><td class="colsep0 rowsep0" align="char" char=".">65.26</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>12</b></td><td class="colsep0 rowsep0" align="left">2-fluorophenyl</td><td class="colsep0 rowsep0" align="left">CH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">N</td><td class="colsep0 rowsep0" align="char" char="±">25.9 ± 3.7</td><td class="colsep0 rowsep0" align="char" char="±">19 655 ± 4441</td><td class="colsep0 rowsep0" align="char" char=".">759</td><td class="colsep0 rowsep0" align="char" char=".">5.03</td><td class="colsep0 rowsep0" align="char" char=".">43.67</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>13</b></td><td class="colsep0 rowsep0" align="left">4-fluorophenyl</td><td class="colsep0 rowsep0" align="left">CH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">N</td><td class="colsep0 rowsep0" align="char" char="±">39.8 ± 11.9</td><td class="colsep0 rowsep0" align="char" char="±">15 768 ± 1661</td><td class="colsep0 rowsep0" align="char" char=".">396</td><td class="colsep0 rowsep0" align="char" char=".">5.03</td><td class="colsep0 rowsep0" align="char" char=".">43.67</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>14</b></td><td class="colsep0 rowsep0" align="left">cyclohexyl</td><td class="colsep0 rowsep0" align="left">CH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">N</td><td class="colsep0 rowsep0" align="char" char="±">57.0 ± 13.6</td><td class="colsep0 rowsep0" align="char" char="±">12 584 ± 1732</td><td class="colsep0 rowsep0" align="char" char=".">221</td><td class="colsep0 rowsep0" align="char" char=".">5.17</td><td class="colsep0 rowsep0" align="char" char=".">43.67</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>15</b></td><td class="colsep0 rowsep0" align="left">phenyl</td><td class="colsep0 rowsep0" align="left">CH<sub>2</sub>CH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">N</td><td class="colsep0 rowsep0" align="char" char="±">48.7 ± 8.9</td><td class="colsep0 rowsep0" align="char" char="±">5650 ± 893</td><td class="colsep0 rowsep0" align="char" char=".">116</td><td class="colsep0 rowsep0" align="char" char=".">5.55</td><td class="colsep0 rowsep0" align="char" char=".">43.67</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>16</b></td><td class="colsep0 rowsep0" align="left">phenyl</td><td class="colsep0 rowsep0" align="left">NH<sub>2</sub></td><td class="colsep0 rowsep0" align="left">N</td><td class="colsep0 rowsep0" align="char" char="±">75.0 ± 6.3</td><td class="colsep0 rowsep0" align="char" char="±">13 904 ± 453</td><td class="colsep0 rowsep0" align="char" char=".">185</td><td class="colsep0 rowsep0" align="char" char=".">4.90</td><td class="colsep0 rowsep0" align="char" char=".">69.69</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>17</b></td><td class="colsep0 rowsep0" align="left">phenyl</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">N</td><td class="colsep0 rowsep0" align="char" char="±">32.5 ± 2.6</td><td class="colsep0 rowsep0" align="char" char="±">1162 ± 229</td><td class="colsep0 rowsep0" align="char" char=".">35.7</td><td class="colsep0 rowsep0" align="char" char=".">5.06</td><td class="colsep0 rowsep0" align="char" char=".">52.46</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>18</b></td><td class="colsep0 rowsep0" align="left">phenyl</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">CH</td><td class="colsep0 rowsep0" align="char" char="±">383 ± 53.7</td><td class="colsep0 rowsep0" align="char" char="±">5891 ± 267</td><td class="colsep0 rowsep0" align="char" char=".">15.4</td><td class="colsep0 rowsep0" align="char" char=".">6.24</td><td class="colsep0 rowsep0" align="char" char=".">40.1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>19</b></td><td class="colsep0 rowsep0" align="left">phenyl</td><td class="colsep0 rowsep0" align="left">CH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">CH</td><td class="colsep0 rowsep0" align="char" char="±">418 ± 49.8</td><td class="colsep0 rowsep0" align="char" char="±">35 720 ± 5804</td><td class="colsep0 rowsep0" align="char" char=".">85.4</td><td class="colsep0 rowsep0" align="char" char=".">6.26</td><td class="colsep0 rowsep0" align="char" char=".">31.21</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t1fn1"><div class="footnote" id="t1fn1"><sup><sup>a</sup></sup><p class="last">Spiperone assayed under the same conditions as a reference blocker: D<sub>2</sub>R, 0.06 ± 0.001 nM; D<sub>3</sub>R, 0.33 ± 0.02 nM; D<sub>4</sub>R, 0.45 ± 0.01 nM.</p></div><div class="footnote" id="t1fn2"><sup><sup>b</sup></sup><p class="last">Mean ± standard error of the mean (SEM); <i>K</i><sub>i</sub> values were determined by at least three experiments.</p></div><div class="footnote" id="t1fn3"><sup><sup>c</sup></sup><p class="last"><i>K</i><sub>i</sub> values for D<sub>3</sub> receptors were measured using human D<sub>3</sub> expressed in HEK cells with [<sup>125</sup>I]IABN as the radioligand.</p></div><div class="footnote" id="t1fn4"><sup><sup>d</sup></sup><p class="last"><i>K</i><sub>i</sub> values for D<sub>2</sub> receptors were measured using human D<sub>2</sub> expressed in HEK cells with [<sup>125</sup>I]IABN as the radioligand.</p></div><div class="footnote" id="t1fn5"><sup><sup>e</sup></sup><p class="last">(<i>K</i><sub>i</sub> for D<sub>2</sub> receptors)/(<i>K</i><sub>i</sub> for D<sub>3</sub> receptors).</p></div><div class="footnote" id="t1fn6"><sup><sup>f</sup></sup><p class="last">Calculated using ChemDraw Professional 15.1.</p></div><div class="footnote" id="t1fn7"><sup><sup>g</sup></sup><p class="last">Compound reported in our initial work ref <a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a>.</p></div></div></div><div class="NLM_p">We first modified the aryl 1,2,4-triazole ring system in <b>1</b> and evaluated several aryl moieties found to be tolerable in azaspirocyclic D<sub>3</sub>R ligand architectures previously disclosed by Micheli and co-workers.<a onclick="showRef(event, 'ref18 ref19 ref20'); return false;" href="javascript:void(0);" class="ref ref18 ref19 ref20">(18−20)</a> However, we observed a drastic decrease in receptor selectivity after installing the 4-(1,3-oxazol-2-yl)-phenyl (<b>11</b>) and cyclohexyl (<b>14</b>) substitutions (D<sub>2</sub>R/D<sub>3</sub>R ratio = 62 and 221, respectively), indicating that our 1,2,4-triazole ligand architecture follows a different structure–activity relationship (SAR) within the D<sub>3</sub>R. When modifying the aryl ring with fluorine substitutions, we found the ortho position to be more preferred (<b>12</b>, <i>K</i><sub>i</sub> = 25.9 nM, D<sub>2</sub>R/D<sub>3</sub>R ratio = 759), as the 4-fluoro analog resulted in a 2-fold decrease in the receptor selectivity (<b>13</b>, <i>K</i><sub>i</sub> = 39.8 nM, D<sub>2</sub>R/D<sub>3</sub>R ratio = 396).</div><div class="NLM_p">Next, binding profiles of ligands containing structural modifications to the 1,2,4-triazole ring system were evaluated (<b>15</b>–<b>19</b>). With respect to <b>1</b>, replacing the −CH<sub>3</sub> group for a −CH<sub>2</sub>CH<sub>3</sub> (<b>15</b>) or −NH<sub>2</sub> (<b>16</b>) substituent resulted in a 7-fold and 5-fold decrease in receptor selectivity, respectively. Similarly, the deletion of the −CH<sub>3</sub> group resulted in a drastic loss of receptor selectivity, affording a 35-fold D<sub>2</sub>R/D<sub>3</sub>R ratio for <b>17</b>, combined with a moderate decrease in D<sub>3</sub>R affinity (<i>K</i><sub>i</sub> = 32.5). Imidazole systems were also evaluated as triazole alternatives, however, we found a significant loss in receptor affinity and binding selectivity for ligands <b>18</b> and <b>19</b>.</div><div class="NLM_p">We then explored the effect on D<sub>3</sub>R binding by manipulating the linker length in compounds <b>20</b> and <b>21</b> (<a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a></a>). However, this modification afforded an ∼8-fold reduction in D<sub>3</sub>R selectivity, demonstrating the <i>N</i>-propyl linker to be the more optimal spacer. Next, we probed the influence of the 2-methoxy substituent in compound <b>1</b> on D<sub>3</sub>R ligand binding. When replacing the 2-methoxy with a 2-ethoxy in <b>22</b>, receptor selectivity was diminished (D<sub>2</sub>R/D<sub>3</sub>R ratio = 114), along with a moderate decrease in binding affinity (<i>K</i><sub>i</sub> = 45.1 nM). Compared to <b>20</b>, the 2-fluoroethoxy substituent showed to be more compatible, affording an increase in overall binding and selectivity (<i>K</i><sub>i</sub> = 33.3 nM, D<sub>2</sub>R/D<sub>3</sub>R ratio = 192). In our initial report, we found that moving the aryl methoxy substituent from the 2-position in <b>1</b> to the 4-position in <b>25</b> further enhanced the D<sub>3</sub>R selectivity (D<sub>2</sub>R/D<sub>3</sub>R ratio = ∼1000-fold) but also diminished ligand affinity for the receptor (<i>K</i><sub>i</sub> = 97.7 nM).<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a> Thus, we evaluated <b>26</b>, a compound containing methoxy substituents in the ortho and para positions of the aryl ring, to determine if affinity could be enhanced while maintaining similar selectivity. Instead, we found the receptor affinity for <b>26</b> (<i>K</i><sub>i</sub> = 112 nM) to be comparable to <b>25</b>, along with a ∼2-fold reduction in D<sub>3</sub>R selectivity (D<sub>2</sub>R/D<sub>3</sub>R ratio = 584).</div><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. D<sub>3</sub>R/D<sub>2</sub>R Binding Profiles of <b>1</b> Analogs with Modifications to the Linker and Aryl Ring<a class="ref internalNav" href="#t2fn1" aria-label="a">a</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-10/acs.jmedchem.9b00412/20190516/images/medium/jm-2019-004124_0008.gif" alt="" id="fx2" /></img><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="char" char="±" /></col><col align="char" char="±" /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="2" align="center" char="±"><i>K</i><sub>i</sub> ± SEM (nM)<a class="ref internalNav" href="#t2fn2" aria-label="b">b</a></th><th class="colsep0 rowsep0" align="center" char="."> </th><th class="colsep0 rowsep0" align="center" char="."> </th><th class="rowsep1 colsep0" align="center" char="."><a class="ref internalNav" href="#t2fn6" aria-label="f">f</a></th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compound</th><th class="colsep0 rowsep0" align="center"><i>n</i></th><th class="colsep0 rowsep0" align="center">R</th><th class="colsep0 rowsep0" align="center" char="±">D<sub>3</sub>R<a class="ref internalNav" href="#t2fn3" aria-label="c">c</a></th><th class="colsep0 rowsep0" align="center" char="±">D<sub>2</sub>R<a class="ref internalNav" href="#t2fn4" aria-label="d">d</a></th><th class="colsep0 rowsep0" align="center" char=".">D<sub>2</sub>/D<sub>3</sub> ratio<a class="ref internalNav" href="#t2fn5" aria-label="e">e</a></th><th class="colsep0 rowsep0" align="center" char="."><i>c</i>log <i>P</i><a class="ref internalNav" href="#t2fn6" aria-label="f">f</a></th><th class="colsep0 rowsep0" align="center" char=".">tPSA<a class="ref internalNav" href="#t2fn6" aria-label="f">f</a></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>20</b></td><td class="colsep0 rowsep0" align="left">0</td><td class="colsep0 rowsep0" align="left">2-methoxy</td><td class="colsep0 rowsep0" align="char" char="±">89.7 ± 22.5</td><td class="colsep0 rowsep0" align="char" char="±">9004 ± 1133</td><td class="colsep0 rowsep0" align="char" char=".">100</td><td class="colsep0 rowsep0" align="char" char=".">4.54</td><td class="colsep0 rowsep0" align="char" char=".">43.67</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>21</b></td><td class="colsep0 rowsep0" align="left">2</td><td class="colsep0 rowsep0" align="left">2-methoxy</td><td class="colsep0 rowsep0" align="char" char="±">59.2 ± 5.1</td><td class="colsep0 rowsep0" align="char" char="±">9248 ± 1745</td><td class="colsep0 rowsep0" align="char" char=".">156</td><td class="colsep0 rowsep0" align="char" char=".">5.06</td><td class="colsep0 rowsep0" align="char" char=".">43.67</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>22</b></td><td class="colsep0 rowsep0" align="left">1</td><td class="colsep0 rowsep0" align="left">2-ethoxy</td><td class="colsep0 rowsep0" align="char" char="±">45.1 ± 9.7</td><td class="colsep0 rowsep0" align="char" char="±">5165 ± 525</td><td class="colsep0 rowsep0" align="char" char=".">114</td><td class="colsep0 rowsep0" align="char" char=".">5.41</td><td class="colsep0 rowsep0" align="char" char=".">43.67</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>23</b></td><td class="colsep0 rowsep0" align="left">1</td><td class="colsep0 rowsep0" align="left">2-hydroxy</td><td class="colsep0 rowsep0" align="char" char="±">396 ± 17.3</td><td class="colsep0 rowsep0" align="char" char="±">17 595 ± 4185</td><td class="colsep0 rowsep0" align="char" char=".">44.4</td><td class="colsep0 rowsep0" align="char" char=".">4.33</td><td class="colsep0 rowsep0" align="char" char=".">54.67</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>24</b></td><td class="colsep0 rowsep0" align="left">1</td><td class="colsep0 rowsep0" align="left">2-fluorethoxy</td><td class="colsep0 rowsep0" align="char" char="±">33.3 ± 1.7</td><td class="colsep0 rowsep0" align="char" char="±">6379 ± 964</td><td class="colsep0 rowsep0" align="char" char=".">192</td><td class="colsep0 rowsep0" align="char" char=".">5.27</td><td class="colsep0 rowsep0" align="char" char=".">43.67</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>25</b><a class="ref internalNav" href="#t2fn7" aria-label="g">g</a></td><td class="colsep0 rowsep0" align="left">1</td><td class="colsep0 rowsep0" align="left">4-methoxy</td><td class="colsep0 rowsep0" align="char" char="±">97.7 ± 17.4</td><td class="colsep0 rowsep0" align="char" char="±">104 847 ± 29 076</td><td class="colsep0 rowsep0" align="char" char=".">1073</td><td class="colsep0 rowsep0" align="char" char=".">4.88</td><td class="colsep0 rowsep0" align="char" char=".">43.67</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>26</b></td><td class="colsep0 rowsep0" align="left">1</td><td class="colsep0 rowsep0" align="left">2,4-dimethoxy</td><td class="colsep0 rowsep0" align="char" char="±">112 ± 24.5</td><td class="colsep0 rowsep0" align="char" char="±">65 229 ± 37 252</td><td class="colsep0 rowsep0" align="char" char=".">584</td><td class="colsep0 rowsep0" align="char" char=".">4.89</td><td class="colsep0 rowsep0" align="char" char=".">52.90</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>27</b><a class="ref internalNav" href="#t2fn7" aria-label="g">g</a></td><td class="colsep0 rowsep0" align="left">1</td><td class="colsep0 rowsep0" align="left">4-fluoro</td><td class="colsep0 rowsep0" align="char" char="±">25.6 ± 5.6</td><td class="colsep0 rowsep0" align="char" char="±">9792 ± 1790</td><td class="colsep0 rowsep0" align="char" char=".">383</td><td class="colsep0 rowsep0" align="char" char=".">5.32</td><td class="colsep0 rowsep0" align="char" char=".">34.44</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>28</b></td><td class="colsep0 rowsep0" align="left">1</td><td class="colsep0 rowsep0" align="left">2-fluoro</td><td class="colsep0 rowsep0" align="char" char="±">208 ± 9.6</td><td class="colsep0 rowsep0" align="char" char="±">26 253 ± 6866</td><td class="colsep0 rowsep0" align="char" char=".">126</td><td class="colsep0 rowsep0" align="char" char=".">5.32</td><td class="colsep0 rowsep0" align="char" char=".">34.44</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>29</b></td><td class="colsep0 rowsep0" align="left">1</td><td class="colsep0 rowsep0" align="left">2-fluoro-4-trifluoromethyl</td><td class="colsep0 rowsep0" align="char" char="±">370 ± 17.8</td><td class="colsep0 rowsep0" align="char" char="±">21 172 ± 1499</td><td class="colsep0 rowsep0" align="char" char=".">57.2</td><td class="colsep0 rowsep0" align="char" char=".">6.38</td><td class="colsep0 rowsep0" align="char" char=".">34.44</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>30</b></td><td class="colsep0 rowsep0" align="left">1</td><td class="colsep0 rowsep0" align="left">2-methoxy-4-fluoro</td><td class="colsep0 rowsep0" align="char" char="±">21.0 ± 1.4</td><td class="colsep0 rowsep0" align="char" char="±">19 634 ± 3691</td><td class="colsep0 rowsep0" align="char" char=".">934</td><td class="colsep0 rowsep0" align="char" char=".">5.17</td><td class="colsep0 rowsep0" align="char" char=".">43.67</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t2fn1"><div class="footnote" id="t2fn1"><sup><sup>a</sup></sup><p class="last">Spiperone assayed under the same conditions as a reference blocker: D<sub>2</sub>R, 0.06 ± 0.001 nM; D<sub>3</sub>R, 0.33 ± 0.02 nM; D<sub>4</sub>R, 0.45 ± 0.01 nM.</p></div><div class="footnote" id="t2fn2"><sup><sup>b</sup></sup><p class="last">Mean ± SEM; <i>K</i><sub>i</sub> values were determined by at least three experiments.</p></div><div class="footnote" id="t2fn3"><sup><sup>c</sup></sup><p class="last"><i>K</i><sub>i</sub> values for D<sub>3</sub> receptors were measured using human D<sub>3</sub> expressed in HEK cells with [<sup>125</sup>I]IABN as the radioligand.</p></div><div class="footnote" id="t2fn4"><sup><sup>d</sup></sup><p class="last"><i>K</i><sub>i</sub> values for D<sub>2</sub> receptors were measured using human D<sub>2</sub> expressed in HEK cells with [<sup>125</sup>I]IABN as the radioligand.</p></div><div class="footnote" id="t2fn5"><sup><sup>e</sup></sup><p class="last">(<i>K</i><sub>i</sub> for D<sub>2</sub> receptors)/(<i>K</i><sub>i</sub> for D<sub>3</sub> receptors).</p></div><div class="footnote" id="t2fn6"><sup><sup>f</sup></sup><p class="last">Calculated using ChemDraw Professional 15.1.</p></div><div class="footnote" id="t2fn7"><sup><sup>g</sup></sup><p class="last">Compound reported in our initial work ref <a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a>.</p></div></div></div><div class="NLM_p">Next, we examined the binding profiles of fluorinated derivatives <b>28</b>–<b>30</b>. When moving the fluorine atom from the 4-position (<b>27</b>) to the 2-position in <b>28</b>, a loss in receptor affinity (<i>K</i><sub>i</sub> = 208 nM) and selectivity (D<sub>2</sub>R/D<sub>3</sub>R ratio = 126) is observed. Upon installing a −CF<sub>3</sub> functional group in the para position of the aryl ring in <b>29</b>, we observed a further decrease in both D<sub>3</sub>R affinity (<i>K</i><sub>i</sub> = 370 nM) and selectivity (D<sub>2</sub>R/D<sub>3</sub>R ratio = 57). Due to the excellent D<sub>3</sub>R binding properties observed with compounds <b>1</b> and <b>27</b>, we evaluated the 4-fluoro-2-methoxyphenyl ring system in ligand <b>30</b>. Compared to <b>1</b>, compound <b>30</b> was found to have a comparable D<sub>3</sub>R binding affinity (<i>K</i><sub>i</sub> = 21.0 nM) to <b>1</b>, along with a modest improvement in receptor selectivity (D<sub>2</sub>R/D<sub>3</sub>R ratio = 934).</div><div class="NLM_p">Next, we evaluated two additional analogs containing modified diazaspiro cores (<a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a></a>). In contrast to <b>1</b> and <b>31</b>, unsaturated ligand <b>32</b>, containing a novel diazaspiro[5.5]undec-1-ene amino core, was found to bind with a higher affinity at the D<sub>3</sub>R (<i>K</i><sub>i</sub> = 3.2 nM), although receptor selectivity was not maintained (D<sub>2</sub>R/D<sub>3</sub>R ratio = 60). Interestingly, when reversing the diazaspiro[4.5]decane moiety found in <b>33</b>, a 2-fold increase in receptor selectivity was observed for ligand <b>34</b> (D<sub>2</sub>R/D<sub>3</sub>R ratio = 758), along with a similar D<sub>3</sub>R binding affinity (<i>K</i><sub>i</sub> = 27.8 nM).</div><div class="NLM_table-wrap" id="tbl3"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 3. D<sub>3</sub>R/D<sub>2</sub>R Binding Profiles of <b>1</b> Analogs with Modifications to the Amino Core<a class="ref internalNav" href="#t3fn1" aria-label="a">a</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-10/acs.jmedchem.9b00412/20190516/images/medium/jm-2019-004124_0009.gif" alt="" id="fx3" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-10/acs.jmedchem.9b00412/20190516/images/medium/jm-2019-004124_0010.gif" alt="" id="fx4" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t3fn1"><div class="footnote" id="t3fn1"><sup><sup>a</sup></sup><p class="last">Spiperone assayed under the same conditions as a reference blocker: D<sub>2</sub>R, 0.06 ± 0.001 nM; D<sub>3</sub>R, 0.33 ± 0.02 nM; D<sub>4</sub>R, 0.45 ± 0.01 nM.</p></div><div class="footnote" id="t3fn2"><sup><sup>b</sup></sup><p class="last">Mean ± SEM; <i>K</i><sub>i</sub> values were determined by at least three experiments.</p></div><div class="footnote" id="t3fn3"><sup><sup>c</sup></sup><p class="last"><i>K</i><sub>i</sub> values for D<sub>3</sub> receptors were measured using human D<sub>3</sub> expressed in HEK cells with [<sup>125</sup>I]IABN as the radioligand.</p></div><div class="footnote" id="t3fn4"><sup><sup>d</sup></sup><p class="last"><i>K</i><sub>i</sub> values for D<sub>2</sub> receptors were measured using human D<sub>2</sub> expressed in HEK cells with [<sup>125</sup>I]IABN as the radioligand.</p></div><div class="footnote" id="t3fn5"><sup><sup>e</sup></sup><p class="last">(<i>K</i><sub>i</sub> for D<sub>2</sub> receptors)/(<i>K</i><sub>i</sub> for D<sub>3</sub> receptors).</p></div><div class="footnote" id="t3fn6"><sup><sup>f</sup></sup><p class="last">Calculated using ChemDraw Professional 15.1.</p></div><div class="footnote" id="t3fn7"><sup><sup>g</sup></sup><p class="last">Compound reported in our initial work ref <a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a>.</p></div></div><div></div></div><div class="NLM_p">Finally, we evaluated the diazaspiro[5.5]undecane amino core in two aryl amide templates that were previously identified as excellent D<sub>3</sub>R-prefering scaffolds when conjugated to the 1-(2-methoxyphenyl)piperazine system (<a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a></a>).<a onclick="showRef(event, 'ref21 ref22'); return false;" href="javascript:void(0);" class="ref ref21 ref22">(21,22)</a> When maintaining the 2-methoxyphenyl aryl system, we investigated 4-(dimethylamino)- and 4-(thiophen-3-yl)-benzamides with a four-carbon spacer linked to the diazaspiro[5.5]undecane moiety. However, using this ligand framework, compounds <b>35</b> and <b>36</b> both exhibited poor D<sub>3</sub>R receptor affinity and selectivity. This diazaspiro core was then evaluated in a D<sub>2</sub>R-prefering aripiprazole ligand architecture disclosed in our previous work.<a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a> Although <b>37</b> appears to be slightly D<sub>2</sub>R-selective, receptor affinity was low.</div><div class="NLM_table-wrap" id="tbl4"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 4. D<sub>3</sub>R/D<sub>2</sub>R Binding Profiles of <b>1</b> Analogs with Modifications to the Aryl Head Group<a class="ref internalNav" href="#t4fn1" aria-label="a">a</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-10/acs.jmedchem.9b00412/20190516/images/medium/jm-2019-004124_0011.gif" alt="" id="fx5" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-10/acs.jmedchem.9b00412/20190516/images/medium/jm-2019-004124_0012.gif" alt="" id="fx6" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t4fn1"><div class="footnote" id="t4fn1"><sup><sup>a</sup></sup><p class="last">Spiperone assayed under the same conditions as a reference blocker: D<sub>2</sub>R, 0.06 ± 0.001 nM; D<sub>3</sub>R, 0.33 ± 0.02 nM; D<sub>4</sub>R, 0.45 ± 0.01 nM.</p></div><div class="footnote" id="t4fn2"><sup><sup>b</sup></sup><p class="last">Mean ± SEM; <i>K</i><sub>i</sub> values were determined by at least three experiments.</p></div><div class="footnote" id="t4fn3"><sup><sup>c</sup></sup><p class="last"><i>K</i><sub>i</sub> values for D<sub>3</sub> receptors were measured using human D<sub>3</sub> expressed in HEK cells with [<sup>125</sup>I]IABN as the radioligand.</p></div><div class="footnote" id="t4fn4"><sup><sup>d</sup></sup><p class="last"><i>K</i><sub>i</sub> values for D<sub>2</sub> receptors were measured using human D<sub>2</sub> expressed in HEK cells with [<sup>125</sup>I]IABN as the radioligand.</p></div><div class="footnote" id="t4fn5"><sup><sup>e</sup></sup><p class="last">(<i>K</i><sub>i</sub> for D<sub>2</sub> receptors)/(<i>K</i><sub>i</sub> for D<sub>3</sub> receptors).</p></div><div class="footnote" id="t4fn6"><sup><sup>f</sup></sup><p class="last">Calculated using ChemDraw Professional 15.1.</p></div></div><div></div></div><div class="NLM_p">Lead compound <b>1</b> was fragmented to identify synthons acting as primary (PP) or secondary pharmacophores (SP). Unexpectedly, fragments <b>4b′</b> and <b>5a</b> were found to have a micromolar affinity for the receptor, with <b>5a</b> exhibiting nominal D<sub>3</sub>R selectivity (<a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">Table <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a></a>). Low receptor binding was also observed with synthons <b>5b</b> and <b>5c</b>, despite the <i>K</i><sub>i</sub> values of 19.6 nM and 24.2 nM obtained from the parent compounds <b>2</b> and <b>3</b>, respectively. The binding affinities obtained with <b>5a</b>–<b>c</b> are in contrast to those reported for alkylated aryl piperazine synthons (i.e., <b>5d</b><a onclick="showRef(event, 'ref11'); return false;" href="javascript:void(0);" class="ref ref11">(11)</a> and <b>5e</b><a onclick="showRef(event, 'ref21 ref23'); return false;" href="javascript:void(0);" class="ref ref21 ref23">(21,23)</a>) of potent D<sub>3</sub>R ligand scaffolds. These PP typically show <i>K</i><sub>i</sub> values of ∼10–20 nM at the receptor by engaging the orthosteric binding pocket (OBP) of the protein. This allows the ionizable nitrogen of these PP to form an ionic interaction with the highly conserved Asp110 [3.32] residue within the OBP, affording the favorable receptor affinity of these orthosteric fragments.</div><div class="NLM_table-wrap" id="tbl5"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 5. D<sub>3</sub>R/D<sub>2</sub>R Binding Profiles of Synthons<a class="ref internalNav" href="#t5fn1" aria-label="a">a</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-10/acs.jmedchem.9b00412/20190516/images/medium/jm-2019-004124_0013.gif" alt="" id="fx7" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t5fn1"><div class="footnote" id="t5fn1"><sup><sup>a</sup></sup><p class="last">Spiperone assayed under the same conditions as a reference blocker: D<sub>2</sub>R, 0.06 ± 0.001 nM; D<sub>3</sub>R, 0.33 ± 0.02 nM; D<sub>4</sub>R, 0.45 ± 0.01 nM.</p></div><div class="footnote" id="t5fn2"><sup><sup>b</sup></sup><p class="last">Mean ± SEM; <i>K</i><sub>i</sub> values were determined by at least three experiments.</p></div><div class="footnote" id="t5fn3"><sup><sup>c</sup></sup><p class="last"><i>K</i><sub>i</sub> values for D<sub>3</sub> receptors were measured using human D<sub>3</sub> expressed in HEK cells with [<sup>125</sup>I]IABN as the radioligand.</p></div><div class="footnote" id="t5fn4"><sup><sup>d</sup></sup><p class="last"><i>K</i><sub>i</sub> values for D<sub>2</sub> receptors were measured using human D expressed in HEK cells with [<sup>125</sup>I]IABN as the radioligand.</p></div><div class="footnote" id="t5fn5"><sup><sup>e</sup></sup><p class="last">(<i>K</i><sub>i</sub> for D<sub>2</sub> receptors)/(<i>K</i><sub>i</sub> for D<sub>3</sub> receptors).</p></div><div class="footnote" id="t5fn6"><sup><sup>f</sup></sup><p class="last">Compound and receptor binding data from ref <a onclick="showRef(event, 'ref11'); return false;" href="javascript:void(0);" class="ref ref11">(11)</a>.</p></div></div><div></div></div><div class="NLM_p last">Binding studies continued with the evaluation of synthons from the right-half of lead compound <b>1</b> to determine if receptor affinity was being engaged by an unexpected 1,2,4-triazole pharmacophore. Similar to the displacement observed with synthon <b>5a</b>, low receptor binding was observed with fragments <b>6a</b>, <b>6c</b>, <b>6d</b>, and <b>6f</b>. Although minimal potency was observed with these 1,2,4-trizole synthons, a trend of increasing affinity was observed when elongating fragment <b>6a</b> with piperdine (<b>6c</b>), and 4,4-dimethylpiperidine (<b>6d</b>). In addition, we found <b>6f</b> to be ∼197-fold selective for the D<sub>3</sub>R over the D<sub>2</sub>R, whereas piperazine analog <b>6h</b> illustrated no receptor selectivity. We hypothesized that the 1,2,4-triazole system may be key in directing, and subsequently, stabilizing the bulky diazaspiro PPs of <b>1</b>–<b>3</b>, within the OBP of the receptor. Once stabilized, these diazaspiro systems may be able to interact with residues within the OBP due to the large structural space these systems inhabit which are not accessible to the piperazine PP of <b>31</b>.</div></div><div id="sec2_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i13" class="anchor-spacer"></div><h3 class="article-section__title" id="_i13"> Molecular Docking Studies</h3><div class="NLM_p">To probe these potential protein–ligand interactions, selected compounds were modeled within the D<sub>3</sub>R (3PBL) to identify residue contacts within orthosteric and SBP of the receptor (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>A). A top docking pose of <b>1</b> was found to engage in multiple polar and nonpolar contacts between the arylated diazaspiro[5.5]undecane moiety, including π–π stacking interactions between the aryl ring and the Phe346<sup>6.52</sup> residue within the OBP of the receptor (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>B). Similarly, ligand docking also predicted the diazaspiro[5.5]undecane moiety of ligand <b>17</b> and diazaspiro[5.5]undec-1-ene system of high-affinity compound <b>32</b>, to also engage in hydrophobic interactions with residues Phe346 [6.52] and Phe345 [6.51] (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>C,F). When evaluating the potential salt bridge formation between residue Asp110 [3.32] and the ionizable nitrogens in the diazaspiro cores of scaffolds <b>1</b>, <b>17</b>, and <b>32</b>, we identified distances of 3.4, 3.2, and 3.1 Å, respectively. Interestingly, these were all found to be greater than the predicted 2.7 Å distance observed with the binding pose of compound <b>31</b> (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>E). These results could explain the contrasting receptor binding affinity observed between diazaspiro PP <b>5a</b> and piperazine PP <b>5d</b>. Thus, we surmise that the 1,2,4-triazole side of the molecule appropriately positions the bulky diazaspiro[5.5]undecane moiety within the hydrophobic cavity of the D<sub>3</sub>R OBP, allowing the amino core to engage in nonpolar interactions with residues Phe346 [6.52] and Phe345 [6.51]. These contacts then assist in stabilizing this “weaker” ionic interaction with Asp110 [3.32], resulting in the observed receptor affinities for <b>1</b>, <b>17</b>, and <b>32</b>. This analysis is also consistent with the poor binding affinity for compound <b>19</b>, as the docking pose predicted minimal hydrophobic interactions with residues Phe345 [6.52] and Phe346 [6.51], and a distance of 4.2 Å between the protonated nitrogen of the ligand and the conserved Asp110 [3.32] side chain (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>D).</div><figure id="fig2" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-10/acs.jmedchem.9b00412/20190516/images/medium/jm-2019-004124_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-10/acs.jmedchem.9b00412/20190516/images/large/jm-2019-004124_0002.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. (A) Predicted binding modes of compound <b>1</b> derivatives in complex with the D<sub>3</sub>R (3PBL). Predicted polar (yellow, 3.0 Å cut-off), weak hydrogen bonding (magenta, 3.6 Å cut-off), π–π stacking (purple, 5.5 Å cut-off), and hydrophobic (black, 4.0 Å cut-off) residue interactions with compounds <b>1</b> (B), <b>17</b> (C), <b>19</b> (D), <b>31</b> (E), and <b>32</b> (F) within the binding pocket of the receptor. Interaction between the Asp110 [3.32] residue and the ionizable nitrogen of the ligand scaffold is shown in red.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-10/acs.jmedchem.9b00412/20190516/images/large/jm-2019-004124_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00412&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Next, we evaluated interactions between the nonconserved residues within the SBP of the D<sub>3</sub>R, responsible for ligand selectivity,<a onclick="showRef(event, 'ref11'); return false;" href="javascript:void(0);" class="ref ref11">(11)</a> and the predicted binding modes of <b>1</b> and its derivatives. In addition to the significant polar and nonpolar interactions between Val86 [2.61] and the 1,2,4-triazole system of lead compound <b>1</b>, we also identified a potential weak hydrogen bond interaction between Glu90 [2.65] and the methyl substituent of the <i>N</i>-heterocycle (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>B). Disruption of this C–H···O interaction may explain the reduction in receptor selectivity for compound <b>17</b> (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>C), in which the only structural difference between this ligand and <b>1</b> is the removal of the −CH<sub>3</sub> group. When substituting the −CH<sub>3</sub> with −CH<sub>2</sub>CH<sub>3</sub> (<b>15</b>) or −NH<sub>2</sub> (<b>16</b>), receptor selectivity is again diminished, while binding affinity is moderately maintained. Although the N–H···O hydrogen bond interactions of <b>17</b> and Glu90 [2.65] would appear to be more favorable than the C–H···O interactions of <b>1</b>, previous studies have shown the latter to result in more favorable binding profiles due to the potential penalty associated with −NH<sub>2</sub> desolvation upon ligand binding.<a onclick="showRef(event, 'ref24 ref25'); return false;" href="javascript:void(0);" class="ref ref24 ref25">(24,25)</a></div><div class="NLM_p last">Previous reports have discussed the critical role EL1 Gly residues play in determining D<sub>2</sub>R/D<sub>3</sub>R selectivity of ligands.<a onclick="showRef(event, 'ref26 ref27'); return false;" href="javascript:void(0);" class="ref ref26 ref27">(26,27)</a> Glycine can act as an acceptor in weak hydrogen bond interactions in many protein–ligand complexes.<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a> In our study, the predicted binding pose of <b>1</b> places the aryl ring off of the 1,2,4-triazole moiety in close proximity to the Gly93 [EL1] residue, affording potential weak C–H···O interactions. However, this interaction is found to be absent in the binding poses of less selective ligands <b>31</b> and <b>32</b>. We hypothesize that the lack of receptor selectivity observed for compounds <b>10</b>–<b>11</b> and <b>13</b> may be a result of steric clashing between the para substituents of these ligands and the Gly93 [EL1] residue in the SBS. This steric clash could also explain the lack of receptor selectivity for compounds <b>21</b> and <b>35</b>–<b>36</b>, which all contain a butyl spacer group, compared to the shorter propyl linker of <b>1</b>. We observed this proposed SAR trend after installing a C–F bond in the para position of <b>1</b>, resulting in a loss of receptor selectivity for <b>13</b> (D<sub>2</sub>R/D<sub>3</sub>R = 905 vs 396, respectively). Receptor selectivity was able to be slightly restored, however, after moving the C–F substitution to ortho site of the aryl ring in <b>12</b>, potentially alleviating steric interactions afforded with Gly93 [EL1] and compound <b>13</b>.</div></div><div id="sec2_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i14" class="anchor-spacer"></div><h3 class="article-section__title" id="_i14"> Compound <b>1</b> Competitively Inhibits DA at the OBP</h3><div class="NLM_p">To confirm that the binding mode of <b>1</b> does indeed require occupancy within the OBP, we evaluated <b>1</b> (<a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>A), <b>31</b> (<a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>B), and known allosteric modulator SB269652<a onclick="showRef(event, 'ref28 ref29'); return false;" href="javascript:void(0);" class="ref ref28 ref29">(28,29)</a> (<a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>C) in a β-arrestin assay with endogenous ligand dopamine (DA) as the orthosteric ligand. Both <b>1</b> and <b>31</b> caused a limitless rightward shift in the dopamine–dose response curves, suggesting a competitive mode of action at the OBP.<a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a> This is in contrast to the limited dextral shift that is observed with SB269652, resulting from the allosteric pharmacology of the compound at the receptor. Furthermore, when plotting the concentration–response curves for <b>1</b> and SB269652 into a Schild plot, a linear regression slope near unity is obtained for <b>1</b>, indicative of competitive antagonism,<a onclick="showRef(event, 'ref31'); return false;" href="javascript:void(0);" class="ref ref31">(31)</a> whereas a nonlinear regression slope is observed for SB269652, indicating an allosteric mode of the antagonism (see <a href="/doi/suppl/10.1021/acs.jmedchem.9b00412/suppl_file/jm9b00412_si_001.pdf" class="ext-link">Supporting Information</a>).<a onclick="showRef(event, 'ref32 ref33 ref34'); return false;" href="javascript:void(0);" class="ref ref32 ref33 ref34">(32−34)</a> Overall, these data clearly indicate that <b>1</b> behaves in a competitive manner at the OBP with the orthosteric endogenous ligand DA, ruling out an allosteric binding mechanism for the diazaspiro ligand.</div><figure id="fig3" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-10/acs.jmedchem.9b00412/20190516/images/medium/jm-2019-004124_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-10/acs.jmedchem.9b00412/20190516/images/large/jm-2019-004124_0003.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Curve shift analysis of <b>1</b> (A), <b>31</b> (B), and SB269,625 (C) using a dopamine (DA)-mediated β-arrestin 2 recruitment assay. The receptor was stimulated with the indicated concentration of DA along with and without concentrations of the test compound. Data points represent the mean ± SEM of dopamine-induced luminescence response obtained from 7 to 16 replicates.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-10/acs.jmedchem.9b00412/20190516/images/large/jm-2019-004124_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00412&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i15" class="anchor-spacer"></div><h3 class="article-section__title" id="_i15"> Psychoactive Drug Screening Program (PDSP) Pharmacological Evaluation</h3><div class="NLM_p">Compounds <b>1</b> and <b>31</b> were then submitted to the Psychoactive Drug Screening Program (PDSP)<a onclick="showRef(event, 'ref35 ref36'); return false;" href="javascript:void(0);" class="ref ref35 ref36">(35,36)</a> to evaluate the binding (<a class="ref showTableEvent internalNav" data-ID="tbl6" href="#tbl6">Table <a class="ref showTableEvent internalNav" data-ID="tbl6" href="#tbl6">6</a></a>) and functional behavior of the ligands at D<sub>1</sub>- and D<sub>2</sub>-like receptors (<a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>). Compared to our initial report,<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a> the <i>K</i><sub>i</sub> values obtained by the PDSP for <b>1</b> and <b>31</b> differed slightly at the D<sub>3</sub>R and D<sub>2</sub>R. However, this is most likely due to the use of [<sup>3</sup>H]<i>N</i>-methylspiperone by the PDSP in their binding assay, compared to our use of [<sup>125</sup>I]IABN, a high-affinity radioligand with negligible nonspecific binding.<a onclick="showRef(event, 'ref37'); return false;" href="javascript:void(0);" class="ref ref37">(37)</a> Compound <b>1</b> showed no interaction at the D<sub>4</sub>R- or D<sub>1</sub>-like receptors, whereas <b>31</b> exhibited <i>K</i><sub>i</sub> values of 721 nM and ∼3 μM at the D<sub>4</sub>R and D<sub>5</sub>R, respectively (<a class="ref showTableEvent internalNav" data-ID="tbl6" href="#tbl6">Table <a class="ref showTableEvent internalNav" data-ID="tbl6" href="#tbl6">6</a></a>). Lead compound <b>1</b> was found to behave as a preferential D<sub>3</sub>R antagonist (IC<sub>50</sub> = 41.4 nM) with negligible functional potency at the D<sub>2</sub>R (IC<sub>50</sub> > 1.5 μM) (<a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>D). Although antagonist affinities are known to vary depending on the competing agonist used,<a onclick="showRef(event, 'ref38'); return false;" href="javascript:void(0);" class="ref ref38">(38)</a> we are currently evaluating <b>1</b> in other cell-signaling cascade models to further assess the 39-fold D<sub>2</sub>R/D<sub>3</sub>R selectivity ratio observed in the PDSP Tango functional assays. Ligand <b>31</b>, however, was found to be a weak agonist/antagonist at both the D<sub>2</sub>R and D<sub>3</sub>R (<a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>C–F), a common nuance that has been disclosed with previously reported D<sub>3</sub>R selective piperazine-based scaffolds.<a onclick="showRef(event, 'ref11 ref39'); return false;" href="javascript:void(0);" class="ref ref11 ref39">(11,39)</a> This can be attributed to the lack of receptor selectivity that is engaged with the aryl piperazine orthosteric PP of the ligand scaffold. Finally, compound <b>31</b> was also identified as a weak partial agonist at the D<sub>4</sub>R (IC<sub>50</sub> = 427 nM) (<a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>G).</div><figure id="fig4" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-10/acs.jmedchem.9b00412/20190516/images/medium/jm-2019-004124_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-10/acs.jmedchem.9b00412/20190516/images/large/jm-2019-004124_0004.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Agonist and antagonist selectivity profiling with G-protein-independent β-arrestin recruitment Tango assays at human D<sub>1</sub>- and D<sub>2</sub>-like receptors. (A) Concentration–response to varying doses of D<sub>1</sub>R agonists and control SKF81297. (B) Response to varying doses of D<sub>1</sub>R antagonists and control SCH23390, added 30 min before the addition of a final EC<sub>80</sub> concentration (3 μM) of a reference agonist SKF81297. (C) Concentration–response to varying doses of D<sub>2</sub>R agonists and control quinpirole. (D) Concentration–response to varying doses of D<sub>2</sub>R antagonists and control haloperidol, added 30 min before the addition of a final EC<sub>80</sub> concentration (3 nM) of reference agonist quinpirole. (E) Concentration–response to varying doses of D<sub>3</sub>R agonists and control quinpirole. (F) Concentration–response to varying doses of D<sub>3</sub>R antagonists and control haloperidol, added 30 min before the addition of a final EC<sub>80</sub> concentration (3 nM) of the reference agonist quinpirole. (G) Concentration–response to varying doses of D<sub>4</sub>R agonists and control lisuride. (H) Concentration–response to varying doses of D<sub>4</sub>R antagonists and control nemonapride, added 30 min before the addition of a final EC<sub>80</sub> concentration (100 nM) of reference agonist lisuride. Data are shown as mean ± SEM of three independent experiments. N/A, not active. N/C, data not converged.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-10/acs.jmedchem.9b00412/20190516/images/large/jm-2019-004124_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00412&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_table-wrap" id="tbl6"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 6. Binding Affinities of Compounds <b>1</b> and <b>31</b> at Select GPCRs<a class="ref internalNav" href="#t6fn1" aria-label="a">a</a></div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" colspan="2" align="center"> </th><th class="rowsep1 colsep0" colspan="2" align="center"><i>K</i><sub>i</sub> (nM)<a class="ref internalNav" href="#t6fn1" aria-label="a">a</a> or % inhibition at 10 μM<a class="ref internalNav" href="#t6fn2" aria-label="b">b</a></th><th class="colsep0 rowsep0" colspan="2" align="center"> </th><th class="rowsep1 colsep0" colspan="2" align="center"><i>K</i><sub>i</sub> (nM)<a class="ref internalNav" href="#t6fn1" aria-label="a">a</a> or % inhibition at 10 μM<a class="ref internalNav" href="#t6fn2" aria-label="b">b</a></th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" colspan="2" align="center">GPCR</th><th class="colsep0 rowsep0" align="center"><b>1</b></th><th class="colsep0 rowsep0" align="center"><b>31</b></th><th class="colsep0 rowsep0" colspan="2" align="center">GPCR</th><th class="colsep0 rowsep0" align="center"><b>1</b></th><th class="colsep0 rowsep0" align="center"><b>31</b></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" rowspan="5" align="left">dopamine</td><td class="colsep0 rowsep0" align="left">D<sub>1</sub></td><td class="colsep0 rowsep0" align="left">N/A</td><td class="colsep0 rowsep0" align="left">N/A</td><td class="colsep0 rowsep0" rowspan="5" align="left">muscarinic</td><td class="colsep0 rowsep0" align="left">M<sub>1</sub></td><td class="colsep0 rowsep0" align="left">54%</td><td class="colsep0 rowsep0" align="left">N/A</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">D<sub>2</sub></td><td class="colsep0 rowsep0" align="left">N/A</td><td class="colsep0 rowsep0" align="left">577</td><td class="colsep0 rowsep0" align="left">M<sub>2</sub></td><td class="colsep0 rowsep0" align="left">52</td><td class="colsep0 rowsep0" align="left">N/A</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">D<sub>3</sub></td><td class="colsep0 rowsep0" align="left">94</td><td class="colsep0 rowsep0" align="left">6</td><td class="colsep0 rowsep0" align="left">M<sub>3</sub></td><td class="colsep0 rowsep0" align="left">514</td><td class="colsep0 rowsep0" align="left">N/A</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">D<sub>4</sub></td><td class="colsep0 rowsep0" align="left">N/A</td><td class="colsep0 rowsep0" align="left">721</td><td class="colsep0 rowsep0" align="left">M<sub>4</sub></td><td class="colsep0 rowsep0" align="left">590</td><td class="colsep0 rowsep0" align="left">N/A</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">D<sub>5</sub></td><td class="colsep0 rowsep0" align="left">N/A</td><td class="colsep0 rowsep0" align="left">3016</td><td class="colsep0 rowsep0" align="left">M<sub>5</sub></td><td class="colsep0 rowsep0" align="left">N/A</td><td class="colsep0 rowsep0" align="left">N/A</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" rowspan="11" align="left">serotonin</td><td class="colsep0 rowsep0" align="left">5-HT<sub>1A</sub></td><td class="colsep0 rowsep0" align="left">1297</td><td class="colsep0 rowsep0" align="left">0.9</td><td class="colsep0 rowsep0" rowspan="14" align="left">adrenergic</td><td class="colsep0 rowsep0" align="left">α<sub>1A</sub></td><td class="colsep0 rowsep0" align="left">2178</td><td class="colsep0 rowsep0" align="left">49</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">5-HT<sub>1B</sub></td><td class="colsep0 rowsep0" align="left">N/A</td><td class="colsep0 rowsep0" align="left">2032</td><td class="colsep0 rowsep0" align="left">α<sub>1B</sub></td><td class="colsep0 rowsep0" align="left">2173</td><td class="colsep0 rowsep0" align="left">94</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">5-HT<sub>1D</sub></td><td class="colsep0 rowsep0" align="left">N/A</td><td class="colsep0 rowsep0" align="left">>50%</td><td class="colsep0 rowsep0" align="left">α<sub>2A</sub></td><td class="colsep0 rowsep0" align="left">N/A</td><td class="colsep0 rowsep0" align="left">221</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">5-HT<sub>1E</sub></td><td class="colsep0 rowsep0" align="left">N/A</td><td class="colsep0 rowsep0" align="left">N/A</td><td class="colsep0 rowsep0" align="left">α<sub>2B</sub></td><td class="colsep0 rowsep0" align="left">N/A</td><td class="colsep0 rowsep0" align="left">241</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">5-HT<sub>2A</sub></td><td class="colsep0 rowsep0" align="left">N/A</td><td class="colsep0 rowsep0" align="left">1415</td><td class="colsep0 rowsep0" align="left">α<sub>2C</sub></td><td class="colsep0 rowsep0" align="left">1557</td><td class="colsep0 rowsep0" align="left">433</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">5-HT<sub>2B</sub></td><td class="colsep0 rowsep0" align="left">2144</td><td class="colsep0 rowsep0" align="left">42</td><td class="colsep0 rowsep0" align="left">α<sub>2</sub>β<sub>2</sub></td><td class="colsep0 rowsep0" align="left">N/A</td><td class="colsep0 rowsep0" align="left">N/A</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">5-HT<sub>2C</sub></td><td class="colsep0 rowsep0" align="left">N/A</td><td class="colsep0 rowsep0" align="left">159</td><td class="colsep0 rowsep0" align="left">α<sub>2</sub>β<sub>4</sub></td><td class="colsep0 rowsep0" align="left">N/A</td><td class="colsep0 rowsep0" align="left">N/A</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">5-HT<sub>3</sub></td><td class="colsep0 rowsep0" align="left">N/A</td><td class="colsep0 rowsep0" align="left">N/A</td><td class="colsep0 rowsep0" align="left">α<sub>3</sub>β<sub>2</sub></td><td class="colsep0 rowsep0" align="left">N/A</td><td class="colsep0 rowsep0" align="left">N/A</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">5-HT<sub>5A</sub></td><td class="colsep0 rowsep0" align="left">N/A</td><td class="colsep0 rowsep0" align="left">N/A</td><td class="colsep0 rowsep0" align="left">α<sub>3</sub>β<sub>4</sub></td><td class="colsep0 rowsep0" align="left">8523</td><td class="colsep0 rowsep0" align="left">N/A</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">5-HT<sub>6</sub></td><td class="colsep0 rowsep0" align="left">N/A</td><td class="colsep0 rowsep0" align="left">N/A</td><td class="colsep0 rowsep0" align="left">α<sub>4</sub>β<sub>2</sub></td><td class="colsep0 rowsep0" align="left">N/A</td><td class="colsep0 rowsep0" align="left">N/A</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">5-HT<sub>7A</sub></td><td class="colsep0 rowsep0" align="left">N/A</td><td class="colsep0 rowsep0" align="left">128</td><td class="colsep0 rowsep0" align="left">α<sub>4</sub>β<sub>4</sub></td><td class="colsep0 rowsep0" align="left">N/A</td><td class="colsep0 rowsep0" align="left">N/A</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" rowspan="4" align="left">histamine</td><td class="colsep0 rowsep0" align="left">H<sub>1</sub></td><td class="colsep0 rowsep0" align="left">8</td><td class="colsep0 rowsep0" align="left">40</td><td class="colsep0 rowsep0" align="left">β<sub>1</sub></td><td class="colsep0 rowsep0" align="left">N/A</td><td class="colsep0 rowsep0" align="left">N/A</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">H<sub>2</sub></td><td class="colsep0 rowsep0" align="left">596</td><td class="colsep0 rowsep0" align="left">871</td><td class="colsep0 rowsep0" align="left">β<sub>2</sub></td><td class="colsep0 rowsep0" align="left">N/A</td><td class="colsep0 rowsep0" align="left">60%</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">H<sub>3</sub></td><td class="colsep0 rowsep0" align="left">509</td><td class="colsep0 rowsep0" align="left">N/A</td><td class="colsep0 rowsep0" align="left">β<sub>3</sub></td><td class="colsep0 rowsep0" align="left">N/A</td><td class="colsep0 rowsep0" align="left">N/A</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">H<sub>4</sub></td><td class="colsep0 rowsep0" align="left">N/A</td><td class="colsep0 rowsep0" align="left">N/A</td><td class="colsep0 rowsep0" colspan="2" align="left">dopamine active transporter (DAT)</td><td class="colsep0 rowsep0" align="left">N/A</td><td class="colsep0 rowsep0" align="left">N/A</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" rowspan="3" align="left">opioid</td><td class="colsep0 rowsep0" align="left">μ</td><td class="colsep0 rowsep0" align="left">N/A</td><td class="colsep0 rowsep0" align="left">N/A</td><td class="colsep0 rowsep0" colspan="2" align="left">norepinephrine transporter (NET)</td><td class="colsep0 rowsep0" align="left">931</td><td class="colsep0 rowsep0" align="left">N/A</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">κ</td><td class="colsep0 rowsep0" align="left">N/A</td><td class="colsep0 rowsep0" align="left">N/A</td><td class="colsep0 rowsep0" colspan="2" align="left">serotonin transporter (SERT)</td><td class="colsep0 rowsep0" align="left">295</td><td class="colsep0 rowsep0" align="left">N/A</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">δ</td><td class="colsep0 rowsep0" align="left">N/A</td><td class="colsep0 rowsep0" align="left">N/A</td><td class="colsep0 rowsep0" colspan="2" align="left">GABA<sub>A</sub></td><td class="colsep0 rowsep0" align="left">N/A</td><td class="colsep0 rowsep0" align="left">N/A</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t6fn1"><div class="footnote" id="t6fn1"><sup><sup>a</sup></sup><p class="last">N/A, not active (<50% inhibition obtained in primary assay at 10 μM of the compound). <i>K</i><sub>i</sub> values determined by at least three experiments.</p></div><div class="footnote" id="t6fn2"><sup><sup>b</sup></sup><p class="last">% of receptor inhibition at 10 μM of the compound, values determined by at least three experiments.</p></div></div></div><div class="NLM_p">PDSP also evaluated compounds <b>1</b> and <b>31</b> for off-target interactions with other GPCRs (<a class="ref showTableEvent internalNav" data-ID="tbl6" href="#tbl6">Table <a class="ref showTableEvent internalNav" data-ID="tbl6" href="#tbl6">6</a></a>). Similar to the findings in our initial publication,<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a> ligand <b>31</b> was found to bind with high affinity at the 5-HT<sub>1A</sub> (<i>K</i><sub>i</sub> = 0.9 nM) and 5-HT<sub>2B</sub> (<i>K</i><sub>i</sub> = 42 nM) receptors and was also found to exhibit marginal inhibitions at the 5-HT<sub>2C</sub> (<i>K</i><sub>i</sub> = 159 nM) and 5-HT<sub>7A</sub> (<i>K</i><sub>i</sub> = 128 nM). Compound <b>1</b>, however, exhibited negligible affinities (<i>K</i><sub>i</sub> > 1 μM) for all of the serotonin subclass receptors in the study. These findings show the potential of <b>1</b> as a D<sub>3</sub>R PET agent, as serotoninergic interactions are known to hinder many piperazine-containing scaffolds.<a onclick="showRef(event, 'ref23 ref40 ref41 ref42 ref43'); return false;" href="javascript:void(0);" class="ref ref23 ref40 ref41 ref42 ref43">(23,40−43)</a></div><div class="NLM_p">Among the subclass of histamine GPCRs screened, both compounds bind at the H<sub>1</sub> histamine receptor, with a high affinity (<b>1</b>, <i>K</i><sub>i</sub> = 8 nM; <b>31</b>, <i>K</i><sub>i</sub> = 40 nM). No appreciable opioid receptor inhibition was identified during the primary screen for <b>1</b> and <b>31</b> at 10 μM drug concentrations. Lead compound <b>1</b> was found to weakly interact at the muscarinic M<sub>1</sub> (54% inhibition at 10 μM of the compound) and M<sub>3</sub> (<i>K</i><sub>i</sub> = 514 nM) receptors as well.</div><div class="NLM_p last">Off-target interactions were discovered with compounds <b>1</b> and <b>31</b> at the subfamilies of the α<sub>1</sub>- and α<sub>2</sub>-adrenergic receptors, which are GPCRs known to play a role in vasoconstriction.<a onclick="showRef(event, 'ref44'); return false;" href="javascript:void(0);" class="ref ref44">(44)</a> Although <b>1</b> showed no appreciable interactions at the examined adrenergic sites, compound <b>31</b> was found to be active at the α<sub>1A</sub> (<i>K</i><sub>i</sub> = 49 nM) and the α<sub>1B</sub> (<i>K</i><sub>i</sub> = 94 nM) receptors, with moderate inhibitive action at the α<sub>2</sub> subclass group. Adrenergic interactions have been observed with many piperazine-containing D<sub>3</sub>R ligand scaffolds,<a onclick="showRef(event, 'ref45'); return false;" href="javascript:void(0);" class="ref ref45">(45)</a> including BP 897.<a onclick="showRef(event, 'ref46'); return false;" href="javascript:void(0);" class="ref ref46">(46)</a> This is consistent with a recent study indicating α<sub>2</sub>-adrenoceptors are targets for known D<sub>2</sub>-like receptor ligands including 7-OH-PIPAT, RO-105824, and dopamine.<a onclick="showRef(event, 'ref47'); return false;" href="javascript:void(0);" class="ref ref47">(47)</a> Unsurprisingly, the liability of D<sub>3</sub>R antagonists to induce hypertension, observed with GSK598809 in dog models,<a onclick="showRef(event, 'ref48'); return false;" href="javascript:void(0);" class="ref ref48">(48)</a> has hindered these class of compounds from progressing in clinical trials as potential addiction therapeutics,<a onclick="showRef(event, 'ref49'); return false;" href="javascript:void(0);" class="ref ref49">(49)</a> making the selective nature of <b>1</b> over the adrenergic receptors particularly encouraging.</div></div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i17">Conclusions</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_54746" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_54746" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p last">In our previous report, we identified <b>1</b> as a new lead D<sub>3</sub>R selective compound containing a novel diazaspiro[5.5]undecane amino core.<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a> In this study, we imposed structural modification to <b>1</b>, affording analogs with slightly enhanced D<sub>3</sub>R selectivity (<b>30</b>, D<sub>3</sub>R <i>K</i><sub>i</sub> = 21.0 nM, D<sub>2</sub>R/D<sub>3</sub>R ratio = 934) and affinity (<b>32</b>, D<sub>3</sub>R <i>K</i><sub>i</sub> = 3.2 nM, D<sub>2</sub>R/D<sub>3</sub>R ratio = 60). The fragmentation of <b>1</b> revealed diazaspiro[5.5]undecane synthon <b>5a</b> to be a low-affinity PP for the receptor (<b>5a</b>, D<sub>3</sub>R <i>K</i><sub>i</sub> > 2.7 μM), despite the excellent potency observed with the full-length compound (<b>1</b>, D<sub>3</sub>R <i>K</i><sub>i</sub> = 12.0 nM). Molecular docking studies predicted the 1,2,4-triazole half of <b>1</b> to favorably position the bulky diazaspiro within the OBP of the receptor, allowing the amino core to engage in hydrophobic interactions with the Phe345 [6.52] and Phe346 [6.51] residues, ultimately stabilizing the “weak” ionic interaction between the ionizable nitrogen of the PP and the highly conserved Asp110 [3.32]. To verify that <b>1</b> was not interacting at another receptor site (i.e., allosteric behavior), we utilized a dopamine-mediated β-arrestin 2 recruitment assay to show the competitive manner in which <b>1</b> behaves with the orthosteric ligand, revealing that the binding mode of <b>1</b> does indeed require OBP occupancy. Upon examining the functional behavior of compounds <b>1</b> and <b>31</b> at D<sub>1</sub>- and D<sub>2</sub>-like receptors, we found <b>1</b> to be a more D<sub>3</sub>R selective ligand for both receptor binding and cell signaling. These results, combined with the minimal off-target interactions observed with <b>1</b> at other GPCRs, suggest that the unique binding contacts between the PP of <b>1</b> and the highly conserved residues within OBP of the D<sub>3</sub>R receptor play a pivotal role in diminishing nonspecific ligand binding with other closely related serotoninergic and adrenergic sites. As such, installing low-affinity amino fragments, such as <b>5a</b>, into D<sub>3</sub>R ligand systems may be beneficial in overcoming drug promiscuity, commonly encountered with piperazine-based ligand scaffolds. This unorthodox approach could be exploited for the development of clinically viable D<sub>3</sub>R selective compounds for addiction therapeutic and PET imaging applications.</div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i18">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_35674" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_35674" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec4_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i19" class="anchor-spacer"></div><h3 class="article-section__title" id="_i19"> Chemistry</h3><div class="NLM_p last">Arylated amine synthons <b>4</b> and <b>A</b>–<b>B</b> were synthesized following our previously disclosed Pd-catalyzed C–N cross-coupling reports.<a onclick="showRef(event, 'ref15 ref16'); return false;" href="javascript:void(0);" class="ref ref15 ref16">(15,16)</a> Compounds <b>C</b>, <b>G</b>, <b>6b</b>, <b>1</b>–<b>3</b>, <b>25</b>, <b>27</b>, <b>31</b>, and <b>33</b> were obtained following the synthetic procedures outlined in our initial publication.<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a> Finally, 1,2,4-triazole compounds <b>D</b> and all other commercial reagents were purchased and used as without further purification. However, <b>D</b> analogs were also able to be obtained in good yield following the protocol described by Micheli and co-workers.<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a> NMR spectra were taken on a Bruker DMX 500 MHz. Compound structures and identity were confirmed by <sup>1</sup>H and <sup>13</sup>C NMR, mass spectrometry. Compound purity greater than 95% was determined by liquid chromatography–mass spectrometry (LC–MS) analysis using a 2695 Alliance LC–MS. The purification of organic compounds was carried out on a Biotage Isolera One with a dual wavelength UV–vis. detector. Chemical shifts (δ) in the NMR spectra (<sup>1</sup>H and <sup>13</sup>C) were referenced by assigning the residual solvent peaks. Compounds were taken up with CH<sub>2</sub>Cl<sub>2</sub> followed by the dropwise addition of a 2.0 M HCl solution in diethyl ether. After stirring at room temperature for 1 h, the solvent was removed under reduced pressure to afford the desired compound as a hydrochloride salt for in vitro studies.</div></div><div id="sec4_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i20" class="anchor-spacer"></div><h3 class="article-section__title" id="_i20"> General Method A: Synthesis of Fragmented Synthons <b>4</b>–<b>5</b></h3><div class="NLM_p last">The appropriate arylated diazaspiro and piperazine precursors (<b>4</b>), obtained following our previous reports,<a onclick="showRef(event, 'ref15 ref16'); return false;" href="javascript:void(0);" class="ref ref15 ref16">(15,16)</a> were dissolved in CH<sub>2</sub>Cl<sub>2</sub> (2 mL), followed by the dropwise addition of CF<sub>3</sub>COOH (2 mL), and stirred at room temperature for 3 h. Volatiles were then removed under reduced pressure, and the crude product was neutralized with a saturated NaHCo<sub>3(aq)</sub> solution (10 mL). The reaction mixture was extracted with CH<sub>2</sub>Cl<sub>2</sub> (3 × 20 mL), and the organic layers were combined, dried, and concentrated to afford the free-amine intermediates (<b>4′</b>), which were used without further purification. A mixture of <b>4′</b> (1.0 mmol), 1-bromobutane (1.1 mmol), and K<sub>2</sub>CO<sub>3</sub> (1.5 mmol) was stirred in acetone (5 mL) at room temperature for 5 h. The crude reaction mixture was then filtered, and the solvent was removed under reduced pressure. The residue was purified by flash chromatography on silica gel eluting with MeOH solution/CH<sub>2</sub>Cl<sub>2</sub> (1:10) affording target compounds (<b>5</b>).</div></div><div id="sec4_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i21" class="anchor-spacer"></div><h3 class="article-section__title" id="_i21"> General Method B: Synthesis of Diazaspiro Analogs <b>1</b>–<b>3</b> and <b>7</b>–<b>34</b></h3><div class="NLM_p">Target compounds can be obtained following the synthetic procedures outlined in our initial.<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a> Briefly, the appropriate arylated diazaspiro and piperazine precursors (<b>A</b>), obtained following our previous reports,<a onclick="showRef(event, 'ref15 ref16'); return false;" href="javascript:void(0);" class="ref ref15 ref16">(15,16)</a> were dissolved in CH<sub>2</sub>Cl<sub>2</sub> (2 mL), followed by the dropwise addition of CF<sub>3</sub>COOH (2 mL), and stirred at room temperature for 3 h. Volatiles were then removed under reduced pressure, and the crude product was neutralized with a saturated NaHCo<sub>3(aq)</sub> solution (10 mL). The reaction mixture was extracted with CH<sub>2</sub>Cl<sub>2</sub> (3 × 20 mL), and the organic layers were combined, dried, and concentrated to afford the free-amine intermediates (<b>B</b>) which were used without further purification. A mixture of <b>B</b> (1 mmol), alkylating reagent (2 mmol), and K<sub>2</sub>CO<sub>3</sub> (1.5 mmol) was stirred in acetone (5 mL) at room temperature for 12 h. The crude reaction mixture was then filtered, and the solvent was removed under reduced pressure. The residue was loaded onto a Biotage SNAP flash purification cartridge and eluded with 5% MeOH in CH<sub>2</sub>Cl<sub>2</sub> affording intermediates <b>C</b>. Finally, a mixture of <b>D</b> (1 mmol), TEA (1.5 mmol), and ethanol (10 mL) was stirred at 75 °C for 15 min. The appropriate intermediate <b>C</b> (1 mmol) was then added, and the solution was stirred at 75 °C for 12 h. The solvent from the crude reaction mixture was then removed under reduced pressure. The residue was loaded onto a Biotage SNAP flash purification cartridge and eluded with 10% 7 N NH<sub>3</sub> in MeOH solution/CH<sub>2</sub>Cl<sub>2</sub> to give the target compounds <b>1</b>–<b>3</b> and <b>7</b>–<b>34</b>. The residue was loaded onto a Biotage SNAP flash purification cartridge and eluded with 10% 7 N NH<sub>3</sub> in MeOH solution/CH<sub>2</sub>Cl<sub>2</sub> to give the target compounds <b>1</b>–<b>3</b> and <b>7</b>–<b>34</b>.</div><div id="sec4_3_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i22" class="anchor-spacer"></div><h4 class="article-section__title" id="_i22"> 2-(4-(9-(2-Methoxyphenyl)-3,9-diazaspiro[5.5]undecan-3-yl)butyl)isoindoline-1,3-dione (<b>E</b>)</h4><div class="NLM_p last"><b>4b′</b> (1 mmol), 2-(4-bromobutyl)isoindoline-1,3-dione (1.2 mmol), KI (1.0 mmol) and Cs<sub>2</sub>CO<sub>3</sub> (2.5 mmol) were dissolved in acetonitrile (5 mL), and the reaction mixture was stirred at 75 °C for 3 h. The reaction mixture was then filtered, and the solvent was removed under reduced pressure. Crude residue was purified by silica gel column chromatography using ethyl acetate/hexane (1:1) as the mobile phase to afford <b>E</b> as a light-orange solid (Yield 64%). <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 7.75–7.74 (m, 2H), 7.62–7.61 (m, 2H), 6.90–6.87 (m, 2H), 6.84–6.82 (m, 1H), 6.77 (d, <i>J</i> = 7.9 Hz, 1H), 3.77 (s, 3H), 3.63 (t, <i>J</i> = 6.9 Hz, 2H), 2.91–2.89 (m, 4H), 2.33–2.28 (m, 6H), 1.62–1.59 (m, 6H), 1.52–1.45 (m, 6H); <sup>13</sup>C NMR (125 MHz, CDCl<sub>3</sub>) δ 168.1, 152.0, 142.0, 133.7, 131.9, 122.9, 122.4, 120.7, 118.0, 110.8, 58.3, 55.1, 49.1, 46.5, 37.6, 35.6, 29.0, 26.5, 24.2; LC–MS (ESI) <i>m</i>/<i>z</i>: 462.64 [M + H].</div></div><div id="sec4_3_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i23" class="anchor-spacer"></div><h4 class="article-section__title" id="_i23"> 4-(9-(2-Methoxyphenyl)-3,9-diazaspiro[5.5]undecan-3-yl)butan-1-amine (<b>F</b>)</h4><div class="NLM_p last"><b>E</b> (1 mmol) and hydrazine hydrate (50–60%) were dissolved in ethanol (5 mL), and the reaction mixture was stirred at 75 °C for 2 h. The reaction mixture was then filtered, and the solvent was removed under reduced pressure. Crude residue was purified by silica gel column chromatography 10% 7 N NH<sub>3</sub> in MeOH solution/CH<sub>2</sub>Cl<sub>2</sub> (1.5:1) to afford <b>F</b> as a clear oil (Yield 97%). <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 6.89–6.86 (m, 2H), 6.82–6.78 (m, 1H), 6.75–6.73 (m, 2H), 3.75 (s, 3H), 2.89–2.87 (m, 4H), 2.62–2.59 (t, <i>J</i> = 6.7 Hz, 2H), 2.31 (bs, 4H), 2.26–2.23 (t, <i>J</i> = 7.0 Hz, 2H), 1.59–1.1.57 (m, 4H), 1.50–1.49 (m, 4H), 1.46–1.41 (m, 2H), 1.38–1.34 (m, 2H), 1.21 (bs, 2H); <sup>13</sup>C NMR (125 MHz, CDCl<sub>3</sub>) δ 152.0, 142.0, 122.3, 120.6, 117.9, 110.8, 58.8, 55.1, 49.1, 46.5, 41.9, 35.6, 31.7, 28.9, 24.3; LC–MS (ESI) <i>m</i>/<i>z</i>: 332.65 [M + H].</div></div><div id="sec4_3_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i24" class="anchor-spacer"></div><h4 class="article-section__title" id="_i24"> <i>tert</i>-Butyl 9-(2-methoxyphenyl)-3,9-diazaspiro[5.5]undec-7-ene-3-carboxylate (<b>4a</b>)</h4><div class="NLM_p last">Compound <b>4a</b> can be synthesized following the reaction conditions disclosed in Pd C–N cross-coupling report.<a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a> The separation of <b>4a</b> and the saturated major product <b>4b</b> was achieved by flash chromatography on silica gel eluting with a 40% EtOAc/hexane gradient to afford a tan oil. (Yield 9%). <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 7.02–6.98 (m, 1H), 6.95–6.93 (m, 1H), 6.91–6.86 (m, 2H), 6.28 (d, <i>J</i> = 8.1 Hz, 1H), 4.64 (d, <i>J</i> = 8.2 Hz, 1H), 3.83 (s, 3H), 3.53–3.50 (m, 2H), 3.46–3.43 (m, 2H), 3.41–3.35 (m, 2H), 1.74–1.72 (m, 2H), 1.54 (bs, 2H), 1.46 (s, 9H), 1.44–1.42 (m, 2H); <sup>13</sup>C NMR (125 MHz, CDCl<sub>3</sub>) δ 155.1, 152.4, 137.6, 132.0, 123.7, 122.2, 121.1, 112.1, 105.5, 79.3, 55.7, 44.2, 39.9, 38.5, 34.5, 30.3, 28.6; LC–MS (ESI) <i>m</i>/<i>z</i>: 303.47 [M – C(CH<sub>3</sub>)<sub>3</sub> + H].</div></div><div id="sec4_3_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i25" class="anchor-spacer"></div><h4 class="article-section__title" id="_i25"> 3-Butyl-9-(2-methoxyphenyl)-3,9-diazaspiro[5.5]undecane (<b>5a</b>)</h4><div class="NLM_p last">Following general method A, <b>5a</b> was obtained as a white semisolid. (Yield 38%). <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 6.97–6.93 (m, 2H), 6.90–6.88 (m, 1H), 6.83–6.82 (m, 1H), 3.83 (s, 3H), 2.97–2.95 (m, 4H), 2.45 (bs, 4H), 2.38–2.35 (m, 2H), 1.68–1.65 (m, 4H), 1.61–1.59 (m, 4H), 1.52–1.46 (m, 2H), 1.34–1.28 (m, 2H) 0.90 (t, <i>J</i> = 7.3 Hz, 3H); <sup>13</sup>C NMR (125 MHz, CDCl<sub>3</sub>) δ 152.3, 142.2, 122.6, 120.9, 118.2, 111.0, 58.8, 55.3, 49.3, 46.7, 35.6, 29.1, 29.0, 20.9, 14.1; LC–MS (ESI) <i>m</i>/<i>z</i>: 317.68 [M + H].</div></div><div id="sec4_3_5" class="NLM_sec NLM_sec_level_3"><div id="ac_i26" class="anchor-spacer"></div><h4 class="article-section__title" id="_i26"> 8-Butyl-2-(2-methoxyphenyl)-2,8-diazaspiro[4.5]decane (<b>5b</b>)</h4><div class="NLM_p last">Following general method A, compound <b>5b</b> was obtained as an off-white semisolid. (Yield 59%). <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 6.88–6.82 (m, 3H), 6.70 (d, <i>J</i> = 7.0 Hz, 1H), 3.80 (s, 3H), 3.37 (t, <i>J</i> = 6.9 Hz, 2H), 3.21 (s, 2H), 2.98 (bs, 2H), 2.81–2.78 (m, 2H), 1.99 (bs, 4H), 1.82 (t, <i>J</i> = 6.8 Hz, 2H), 1.76–1.73 (m, 2H), 1.38–1.34 (m, 2H), 0.94 (t, <i>J</i> = 7.3 Hz, 3H); <sup>13</sup>C NMR (125 MHz, CDCl<sub>3</sub>) δ 150.3, 139.2, 121.3, 120.0, 115.3, 112.0, 55.7, 50.5, 48.9, 38.9, 33.3, 26.5, 20.4, 13.7; LC–MS (ESI) <i>m</i>/<i>z</i>: 303.52 [M + H].</div></div><div id="sec4_3_6" class="NLM_sec NLM_sec_level_3"><div id="ac_i27" class="anchor-spacer"></div><h4 class="article-section__title" id="_i27"> 2-Butyl-7-(2-methoxyphenyl)-2,7-diazaspiro[4.4]nonane (<b>5c</b>)</h4><div class="NLM_p last">Following general method A, <b>5c</b> was obtained as an oil. (Yield 38%). <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 6.87–6.80 (m, 3H), 6.68–6.67 (m, 1H), 3.80 (s, 3H), 3.45–3.35 (m, 3H), 3.29 (d, <i>J</i> = 9.4 Hz, 1H), 3.12 (bs, 2H), 3.00 (bs, 2H), 2.78–2.75 (m, 2H), 2.07–1.91 (m, 4H), 1.65–1.58 (m, 2H), 1.38–1.33 (m, 2H), 0.92 (t, <i>J</i> = 7.3 Hz, 3H); <sup>13</sup>C NMR (125 MHz, CDCl<sub>3</sub>) δ 150.0, 139.1, 121.2, 119.6, 114.8, 112.0, 63.9, 61.8, 56.3, 55.6, 49.6, 47.6, 37.3, 35.7, 29.9, 20.4, 13.8; LC–MS (ESI) <i>m</i>/<i>z</i>: 289.93 [M + H].</div></div><div id="sec4_3_7" class="NLM_sec NLM_sec_level_3"><div id="ac_i28" class="anchor-spacer"></div><h4 class="article-section__title" id="_i28"> 1-Butyl-4-(2-(2-fluoroethoxy)phenyl)piperazine (<b>5e</b>)</h4><div class="NLM_p last">Following general method A, <b>5e</b><a onclick="showRef(event, 'ref50'); return false;" href="javascript:void(0);" class="ref ref50">(50)</a> was obtained as a colorless oil. (Yield 41%). <sup>1</sup>H NMR (360 MHz, CDCl<sub>3</sub>) δ 6.97–6.95 (m, 3H), 6.85 (m, 1H), 4.77 (dt, <i>J</i> = 47.5, 4.0 Hz, 2H), 4.25 (dt, <i>J</i> = 29.0, 4.0 Hz, 2H), 3.16 (s, 4H), 2.68 (s, 4H), 2.43 (t, <i>J</i> = 7.8 Hz, 3H), 1.54 (m, 2H), 1.35 (m, 2H) 0.93 (t, <i>J</i> = 7.3 Hz, 3H); <sup>13</sup>C NMR (126 MHz, CDCl<sub>3</sub>) δ 150.9, 141.9, 122.6, 122.1, 118.4, 113.7, 82.5, 81.2, 67.6, 67.4, 58.5, 53.4, 50.3, 28.6, 20.7, 11.9; LC–MS (ESI) <i>m</i>/<i>z</i>: 281.20 [M + H].</div></div><div id="sec4_3_8" class="NLM_sec NLM_sec_level_3"><div id="ac_i29" class="anchor-spacer"></div><h4 class="article-section__title" id="_i29"> 4-Methyl-3-phenyl-5-(propylthio)-4<i>H</i>-1,2,4-triazole (<b>6a</b>)</h4><div class="NLM_p last">A mixture of 4-methyl-5-phenyl-4<i>H</i>-1,2,4-triazole-3-thiol (1.0 mmol), 1-bromobutane (1.1 mmol), and K<sub>2</sub>CO<sub>3</sub> (1.5 mmol) was stirred in acetone (5 mL) at room temperature for 12 h. The crude reaction mixture was then filtered, and the solvent was removed under reduced pressure. The residue was purified by flash chromatography on silica gel eluting with 10% 7 N NH<sub>3</sub> in MeOH solution/CH<sub>2</sub>Cl<sub>2</sub> (1:10) affording <b>6a</b> as a white solid. (Yield 81%). <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 7.58–7.56 (m, 2H), 7.44–7.41 (m, 3H), 3.53 (s, 3H), 3.19 (t, <i>J</i> = 7.2 Hz, 2H), 1.78–1.74 (quint, <i>J</i> = 7.2 Hz, 2H), 1.00 (t, <i>J</i> = 7.3 Hz, 3H); <sup>13</sup>C NMR (125 MHz, CDCl<sub>3</sub>) δ 155.8, 129.9, 128.8, 128.5, 127.1, 35.4, 31.6, 22.9, 13.2; LC–MS (ESI) <i>m</i>/<i>z</i>: 234.17 [M + H].</div></div><div id="sec4_3_9" class="NLM_sec NLM_sec_level_3"><div id="ac_i30" class="anchor-spacer"></div><h4 class="article-section__title" id="_i30"> 1-(3-((4-Methyl-5-phenyl-4<i>H</i>-1,2,4-triazol-3-yl)thio)propyl)piperidine (<b>6c</b>)</h4><div class="NLM_p last">A mixture of <b>6b</b><a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a> (1.0 mmol), piperdine (1.1 mmol), and Cs<sub>2</sub>CO<sub>3</sub> (1.5 mmol) was stirred in acetonitrile (3 mL) at 70 °C for 12 h. The crude reaction mixture was then filtered, and the solvent was removed under reduced pressure. The residue was purified by flash chromatography on silica gel eluting with 10% 7 N NH<sub>3</sub> in MeOH solution/CH<sub>2</sub>Cl<sub>2</sub> (1:10) affording <b>6c</b> as a white solid. (Yield 20%). <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 7.60–7.58 (m, 2H), 7.47–7.45 (m, 3H), 3.56 (s, 3H), 3.26 (t, <i>J</i> = 7.2 Hz, 2H), 2.51 (t, <i>J</i> = 7.3 Hz, 2H), 2.44 (bs, 4H), 2.04–1.98 (m, 2H), 1.61–1.57 (quint, <i>J</i> = 5.6 Hz, 4H), 1.41 (bs, 2H); <sup>13</sup>C NMR (125 MHz, CDCl<sub>3</sub>) δ 155.9, 151.8, 130.0, 128.9, 128.6, 127.1, 57.5, 54.5, 31.6, 31.5, 26.5, 25.5, 24.1; LC–MS (ESI) <i>m</i>/<i>z</i>: 317.15 [M + H].</div></div><div id="sec4_3_10" class="NLM_sec NLM_sec_level_3"><div id="ac_i31" class="anchor-spacer"></div><h4 class="article-section__title" id="_i31"> 4,4-Dimethyl-1-(3-((4-methyl-5-phenyl-4<i>H</i>-1,2,4-triazol-3-yl)thio)propyl)piperidine (<b>6d</b>)</h4><div class="NLM_p last">A mixture of <b>6b</b><a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a> (1.0 mmol), 4,4-dimethylpiperdine (1.1 mmol), and Cs<sub>2</sub>CO<sub>3</sub> (1.5 mmol) was stirred in acetonitrile (3 mL) at 70 °C for 8 h. The crude reaction mixture was then filtered, and the solvent was removed under reduced pressure. The residue was purified by flash chromatography on silica gel eluting with 10% 7 N NH<sub>3</sub> in MeOH solution/CH<sub>2</sub>Cl<sub>2</sub> (1:10) affording <b>6d</b> as a white solid. (Yield 26%).<sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 7.59–7.58 (m, 2H), 7.46–7.44 (m, 3H), 3.57 (s, 3H), 3.25 (t, <i>J</i> = 6.7 Hz, 2H), 2.92–2.89 (m, 2H), 2.80 (bs, 4H), 2.24–2.20 (m, 2H), 1.60 (bs, 4H), 0.93 (s, 6H); <sup>13</sup>C NMR (125 MHz, CDCl<sub>3</sub>) δ 156.1, 151.3, 130.1, 128.9, 128.6, 126.9, 56.1, 49.6, 36.4, 31.7, 30.6, 28.0, 25.2; LC–MS (ESI) <i>m</i>/<i>z</i>: 345.18 [M + H].</div></div><div id="sec4_3_11" class="NLM_sec NLM_sec_level_3"><div id="ac_i32" class="anchor-spacer"></div><h4 class="article-section__title" id="_i32"> <i>tert</i>-Butyl 9-(3-((4-methyl-5-phenyl-4<i>H</i>-1,2,4-triazol-3-yl)thio)propyl)-3,9-diazaspiro[5.5]undecane-3-carboxylate (<b>6e</b>)</h4><div class="NLM_p last">A mixture of <b>6b</b><a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a> (1.0 mmol), <i>tert</i>-butyl 3,9-diazaspiro[5.5]undecane-3-carboxylate (1.1 mmol), and Cs<sub>2</sub>CO<sub>3</sub> (1.5 mmol) was stirred in acetonitrile (5 mL) at 70 °C for 12 h. The crude reaction mixture was then filtered, and the solvent was removed under reduced pressure. The residue was purified by flash chromatography on silica gel eluting with 10% 7 N NH<sub>3</sub> in MeOH solution/CH<sub>2</sub>Cl<sub>2</sub> (1:10) affording <b>6e</b> as an off-white solid (Yield 47%). <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 7.55–7.54 (m, 2H), 7.42–7.40 (m, 3H), 3.52 (s, 3H), 3.28–3.26 (m, 4H), 3.21 (t, <i>J</i> = 7.0 Hz, 2H), 2.51 (t, <i>J</i> = 7.1 Hz, 2H), 2.42 (bs, 4H), 1.99–1.93 (quint, <i>J</i> = 7.1 Hz, 2H), 1.48 (t, <i>J</i> = 5.6 Hz, 4H), 1.36 (s, 9H), 1.34 (bs, 4H); <sup>13</sup>C NMR (125 MHz, CDCl<sub>3</sub>) δ 155.7, 154.8, 151.7, 129.9, 128.8, 128.4, 126.9, 79.1, 65.7, 56.9, 48.9, 39.6, 38.8, 34.8, 31.5, 30.9, 29.4, 28.3, 26.4, 15.2; LC–MS (ESI) <i>m</i>/<i>z</i>: 486.17 [M + H].</div></div><div id="sec4_3_12" class="NLM_sec NLM_sec_level_3"><div id="ac_i33" class="anchor-spacer"></div><h4 class="article-section__title" id="_i33"> 3-(2-((4-Methyl-5-phenyl-4<i>H</i>-1,2,4-triazol-3-yl)thio)propyl)-3,9-diazaspiro[5.5]undecane (<b>6f</b>)</h4><div class="NLM_p last">The compound was dissolved in CH<sub>2</sub>Cl<sub>2</sub> (2 mL), followed by the dropwise addition of CF<sub>3</sub>COOH (2 mL), and stirred at room temperature for 3 h. Volatiles were then removed under reduced pressure, and the crude product was neutralized with a saturated NaHCO<sub>3 (aq)</sub> solution (10 mL). The reaction mixture was extracted with CH<sub>2</sub>Cl<sub>2</sub> (3 × 20 mL), and the organic layers were combined, dried, and concentrated to afford <b>6f</b> as an off-white solid (Yield 97%). (HCl salt) <sup>1</sup>H NMR (500 MHz, (CD<sub>3</sub>)<sub>2</sub>SO) δ 10.97 (bs, 1H), 7.78–7.76 (m, 2H), 7.62–7.59 (m, 3H), 3.65 (s, 3H), 3.35 (t, <i>J</i> = 6.9 Hz, 2H), 3.29–3.26 (m, 2H), 3.21–3.16 (m, 2H), 2.99 (bs, 6H), 2.22–2.17 (m, 2H), 1.83–1.77 (m, 6H), 1.54–1.52 (m, 2H); <sup>13</sup>C NMR (125 MHz, (CD<sub>3</sub>)<sub>2</sub>SO) δ 154.7, 151.2, 130.8, 128.9, 128.8, 125.0, 53.7, 47.0, 38.7, 38.6, 34.6, 32.2, 31.1, 30.1, 27.9, 26.7, 23.4; LC–MS (ESI) <i>m</i>/<i>z</i>: 386.68 [M + H].</div></div><div id="sec4_3_13" class="NLM_sec NLM_sec_level_3"><div id="ac_i34" class="anchor-spacer"></div><h4 class="article-section__title" id="_i34"> 1-(3-((4-Methyl-5-phenyl-4<i>H</i>-1,2,4-triazol-3-yl)thio)propyl)piperazine (<b>6h</b>)</h4><div class="NLM_p last">Following the procedure for <b>6f</b>, compound <b>6h</b> was obtained as a light tan oil. (Yield 12%). <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 7.56–7.54 (m, 2H), 7.43–7.41 (m, 3H), 3.52 (s, 3H), 3.25–3.22 (m, 2H), 3.21 (s, 1H), 2.85–2.83 (t, <i>J</i> = 4.8 Hz, 4H), 2.42–2.38 (m, 6H), 1.95–1.89 (quint, <i>J</i> = 7.1 Hz, 2H); <sup>13</sup>C NMR (125 MHz, CDCl<sub>3</sub>) δ 155.7, 151.9, 130.0, 128.8, 128.5, 127.0, 57.2, 53.8, 45.6, 31.5, 31.0, 26.5; LC–MS (ESI) <i>m</i>/<i>z</i>: 318.66 [M + H].</div></div><div id="sec4_3_14" class="NLM_sec NLM_sec_level_3"><div id="ac_i35" class="anchor-spacer"></div><h4 class="article-section__title" id="_i35"> 4-(5-((3-(9-(2-Methoxyphenyl)-3,9-diazaspiro[5.5]undecan-3-yl)propyl)thio)-4-methyl-4<i>H</i>-1,2,4-triazol-3-yl)-<i>N</i>,<i>N</i>-dimethylaniline (<b>7</b>)</h4><div class="NLM_p last">Following general method B, <b>7</b> was obtained as a tan oil. (Yield 48%). <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 7.46 (d, <i>J</i> = 8.8 Hz, 2H), 6.92–6.89 (m, 2H), 6.86–6.83 (m, 1H), 6.80–6.78 (m, 1H), 6.72 (d, <i>J</i> = 8.8 Hz, 2H), 3.79 (s, 3H), 3.54 (s, 3H), 3.20 (t, <i>J</i> = 7.1 Hz, 2H), 2.96 (s, 3H), 2.93–2.91 (m, 4H), 2.65 (t, <i>J</i> = 7.1 Hz, 2H), 2.57 (bs, 4H), 2.08–2.02 (quint, <i>J</i> = 7.1 Hz, 2H), 1.63 (bs, 8H); <sup>13</sup>C NMR (125 MHz, CDCl<sub>3</sub>) δ 156.4, 152.1, 151.1, 150.5, 141.9, 129.3, 122.6, 120.7, 118.1, 113.9, 111.7, 110.9, 56.7, 55.2, 48.9, 46.5, 45.8, 40.1, 35.8, 34.7, 31.6, 31.0, 28.9, 26.1; LC–MS (ESI) <i>m</i>/<i>z</i>: 535.32 [M + H].</div></div><div id="sec4_3_15" class="NLM_sec NLM_sec_level_3"><div id="ac_i36" class="anchor-spacer"></div><h4 class="article-section__title" id="_i36"> 3-(2-Methoxyphenyl)-9-(3-((5-(2-methoxyphenyl)-4-methyl-4<i>H</i>-1,2,4-triazol-3-yl)thio)propyl)-3,9-diazaspiro[5.5]undecane (<b>8</b>)</h4><div class="NLM_p last">Following general method B, <b>8</b> was obtained as a clear oil. (Yield 39%). <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 7.46–7.43 (m, 2H), 7.05–7.02 (m, 1H), 6.97–6.95 (m, 1H), 6.93–6.92 (m, 2H), 6.88–6.86 (m, 1H), 6.81 (d, <i>J</i> = 7.8 Hz, 1H), 3.82 (s, 3H), 3.78 (s, 3H), 3.35 (s, 3H), 3.28 (t, <i>J</i> = 6.9 Hz, 2H), 2.94 (t, <i>J</i> = 4.6 Hz, 4H), 2.54 (t, <i>J</i> = 7.1 Hz, 2H), 2.47 (bs, 4H), 2.03–2.00 (m, 2H), 1.66–164 (m, 4H), 1.60–1.58 (m, 4H); <sup>13</sup>C NMR (125 MHz, CDCl<sub>3</sub>) δ 157.2, 154.3, 152.2, 151.1, 142.1, 132.2, 132.0, 122.6, 121.0, 120.8, 118.2, 116.3, 111.0 (2 × CH), 57.2, 55.5, 55.3, 49.2, 46.6, 36.0, 35.5, 31.1, 30.9, 29.1, 26.7; LC–MS (ESI) <i>m</i>/<i>z</i>: 522.23 [M + H].</div></div><div id="sec4_3_16" class="NLM_sec NLM_sec_level_3"><div id="ac_i37" class="anchor-spacer"></div><h4 class="article-section__title" id="_i37"> 3-(2-Methoxyphenyl)-9-(3-((4-methyl-5-(pyridin-3-yl)-4<i>H</i>-1,2,4-triazol-3-yl)thio)propyl)-3,9-diazaspiro[5.5]undecane (<b>9</b>)</h4><div class="NLM_p last">Following general method B, <b>9</b> was obtained as a light tan oil. (Yield 53%). <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 8.85 (s, 1H), 8.69–8.68 (m, 1H), 7.98–7.96 (m, 1H), 7.43–7.40 (m, 1H), 6.94–6.90 (m, 2H), 6.86–6.83 (m, 1H), 6.80 (d, <i>J</i> = 7.7 Hz, 1H), 3.80 (s, 3H), 3.59 (s, 3H), 3.29 (t, <i>J</i> = 6.9 Hz, 2H), 2.94–2.92 (m, 4H), 2.56 (t, <i>J</i> = 6.3 Hz, 2H), 2.49 (bs, 4H), 2.06–2.00 (quint, <i>J</i> = 6.9 Hz, 2H), 1.64–1.62 (m, 4H), 1.60–1.58 (m, 4H); <sup>13</sup>C NMR (125 MHz, CDCl<sub>3</sub>) δ 153.1, 152.7, 152.2, 151.0, 148.8, 142.0, 136.0, 123.7, 123.5, 122.6, 120.8, 118.1, 110.9, 57.0, 55.3, 49.2, 46.6, 36.0, 35.3, 31.6, 31.1, 29.0, 26.5, 22.6; LC–MS (ESI) <i>m</i>/<i>z</i>: 493.24 [M + H].</div></div><div id="sec4_3_17" class="NLM_sec NLM_sec_level_3"><div id="ac_i38" class="anchor-spacer"></div><h4 class="article-section__title" id="_i38"> 3-(2-Methoxyphenyl)-9-(3-((4-methyl-5-(4-(thiophen-3-yl)phenyl)-4<i>H</i>-1,2,4-triazol-3-yl)thio)propyl)-3,9-diazaspiro[5.5]undecane (<b>10</b>)</h4><div class="NLM_p last">Following general method B, <b>10</b> was obtained as a white solid. (Yield 15%) <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 7.70 (d, <i>J</i> = 8.3 Hz, 2H), 7.65 (d, <i>J</i> = 8.3 Hz, 2H), 7.51–7.50 (m, 1H), 7.40–7.39 (m, 2H), 6.96–6.93 (m, 2H), 6.89–6.87 (m, 1H), 6.82 (d, <i>J</i> = 8.0 Hz, 1H), 3.82 (s, 3H), 3.59 (s, 3H), 3.29 (t, <i>J</i> = 7.2 Hz, 2H), 2.96–2.94 (m, 4H), 2.49 (t, <i>J</i> = 7.5 Hz, 2H), 2.42–2.40 (m, 4H), 2.02–1.96 (quint, <i>J</i> = 7.1 Hz, 2H), 1.66–1.64 (m, 4H), 1.57–1.55 (m, 4H); <sup>13</sup>C NMR (125 MHz, CDCl<sub>3</sub>) δ 155.5, 152.2, 152.0, 142.1, 141.1, 137.2, 128.9, 126.7, 126.6, 126.0, 125.6, 122.5, 121.3, 120.8, 118.1, 110.9, 57.3, 55.3, 49.2, 46.6, 36.1, 35.8, 31.6, 31.3, 29.1, 26.9; LC–MS (ESI) <i>m</i>/<i>z</i>: 574.19 [M + H].</div></div><div id="sec4_3_18" class="NLM_sec NLM_sec_level_3"><div id="ac_i39" class="anchor-spacer"></div><h4 class="article-section__title" id="_i39"> 2-(4-(5-((3-(9-(2-Methoxyphenyl)-3,9-diazaspiro[5.5]undecan-3-yl)propyl)thio)-4-methyl-4<i>H</i>-1,2,4-triazol-3-yl)phenyl)oxazole (<b>11</b>)</h4><div class="NLM_p last">Following general method B, <b>11</b> was obtained as a beige solid. (Yield 17%) <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 8.17 (d, <i>J</i> = 8.2 Hz, 2H), 7.75 (s, 1H), 7.74 (s, 2H), 7.26 (s, 1H), 6.94–6.93 (m, 2H), 6.89–6.87 (m, 1H), 6.83 (d, <i>J</i> = 7.8 Hz, 1H), 3.83 (s, 3H), 3.62 (s, 3H), 3.32–3.29 (t, <i>J</i> = 7.0 Hz, 2H), 2.96–2.94 (m, 2H), 2.56–2.53 (m, 2H), 2.47 (bs, 4h), 2.06–2.00 (quint, <i>J</i> = 7.0 Hz, 2H), 1.66–1.64 (m, 4H), 1.60–1.58 (m, 4H); <sup>13</sup>C NMR (125 MHz, CDCl<sub>3</sub>) δ 161.0, 155.1, 152.4, 152.3, 142.2, 139.2, 128.9, 128.8, 128.7, 126.8, 122.6, 120.9, 118.2, 111.0, 57.2, 55.3, 49.5, 49.3, 46.7, 36.1, 35.5, 31.8, 31.2, 29.1, 26.8; LC–MS (ESI) <i>m</i>/<i>z</i>: 559.23 [M + H].</div></div><div id="sec4_3_19" class="NLM_sec NLM_sec_level_3"><div id="ac_i40" class="anchor-spacer"></div><h4 class="article-section__title" id="_i40"> 3-(3-((5-(2-Fluorophenyl)-4-methyl-4<i>H</i>-1,2,4-triazol-3-yl)thio)propyl)-9-(2-methoxyphenyl)-3,9-diazaspiro[5.5]undecane (<b>12</b>)</h4><div class="NLM_p last">Following general method B, <b>12</b> was obtained as a beige solid. (Yield 44%) <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 7.56–7.53 (m, 1H), 7.46–7.44 (m, 1H), 7.25–7.21 (m, 1H), 7.16–7.12 (m, 1H), 6.91–6.88 (m, 1H), 6.86–6.81 (m, 2H), 6.79–6.76 (m, 1H), 3.77 (s, 3H), 3.41 (s, 3H), 3.29–3.26 (t, <i>J</i> = 6.7 Hz, 2H), 2.99 (bs, 2H), 2.90 (bs, 8H), 2.28 (m, 2h), 1.81 (bs, 4H), 1.65 (m, 4H); <sup>13</sup>C NMR (125 MHz, CDCl<sub>3</sub>) δ 158.7 (d, <i>J</i><sub>C–F</sub> = 250.3 Hz), 152.2, 152.1, 151.5, 141.7, 132.7 (d, <i>J</i><sub>C–C–C–F</sub> = 8.1 Hz), 132.1, 124.9 (d, <i>J</i><sub>C–C–C–F</sub> = 3.0 Hz), 122.8, 120.8, 118.2, 116.1 (d, <i>J</i><sub>C–C–F</sub> = 21.1 Hz), 115.1 (d, <i>J</i><sub>C–C–F</sub> = 14.3 Hz), 111.0, 55.8, 55.3, 48.7, 46.5, 35.5 (bs), 33.2, 31.2 (d, <i>J</i><sub>CH3–F</sub> = 5.7 Hz), 30.4, 28.7, 24.8; LC–MS (ESI) <i>m</i>/<i>z</i>: 510.78 [M + H].</div></div><div id="sec4_3_20" class="NLM_sec NLM_sec_level_3"><div id="ac_i41" class="anchor-spacer"></div><h4 class="article-section__title" id="_i41"> 3-(3-((5-(4-Fluorophenyl)-4-methyl-4<i>H</i>-1,2,4-triazol-3-yl)thio)propyl)-9-(2-methoxyphenyl)-3,9-diazaspiro[5.5]undecane (<b>13</b>)</h4><div class="NLM_p last">Following general method B, <b>13</b> was obtained as a white solid. (Yield 24%) <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 7.63–7.60 (m, 2H), 7.19–7.15 (m, 2H), 6.97–6.93 (m, 1H), 6.91–6.85 (m, 2H), 6.82–6.80 (m, 1H), 3.82 (s, 3H), 3.59 (s, 3H), 3.30–3.28 (t, <i>J</i> = 6.9 Hz, 2H), 3.06–3.03 (m, 2H), 3.00 (bs, 2H), 2.95–2.93 (m, 6h), 2.36–2.32 (quint, <i>J</i> = 6.8 Hz, 2H), 1.88 (bs, 4H), 1.70 (bs, 4H); <sup>13</sup>C NMR (125 MHz, CDCl<sub>3</sub>) δ 162.8 (d, <i>J</i><sub>C–F</sub> = 250.7 Hz), 155.3, 152.2, 151.2, 141.6, 130.7 (d, <i>J</i><sub>C–C–C–F</sub> = 8.4 Hz), 123.1 (d, <i>J</i><sub>C–C–C–F</sub> = 3.8 Hz), 122.9, 120.9, 118.2, 116.3 (d, <i>J</i><sub>C–C–F</sub> = 22.0 Hz), 111.1, 55.8, 55.4, 48.7, 46.5, 33.2 (bs), 31.8, 30.4, 28.7, 24.7; LC–MS (ESI) <i>m</i>/<i>z</i>: 510.63 [M + H].</div></div><div id="sec4_3_21" class="NLM_sec NLM_sec_level_3"><div id="ac_i42" class="anchor-spacer"></div><h4 class="article-section__title" id="_i42"> 3-(3-((5-Cyclohexyl-4-methyl-4<i>H</i>-1,2,4-triazol-3-yl)thio)propyl)-9-(2-methoxyphenyl)-3,9-diazaspiro[5.5]undecane (<b>14</b>)</h4><div class="NLM_p last">Following general method B, <b>14</b> was obtained as a white semisolid. (Yield 39%) <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 6.95–6.91 (m, 2H), 6.87–6.84 (m, 1H), 6.81–6.79 (m, 1H), 3.81 (s, 3H), 3.44 (s, 3H), 3.15 (t, <i>J</i> = 7.0 Hz, 2H), 2.94–2.92 (m, 4H), 2.60–2.54 (m, 3H), 2.50 (bs, 4H), 2.01–1.96 (quint, <i>J</i> = 7.0 Hz, 2H), 1.90–1.82 (m, 4H), 1.71–1.67 (m, 2H), 1.65–1.59 (m, 9H), 1.36–1.26 (m, 3H); <sup>13</sup>C NMR (125 MHz, CDCl<sub>3</sub>) δ 159.5, 152.2 149.9, 142.0, 122.6, 120.8, 118.1, 110.9, 57.0, 55.3, 49.1, 46.6, 35.9, 35.0, 31.2, 30.7, 29.8, 29.0, 26.4, 26.0, 25.6; LC–MS (ESI) <i>m</i>/<i>z</i>: 498.32 [M + H].</div></div><div id="sec4_3_22" class="NLM_sec NLM_sec_level_3"><div id="ac_i43" class="anchor-spacer"></div><h4 class="article-section__title" id="_i43"> 3-(3-((4-Ethyl-5-phenyl-4<i>H</i>-1,2,4-triazol-3-yl)thio)propyl)-9-(2-methoxyphenyl)-3,9-diazaspiro[5.5]undecane (<b>15</b>)</h4><div class="NLM_p last">Following general method B, <b>15</b> was obtained as a white solid. (Yield 55%) <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 7.56–7.54 (m, 2H), 7.46–7.44 (m, 3H), 6.93–6.89 (m, 2H), 6.87–6.85 (m, 1H), 6.81–6.79 (m, 1H), 3.96–3.92 (quart, <i>J</i> = 7.2 Hz, 2H), 3.80 (s, 3H), 3.30 (t, <i>J</i> = 7.1 Hz, 2H), 2.94–2.92 (m, 4H), 2.76 (t, <i>J</i> = 7.0 Hz, 2H), 2.69 (bs, 4H), 2.20–2.14 (quint, <i>J</i> = 7.1 Hz, 2H), 1.71–1.69 (m, 4H), 1.67–1.65 (m, 4H), 1.27 (t, <i>J</i> = 7.2 Hz, 3H); <sup>13</sup>C NMR (125 MHz, CDCl<sub>3</sub>) δ 155.5, 152.1, 150.9, 141.8, 130.0, 128.9, 128.5, 127.2, 122.7, 120.8, 118.1, 111.0, 56.6, 55.3, 48.9, 46.5, 39.6, 35.6, 34.3, 30.8, 28.9, 25.8, 15.4; LC–MS (ESI) <i>m</i>/<i>z</i>: 506.20 [M + H].</div></div><div id="sec4_3_23" class="NLM_sec NLM_sec_level_3"><div id="ac_i44" class="anchor-spacer"></div><h4 class="article-section__title" id="_i44"> 3-((3-(9-(2-Methoxyphenyl)-3,9-diazaspiro[5.5]undecan-3-yl)propyl)thio)-5-phenyl-4<i>H</i>-1,2,4-triazol-4-amine (<b>16</b>)</h4><div class="NLM_p last">Following general method B, <b>16</b> was obtained as a clear oil. (Yield 46%) <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 8.03–8.01 (m, 2H), 7.42–7.41 (m, 3H), 6.97–6.91 (m, 2H), 6.89–6.88 (m, 1H), 6.82 (d, <i>J</i> = 8.0 Hz, 1H), 5.18 (s, 2H), 3.82 (s, 3H), 3.18 (t, <i>J</i> = 6.9 Hz, 2H), 2.94–2.92 (m, 4H), 2.53 (t, <i>J</i> = 7.0 Hz, 2H), 2.47–2.45 (m, 4H), 1.97–1.91 (quint, <i>J</i> = 7.2 Hz, 2H), 1.64–162 (m, 4H), 1.58–1.56 (m, 4H); <sup>13</sup>C NMR (125 MHz, CDCl<sub>3</sub>) δ 154.3, 152.8, 152.2, 142.0, 130.0, 128.5, 128.2, 126.5, 122.7, 120.9, 118.2, 111.0, 56.8, 55.3, 49.1, 46.6, 35.9, 35.2, 30.9, 29.0, 26.5; LC–MS (ESI) <i>m</i>/<i>z</i>: 493.24 [M + H].</div></div><div id="sec4_3_24" class="NLM_sec NLM_sec_level_3"><div id="ac_i45" class="anchor-spacer"></div><h4 class="article-section__title" id="_i45"> 3-(2-Methoxyphenyl)-9-(3-((5-phenyl-4<i>H</i>-1,2,4-triazol-3-yl)thio)propyl)-3,9-diazaspiro[5.5]undecane (<b>17</b>)</h4><div class="NLM_p last">Following general method B, <b>17</b> was obtained as a clear oil. (Yield 41%) <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 11.1 (bs, 1H), 8.04 (d, <i>J</i> = 7.6 Hz, 2H), 7.36–7.30 (m, 3H), 6.96–6.92 (m, 2H), 6.89–6.86 (m, 1H), 6.81 (d, <i>J</i> = 8.0 Hz, 1H), 3.79 (s, 3H), 3.10 (t, <i>J</i> = 6.4 Hz, 2H), 2.96–2.94 (m, 4H), 2.57 (t, <i>J</i> = 6.3 Hz, 2H), 2.49 (bs, 4H), 1.98–1.92 (quint, <i>J</i> = 6.2 Hz, 2H), 1.69–1.66 (m, 8H); <sup>13</sup>C NMR (125 MHz, CDCl<sub>3</sub>) δ 161.1, 155.7, 152.0, 141.8, 130.0, 129.0, 128.3, 126.2, 122.6, 120.7, 118.1, 110.9, 55.1, 54.8, 48.8, 46.5, 35.6, 34.7, 30.3.28.9, 26.5; LC–MS (ESI) <i>m</i>/<i>z</i>: 478.15 [M + H].</div></div><div id="sec4_3_25" class="NLM_sec NLM_sec_level_3"><div id="ac_i46" class="anchor-spacer"></div><h4 class="article-section__title" id="_i46"> 3-(2-Methoxyphenyl)-9-(3-((5-phenyl-1<i>H</i>-imidazol-2-yl)thio)propyl)-3,9-diazaspiro[5.5]undecane (<b>18</b>)</h4><div class="NLM_p last">Following general method B, <b>18</b> was obtained as a light gray solid. (Yield 82%) <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 10.92 (bs, 1H), 7.73 (d, <i>J</i> = 7.1 Hz, 2H), 7.31 (t, <i>J</i> = 7.7 Hz, 2H), 7.28 (s, 3H), 7.18 (t, <i>J</i> = 7.3 Hz, 1H), 6.99–6.88 (m, 3H), 6.84–6.83 (d, <i>J</i> = 7.8 Hz, 1H), 3.83 (s, 3H), 3.01 (t, <i>J</i> = 6.0 Hz, 2H), 2.97–2.95 (m, 4H), 2.67 (t, <i>J</i> = 6.6 Hz, 2H), 2.55 (bs, 4H), 1.93–1.88 (quint, <i>J</i> = 6.4 Hz, 2H), 1.68–1.64 (m, 8H); <sup>13</sup>C NMR (125 MHz, CDCl<sub>3</sub>) δ 152.2, 141.9, 141.8, 141.0, 133.4, 128.5, 126.6, 124.7, 122.7, 120.8, 118.2, 115.7, 111.1, 55.3, 54.8, 48.5, 46.5, 35.6, 35.0, 32.0, 29.0, 26.2; LC–MS (ESI) <i>m</i>/<i>z</i>: 477.22 [M + H].</div></div><div id="sec4_3_26" class="NLM_sec NLM_sec_level_3"><div id="ac_i47" class="anchor-spacer"></div><h4 class="article-section__title" id="_i47"> 3-(2-Methoxyphenyl)-9-(3-((1-methyl-5-phenyl-1<i>H</i>-imidazol-2-yl)thio)propyl)-3,9-diazaspiro[5.5]undecane (<b>19</b>)</h4><div class="NLM_p last">Following general method B, <b>19</b> was obtained as a tan oil. (Yield 35%) <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 7.39–7.36 (m, 2H), 7.32–7.31 (m, 3H), 7.05 (s, 1H), 6.92–6.90 (m, 2H), 6.86–6.85 (m, 1H), 6.80–6.79 (m, 1H), 3.80 (s, 3H), 3.54 (s, 3H), 3.12–3.10 (t, <i>J</i> = 6.9 Hz, 2H), 2.94–2.92 (m, 4H), 2.59–2.56 (t, <i>J</i> = 6.5 Hz, 2H), 2.51 (bs, 4H), 1.98–1.95 (m, 2H), 1.65–1.60 (m, 8H); <sup>13</sup>C NMR (125 MHz, CDCl<sub>3</sub>) δ 152.1, 142.7, 142.0, 129.9, 128.6, 128.3, 127.8, 122.5, 120.8, 118.1, 111.0, 57.0, 55.2, 49.0, 46.5, 35.8 (bs), 35.0, 32.0, 28.9, 26.5; LC–MS (ESI) <i>m</i>/<i>z</i>: 491.73 [M + H].</div></div><div id="sec4_3_27" class="NLM_sec NLM_sec_level_3"><div id="ac_i48" class="anchor-spacer"></div><h4 class="article-section__title" id="_i48"> 3-(2-Methoxyphenyl)-9-(2-((4-methyl-5-phenyl-4<i>H</i>-1,2,4-triazol-3-yl)thio)ethyl)-3,9-diazaspiro[5.5]undecane (<b>20</b>)</h4><div class="NLM_p last">Following general method B, <b>20</b> was obtained as a tan oil. (Yield 12%) <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 7.62–7.60 (m, 2H), 7.48–7.46 (m, 3H), 6.96–6.93 (m, 2H), 6.89–6.86 (m, 1H), 6.83–6.81 (m, 1H), 3.83 (s, 3H), 3.58 (s, 3H), 3.44 (t, <i>J</i> = 6.7 Hz, 2H), 2.96–2.94 (m, 4H), 2.81 (t, <i>J</i> = 6.7 Hz, 2H), 2.52–2.49 (m, 4H), 1.65–1.63 (m, 4H), 1.57–1.55 (m, 4H); <sup>13</sup>C NMR (125 MHz, CDCl<sub>3</sub>) δ 155.8, 152.2, 152.1, 142.1, 130.0, 128.9, 128.5, 127.1, 122.6, 120.8, 118.2, 111.0, 57.8, 55.3, 49.0, 46.7, 36.0, 35.5, 31.7, 30.6, 29.1; LC–MS (ESI) <i>m</i>/<i>z</i>: 478.42 [M + H].</div></div><div id="sec4_3_28" class="NLM_sec NLM_sec_level_3"><div id="ac_i49" class="anchor-spacer"></div><h4 class="article-section__title" id="_i49"> 3-(2-Methoxyphenyl)-9-(4-((4-methyl-5-phenyl-4<i>H</i>-1,2,4-triazol-3-yl)thio)butyl)-3,9-diazaspiro[5.5]undecane (<b>21</b>)</h4><div class="NLM_p last">Following general method B, <b>21</b> was obtained as a tan oil. (Yield 14%) <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 7.61–7.59 (m, 2H), 7.48–7.46 (m, 3H), 6.96–6.91 (m, 2H), 6.88–6.87 (m, 1H), 6.82–6.81 (m, 1H), 3.82 (s, 3H), 3.58 (s, 3H), 3.27 (t, <i>J</i> = 6.9 Hz, 2H), 2.96–2.94 (m, 4H), 2.61–2.50 (m, 6H), 1.84–1.78 (m, 4H), 1.67–1.66 (m, 8H); <sup>13</sup>C NMR (125 MHz, CDCl<sub>3</sub>) δ 155.9, 152.3, 151.9, 142.0, 130.1, 128.9, 128.6, 127.1, 122.7, 120.9, 118.2, 111.1, 57.9, 55.3, 49.1, 46.6, 34.8, 32.8, 31.6, 29.0, 27.5, 25.1, 22.6; LC–MS (ESI) <i>m</i>/<i>z</i>: 506.20 [M + H].</div></div><div id="sec4_3_29" class="NLM_sec NLM_sec_level_3"><div id="ac_i50" class="anchor-spacer"></div><h4 class="article-section__title" id="_i50"> 3-(2-Ethoxyphenyl)-9-(3-((4-methyl-5-phenyl-4<i>H</i>-1,2,4-triazol-3-yl)thio)propyl)-3,9-diazaspiro[5.5]undecane (<b>22</b>)</h4><div class="NLM_p last">Following general method B, <b>22</b> was obtained as a dark tan oil. (Yield 13%) <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 7.60–7.58 (m, 2H), 7.47–7.45 (m, 3H), 6.90–6.88 (m, 2H), 6.87–6.85 (m, 1H), 6.84–6.78 (m, 1H), 4.03–3.99 (m, 2H), 3.55 (s, 3H), 3.28 (t, <i>J</i> = 7.1 Hz, 2H), 2.98–2.96 (m, 4H), 2.50 (t, <i>J</i> = 7.3 Hz, 2H), 2.43 (bs, 4H), 2.02–1.97 (quint, <i>J</i> = 7.0 Hz, 2H), 1.64–1.62 (m, 4H), 1.57–1.56 (m, 4H), 1.41 (t, <i>J</i> = 7.0 Hz, 3H); <sup>13</sup>C NMR (125 MHz, CDCl<sub>3</sub>) δ 155.7, 151.8, 151.5, 142.2, 129.9, 128.8, 128.5, 127.1, 122.3, 120.8, 118.1, 112.3, 63.4, 57.2, 49.2, 46.5, 36.1, 35.7, 31.5, 31.2, 29.1, 26.8, 14.9; LC–MS (ESI) <i>m</i>/<i>z</i>: 506.20 [M + H].</div></div><div id="sec4_3_30" class="NLM_sec NLM_sec_level_3"><div id="ac_i51" class="anchor-spacer"></div><h4 class="article-section__title" id="_i51"> 2-(9-(3-((4-Methyl-5-phenyl-4<i>H</i>-1,2,4-triazol-3-yl)thio)propyl)-3,9-diazaspiro[5.5]undecan-3-yl)phenol (<b>23</b>)</h4><div class="NLM_p last">Following general method B, <b>23</b> was obtained as a dark tan oil. (Yield 13%) <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 7.63–7.60 (m, 2H), 7.50–7.48 (m, 3H), 7.15–7.13 (dd, <i>J</i><sub>1</sub> = 1.4 Hz, <i>J</i><sub>2</sub> = 1.4 Hz, 1H), 7.05–7.02 (dt, <i>J</i><sub>1</sub> = 1.4 Hz, <i>J</i><sub>2</sub> = 7.9 Hz, 1H), 6.93–6.91 (dd, <i>J</i><sub>1</sub> = 1.4 Hz, <i>J</i><sub>2</sub> = 8.0 Hz, 1H), 6.84–6.81 (dt, <i>J</i><sub>1</sub> = 1.4 Hz, <i>J</i><sub>2</sub> = 7.6 Hz, 1H), 3.59 (s, 3H), 3.32–3.29 (t, <i>J</i> = 7.0 Hz, 2H), 2.79–2.77 (m, 4H), 2.58–2.55 (t, <i>J</i> = 7.3 Hz, 2H), 2.50 (bs, 4H), 2.07–2.01 (m, 2H), 1.99 (s, 1H), 1.64–1.62 (m, 8H); <sup>13</sup>C NMR (125 MHz, CDCl<sub>3</sub>) δ 155.9, 151.9, 151.5, 139.9, 130.1, 129.0, 128.6, 127.2, 126.2, 121.2, 119.9, 113.9, 57.2, 49.2, 48.7, 36.7, 35.6, 31.7, 31.2, 29.1, 26.8, 22.7; LC–MS (ESI) <i>m</i>/<i>z</i>: 478.66 [M + H].</div></div><div id="sec4_3_31" class="NLM_sec NLM_sec_level_3"><div id="ac_i52" class="anchor-spacer"></div><h4 class="article-section__title" id="_i52"> 3-(2-(2-Fluoroethoxy)phenyl)-9-(3-((4-methyl-5-phenyl-4<i>H</i>-1,2,4-triazol-3-yl)thio)propyl)-3,9-diazaspiro[5.5]undecane (<b>24</b>)</h4><div class="NLM_p last">Following general method B, <b>24</b> was obtained as a white solid. (Yield 12%) <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 7.61–7.59 (m, 2H), 7.47–7.45 (m, 3H), 6.92–6.89 (m, 3H), 6.81–6.79 (m, 1H), 4.78–4.77 (m, 1H), 4.69–4.67 (m, 1H), 4.24–4.22 (m, 1H), 4.18–4.16 (m, 1H), 3.57 (s, 3H), 3.27 (t, <i>J</i> = 7.0 Hz, 2H), 2.98–2.96 (m, 4H), 2.85–2.82 (m, 2H), 2.76 (bs, 4H), 2.21–2.16 (quint, <i>J</i> = 7.2 Hz, 2H), 1.75–1.73 (m, 4H), 1.66–164 (m, 4H); <sup>13</sup>C NMR (125 MHz, CDCl<sub>3</sub>) δ 156.0, 151.4, 150.9, 142.4, 130.1, 128.9, 128.5, 126.9, 122.5, 122.0, 118.5, 113.4, 82.7 (d, <i>J</i><sub>C–F</sub> = 170.1 Hz, CH<sub>2</sub>F), 67.5 (d, <i>J</i><sub>C–F</sub> = 20.1 Hz, O–CH<sub>2</sub>CH<sub>2</sub>F), 56.4, 48.9, 46.4, 35.6, 34.0, 31.7, 30.7, 28.9, 25.5; LC–MS (ESI) <i>m</i>/<i>z</i>: 524.23 [M + H].</div></div><div id="sec4_3_32" class="NLM_sec NLM_sec_level_3"><div id="ac_i53" class="anchor-spacer"></div><h4 class="article-section__title" id="_i53"> 3-(2,4-Dimethoxyphenyl)-9-(3-((4-methyl-5-phenyl-4<i>H</i>-1,2,4-triazol-3-yl)thio)propyl)-3,9-diazaspiro[5.5]undecane (<b>26</b>)</h4><div class="NLM_p last">Following general method B, <b>26</b> was obtained as an off-white solid. (Yield 8%) <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 7.62–7.60 (m, 2H), 7.49–7.47 (m, 3H), 6.85–6.83 (m, 1H), 6.44–6.43 (m, 1H), 6.39–6.37 (m, 1H), 3.80 (s, 3H), 3.74 (s, 3H), 3.28 (t, <i>J</i> = 6.9 Hz, 2H), 2.88–2.87 (m, 4H), 2.75 (t, <i>J</i> = 7.0 Hz, 2H), 2.67 (bs, 4H), 2.17–2.11 (quint, <i>J</i> = 7.0 Hz, 2H), 1.69–1.66 (m, 8H); <sup>13</sup>C NMR (125 MHz, CDCl<sub>3</sub>) δ 156.0, 153.4, 151.6, 135.9, 130.1, 128.9, 128.6, 127.0, 118.5, 103.3, 99.8, 56.7, 55.5, 55.4, 49.1, 47.2, 36.0, 34.6, 31.7, 30.9, 28.9, 26.0; LC–MS (ESI) <i>m</i>/<i>z</i>: 522.09 [M + H].</div></div><div id="sec4_3_33" class="NLM_sec NLM_sec_level_3"><div id="ac_i54" class="anchor-spacer"></div><h4 class="article-section__title" id="_i54"> 3-(2-Fluorophenyl)-9-(3-((4-methyl-5-phenyl-4<i>H</i>-1,2,4-triazol-3-yl)thio)propyl)-3,9-diazaspiro[5.5]undecane (<b>28</b>)</h4><div class="NLM_p last">Following general method B, <b>28</b> was obtained as an off-white solid. (Yield 13%) <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 7.62–7.60 (m, 2H), 7.49–7.46 (m, 3H), 7.02–6.95 (m, 1H), 6.94–6.90 (m, 1H), 6.89–6.87 (m, 1H), 3.58 (s, 3H), 3.29–3.27 (t, <i>J</i> = 7.0 Hz, 2H), 2.99–2.97 (m, 4H), 2.74 (bs, 2H), 2.67 (bs, 4H), 2.15–2.12 (m, 2H), 1.68–1.64 (m, 8H); <sup>13</sup>C NMR (125 MHz, CDCl<sub>3</sub>) δ 156.0, 154.8 (d, <i>J</i><sub>C–F</sub> = 245.4 Hz), 151.6, 140.7 (d, <i>J</i><sub>C–C–F</sub> = 8.3 Hz), 130.1, 128.9, 128.6, 127.1, 127.1, 124.4 (d, <i>J</i><sub>C–C–C–F</sub> = 3.5 Hz), 122.2 (d, <i>J</i><sub>C–C–C–F</sub> = 7.8 Hz), 119.1 (d, <i>J</i><sub>C–C–C–C–F</sub> = 2.7 Hz), 116.1 (d, <i>J</i><sub>C–C–F</sub> = 20.9 Hz), 56.7, 49.0, 46.0 (2 × CH), 35.6 (bs), 34.5, 31.7, 30.9, 28.9, 26.0; LC–MS (ESI) <i>m</i>/<i>z</i>: 480.16 [M + H].</div></div><div id="sec4_3_34" class="NLM_sec NLM_sec_level_3"><div id="ac_i55" class="anchor-spacer"></div><h4 class="article-section__title" id="_i55"> 3-(2-Fluoro-4-(trifluoromethyl)phenyl)-9-(3-((4-methyl-5-phenyl-4<i>H</i>-1,2,4-triazol-3-yl)thio)propyl)-3,9-diazaspiro[5.5]undecane (<b>29</b>)</h4><div class="NLM_p last">Following general method B, <b>29</b> was obtained as a white solid. (Yield 28%) <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 7.62–7.60 (m, 2H), 7.49–7.46 (m, 3H), 7.28–7.26 (m, 1H), 7.22–7.19 (dd, <i>J</i><sub>1</sub> = 1.8 Hz, <i>J</i><sub>2</sub> = 12.7 Hz, 1H), 6.96–6.92 (t, <i>J</i> = 8.3 Hz, 1H), 3.58 (s, 3H), 3.30–3.27 (t, <i>J</i> = 7.0 Hz, 2H), 3.08–3.05 (m, 4H), 2.75 (bs, 2H), 2.67 (bs, 4H), 2.15–2.12 (m, 2H), 1.79–1.68 (m, 4H), 1.66–1.64 (m, 4H); <sup>13</sup>C NMR (125 MHz, CDCl<sub>3</sub>) δ 156.0, 153.6 (d, <i>J</i><sub>C–F</sub> = 249.6 Hz), 151.6, 143.5 (d, <i>J</i><sub>C–C–C–F</sub> = 8.5 Hz), 130.1, 129.0, 128.6, 127.1, 121.7 (q, <i>J</i><sub>C–C–CF<sub>3</sub></sub> = 3.5 Hz), 118.7 (d, <i>J</i><sub>C–C–C–F</sub> = 3.6 Hz), 113.4 (d, <i>J</i><sub>C–C–F</sub> = 21.0 Hz) and (quint, <i>J</i><sub>C–C–C–CF<sub>3</sub></sub> = 3.4 Hz), 56.7, 49.0, 46.0 (2 × CH), 35.4 (bs), 34.5, 31.7, 30.9, 29.0, 26.1; LC–MS (ESI) <i>m</i>/<i>z</i>: 548.14 [M + H].</div></div><div id="sec4_3_35" class="NLM_sec NLM_sec_level_3"><div id="ac_i56" class="anchor-spacer"></div><h4 class="article-section__title" id="_i56"> 3-(4-Fluoro-2-methoxyphenyl)-9-(3-((4-methyl-5-phenyl-4<i>H</i>-1,2,4-triazol-3-yl)thio)propyl)-3,9-diazaspiro[5.5]undecane (<b>30</b>)</h4><div class="NLM_p last">Following general method B, <b>30</b> was obtained as an off-white solid. (Yield 24%) <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 7.59–7.57 (m, 2H), 7.45–7.43 (m, 3H), 6.83–6.80 (m, 1H), 6.54–6.51 (m, 2H), 6.89–6.87, 3.78 (s, 3H), 3.54 (s, 3H), 3.28–3.25 (t, <i>J</i> = 7.1 Hz, 2H), 2.86–2.85 (m, 4H), 2.47–2.44 (t, <i>J</i> = 7.1 Hz, 2H), 2.38 (bs, 4H), 1.97–1.95 (quint, <i>J</i> = 7.1 Hz, 2H), 1.62–1.60 (m, 4H), 1.54–1.51 (m, 4H); <sup>13</sup>C NMR (125 MHz, CDCl<sub>3</sub>) δ 157.9 (d, <i>J</i><sub>C–F</sub> = 239.7 Hz), 155.7, 153.2 (d, <i>J</i><sub>C–C–C–F</sub> = 9.3 Hz), 151.9, 138.4 (d, <i>J</i><sub>C–C–C–C–F</sub> = 2.7 Hz), 129.9, 128.8. 128.5, 127.1, 118.4 (d, <i>J</i><sub>C–C–C–F</sub> = 9.6 Hz), 106.0 (d, <i>J</i><sub>C–C–F</sub> = 20.9 Hz), 99.6 (d, <i>J</i><sub>C–C–F</sub> = 26.5 Hz), 57.3, 55.6, 49.2, 47.0, 35.8 (bs), 31.5, 31.2, 29.0, 27.0; LC–MS (ESI) <i>m</i>/<i>z</i>: 510.63 [M + H].</div></div><div id="sec4_3_36" class="NLM_sec NLM_sec_level_3"><div id="ac_i57" class="anchor-spacer"></div><h4 class="article-section__title" id="_i57"> 3-(2-Methoxyphenyl)-9-(3-((4-methyl-5-phenyl-4<i>H</i>-1,2,4-triazol-3-yl)thio)propyl)-3,9-diazaspiro[5.5]undec-1-ene (<b>32</b>)</h4><div class="NLM_p last">Following general method B, <b>32</b> was obtained as a dark red oil. (Yield 18%) <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 7.64–7.62 (m, 2H), 7.51–7.49 (m, 3H), 7.02–6.98 (m, 1H), 6.94–6.92 (m, 1H), 6.90–6.86 (m, 2H), 6.27–6.26 (d, <i>J</i> = 8.1 Hz, 1H), 4.62 (d, <i>J</i> = 7.9 Hz, 1H), 3.83 (s, 3H), 3.60 (s, 3H), 3.43–3.41 (m, 2H), 3.32 (t, <i>J</i> = 7.0 Hz, 2H), 2.80–2.74 (m, 4H), 2.73–2.67 (bs, 2H), 2.20–2.14 (quint, <i>J</i> = 7.5 Hz, 2H), 1.75–1.72 (m, 6H); <sup>13</sup>C NMR (125 MHz, CDCl<sub>3</sub>) δ 156.1, 152.4, 151.7, 137.5, 132.2, 130.2, 129.0, 128.7, 127.1, 123.8, 122.3, 121.1, 112.0, 56.9, 55.7, 49.5, 44.3, 37.7, 31.7, 31.0, 29.7, 26.1; LC–MS (ESI) <i>m</i>/<i>z</i>: 490.17 [M + H].</div></div><div id="sec4_3_37" class="NLM_sec NLM_sec_level_3"><div id="ac_i58" class="anchor-spacer"></div><h4 class="article-section__title" id="_i58"> 8-(2-Methoxyphenyl)-2-(3-((4-methyl-5-phenyl-4<i>H</i>-1,2,4-triazol-3-yl)thio)propyl)-2,8-diazaspiro[4.5]decane (<b>34</b>)</h4><div class="NLM_p last">Following general method B, <b>34</b> was obtained as a tan semisolid. (Yield 40%) <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 7.58–7.57 (m, 2H), 7.45–7.43 (m, 3H), 6.94–6.91 (m, 1H), 6.86–6.83 (m, 2H), 6.79–6.76 (m, 1H), 3.18 (s, 3H), 3.57 (s, 3H), 3.29–3.26 (m, 2H), 3.21–3.10 (m, 4H), 3.00 (bs, 2H), 2.91 (bs, 4H), 2.30–2.27 (m, 2H), 1.93 (bs, 2H), 1.84 (bs, 4H); <sup>13</sup>C NMR (125 MHz, CDCl<sub>3</sub>) δ 156.1, 152.1, 151.0, 141.4, 130.1, 128.9, 128.5, 126.8, 122.9, 120.8, 118.3, 111.0, 55.3, 54.4, 52.9, 48.4, 40.3, 36.7, 35.2, 31.7, 30.2, 26.2; LC–MS (ESI) <i>m</i>/<i>z</i>: 478.81 [M + H].</div></div><div id="sec4_3_38" class="NLM_sec NLM_sec_level_3"><div id="ac_i59" class="anchor-spacer"></div><h4 class="article-section__title" id="_i59"> <i>N</i>-(4-(9-(2-Methoxyphenyl)-3,9-diazaspiro[5.5]undecan-3-yl)butyl)-4-(thiophen-3-yl)benzamide (<b>35</b>)</h4><div class="NLM_p last">Compound <b>F</b> (1.0 mmol), 4-(thiophen-3-yl)benzoic acid (1.1 mmol), 1-hydroxybenzotriazole (HOBt) hydrate (1.0 mmol), 1-ethyl-3-(3′-dimethylaminopropyl)carbodiimide (EDC)·HCl (1.0 mmol) were stirred in 15 mL of CH<sub>2</sub>Cl<sub>2</sub> at room temperature for 2 h. The reaction mixture was then washed with a saturated NaHCO<sub>3(aq)</sub> solution (10 mL). The reaction mixture was extracted with CH<sub>2</sub>Cl<sub>2</sub> (3 × 20 mL), and the organic layers were combined, dried, and concentrated to afford a crude white sold. The residue was purified by flash chromatography on silica gel eluting with MeOH/CH<sub>2</sub>Cl<sub>2</sub> (1:10) to afford <b>35</b> as a white solid. (Yield 31%) <sup>1</sup>H NMR (500 MHz, (CD<sub>3</sub>)<sub>2</sub>SO) δ 8.66 (m, 1H), 8.00 (bs, 1H), 7.95 (d, <i>J</i> = 7.7 Hz, 2H), 7.82 (d, <i>J</i> = 8.2 Hz, 2H), 7.67–7.65 (m, 1H), 7.63–7.62 (m, 1H), 6.91–6.88 (m, 3H), 6.85–6.83 (m, 1H), 3.75 (s, 3H), 3.31 (quint, <i>J</i> = 5.9 Hz, 2H), 2.96–2.87 (m, 9H), 1.69 (bs, 6H), 1.57–1.56 (m, 6H); <sup>13</sup>C NMR (125 MHz, (CD<sub>3</sub>)<sub>2</sub>SO) δ 165.7, 152.0, 141.8, 140.5, 137.5, 132.8, 127.9, 127.3, 126.2, 125.7, 122.3, 122.2, 120.7, 118.1, 111.7, 55.2, 47.5, 45.8, 38.5, 32.6, 28.4, 26.5, 21.5; LC–MS (ESI) <i>m</i>/<i>z</i>: 518.22 [M + H].</div></div><div id="sec4_3_39" class="NLM_sec NLM_sec_level_3"><div id="ac_i60" class="anchor-spacer"></div><h4 class="article-section__title" id="_i60"> 4-(Dimethylamino)-<i>N</i>-(4-(9-(2-methoxyphenyl)-3,9-diazaspiro[5.5]undecan-3-yl)butyl)benzamide (<b>36</b>)</h4><div class="NLM_p last">Compound <b>F</b> (1.0 mmol), 4-dimethylamino benzoic acid (1.1 mmol), 1-hydroxybenzotriazole (HOBt) hydrate (1.0 mmol), 1-ethyl-3-(3′-dimethylaminopropyl)carbodiimide (EDC)·HCl (1.0 mmol) were stirred in 15 mL of CH<sub>2</sub>Cl<sub>2</sub> at room temperature for 2 h. The reaction mixture was then washed with a saturated NaHCO<sub>3 (aq)</sub> solution (10 mL). The reaction mixture was extracted with CH<sub>2</sub>Cl<sub>2</sub> (3 × 20 mL), and the organic layers were combined, dried, and concentrated to afford a crude white sold. The residue was purified by flash chromatography on silica gel eluting with MeOH/CH<sub>2</sub>Cl<sub>2</sub> (1:10) to afford <b>36</b> as a white solid. (Yield 40%) <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 7.85 (d, <i>J</i> = 8.8 Hz, 2H), 7.33 (bs, 1H), 6.99–6.96 (m, 1H), 6.92–6.88 (m, 2H), 6.84–6.83 (m, 1H), 6.65 (d, <i>J</i> = 8.9 Hz, 2H), 3.84 (s, 3H), 3.47–3.44 (m, 2H), 3.10–2.95 (m, 16H), 1.91–1.90 (m, 6H), 1.71–1.67 (m, 6H); <sup>13</sup>C NMR (125 MHz, CDCl<sub>3</sub>) δ 167.8, 152.4, 152.2, 141.5, 128.8, 123.1, 121.0, 120.9, 118.3, 111.2, 111.1, 56.3, 55.4, 48.4, 46.5, 40.2, 38.0, 32.4, 28.7,26.5, 21.1; LC–MS (ESI) <i>m</i>/<i>z</i>: 479.35 [M + H].</div></div><div id="sec4_3_40" class="NLM_sec NLM_sec_level_3"><div id="ac_i61" class="anchor-spacer"></div><h4 class="article-section__title" id="_i61"> 7-(3-(9-(2-Methoxyphenyl)-3,9-diazaspiro[5.5]undecan-3-yl)propoxy)-3,4-dihydroquinolin-2(1<i>H</i>)-one (<b>37</b>)</h4><div class="NLM_p last"><b>4b′</b> (1.5 mmol), <b>G</b><a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a> (1.5 mmol), KI (1.5 mmol), and K<sub>2</sub>CO<sub>3</sub> (5.0 mmol) were dissolved in acetonitrile (15 mL), and the reaction mixture was stirred at 90 °C for 12 h. The reaction mixture was then filtered, and the solvent was removed under reduced pressure. The crude residue was purified by silica gel column chromatography eluting with 10% 7 N NH<sub>3</sub> in MeOH solution/CH<sub>2</sub>Cl<sub>2</sub> (1:10) to afford <b>37</b> as a white solid (Yield 62%). <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 8.88 (s, 1H), 7.02–7.00 (d, <i>J</i> = 8.4 Hz, 1H), 6.98–6.95 (m, 2H), 6.91–6.88 (m, 1H), 6.84–6.83 (d, <i>J</i> = 8.0 Hz, 1H), 6.52–6.50 (dd, <i>J</i><sub>1</sub> = 2.1 Hz, <i>J</i><sub>2</sub> = 8.2 Hz, 1H), 6.37–6.36 (m, 1H), 3.97–3.95 (t, <i>J</i> = 6.1 Hz, 2H), 3.84 (s, 3H), 2.99–2.97 (m, 4H), 2.89–2.86 (t, <i>J</i> = 7.4 Hz, 2H), 2.61–2.58 (t, <i>J</i> = 7.9 Hz, 2H), 2.53–2.50 (t, <i>J</i> = 7.0 Hz, 2H), 2.45 (bs, 4H), 2.01–1.95 (m, 2H), 1.69–1.67 (m, 4H), 1.61–1.59 (m, 4H); <sup>13</sup>C NMR (125 MHz, CDCl<sub>3</sub>) δ 172.2, 158.7, 152.3, 142.3, 138.3 (2 × CH), 128.6, 122.6, 120.9, 118.3, 115.7, 111.1, 108.7, 102.4, 66.7, 55.7, 55.4, 49.4, 46.8, 36.2 (bs), 35.8, 31.1, 29.2, 26.9, 24.6; LC–MS (ESI) <i>m</i>/<i>z</i>: 464.68 [M + H].</div></div></div><div id="sec4_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i62" class="anchor-spacer"></div><h3 class="article-section__title" id="_i62"> Receptor Binding Assays</h3><div class="NLM_p">Receptor <i>K</i><sub>i</sub> values were measured using human D<sub>2</sub> (long) and D<sub>3</sub> expressed in HEK cells with [<sup>125</sup>I]IABN as the radioligand. The binding properties of membrane-associated receptors were characterized by a filtration binding assay.<a onclick="showRef(event, 'ref37'); return false;" href="javascript:void(0);" class="ref ref37">(37)</a> Membrane homogenates were suspended in 50 mM Tris–HCl/150 mM NaCl/10 mM EDTA buffer, pH 7.5, and incubated with [<sup>125</sup>I]IABN<a onclick="showRef(event, 'ref37'); return false;" href="javascript:void(0);" class="ref ref37">(37)</a> at 37 °C for 60 min, using 20 μM (+)-butaclamol to define the nonspecific binding.</div><div class="NLM_p last">The radioligand concentration was equal to approximately 0.5 (D<sub>2/3</sub>R) times the <i>K</i><sub>d</sub>, and the concentration of the competitive inhibitor ranged over 5 orders of magnitude. For each competition curve, two concentrations of inhibitor per decade were used, and triplicates were performed. Binding was terminated by the addition of ice cold wash buffer (D<sub>2/3</sub>R, 10 mM Tris–HCl, 150 mM NaCl, pH 7.5; 5-HT<sub>1A</sub>R, 10 mM Tris–HCl, pH 7.4) and filtration over a glass-fiber filter (D<sub>3/2</sub>R, Schleicher and Schuell No. 32; 5-HT<sub>1A</sub>R, Whatman grade 934-AH, GE Healthcare Bio-Sciences, Pittsburgh, PA). A Packard Cobra scintillation counter was used to measure the radioactivity. The equilibrium dissociation constant and maximum number of binding sites were generated using unweighted nonlinear regression analysis of data modeled according to the equation describing mass R-binding. The concentration of inhibitor that inhibits 50% of the specific binding of the radioligand (IC<sub>50</sub>) was determined by using nonlinear regression analysis to analyze the data of competitive inhibition experiments. Competition curves were modeled for a single site, and the IC<sub>50</sub> values were converted to equilibrium dissociation constants (<i>K</i><sub>i</sub>) using the Cheng and Prusoff<a onclick="showRef(event, 'ref51'); return false;" href="javascript:void(0);" class="ref ref51">(51)</a> correction. Mean <i>K</i><sub>i</sub> ± SEM values are reported for at least three independent experiments.</div></div><div id="sec4_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i63" class="anchor-spacer"></div><h3 class="article-section__title" id="_i63"> β-Arrestin Recruitment Assay</h3><div class="NLM_p">β-arrestin 2 recruitment to D<sub>3</sub>R was assayed using the DiscoverX Pathhunter kit according to the manufacturer’s instructions, with some minor modifications. In brief, CHO-K1 cells expressing human β-arrestin 2 tagged with a β-galactosidase enzyme lacking a part of the catalytic domain, and human D<sub>3</sub>R C-terminally tagged with a complementary fragment of β-galactosidase, were grown in culture medium (DiscoverX) supplemented with G418 and hygromycin. Cells were seeded into white plastic 96-well plates at a density of 2 × 10<sup>4</sup> cells/well, 24 h prior to the assay, in a volume of 50 μL/well of Cell Plating Reagent 2 (CP2; DiscoverX).</div><div class="NLM_p">Test compounds were dissolved in DMSO and diluted to the appropriate concentrations in CP2, added the cells in a volume of 30 μL/well, and preincubated with the cells at 37 °C for 30 min. Next, dopamine (dissolved and diluted in 30 μL CP2 so as to obtain the various concentrations used to construct concentration–response curves) was applied, followed by another 90 min of incubation at 37 °C.</div><div class="NLM_p last">Finally, to detect functional complementation of β-galactosidase upon dopamine-induced β-arrestin 2 recruitment to D<sub>3</sub>R, cells were treated with a detection cocktail containing a coelenterazine-based β-galactosidase substrate (as described by the manufacturer), and incubated for another 60 min at room temperature, prior to assay read-out using a PerkinElmer Enspire plate reader (luminescence mode; read time 1 s/well).</div></div><div id="sec4_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i64" class="anchor-spacer"></div><h3 class="article-section__title" id="_i64"> Molecular Docking Studies</h3><div class="NLM_p last">In silico molecular docking studies were performed following by the previous study.<a onclick="showRef(event, 'ref52'); return false;" href="javascript:void(0);" class="ref ref52">(52)</a> Compounds <b>1</b>, <b>17</b>, <b>19</b>, <b>31</b>, and <b>32</b> were drawn on ChemDraw Profession 15.1 (PerkinElmer Informatics, Inc.), then imported to Chem3D Ultra 15.1 (PerkinElmer Informatics, Inc.) to minimize individual structures by MMFF94 force field for preparation of molecular docking. Molecular docking studies were performed via AutoDock 4.2<a onclick="showRef(event, 'ref53'); return false;" href="javascript:void(0);" class="ref ref53">(53)</a> plugin on PyMOL (<a href="http://pymol.org" class="extLink">pymol.org</a>). X-ray structure of dopamine 3 receptor (D<sub>3</sub>R) (PDB ID <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3PBL">3PBL</a>, Resolution 2.89 Å) was obtained from RCSB Protein Data Bank (<a href="http://www.rcsb.org" class="extLink">www.rcsb.org</a>). Waters and other heteroatoms were removed from the structure, followed by adding polar hydrogens. Nonpolar hydrogens were removed from every compound. A grid box with a dimension of 30 × 30 × 28.2 Å<sup>3</sup> was applied to the D<sub>3</sub>R X-ray structure, covering orthosteric and secondary binding sites. The Lamarckian Genetic Algorithm with a maximum of 2 500 000 energy evaluations was used to calculate 100 protein–ligand binding poses for each compound to each protein. The protein–ligand complex reported for each compound exhibited the most ligand–protein contacts with the lowest free binding energy.</div></div><div id="sec4_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i65" class="anchor-spacer"></div><h3 class="article-section__title" id="_i65"> Data Analysis</h3><div class="NLM_p last">Statistical analyses from pharmacological assays were conducted on a GraphPad Prism 7.04 software.</div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i66"><a href="/doi/suppl/10.1021/acs.jmedchem.9b00412" class="ext-link">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_08787" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_08787" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge on the <a href="/" class="ext-link">ACS Publications website</a> at DOI: <a href="/doi/abs/10.1021/acs.jmedchem.9b00412" class="ext-link">10.1021/acs.jmedchem.9b00412</a>.<ul class="NLM_list-list_type-label" id="silist"><li><p class="inline"><sup>1</sup>H and <sup>13</sup>C NMR spectra and mass spectral data of isolated compounds <b>E</b>, <b>F</b>, <b>4a</b>, <b>5a</b>–<b>c</b>, <b>6a</b>, <b>6c</b>–<b>f</b>, <b>6h</b>, <b>7</b>–<b>24</b>, <b>26</b>, <b>28</b>–<b>30</b>, <b>32</b>, <b>34</b>–<b>37</b>, and LC–MS traces of <b>1</b> and <b>31</b> (<a href="/doi/suppl/10.1021/acs.jmedchem.9b00412/suppl_file/jm9b00412_si_001.pdf" class="ext-link">PDF</a>)</p></li><li><p class="inline">Molecular formula strings and some data (<a href="/doi/suppl/10.1021/acs.jmedchem.9b00412/suppl_file/jm9b00412_si_002.csv" class="ext-link">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.9b00412/suppl_file/jm9b00412_si_001.pdf">jm9b00412_si_001.pdf (3.47 MB)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.9b00412/suppl_file/jm9b00412_si_002.csv">jm9b00412_si_002.csv (3.22 kb)</a></li></ul></div></div></div><div class="testing" data-doi="10.1021/acs.jmedchem.9b00412" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_83248" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_83248" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Author</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Robert H. Mach</span> - <span class="hlFld-Affiliation affiliation">Department
of Radiology, Perelman School of Medicine,
University of Pennsylvania, Philadelphia, Pennsylvania 19104, United States</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-7645-2869" title="Orcid link">http://orcid.org/0000-0002-7645-2869</a>; 
    </span><span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#46342b27252e06362328282b23222f252f282368333623282868232233"><span class="__cf_email__" data-cfemail="03716e62606b4373666d6d6e66676a606a6d662d7673666d6d2d666776">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Sean W. Reilly</span> - <span class="hlFld-Affiliation affiliation">Department
of Radiology, Perelman School of Medicine,
University of Pennsylvania, Philadelphia, Pennsylvania 19104, United States</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-1656-1895" title="Orcid link">http://orcid.org/0000-0002-1656-1895</a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Aladdin A. Riad</span> - <span class="hlFld-Affiliation affiliation">Department
of Radiology, Perelman School of Medicine,
University of Pennsylvania, Philadelphia, Pennsylvania 19104, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Chia-Ju Hsieh</span> - <span class="hlFld-Affiliation affiliation">Department
of Radiology, Perelman School of Medicine,
University of Pennsylvania, Philadelphia, Pennsylvania 19104, United States</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-2833-7727" title="Orcid link">http://orcid.org/0000-0002-2833-7727</a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Kristoffer Sahlholm</span> - <span class="hlFld-Affiliation affiliation">Department
of Radiology, Perelman School of Medicine,
University of Pennsylvania, Philadelphia, Pennsylvania 19104, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Daniel A. Jacome</span> - <span class="hlFld-Affiliation affiliation">Department
of Systems Pharmacology and Translational Therapeutics, University of Pennsylvania, 421 Curie Boulevard, Philadelphia, Pennsylvania 19104, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Suzy Griffin</span> - <span class="hlFld-Affiliation affiliation">Department
of Pharmacology and Neuroscience, University
of North Texas Health Science Center, 3500 Camp Bowie Boulevard, Fort Worth, Texas 76107, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Michelle Taylor</span> - <span class="hlFld-Affiliation affiliation">Department
of Pharmacology and Neuroscience, University
of North Texas Health Science Center, 3500 Camp Bowie Boulevard, Fort Worth, Texas 76107, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Chi-Chang Weng</span> - <span class="hlFld-Affiliation affiliation">Department
of Radiology, Perelman School of Medicine,
University of Pennsylvania, Philadelphia, Pennsylvania 19104, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Kuiying Xu</span> - <span class="hlFld-Affiliation affiliation">Department
of Radiology, Perelman School of Medicine,
University of Pennsylvania, Philadelphia, Pennsylvania 19104, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Nathan Kirschner</span> - <span class="hlFld-Affiliation affiliation">Department
of Radiology, Perelman School of Medicine,
University of Pennsylvania, Philadelphia, Pennsylvania 19104, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Robert R. Luedtke</span> - <span class="hlFld-Affiliation affiliation">Department
of Pharmacology and Neuroscience, University
of North Texas Health Science Center, 3500 Camp Bowie Boulevard, Fort Worth, Texas 76107, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Christopher Parry</span> - <span class="hlFld-Affiliation affiliation">Program
in Molecular Therapeutics, Fox Chase Cancer
Center, 333 Cottman Avenue, Philadelphia, Pennsylvania 19111, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Shipra Malhotra</span> - <span class="hlFld-Affiliation affiliation">Program
in Molecular Therapeutics, Fox Chase Cancer
Center, 333 Cottman Avenue, Philadelphia, Pennsylvania 19111, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">John Karanicolas</span> - <span class="hlFld-Affiliation affiliation">Program
in Molecular Therapeutics, Fox Chase Cancer
Center, 333 Cottman Avenue, Philadelphia, Pennsylvania 19111, United States</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0003-0300-726X" title="Orcid link">http://orcid.org/0000-0003-0300-726X</a></span></div></li></ul></li><li><span class="author-information-subsection-header">Author Contributions</span><p>The manuscript was written through contributions of all authors. All authors have given approval to the final version of the manuscript.</p></li><li><span class="author-information-subsection-header">Funding</span><p>National Institute on Drug Abuse (Grant R01 DA29840-07 to R.H.M., Grant R01 DA23957-06 to R.R.L.) is gratefully acknowledged for financial support. S.W.R. and A.A.R. are supported by Training Grant 5T32DA028874-08.</p></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare no competing financial interest.<br /></br></div></li></ul></div><div class="ack" id="ACK-d7e6733-autogenerated"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i68">Acknowledgments</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_71112" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_71112" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last"><i>K</i><sub>i</sub> determinations, receptor binding profiles, and agonist/antagonist functional data (outlined in Figure 4 and Table 6) was generously provided by the National Institute of Mental Health’s Psychoactive Drug Screening Program, Contract #HHSN-271-2013-00017-C (NIMH PDSP). The NIMH PDSP is Directed by Bryan L. Roth at the University of North Carolina at Chapel Hill and Project Officer Jamie Driscoll at NIMH, Bethesda MD. For experimental details, please refer to the PDSP website <a href="https://pdsp.unc.edu/ims/investigator/web/" class="extLink">https://pdsp.unc.edu/ims/investigator/web/</a>.</p></div><table summary="" class="NLM_def-list" id="dl1"><tr><td colspan="2" class="NLM_title">Abbreviations</td></tr><tr><td class="NLM_term">ACN</td><td class="NLM_def"><p class="first last">acetonitrile</p></td></tr><tr><td class="NLM_term">AMP</td><td class="NLM_def"><p class="first last">adenosine monophosphate</p></td></tr><tr><td class="NLM_term">CNS</td><td class="NLM_def"><p class="first last">central nervous system</p></td></tr><tr><td class="NLM_term">DA</td><td class="NLM_def"><p class="first last">dopamine</p></td></tr><tr><td class="NLM_term">DCM</td><td class="NLM_def"><p class="first last">dichloromethane</p></td></tr><tr><td class="NLM_term">D<sub>2</sub>R</td><td class="NLM_def"><p class="first last">dopamine D<sub>2</sub> receptor</p></td></tr><tr><td class="NLM_term">D<sub>3</sub>R</td><td class="NLM_def"><p class="first last">dopamine D<sub>3</sub> receptor</p></td></tr><tr><td class="NLM_term">GPCR</td><td class="NLM_def"><p class="first last">G-protein-coupled receptor</p></td></tr><tr><td class="NLM_term">HEK</td><td class="NLM_def"><p class="first last">human embryonic kidney 293</p></td></tr><tr><td class="NLM_term">[<sup>125</sup>I]IABN</td><td class="NLM_def"><p class="first last">[<sup>125</sup>I]-<i>N</i>-benzyl-5-iodo-2,3-dimethoxy[3.3.1]azabicyclononan-3-β-ylbenzamide</p></td></tr><tr><td class="NLM_term">Pd</td><td class="NLM_def"><p class="first last">palladium</p></td></tr><tr><td class="NLM_term">PET</td><td class="NLM_def"><p class="first last">positron-emission tomography</p></td></tr><tr><td class="NLM_term">TFA</td><td class="NLM_def"><p class="first last">trifluoroacetic acid</p></td></tr></table><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i70">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_74761" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_74761" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 53 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Leggio, G. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bucolo, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Platania, C. B. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Salomone, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Drago, F.</span></span> <span> </span><span class="NLM_article-title">Current Drug Treatments Targeting Dopamine D3 Receptor</span>. <i>Pharmacol. Ther.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>165</i></span>,  <span class="NLM_fpage">164</span>– <span class="NLM_lpage">177</span>, <span class="refDoi"> DOI: 10.1016/j.pharmthera.2016.06.007</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00412&amp;key=10.1016%2Fj.pharmthera.2016.06.007" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00412&amp;key=27343365" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00412&amp;key=1%3ACAS%3A528%3ADC%252BC28XhtVGisbfF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=165&publication_year=2016&pages=164-177&author=G.+M.+Leggioauthor=C.+Bucoloauthor=C.+B.+M.+Plataniaauthor=S.+Salomoneauthor=F.+Drago&title=Current+Drug+Treatments+Targeting+Dopamine+D3+Receptor&doi=10.1016%2Fj.pharmthera.2016.06.007"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Current drug treatments targeting dopamine D3 receptor</span></div><div class="casAuthors">Leggio, Gian Marco; Bucolo, Claudio; Platania, Chiara Bianca Maria; Salomone, Salvatore; Drago, Filippo</div><div class="citationInfo"><span class="NLM_cas:title">Pharmacology & Therapeutics</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">165</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">164-177</span>CODEN:
                <span class="NLM_cas:coden">PHTHDT</span>;
        ISSN:<span class="NLM_cas:issn">0163-7258</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">Dopamine receptors (DR) have been extensively studied, but only in recent years they became object of investigation to elucidate the specific role of different subtypes (D1R, D2R, D3R, D4R, D5R) in neural transmission and circuitry.  D1-like receptors (D1R and D5R) and D2-like receptors (D2R, D2R and D4R) differ in signal transduction, binding profile, localization in the central nervous system and physiol. effects.  D3R is involved in a no. of pathol. conditions, including schizophrenia, Parkinson's disease, addiction, anxiety, depression and glaucoma.  Development of selective D3R ligands has been so far challenging, due to the high sequence identity and homol. shared by D2R and D3R.  As a consequence, despite a rational design of selective DR ligands has been carried out, none of currently available medicines selectively target a given D2-like receptor subtype.  The availability of the D3R ligand [11C]-(+)-PHNO for positron emission tomog. studies in animal models as well as in humans, allows researchers to est. the expression of D3R in vivo; displacement of [11C]-(+)-PHNO binding by concurrent drug treatments is used to est. the in vivo occupancy of D3R.  Here we provide an overview of studies indicating D3R as a target for pharmacol. therapy, and a review of market approved drugs endowed with significant affinity at D3R that are used to treat disorders where D3R plays a relevant role.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGripJ2xDVYRubVg90H21EOLACvtfcHk0liwCico3sk76g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhtVGisbfF&md5=e29dffe5b17b48f68d33ec838ece35dc</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1016%2Fj.pharmthera.2016.06.007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.pharmthera.2016.06.007%26sid%3Dliteratum%253Aachs%26aulast%3DLeggio%26aufirst%3DG.%2BM.%26aulast%3DBucolo%26aufirst%3DC.%26aulast%3DPlatania%26aufirst%3DC.%2BB.%2BM.%26aulast%3DSalomone%26aufirst%3DS.%26aulast%3DDrago%26aufirst%3DF.%26atitle%3DCurrent%2520Drug%2520Treatments%2520Targeting%2520Dopamine%2520D3%2520Receptor%26jtitle%3DPharmacol.%2520Ther.%26date%3D2016%26volume%3D165%26spage%3D164%26epage%3D177%26doi%3D10.1016%2Fj.pharmthera.2016.06.007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Keck, T. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">John, W. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Czoty, P. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nader, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Newman, A. H.</span></span> <span> </span><span class="NLM_article-title">Identifying Medication Targets for Psychostimulant Addiction: Unraveling the Dopamine D3 Receptor Hypothesis</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>58</i></span>,  <span class="NLM_fpage">5361</span>– <span class="NLM_lpage">5380</span>, <span class="refDoi"> DOI: 10.1021/jm501512b</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm501512b" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00412&amp;key=1%3ACAS%3A528%3ADC%252BC2MXlsFGgu74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2015&pages=5361-5380&author=T.+M.+Keckauthor=W.+S.+Johnauthor=P.+W.+Czotyauthor=M.+A.+Naderauthor=A.+H.+Newman&title=Identifying+Medication+Targets+for+Psychostimulant+Addiction%3A+Unraveling+the+Dopamine+D3+Receptor+Hypothesis&doi=10.1021%2Fjm501512b"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Identifying Medication Targets for Psychostimulant Addiction: Unraveling the Dopamine D3 Receptor Hypothesis</span></div><div class="casAuthors">Keck, Thomas M.; John, William S.; Czoty, Paul W.; Nader, Michael A.; Newman, Amy Hauck</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">5361-5380</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The dopamine D3 receptor (D3R) is a target for developing medications to treat substance use disorders.  D3R-selective compds. with high affinity and varying efficacies have been discovered, providing crit. research tools for cell-based studies that have been translated to in vivo models of drug abuse.  D3R antagonists and partial agonists have shown esp. promising results in rodent models of relapse-like behavior, including stress-, drug-, and cue-induced reinstatement of drug seeking.  However, to date, translation to human studies has been limited.  Herein, we present an overview and illustrate some of the pitfalls and challenges of developing novel D3R-selective compds. toward clin. utility, esp. for treatment of cocaine abuse.  Future research and development of D3R-selective antagonists and partial agonists for substance abuse remains critically important but will also require further evaluation and development of translational animal models to det. the best time in the addiction cycle to target D3Rs for optimal therapeutic efficacy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpKVPGvcTvN87Vg90H21EOLACvtfcHk0lgSkECP3nizfQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXlsFGgu74%253D&md5=99f531d840ad7f94d0eeadeb6fd48100</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1021%2Fjm501512b&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm501512b%26sid%3Dliteratum%253Aachs%26aulast%3DKeck%26aufirst%3DT.%2BM.%26aulast%3DJohn%26aufirst%3DW.%2BS.%26aulast%3DCzoty%26aufirst%3DP.%2BW.%26aulast%3DNader%26aufirst%3DM.%2BA.%26aulast%3DNewman%26aufirst%3DA.%2BH.%26atitle%3DIdentifying%2520Medication%2520Targets%2520for%2520Psychostimulant%2520Addiction%253A%2520Unraveling%2520the%2520Dopamine%2520D3%2520Receptor%2520Hypothesis%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2015%26volume%3D58%26spage%3D5361%26epage%3D5380%26doi%3D10.1021%2Fjm501512b" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Strange, P. G.</span></span> <span> </span><span class="NLM_article-title">Antipsychotic Drug Action: Antagonism, Inverse Agonism or Partial Agonism</span>. <i>Trends Pharmacol. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>29</i></span>,  <span class="NLM_fpage">314</span>– <span class="NLM_lpage">321</span>, <span class="refDoi"> DOI: 10.1016/j.tips.2008.03.009</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00412&amp;key=10.1016%2Fj.tips.2008.03.009" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=2008&pages=314-321&author=P.+G.+Strange&title=Antipsychotic+Drug+Action%3A+Antagonism%2C+Inverse+Agonism+or+Partial+Agonism&doi=10.1016%2Fj.tips.2008.03.009"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1016%2Fj.tips.2008.03.009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.tips.2008.03.009%26sid%3Dliteratum%253Aachs%26aulast%3DStrange%26aufirst%3DP.%2BG.%26atitle%3DAntipsychotic%2520Drug%2520Action%253A%2520Antagonism%252C%2520Inverse%2520Agonism%2520or%2520Partial%2520Agonism%26jtitle%3DTrends%2520Pharmacol.%2520Sci.%26date%3D2008%26volume%3D29%26spage%3D314%26epage%3D321%26doi%3D10.1016%2Fj.tips.2008.03.009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Murray, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ryoo, H. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gurevich, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Joyce, J. N.</span></span> <span> </span><span class="NLM_article-title">Localization of Dopamine D3 Receptors to Mesolimbic and D2 Receptors to Mesostriatal Regions of Human Forebrain</span>. <i>Proc. Natl. Acad. Sci. U.S.A.</i> <span class="NLM_year" style="font-weight: bold;">1994</span>,  <span class="NLM_volume"><i>91</i></span>,  <span class="NLM_fpage">11271</span>– <span class="NLM_lpage">11275</span>, <span class="refDoi"> DOI: 10.1073/pnas.91.23.11271</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00412&amp;key=10.1073%2Fpnas.91.23.11271" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00412&amp;key=7972046" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00412&amp;key=1%3ACAS%3A528%3ADyaK2cXmvFems70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=91&publication_year=1994&pages=11271-11275&author=A.+M.+Murrayauthor=H.+L.+Ryooauthor=E.+Gurevichauthor=J.+N.+Joyce&title=Localization+of+Dopamine+D3+Receptors+to+Mesolimbic+and+D2+Receptors+to+Mesostriatal+Regions+of+Human+Forebrain&doi=10.1073%2Fpnas.91.23.11271"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Localization of dopamine D3 receptors to mesolimbic and D2 receptors to mesostriatal regions of human forebrain</span></div><div class="casAuthors">Murray, Angela M.; Ryoo, Han L.; Gurevich, Eugenia; Joyce, Jeffrey N.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">1994</span>),
    <span class="NLM_cas:volume">91</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">11271-5</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">We characterized the binding of [125I]epidepride to dopamine D2-like and D3-like receptors in tissue sections of human striatum.  The competition for binding of [125I]epidepride by domperidone, quinpirole, and 7-hydroxy-N,N-di(1-propyl)-2-aminotetralin (7-OH-DPAT) was best fit by assuming one site in the caudate but two sites in nucleus accumbens.  Guanosine 5'-[β,γ-imido]triphosphate showed a large modulatory influence in agonist inhibition of [125I]epidepride binding in caudate but not in nucleus accumbens.  The binding of [125I]epidepride in the presence of 7-OH-DPAT (1000-fold selective for D3-like vs. D2-like sites) and domperidone (20-fold selective for D2 vs. D3-like sites) was used to quantify the nos. of D2-like and D3-like receptors in areas of human brain.  The distribution of D2-like and D3-like receptors was largely nonoverlapping.  Binding of [125I]epidepride to D3-like receptors was negligible in the dorsal striatum but was concd. in islands of dense binding in the nucleus accumbens and ventral putamen that aligned with acetylcholinesterase-poor striosomes.  Binding to D3-like receptors was also enriched in the internal globus pallidus, ventral palladium, septum, islands of Calleja, nucleus basalis, amygdalostriatal transition nucleus of the amygdala, central nucleus of the amygdala, and ventral tegmental area.  Binding of [125I]epidepride to D2 but not D3 receptors was detected in cortex and hippocampus.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqXhwrtC4swVrVg90H21EOLACvtfcHk0lgSkECP3nizfQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2cXmvFems70%253D&md5=229c93d0b8695eb673e9c7265a1d574f</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1073%2Fpnas.91.23.11271&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.91.23.11271%26sid%3Dliteratum%253Aachs%26aulast%3DMurray%26aufirst%3DA.%2BM.%26aulast%3DRyoo%26aufirst%3DH.%2BL.%26aulast%3DGurevich%26aufirst%3DE.%26aulast%3DJoyce%26aufirst%3DJ.%2BN.%26atitle%3DLocalization%2520of%2520Dopamine%2520D3%2520Receptors%2520to%2520Mesolimbic%2520and%2520D2%2520Receptors%2520to%2520Mesostriatal%2520Regions%2520of%2520Human%2520Forebrain%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D1994%26volume%3D91%26spage%3D11271%26epage%3D11275%26doi%3D10.1073%2Fpnas.91.23.11271" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Heidbreder, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Newman, A. H.</span></span> <span> </span><span class="NLM_article-title">Current Perspectives on Selective Dopamine D3 Receptor Antagonists as Pharmacotherapeutics for Addictions and Related Disorders</span>. <i>Ann. N. Y. Acad. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>1187</i></span>,  <span class="NLM_fpage">4</span>– <span class="NLM_lpage">34</span>, <span class="refDoi"> DOI: 10.1111/j.1749-6632.2009.05149.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00412&amp;key=10.1111%2Fj.1749-6632.2009.05149.x" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1187&publication_year=2010&pages=4-34&author=C.+A.+Heidbrederauthor=A.+H.+Newman&title=Current+Perspectives+on+Selective+Dopamine+D3+Receptor+Antagonists+as+Pharmacotherapeutics+for+Addictions+and+Related+Disorders&doi=10.1111%2Fj.1749-6632.2009.05149.x"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1111%2Fj.1749-6632.2009.05149.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1749-6632.2009.05149.x%26sid%3Dliteratum%253Aachs%26aulast%3DHeidbreder%26aufirst%3DC.%2BA.%26aulast%3DNewman%26aufirst%3DA.%2BH.%26atitle%3DCurrent%2520Perspectives%2520on%2520Selective%2520Dopamine%2520D3%2520Receptor%2520Antagonists%2520as%2520Pharmacotherapeutics%2520for%2520Addictions%2520and%2520Related%2520Disorders%26jtitle%3DAnn.%2520N.%2520Y.%2520Acad.%2520Sci.%26date%3D2010%26volume%3D1187%26spage%3D4%26epage%3D34%26doi%3D10.1111%2Fj.1749-6632.2009.05149.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Slifstein, M.</span>; <span class="NLM_string-name">Rabiner, E. A.</span>; <span class="NLM_string-name">Gunn, R. N.</span></span> <span> </span><span class="NLM_article-title">Imaging the Dopamine D3 Receptor In Vivo</span>. In  <i>Imaging of the Human Brain in Health and Disease</i>; <span class="NLM_publisher-name">Academic Press</span>: <span class="NLM_publisher-loc">Boston</span>, <span class="NLM_year">2014</span>; Chapter 11, pp  <span class="NLM_fpage">265</span>– <span class="NLM_lpage">287</span>.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00412&amp;key=10.1016%2FB978-0-12-418677-4.00011-7" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2014&pages=265-287&author=M.+Slifstein&author=E.+A.+Rabiner&author=R.+N.+Gunn&title=Imaging+of+the+Human+Brain+in+Health+and+Disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1016%2FB978-0-12-418677-4.00011-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26id%3Ddoi%3A10.1016%252FB978-0-12-418677-4.00011-7%26sid%3Dliteratum%253Aachs%26aulast%3DSlifstein%26aufirst%3DM.%26atitle%3DImaging%2520the%2520Dopamine%2520D3%2520Receptor%2520In%2520Vivo%26btitle%3DImaging%2520of%2520the%2520Human%2520Brain%2520in%2520Health%2520and%2520Disease%26pub%3DAcademic%2520Press%26date%3D2014%26spage%3D265%26epage%3D287" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Searle, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beaver, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Comley, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bani, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tziortzi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Slifstein, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mugnaini, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Griffante, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wilson, A. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Merlo-Pich, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Houle, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gunn, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rabiner, E. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Laruelle, M.</span></span> <span> </span><span class="NLM_article-title">Imaging Dopamine D<sub>3</sub> Receptors in the Human Brain with Positron Emission Tomography, [<sup>11</sup>C]PHNO, and a Selective D<sub>3</sub> Receptor Antagonist</span>. <i>Biol. Psychiatry</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>68</i></span>,  <span class="NLM_fpage">392</span>– <span class="NLM_lpage">399</span>, <span class="refDoi"> DOI: 10.1016/j.biopsych.2010.04.038</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00412&amp;key=10.1016%2Fj.biopsych.2010.04.038" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00412&amp;key=20599188" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00412&amp;key=1%3ACAS%3A528%3ADC%252BC3cXps1eitrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=68&publication_year=2010&pages=392-399&author=G.+Searleauthor=J.+D.+Beaverauthor=R.+A.+Comleyauthor=M.+Baniauthor=A.+Tziortziauthor=M.+Slifsteinauthor=M.+Mugnainiauthor=C.+Griffanteauthor=A.+A.+Wilsonauthor=E.+Merlo-Pichauthor=S.+Houleauthor=R.+Gunnauthor=E.+A.+Rabinerauthor=M.+Laruelle&title=Imaging+Dopamine+D3+Receptors+in+the+Human+Brain+with+Positron+Emission+Tomography%2C+%5B11C%5DPHNO%2C+and+a+Selective+D3+Receptor+Antagonist&doi=10.1016%2Fj.biopsych.2010.04.038"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Imaging dopamine D3 receptors in the human brain with positron emission tomography, [11C]PHNO, and a selective D3 receptor antagonist</span></div><div class="casAuthors">Searle, Graham; Beaver, John D.; Comley, Robert A.; Bani, Massimo; Tziortzi, Andri; Slifstein, Mark; Mugnaini, Manolo; Griffante, Cristiana; Wilson, Alan A.; Merlo-Pich, Emilio; Houle, Sylvain; Gunn, Roger; Rabiner, Eugenii A.; Laruelle, Marc</div><div class="citationInfo"><span class="NLM_cas:title">Biological Psychiatry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">68</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">392-399</span>CODEN:
                <span class="NLM_cas:coden">BIPCBF</span>;
        ISSN:<span class="NLM_cas:issn">0006-3223</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">Dopamine D3 receptors are involved in the pathophysiol. of several neuropsychiatric conditions. [11C]-(+)-PHNO is a radiolabeled D2 and D3 agonist, suitable for imaging the agonist binding sites (denoted D2HIGH and D3) of these receptors with positron emission tomog. (PET).  PET studies in nonhuman primates documented that, in vivo, [11C]-(+)-PHNO displays a relative selectivity for D3 compared with D2HIGH receptor sites and that the [11C]-(+)-PHNO signal is enriched in D3 contribution compared with conventional ligands such as [11C] raclopride.  To define the D3 contribution (fPHNOD3) to [11C]-(+)-PHNO binding potential (BPND) in healthy humans, 52 PET scans were obtained in 19 healthy volunteers at baseline and following oral administration of various doses of the selective D3 receptor antagonist, GSK598809.  The impact of GSK598809 on [11C]-(+)-PHNO was regionally selective.  In dorsal regions of the striatum, GSK598809 did not significantly affect [11C]-(+)-PHNO BPND (fPHNOD3 ≈ 0%).  Conversely, in the substantia nigra, GSK598809 dose-dependently reduced [11C]-(+)-PHNO binding to nonspecific level (fPHNOD3 ≈ 100%).  In ventral striatum (VST), globus pallidus and thalamus (THA), [11C]-(+)-PHNO BPND was attributable to a combination of D2HIGH and D3 receptor sites, with fPHNOD3 of 26%, 67% and 46%, resp.  D3 receptor binding potential (BPNDD3) was highest in globus pallidus (1.90) and substantial nigra (1.39), with lower levels in VST (.77) and THA (.18) and negligible levels in dorsal striatum.  This study elucidated the pharmacol. nature of the [11C]-(+)-PHNO signal in healthy subjects and provided the first quantification of D3 receptor availability with PET in the living human brain.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqEJHz3sXsWDrVg90H21EOLACvtfcHk0ljur4qbD_UNZg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXps1eitrc%253D&md5=dbb2800b668a23be61f9b0c90f2725c3</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1016%2Fj.biopsych.2010.04.038&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.biopsych.2010.04.038%26sid%3Dliteratum%253Aachs%26aulast%3DSearle%26aufirst%3DG.%26aulast%3DBeaver%26aufirst%3DJ.%2BD.%26aulast%3DComley%26aufirst%3DR.%2BA.%26aulast%3DBani%26aufirst%3DM.%26aulast%3DTziortzi%26aufirst%3DA.%26aulast%3DSlifstein%26aufirst%3DM.%26aulast%3DMugnaini%26aufirst%3DM.%26aulast%3DGriffante%26aufirst%3DC.%26aulast%3DWilson%26aufirst%3DA.%2BA.%26aulast%3DMerlo-Pich%26aufirst%3DE.%26aulast%3DHoule%26aufirst%3DS.%26aulast%3DGunn%26aufirst%3DR.%26aulast%3DRabiner%26aufirst%3DE.%2BA.%26aulast%3DLaruelle%26aufirst%3DM.%26atitle%3DImaging%2520Dopamine%2520D3%2520Receptors%2520in%2520the%2520Human%2520Brain%2520with%2520Positron%2520Emission%2520Tomography%252C%2520%255B11C%255DPHNO%252C%2520and%2520a%2520Selective%2520D3%2520Receptor%2520Antagonist%26jtitle%3DBiol.%2520Psychiatry%26date%3D2010%26volume%3D68%26spage%3D392%26epage%3D399%26doi%3D10.1016%2Fj.biopsych.2010.04.038" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Nebel, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maschauer, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuwert, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hocke, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prante, O.</span></span> <span> </span><span class="NLM_article-title">In Vitro and In Vivo Characterization of Selected Fluorine-18 Labeled Radioligands for PET Imaging of the Dopamine D3 Receptor</span>. <i>Molecules</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>21</i></span>, <span class="NLM_elocation-id">1144</span> <span class="refDoi"> DOI: 10.3390/molecules21091144</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00412&amp;key=10.3390%2Fmolecules21091144" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2016&author=N.+Nebelauthor=S.+Maschauerauthor=T.+Kuwertauthor=C.+Hockeauthor=O.+Prante&title=In+Vitro+and+In+Vivo+Characterization+of+Selected+Fluorine-18+Labeled+Radioligands+for+PET+Imaging+of+the+Dopamine+D3+Receptor&doi=10.3390%2Fmolecules21091144"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.3390%2Fmolecules21091144&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3390%252Fmolecules21091144%26sid%3Dliteratum%253Aachs%26aulast%3DNebel%26aufirst%3DN.%26aulast%3DMaschauer%26aufirst%3DS.%26aulast%3DKuwert%26aufirst%3DT.%26aulast%3DHocke%26aufirst%3DC.%26aulast%3DPrante%26aufirst%3DO.%26atitle%3DIn%2520Vitro%2520and%2520In%2520Vivo%2520Characterization%2520of%2520Selected%2520Fluorine-18%2520Labeled%2520Radioligands%2520for%2520PET%2520Imaging%2520of%2520the%2520Dopamine%2520D3%2520Receptor%26jtitle%3DMolecules%26date%3D2016%26volume%3D21%26doi%3D10.3390%2Fmolecules21091144" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Boileau, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nakajima, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Payer, D.</span></span> <span> </span><span class="NLM_article-title">Imaging the D3 Dopamine Receptor Across Behavioral and Drug Addictions: Positron Emission Tomography Studies with [11C]-(+)-PHNO</span>. <i>Eur. Neuropsychopharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>25</i></span>,  <span class="NLM_fpage">1410</span>– <span class="NLM_lpage">1420</span>, <span class="refDoi"> DOI: 10.1016/j.euroneuro.2015.06.002</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00412&amp;key=10.1016%2Fj.euroneuro.2015.06.002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00412&amp;key=26141509" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00412&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhtV2lsrbP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2015&pages=1410-1420&author=I.+Boileauauthor=S.+Nakajimaauthor=D.+Payer&title=Imaging+the+D3+Dopamine+Receptor+Across+Behavioral+and+Drug+Addictions%3A+Positron+Emission+Tomography+Studies+with+%5B11C%5D-%28%2B%29-PHNO&doi=10.1016%2Fj.euroneuro.2015.06.002"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Imaging the D3 dopamine receptor across behavioral and drug addictions: Positron emission tomography studies with [11C]-(+)-PHNO</span></div><div class="casAuthors">Boileau, Isabelle; Nakajima, Shinichiro; Payer, Doris</div><div class="citationInfo"><span class="NLM_cas:title">European Neuropsychopharmacology</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1410-1420</span>CODEN:
                <span class="NLM_cas:coden">EURNE8</span>;
        ISSN:<span class="NLM_cas:issn">0924-977X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Chronic drug use has been assocd. with dopaminergic abnormalities, detectable in humans with positron emission tomog. (PET).  Among these, a hallmark feature is low D2 dopamine receptor availability, which has been linked to clin. outcomes, but has not yet translated into a therapeutic strategy.  The D3 dopamine receptor on the other hand has gained increasing attention, as, in contrast to D2, chronic exposure to drugs has been shown to up-regulate this receptor subtype in preclin. models of addiction-a phenomenon linked to dopamine system sensitization and drug-seeking.  The present article summarizes the literature to date in humans, suggesting that the D3 receptor may indeed contribute to core features of addiction such as impulsiveness and cognitive impairment.  A particularly useful tool in investigating this question is the PET imaging probe [11C]-(+)-PHNO, which binds to D2/3 dopamine receptors but has preferential affinity for D3.  This technique has been used to demonstrate D3 up-regulation in humans, and can be applied to assess pharmacol. interventions for development of D3-targeted strategies in addiction treatment.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpW6zsdhIO0K7Vg90H21EOLACvtfcHk0likYged66HrYw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtV2lsrbP&md5=c6ceb2674c5f29987418ada62ca80f38</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1016%2Fj.euroneuro.2015.06.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.euroneuro.2015.06.002%26sid%3Dliteratum%253Aachs%26aulast%3DBoileau%26aufirst%3DI.%26aulast%3DNakajima%26aufirst%3DS.%26aulast%3DPayer%26aufirst%3DD.%26atitle%3DImaging%2520the%2520D3%2520Dopamine%2520Receptor%2520Across%2520Behavioral%2520and%2520Drug%2520Addictions%253A%2520Positron%2520Emission%2520Tomography%2520Studies%2520with%2520%255B11C%255D-%2528%252B%2529-PHNO%26jtitle%3DEur.%2520Neuropsychopharmacol.%26date%3D2015%26volume%3D25%26spage%3D1410%26epage%3D1420%26doi%3D10.1016%2Fj.euroneuro.2015.06.002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mach, R. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luedtke, R. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reichert, D. E.</span></span> <span> </span><span class="NLM_article-title">Subtype Selectivity of Dopamine Receptor Ligands: Insights from Structure and Ligand-Based Methods</span>. <i>J. Chem. Inf. Model.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>50</i></span>,  <span class="NLM_fpage">1970</span>– <span class="NLM_lpage">1985</span>, <span class="refDoi"> DOI: 10.1021/ci1002747</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ci1002747" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00412&amp;key=1%3ACAS%3A528%3ADC%252BC3cXht1OisrzJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2010&pages=1970-1985&author=Q.+Wangauthor=R.+H.+Machauthor=R.+R.+Luedtkeauthor=D.+E.+Reichert&title=Subtype+Selectivity+of+Dopamine+Receptor+Ligands%3A+Insights+from+Structure+and+Ligand-Based+Methods&doi=10.1021%2Fci1002747"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Subtype selectivity of dopamine receptor ligands: insights from structure and ligand-based methods</span></div><div class="casAuthors">Wang, Qi; Mach, Robert H.; Luedtke, Robert R.; Reichert, David E.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Chemical Information and Modeling</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">50</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1970-1985</span>CODEN:
                <span class="NLM_cas:coden">JCISD8</span>;
        ISSN:<span class="NLM_cas:issn">1549-9596</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Subtype selective dopamine receptor ligands have long been sought after as therapeutic and/or imaging agents for the treatment and monitoring of neurol. disorders.  We report herein on a combined structure- and ligand-based approach to explore the mol. mechanism of the subtype selectivity for a large class of D2-like dopamine receptor ligands (163 ligands in total).  Homol. models were built for both human D2L and D3 receptors in complex with haloperidol.  Other ligands, which included multiple examples of substituted phenylpiperazines, were aligned against the binding conformations of haloperidol, and three-dimensional quant. structure activity relationship (3D-QSAR) analyses were carried out.  The receptor models show that although D2 and D3 share highly similar folds and 3D conformations, the slight sequence differences at their extracellular loop regions result in the binding cavity in D2 being comparably shallower than in D3, which may explain why some larger ligands bind with greater affinity at D3 compared to D2 receptors.  The QSAR models show excellent correlation and high predictive power even when evaluated by the most stringent criteria.  They confirm that the origins of subtype selectivity for the ligands arise primarily due to differences in the contours of the two binding sites.  The predictive models suggest that while both steric and electrostatic interactions contribute to the compds.' binding affinity, the major contribution arises from hydrophobic interactions, with hydrogen bonding conferring binding specificity.  The current work provides clues for the development of more subtype selective dopamine receptor ligands.  Furthermore, it demonstrates the possibility of being able to apply similar modeling methods to other subtypes or classes of receptors to study GPCR receptor-ligand interactions at a mol. level.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGokZTtMqvRrXbVg90H21EOLACvtfcHk0likYged66HrYw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXht1OisrzJ&md5=7c923cdaa5e10b1089c7152cedcd9cb0</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1021%2Fci1002747&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fci1002747%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DQ.%26aulast%3DMach%26aufirst%3DR.%2BH.%26aulast%3DLuedtke%26aufirst%3DR.%2BR.%26aulast%3DReichert%26aufirst%3DD.%2BE.%26atitle%3DSubtype%2520Selectivity%2520of%2520Dopamine%2520Receptor%2520Ligands%253A%2520Insights%2520from%2520Structure%2520and%2520Ligand-Based%2520Methods%26jtitle%3DJ.%2520Chem.%2520Inf.%2520Model.%26date%3D2010%26volume%3D50%26spage%3D1970%26epage%3D1985%26doi%3D10.1021%2Fci1002747" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Newman, A. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beuming, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Banala, A. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Donthamsetti, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pongetti, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">LaBounty, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Levy, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cao, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Michino, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luedtke, R. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Javitch, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shi, L.</span></span> <span> </span><span class="NLM_article-title">Molecular Determinants of Selectivity and Efficacy at the Dopamine D3 Receptor</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>55</i></span>,  <span class="NLM_fpage">6689</span>– <span class="NLM_lpage">6699</span>, <span class="refDoi"> DOI: 10.1021/jm300482h</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm300482h" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00412&amp;key=1%3ACAS%3A528%3ADC%252BC38XnsFCkt7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=6689-6699&author=A.+H.+Newmanauthor=T.+Beumingauthor=A.+K.+Banalaauthor=P.+Donthamsettiauthor=K.+Pongettiauthor=A.+LaBountyauthor=B.+Levyauthor=J.+Caoauthor=M.+Michinoauthor=R.+R.+Luedtkeauthor=J.+A.+Javitchauthor=L.+Shi&title=Molecular+Determinants+of+Selectivity+and+Efficacy+at+the+Dopamine+D3+Receptor&doi=10.1021%2Fjm300482h"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular Determinants of Selectivity and Efficacy at the Dopamine D3 Receptor</span></div><div class="casAuthors">Newman, Amy Hauck; Beuming, Thijs; Banala, Ashwini K.; Donthamsetti, Prashant; Pongetti, Katherine; LaBounty, Alex; Levy, Benjamin; Cao, Jianjing; Michino, Mayako; Luedtke, Robert R.; Javitch, Jonathan A.; Shi, Lei</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">6689-6699</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The dopamine D3 receptor (D3R) has been implicated in substance abuse and other neuropsychiatric disorders.  The high sequence homol. between the D3R and D2R, esp. within the orthosteric binding site (OBS) that binds dopamine, has made the development of D3R-selective compds. challenging.  Here, we deconstruct into pharmacophoric elements a series of D3R-selective substituted-4-phenylpiperazine compds. and use computational simulations and binding and activation studies to dissect the structural bases for D3R selectivity and efficacy.  We find that selectivity arises from divergent interactions within a second binding pocket (SBP) sep. from the OBS, whereas efficacy depends on the binding mode in the OBS.  Our findings reveal structural features of the receptor that are crit. to selectivity and efficacy that can be used to design highly D3R-selective ligands with targeted efficacies.  These findings are generalizable to other GPCRs in which the SBP can be targeted by bitopic or allosteric ligands.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqmBJU7uyvVg7Vg90H21EOLACvtfcHk0likYged66HrYw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XnsFCkt7c%253D&md5=033dd49282723650828a3ec0a31211e5</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1021%2Fjm300482h&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm300482h%26sid%3Dliteratum%253Aachs%26aulast%3DNewman%26aufirst%3DA.%2BH.%26aulast%3DBeuming%26aufirst%3DT.%26aulast%3DBanala%26aufirst%3DA.%2BK.%26aulast%3DDonthamsetti%26aufirst%3DP.%26aulast%3DPongetti%26aufirst%3DK.%26aulast%3DLaBounty%26aufirst%3DA.%26aulast%3DLevy%26aufirst%3DB.%26aulast%3DCao%26aufirst%3DJ.%26aulast%3DMichino%26aufirst%3DM.%26aulast%3DLuedtke%26aufirst%3DR.%2BR.%26aulast%3DJavitch%26aufirst%3DJ.%2BA.%26aulast%3DShi%26aufirst%3DL.%26atitle%3DMolecular%2520Determinants%2520of%2520Selectivity%2520and%2520Efficacy%2520at%2520the%2520Dopamine%2520D3%2520Receptor%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D6689%26epage%3D6699%26doi%3D10.1021%2Fjm300482h" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chien, E. Y.
T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Katritch, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Won Han, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hanson, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shi, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Newman, A. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Javitch, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cherezov, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stevens, R. C.</span></span> <span> </span><span class="NLM_article-title">Structure of the Human Dopamine D3 Receptor in Complex with a D2/D3 Selective Antagonist</span>. <i>Science</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>330</i></span>,  <span class="NLM_fpage">1091</span>– <span class="NLM_lpage">1095</span>, <span class="refDoi"> DOI: 10.1126/science.1197410</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00412&amp;key=10.1126%2Fscience.1197410" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00412&amp;key=21097933" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00412&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhsVahurvM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=330&publication_year=2010&pages=1091-1095&author=E.+Y.%0AT.+Chienauthor=W.+Liuauthor=Q.+Zhaoauthor=V.+Katritchauthor=G.+Won+Hanauthor=M.+A.+Hansonauthor=L.+Shiauthor=A.+H.+Newmanauthor=J.+A.+Javitchauthor=V.+Cherezovauthor=R.+C.+Stevens&title=Structure+of+the+Human+Dopamine+D3+Receptor+in+Complex+with+a+D2%2FD3+Selective+Antagonist&doi=10.1126%2Fscience.1197410"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Structure of the Human Dopamine D3 Receptor in Complex with a D2/D3 Selective Antagonist</span></div><div class="casAuthors">Chien, Ellen Y. T.; Liu, Wei; Zhao, Qiang; Katritch, Vsevolod; Won Han, Gye; Hanson, Michael A.; Shi, Lei; Newman, Amy Hauck; Javitch, Jonathan A.; Cherezov, Vadim; Stevens, Raymond C.</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">330</span>
        (<span class="NLM_cas:issue">6007</span>),
    <span class="NLM_cas:pages">1091-1095</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">Dopamine modulates movement, cognition, and emotion through activation of dopamine G protein-coupled receptors in the brain.  The crystal structure of the human dopamine D3 receptor (D3R) in complex with the small mol. D2R/D3R-specific antagonist eticlopride reveals important features of the ligand binding pocket and extracellular loops.  On the intracellular side of the receptor, a locked conformation of the ionic lock and two distinctly different conformations of intracellular loop 2 are obsd.  Docking of R-22, a D3R-selective antagonist, reveals an extracellular extension of the eticlopride binding site that comprises a second binding pocket for the aryl amide of R-22, which differs between the highly homologous D2R and D3R.  This difference provides direction to the design of D3R-selective agents for treating drug abuse and other neuropsychiatric indications.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoOEcfSdjMm-7Vg90H21EOLACvtfcHk0liH6GIZxPaeAA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhsVahurvM&md5=12c6f343daea9fb14ca605a092f28533</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1126%2Fscience.1197410&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.1197410%26sid%3Dliteratum%253Aachs%26aulast%3DChien%26aufirst%3DE.%2BY.%2BT.%26aulast%3DLiu%26aufirst%3DW.%26aulast%3DZhao%26aufirst%3DQ.%26aulast%3DKatritch%26aufirst%3DV.%26aulast%3DWon%2BHan%26aufirst%3DG.%26aulast%3DHanson%26aufirst%3DM.%2BA.%26aulast%3DShi%26aufirst%3DL.%26aulast%3DNewman%26aufirst%3DA.%2BH.%26aulast%3DJavitch%26aufirst%3DJ.%2BA.%26aulast%3DCherezov%26aufirst%3DV.%26aulast%3DStevens%26aufirst%3DR.%2BC.%26atitle%3DStructure%2520of%2520the%2520Human%2520Dopamine%2520D3%2520Receptor%2520in%2520Complex%2520with%2520a%2520D2%252FD3%2520Selective%2520Antagonist%26jtitle%3DScience%26date%3D2010%26volume%3D330%26spage%3D1091%26epage%3D1095%26doi%3D10.1126%2Fscience.1197410" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Michino, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beuming, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Donthamsetti, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Newman, A. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Javitch, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shi, L.</span></span> <span> </span><span class="NLM_article-title">What Can Crystal Structures of Aminergic Receptors Tell Us about Designing Subtype-Selective Ligands?</span>. <i>Pharmacol. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>67</i></span>,  <span class="NLM_fpage">198</span>– <span class="NLM_lpage">213</span>, <span class="refDoi"> DOI: 10.1124/pr.114.009944</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00412&amp;key=10.1124%2Fpr.114.009944" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00412&amp;key=25527701" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00412&amp;key=1%3ACAS%3A528%3ADC%252BC2MXisVWqu7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=67&publication_year=2015&pages=198-213&author=M.+Michinoauthor=T.+Beumingauthor=P.+Donthamsettiauthor=A.+H.+Newmanauthor=J.+A.+Javitchauthor=L.+Shi&title=What+Can+Crystal+Structures+of+Aminergic+Receptors+Tell+Us+about+Designing+Subtype-Selective+Ligands%3F&doi=10.1124%2Fpr.114.009944"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">What can crystal structures of aminergic receptors tell us about designing subtype-selective ligands?</span></div><div class="casAuthors">Michino, Mayako; Beuming, Thijs; Donthamsetti, Prashant; Newman, Amy Hauck; Javitch, Jonathan A.; Shi, Lei</div><div class="citationInfo"><span class="NLM_cas:title">Pharmacological Reviews</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">67</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">198-213</span>CODEN:
                <span class="NLM_cas:coden">PAREAQ</span>;
        ISSN:<span class="NLM_cas:issn">1521-0081</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">A review.  G protein-coupled receptors (GPCRs) are integral membrane proteins that represent an important class of drug targets.  In particular, aminergic GPCRs interact with a significant portion of drugs currently on the market.  However, most drugs that target these receptors are assocd. with undesirable side effects, which are due in part to promiscuous interactions with close homologs of the intended target receptors.  Here, based on a systematic anal. of all 37 of the currently available high-resoln. crystal structures of aminergic GPCRs, we review structural elements that contribute to and can be exploited for designing subtype-selective compds.  We describe the roles of secondary binding pockets (SBPs), as well as differences in ligand entry pathways to the orthosteric binding site, in detg. selectivity.  In addn., using the available crystal structures, we have identified conformational changes in the SBPs that are assocd. with receptor activation and explore the implications of these changes for the rational development of selective ligands with tailored efficacy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp88D-c63Tm3LVg90H21EOLACvtfcHk0liH6GIZxPaeAA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXisVWqu7s%253D&md5=7ed6698fae95a5e045a8d4e12b18fef5</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1124%2Fpr.114.009944&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fpr.114.009944%26sid%3Dliteratum%253Aachs%26aulast%3DMichino%26aufirst%3DM.%26aulast%3DBeuming%26aufirst%3DT.%26aulast%3DDonthamsetti%26aufirst%3DP.%26aulast%3DNewman%26aufirst%3DA.%2BH.%26aulast%3DJavitch%26aufirst%3DJ.%2BA.%26aulast%3DShi%26aufirst%3DL.%26atitle%3DWhat%2520Can%2520Crystal%2520Structures%2520of%2520Aminergic%2520Receptors%2520Tell%2520Us%2520about%2520Designing%2520Subtype-Selective%2520Ligands%253F%26jtitle%3DPharmacol.%2520Rev.%26date%3D2015%26volume%3D67%26spage%3D198%26epage%3D213%26doi%3D10.1124%2Fpr.114.009944" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Reilly, S. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Griffin, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taylor, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sahlholm, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weng, C.-C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jacome, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luedtke, R. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mach, R. H.</span></span> <span> </span><span class="NLM_article-title">Highly Selective Dopamine D3 Receptor Antagonists with Arylated Diazaspiro Alkane Cores</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>60</i></span>,  <span class="NLM_fpage">9905</span>– <span class="NLM_lpage">9910</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.7b01248</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.7b01248" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00412&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhsl2gsbjL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2017&pages=9905-9910&author=S.+W.+Reillyauthor=S.+Griffinauthor=M.+Taylorauthor=K.+Sahlholmauthor=C.-C.+Wengauthor=K.+Xuauthor=D.+A.+Jacomeauthor=R.+R.+Luedtkeauthor=R.+H.+Mach&title=Highly+Selective+Dopamine+D3+Receptor+Antagonists+with+Arylated+Diazaspiro+Alkane+Cores&doi=10.1021%2Facs.jmedchem.7b01248"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Highly Selective Dopamine D3 Receptor Antagonists with Arylated Diazaspiro Alkane Cores</span></div><div class="casAuthors">Reilly, Sean W.; Griffin, Suzy; Taylor, Michelle; Sahlholm, Kristoffer; Weng, Chi-Chang; Xu, Kuiying; Jacome, Daniel A.; Luedtke, Robert R.; Mach, Robert H.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">9905-9910</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Aryldiazaspirocyclylpropyl phenyltriazolyl thioethers such as I (R = 2-MeOC6H4, 4-FC6H4, 4-MeOC6H4, 2-pyridinyl, 3-NCC6H4, 2,3-Cl2C6H3) were prepd. as selective dopamine D3 receptor (D3R) antagonists; their selectivities for D3R over D2R and for selected compds. over 5-HT1a, 5-HT2a, and 5-HT2c receptors and adenylyl cyclase were detd.  I (R = 2-MeOC6H4, 4-FC6H4) showed favorable D3R affinities (Ki = 12-25.6 nM) and were 264- to 905-fold selective for D3R vs D2R.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpHLC1nn5_14LVg90H21EOLACvtfcHk0liH6GIZxPaeAA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhsl2gsbjL&md5=a60ed8b0524189901b7155e11025d3c6</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.7b01248&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.7b01248%26sid%3Dliteratum%253Aachs%26aulast%3DReilly%26aufirst%3DS.%2BW.%26aulast%3DGriffin%26aufirst%3DS.%26aulast%3DTaylor%26aufirst%3DM.%26aulast%3DSahlholm%26aufirst%3DK.%26aulast%3DWeng%26aufirst%3DC.-C.%26aulast%3DXu%26aufirst%3DK.%26aulast%3DJacome%26aufirst%3DD.%2BA.%26aulast%3DLuedtke%26aufirst%3DR.%2BR.%26aulast%3DMach%26aufirst%3DR.%2BH.%26atitle%3DHighly%2520Selective%2520Dopamine%2520D3%2520Receptor%2520Antagonists%2520with%2520Arylated%2520Diazaspiro%2520Alkane%2520Cores%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2017%26volume%3D60%26spage%3D9905%26epage%3D9910%26doi%3D10.1021%2Facs.jmedchem.7b01248" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Reilly, S. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bryan, N. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mach, R. H.</span></span> <span> </span><span class="NLM_article-title">Pd-catalyzed arylation of linear and angular spirodiamine salts under aerobic conditions</span>. <i>Tetrahedron Lett.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>58</i></span>,  <span class="NLM_fpage">466</span>– <span class="NLM_lpage">469</span>, <span class="refDoi"> DOI: 10.1016/j.tetlet.2016.12.063</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00412&amp;key=10.1016%2Fj.tetlet.2016.12.063" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2017&pages=466-469&author=S.+W.+Reillyauthor=N.+W.+Bryanauthor=R.+H.+Mach&title=Pd-catalyzed+arylation+of+linear+and+angular+spirodiamine+salts+under+aerobic+conditions&doi=10.1016%2Fj.tetlet.2016.12.063"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1016%2Fj.tetlet.2016.12.063&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.tetlet.2016.12.063%26sid%3Dliteratum%253Aachs%26aulast%3DReilly%26aufirst%3DS.%2BW.%26aulast%3DBryan%26aufirst%3DN.%2BW.%26aulast%3DMach%26aufirst%3DR.%2BH.%26atitle%3DPd-catalyzed%2520arylation%2520of%2520linear%2520and%2520angular%2520spirodiamine%2520salts%2520under%2520aerobic%2520conditions%26jtitle%3DTetrahedron%2520Lett.%26date%3D2017%26volume%3D58%26spage%3D466%26epage%3D469%26doi%3D10.1016%2Fj.tetlet.2016.12.063" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Reilly, S. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mach, R. H.</span></span> <span> </span><span class="NLM_article-title">Pd-Catalyzed Synthesis of Piperazine Scaffolds Under Aerobic and Solvent-Free Conditions</span>. <i>Org. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>18</i></span>,  <span class="NLM_fpage">5272</span>– <span class="NLM_lpage">5275</span>, <span class="refDoi"> DOI: 10.1021/acs.orglett.6b02591</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.orglett.6b02591" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00412&amp;key=1%3ACAS%3A528%3ADC%252BC28Xhs1GmtrnL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2016&pages=5272-5275&author=S.+W.+Reillyauthor=R.+H.+Mach&title=Pd-Catalyzed+Synthesis+of+Piperazine+Scaffolds+Under+Aerobic+and+Solvent-Free+Conditions&doi=10.1021%2Facs.orglett.6b02591"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Pd-Catalyzed Synthesis of Piperazine Scaffolds Under Aerobic and Solvent-Free Conditions</span></div><div class="casAuthors">Reilly, Sean W.; Mach, Robert H.</div><div class="citationInfo"><span class="NLM_cas:title">Organic Letters</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">20</span>),
    <span class="NLM_cas:pages">5272-5275</span>CODEN:
                <span class="NLM_cas:coden">ORLEF7</span>;
        ISSN:<span class="NLM_cas:issn">1523-7052</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A facile Pd-catalyzed methodol. providing an efficient synthetic route to biol. relevant arylpiperazines under aerobic conditions is reported.  Electron donating and sterically hindered aryl chlorides were aminated to afford yields up to 97%, with examples using piperazine as solvent, illustrating an ecofriendly, cost-effective synthesis of these privileged structures.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqXeVVzuPjiTrVg90H21EOLACvtfcHk0lg7PnyyHMax7A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xhs1GmtrnL&md5=4ef3b43051bc8bd715b31ee464921efa</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1021%2Facs.orglett.6b02591&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.orglett.6b02591%26sid%3Dliteratum%253Aachs%26aulast%3DReilly%26aufirst%3DS.%2BW.%26aulast%3DMach%26aufirst%3DR.%2BH.%26atitle%3DPd-Catalyzed%2520Synthesis%2520of%2520Piperazine%2520Scaffolds%2520Under%2520Aerobic%2520and%2520Solvent-Free%2520Conditions%26jtitle%3DOrg.%2520Lett.%26date%3D2016%26volume%3D18%26spage%3D5272%26epage%3D5275%26doi%3D10.1021%2Facs.orglett.6b02591" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Vangveravong, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taylor, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bearden, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cui, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luedtke, R. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mach, R. H.</span></span> <span> </span><span class="NLM_article-title">Synthesis and Characterization of Selective Dopamine D2 Receptor Ligands Using Aripiprazole as the Lead Compound</span>. <i>Bioorg. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>19</i></span>,  <span class="NLM_fpage">3502</span>– <span class="NLM_lpage">3511</span>, <span class="refDoi"> DOI: 10.1016/j.bmc.2011.04.021</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00412&amp;key=10.1016%2Fj.bmc.2011.04.021" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00412&amp;key=21536445" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00412&amp;key=1%3ACAS%3A528%3ADC%252BC3MXmvFWmt7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2011&pages=3502-3511&author=S.+Vangveravongauthor=Z.+Zhangauthor=M.+Taylorauthor=M.+Beardenauthor=J.+Xuauthor=J.+Cuiauthor=W.+Wangauthor=R.+R.+Luedtkeauthor=R.+H.+Mach&title=Synthesis+and+Characterization+of+Selective+Dopamine+D2+Receptor+Ligands+Using+Aripiprazole+as+the+Lead+Compound&doi=10.1016%2Fj.bmc.2011.04.021"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and characterization of selective dopamine D2 receptor ligands using aripiprazole as the lead compound</span></div><div class="casAuthors">Vangveravong, Suwanna; Zhang, Zhanbin; Taylor, Michelle; Bearden, Melissa; Xu, Jinbin; Cui, Jinquan; Wang, Wei; Luedtke, Robert R.; Mach, Robert H.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">3502-3511</span>CODEN:
                <span class="NLM_cas:coden">BMECEP</span>;
        ISSN:<span class="NLM_cas:issn">0968-0896</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A series of compds. structurally related to aripiprazole (1), an atypical antipsychotic and antidepressant used clin. for the treatment of schizophrenia, bipolar disorder, and depression, have been prepd. and evaluated for affinity at D2-like dopamine receptors.  These compds. also share structural elements with the classical D2-like dopamine receptor antagonists, haloperidol, N-methylspiperone, domperidone and benperidol.  Two new compds., 7-(4-(4-(2-methoxyphenyl)piperazin-1-yl)butoxy)-3,4-dihydroquinolin-2(1H)-one oxalate (6) and 7-(4-(4-(2-(2-fluoroethoxy)phenyl)piperazin-1-yl)butoxy)-3,4-dihydroquinolin-2(1H)-one oxalate (7) were found to (a) bind to the D2 receptor subtype with high affinity (K i values <0.3 nM), (b) exhibit >50-fold D2 vs. D3 receptor binding selectivity and (c) be partial agonists at both the D2 and D3 receptor subtype.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGopvLSFYukyzrVg90H21EOLACvtfcHk0lg7PnyyHMax7A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXmvFWmt7o%253D&md5=4b71878d8f8e2dc6cbbb4c59c2b5872d</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2011.04.021&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2011.04.021%26sid%3Dliteratum%253Aachs%26aulast%3DVangveravong%26aufirst%3DS.%26aulast%3DZhang%26aufirst%3DZ.%26aulast%3DTaylor%26aufirst%3DM.%26aulast%3DBearden%26aufirst%3DM.%26aulast%3DXu%26aufirst%3DJ.%26aulast%3DCui%26aufirst%3DJ.%26aulast%3DWang%26aufirst%3DW.%26aulast%3DLuedtke%26aufirst%3DR.%2BR.%26aulast%3DMach%26aufirst%3DR.%2BH.%26atitle%3DSynthesis%2520and%2520Characterization%2520of%2520Selective%2520Dopamine%2520D2%2520Receptor%2520Ligands%2520Using%2520Aripiprazole%2520as%2520the%2520Lead%2520Compound%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2011%26volume%3D19%26spage%3D3502%26epage%3D3511%26doi%3D10.1016%2Fj.bmc.2011.04.021" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Micheli, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bacchi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Braggio, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Castelletti, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cavallini, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cavanni, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cremonesi, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dal Cin, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feriani, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gehanne, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kajbaf, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marchió, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nola, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oliosi, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pellacani, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perdonà, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sava, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Semeraro, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tarsi, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tomelleri, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wong, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Visentini, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zonzini, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heidbreder, C.</span></span> <span> </span><span class="NLM_article-title">1,2,4-Triazolyl 5-Azaspiro[2.4]heptanes: Lead Identification and Early Lead Optimization of a New Series of Potent and Selective Dopamine D3 Receptor Antagonists</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>59</i></span>,  <span class="NLM_fpage">8549</span>– <span class="NLM_lpage">8576</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.6b00972</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.6b00972" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00412&amp;key=1%3ACAS%3A528%3ADC%252BC28XhsVWltrjN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2016&pages=8549-8576&author=F.+Micheliauthor=A.+Bacchiauthor=S.+Braggioauthor=L.+Castellettiauthor=P.+Cavalliniauthor=P.+Cavanniauthor=S.+Cremonesiauthor=M.+Dal+Cinauthor=A.+Ferianiauthor=S.+Gehanneauthor=M.+Kajbafauthor=L.+Marchi%C3%B3author=S.+Nolaauthor=B.+Oliosiauthor=A.+Pellacaniauthor=E.+Perdon%C3%A0author=A.+Savaauthor=T.+Semeraroauthor=L.+Tarsiauthor=S.+Tomelleriauthor=A.+Wongauthor=F.+Visentiniauthor=L.+Zonziniauthor=C.+Heidbreder&title=1%2C2%2C4-Triazolyl+5-Azaspiro%5B2.4%5Dheptanes%3A+Lead+Identification+and+Early+Lead+Optimization+of+a+New+Series+of+Potent+and+Selective+Dopamine+D3+Receptor+Antagonists&doi=10.1021%2Facs.jmedchem.6b00972"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">1,2,4-Triazolyl 5-Azaspiro[2.4]heptanes: Lead Identification and Early Lead Optimization of a New Series of Potent and Selective Dopamine D3 Receptor Antagonists</span></div><div class="casAuthors">Micheli, Fabrizio; Bacchi, Alessia; Braggio, Simone; Castelletti, Laura; Cavallini, Palmina; Cavanni, Paolo; Cremonesi, Susanna; Dal Cin, Michele; Feriani, Aldo; Gehanne, Sylvie; Kajbaf, Mahmud; Marchio, Luciano; Nola, Selena; Oliosi, Beatrice; Pellacani, Annalisa; Perdona, Elisabetta; Sava, Anna; Semeraro, Teresa; Tarsi, Luca; Tomelleri, Silvia; Wong, Andrea; Visentini, Filippo; Zonzini, Laura; Heidbreder, Christian</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">8549-8576</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A novel series of 1,2,4-triazolyl 5-azaspiro[2.4]heptanes with high affinity and selectivity at the dopamine (DA) D3 receptor (D3R) is described.  Some of these compds. also have high selectivity over the hERG channel and were characterized with respect to their pharmacokinetic properties both in vitro and in vivo during lead identification and early lead optimization phases.  A few derivs. with overall favorable developability characteristics were selected for further late lead optimization studies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqCKMOaVTpugrVg90H21EOLACvtfcHk0liY3i1VTMx75A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhsVWltrjN&md5=9588db3bf4e320c6d082b4318a8143a4</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.6b00972&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.6b00972%26sid%3Dliteratum%253Aachs%26aulast%3DMicheli%26aufirst%3DF.%26aulast%3DBacchi%26aufirst%3DA.%26aulast%3DBraggio%26aufirst%3DS.%26aulast%3DCastelletti%26aufirst%3DL.%26aulast%3DCavallini%26aufirst%3DP.%26aulast%3DCavanni%26aufirst%3DP.%26aulast%3DCremonesi%26aufirst%3DS.%26aulast%3DDal%2BCin%26aufirst%3DM.%26aulast%3DFeriani%26aufirst%3DA.%26aulast%3DGehanne%26aufirst%3DS.%26aulast%3DKajbaf%26aufirst%3DM.%26aulast%3DMarchi%25C3%25B3%26aufirst%3DL.%26aulast%3DNola%26aufirst%3DS.%26aulast%3DOliosi%26aufirst%3DB.%26aulast%3DPellacani%26aufirst%3DA.%26aulast%3DPerdon%25C3%25A0%26aufirst%3DE.%26aulast%3DSava%26aufirst%3DA.%26aulast%3DSemeraro%26aufirst%3DT.%26aulast%3DTarsi%26aufirst%3DL.%26aulast%3DTomelleri%26aufirst%3DS.%26aulast%3DWong%26aufirst%3DA.%26aulast%3DVisentini%26aufirst%3DF.%26aulast%3DZonzini%26aufirst%3DL.%26aulast%3DHeidbreder%26aufirst%3DC.%26atitle%3D1%252C2%252C4-Triazolyl%25205-Azaspiro%255B2.4%255Dheptanes%253A%2520Lead%2520Identification%2520and%2520Early%2520Lead%2520Optimization%2520of%2520a%2520New%2520Series%2520of%2520Potent%2520and%2520Selective%2520Dopamine%2520D3%2520Receptor%2520Antagonists%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2016%26volume%3D59%26spage%3D8549%26epage%3D8576%26doi%3D10.1021%2Facs.jmedchem.6b00972" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Micheli, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arista, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bertani, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Braggio, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Capelli, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cremonesi, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Di-Fabio, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gelardi, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gentile, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marchioro, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pasquarello, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Provera, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tedesco, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tarsi, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Terreni, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Worby, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heidbreder, C.</span></span> <span> </span><span class="NLM_article-title">Exploration of the Amine Terminus in a Novel Series of 1,2,4-Triazolo-3-yl-azabicyclo[3.1.0]hexanes as Selective Dopamine D3 Receptor Antagonists</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>53</i></span>,  <span class="NLM_fpage">7129</span>– <span class="NLM_lpage">7139</span>, <span class="refDoi"> DOI: 10.1021/jm100832d</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm100832d" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=7129-7139&author=F.+Micheliauthor=L.+Aristaauthor=B.+Bertaniauthor=S.+Braggioauthor=A.+M.+Capelliauthor=S.+Cremonesiauthor=R.+Di-Fabioauthor=G.+Gelardiauthor=G.+Gentileauthor=C.+Marchioroauthor=A.+Pasquarelloauthor=S.+Proveraauthor=G.+Tedescoauthor=L.+Tarsiauthor=S.+Terreniauthor=A.+Worbyauthor=C.+Heidbreder&title=Exploration+of+the+Amine+Terminus+in+a+Novel+Series+of+1%2C2%2C4-Triazolo-3-yl-azabicyclo%5B3.1.0%5Dhexanes+as+Selective+Dopamine+D3+Receptor+Antagonists&doi=10.1021%2Fjm100832d"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1021%2Fjm100832d&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm100832d%26sid%3Dliteratum%253Aachs%26aulast%3DMicheli%26aufirst%3DF.%26aulast%3DArista%26aufirst%3DL.%26aulast%3DBertani%26aufirst%3DB.%26aulast%3DBraggio%26aufirst%3DS.%26aulast%3DCapelli%26aufirst%3DA.%2BM.%26aulast%3DCremonesi%26aufirst%3DS.%26aulast%3DDi-Fabio%26aufirst%3DR.%26aulast%3DGelardi%26aufirst%3DG.%26aulast%3DGentile%26aufirst%3DG.%26aulast%3DMarchioro%26aufirst%3DC.%26aulast%3DPasquarello%26aufirst%3DA.%26aulast%3DProvera%26aufirst%3DS.%26aulast%3DTedesco%26aufirst%3DG.%26aulast%3DTarsi%26aufirst%3DL.%26aulast%3DTerreni%26aufirst%3DS.%26aulast%3DWorby%26aufirst%3DA.%26aulast%3DHeidbreder%26aufirst%3DC.%26atitle%3DExploration%2520of%2520the%2520Amine%2520Terminus%2520in%2520a%2520Novel%2520Series%2520of%25201%252C2%252C4-Triazolo-3-yl-azabicyclo%255B3.1.0%255Dhexanes%2520as%2520Selective%2520Dopamine%2520D3%2520Receptor%2520Antagonists%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26spage%3D7129%26epage%3D7139%26doi%3D10.1021%2Fjm100832d" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cremonesi, S.</span>; <span class="NLM_string-name">Micheli, F.</span>; <span class="NLM_string-name">Semeraro, T.</span>; <span class="NLM_string-name">Tarsi, L.</span></span> <span> </span><span class="NLM_article-title">Azaspirocyclic Compounds as Dopamine D3 Receptor Antagonists and their Preparation</span>. WO Patent <span class="NLM_patent">WO2016067043A1</span>, <span class="NLM_year">2016</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2016&author=S.+Cremonesi&author=F.+Micheli&author=T.+Semeraro&author=L.+Tarsi&title=Azaspirocyclic+Compounds+as+Dopamine+D3+Receptor+Antagonists+and+their+Preparation"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DCremonesi%26aufirst%3DS.%26atitle%3DAzaspirocyclic%2520Compounds%2520as%2520Dopamine%2520D3%2520Receptor%2520Antagonists%2520and%2520their%2520Preparation%26date%3D2016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tu, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cui, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taylor, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ho, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luedtke, R. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mach, R. H.</span></span> <span> </span><span class="NLM_article-title">Synthesis and Pharmacological Evaluation of Fluorine-Containing D3 Dopamine Receptor Ligands</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>54</i></span>,  <span class="NLM_fpage">1555</span>– <span class="NLM_lpage">1564</span>, <span class="refDoi"> DOI: 10.1021/jm101323b</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm101323b" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00412&amp;key=1%3ACAS%3A528%3ADC%252BC3MXisFWntrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2011&pages=1555-1564&author=Z.+Tuauthor=S.+Liauthor=J.+Cuiauthor=J.+Xuauthor=M.+Taylorauthor=D.+Hoauthor=R.+R.+Luedtkeauthor=R.+H.+Mach&title=Synthesis+and+Pharmacological+Evaluation+of+Fluorine-Containing+D3+Dopamine+Receptor+Ligands&doi=10.1021%2Fjm101323b"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and Pharmacological Evaluation of Fluorine-Containing D3 Dopamine Receptor Ligands</span></div><div class="casAuthors">Tu, Zhu-De; Li, Shi-Hong; Cui, Jin-Quan; Xu, Jin-Bin; Taylor, Michelle; Ho, David; Luedtke, Robert R.; Mach, Robert H.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1555-1564</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A series of fluorine-contg. N-(2-methoxyphenyl)piperazine and N-(2-fluoroethoxy)piperazine analogs, e. g. I, were synthesized, and their affinities for human dopamine D2, D3, and D4 receptors were detd.  Radioligand binding studies identified five compds., 18a, 20a, 20c, 20e, and 21e, which bind with high affinity at D3 (Ki = 0.17-5 nM) and moderate to high selectivity for D3 vs D2 receptors (ranging from ∼25- to 163-fold).  These compds. were also evaluated for intrinsic activity at D2 and D3 receptors using a forskolin-dependent adenylyl cyclase assay.  This panel of compds. exhibits varying receptor subtype binding selectivity and intrinsic activity at D2 vs D3 receptors.  These compds. may be useful for behavioral pharmacol. studies on the role of D2-like dopamine receptors in neuropsychiatric and neurol. disorders.  Furthermore, compd. 20e, which has the highest binding affinity and selectivity for the D3 receptor (Ki = 0.17 nM for D3, 163-fold selectivity for D3 vs D2 receptors), represents a candidate fluorine-18 radiotracer for in vivo PET imaging studies on the regulation of D3 receptor expression.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp_lRIZaeiUnbVg90H21EOLACvtfcHk0lhIvwMnV1TzSA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXisFWntrY%253D&md5=138e7cf0e434cd726af353d75f99b0f6</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1021%2Fjm101323b&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm101323b%26sid%3Dliteratum%253Aachs%26aulast%3DTu%26aufirst%3DZ.%26aulast%3DLi%26aufirst%3DS.%26aulast%3DCui%26aufirst%3DJ.%26aulast%3DXu%26aufirst%3DJ.%26aulast%3DTaylor%26aufirst%3DM.%26aulast%3DHo%26aufirst%3DD.%26aulast%3DLuedtke%26aufirst%3DR.%2BR.%26aulast%3DMach%26aufirst%3DR.%2BH.%26atitle%3DSynthesis%2520and%2520Pharmacological%2520Evaluation%2520of%2520Fluorine-Containing%2520D3%2520Dopamine%2520Receptor%2520Ligands%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2011%26volume%3D54%26spage%3D1555%26epage%3D1564%26doi%3D10.1021%2Fjm101323b" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chu, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tu, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McElveen, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taylor, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luedtke, R. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mach, R. H.</span></span> <span> </span><span class="NLM_article-title">Synthesis and In Vitro Binding of <i>N</i>-Phenyl Piperazine Analogs as Potential Dopamine D3 Receptor Ligands</span>. <i>Bioorg. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>13</i></span>,  <span class="NLM_fpage">77</span>– <span class="NLM_lpage">87</span>, <span class="refDoi"> DOI: 10.1016/j.bmc.2004.09.054</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00412&amp;key=10.1016%2Fj.bmc.2004.09.054" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2005&pages=77-87&author=W.+Chuauthor=Z.+Tuauthor=E.+McElveenauthor=J.+Xuauthor=M.+Taylorauthor=R.+R.+Luedtkeauthor=R.+H.+Mach&title=Synthesis+and+In+Vitro+Binding+of+N-Phenyl+Piperazine+Analogs+as+Potential+Dopamine+D3+Receptor+Ligands&doi=10.1016%2Fj.bmc.2004.09.054"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2004.09.054&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2004.09.054%26sid%3Dliteratum%253Aachs%26aulast%3DChu%26aufirst%3DW.%26aulast%3DTu%26aufirst%3DZ.%26aulast%3DMcElveen%26aufirst%3DE.%26aulast%3DXu%26aufirst%3DJ.%26aulast%3DTaylor%26aufirst%3DM.%26aulast%3DLuedtke%26aufirst%3DR.%2BR.%26aulast%3DMach%26aufirst%3DR.%2BH.%26atitle%3DSynthesis%2520and%2520In%2520Vitro%2520Binding%2520of%2520N-Phenyl%2520Piperazine%2520Analogs%2520as%2520Potential%2520Dopamine%2520D3%2520Receptor%2520Ligands%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2005%26volume%3D13%26spage%3D77%26epage%3D87%26doi%3D10.1016%2Fj.bmc.2004.09.054" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mach, R. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tu, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jones, L. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taylor, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luedtke, R. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Derdeyn, C. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perlmutter, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mintun, M. A.</span></span> <span> </span><span class="NLM_article-title">Endogenous Dopamine (DA) Competes with the Binding of a Radiolabeled D(3) Receptor Partial Agonist In Vivo: A Positron Emission Tomography Study</span>. <i>Synapse</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>65</i></span>,  <span class="NLM_fpage">724</span>– <span class="NLM_lpage">732</span>, <span class="refDoi"> DOI: 10.1002/syn.20891</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00412&amp;key=10.1002%2Fsyn.20891" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=65&publication_year=2011&pages=724-732&author=R.+H.+Machauthor=Z.+Tuauthor=J.+Xuauthor=S.+Liauthor=L.+A.+Jonesauthor=M.+Taylorauthor=R.+R.+Luedtkeauthor=C.+P.+Derdeynauthor=J.+S.+Perlmutterauthor=M.+A.+Mintun&title=Endogenous+Dopamine+%28DA%29+Competes+with+the+Binding+of+a+Radiolabeled+D%283%29+Receptor+Partial+Agonist+In+Vivo%3A+A+Positron+Emission+Tomography+Study&doi=10.1002%2Fsyn.20891"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1002%2Fsyn.20891&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fsyn.20891%26sid%3Dliteratum%253Aachs%26aulast%3DMach%26aufirst%3DR.%2BH.%26aulast%3DTu%26aufirst%3DZ.%26aulast%3DXu%26aufirst%3DJ.%26aulast%3DLi%26aufirst%3DS.%26aulast%3DJones%26aufirst%3DL.%2BA.%26aulast%3DTaylor%26aufirst%3DM.%26aulast%3DLuedtke%26aufirst%3DR.%2BR.%26aulast%3DDerdeyn%26aufirst%3DC.%2BP.%26aulast%3DPerlmutter%26aufirst%3DJ.%2BS.%26aulast%3DMintun%26aufirst%3DM.%2BA.%26atitle%3DEndogenous%2520Dopamine%2520%2528DA%2529%2520Competes%2520with%2520the%2520Binding%2520of%2520a%2520Radiolabeled%2520D%25283%2529%2520Receptor%2520Partial%2520Agonist%2520In%2520Vivo%253A%2520A%2520Positron%2520Emission%2520Tomography%2520Study%26jtitle%3DSynapse%26date%3D2011%26volume%3D65%26spage%3D724%26epage%3D732%26doi%3D10.1002%2Fsyn.20891" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ferreira
de Freitas, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schapira, M.</span></span> <span> </span><span class="NLM_article-title">A Systematic Analysis of Atomic Protein–Ligand Interactions in the PDB</span>. <i>MedChemComm</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">1970</span>– <span class="NLM_lpage">1981</span>, <span class="refDoi"> DOI: 10.1039/C7MD00381A</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00412&amp;key=10.1039%2FC7MD00381A" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00412&amp;key=29308120" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00412&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhsFOiu7nE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2017&pages=1970-1981&author=R.+Ferreira%0Ade+Freitasauthor=M.+Schapira&title=A+Systematic+Analysis+of+Atomic+Protein%E2%80%93Ligand+Interactions+in+the+PDB&doi=10.1039%2FC7MD00381A"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">A systematic analysis of atomic protein-ligand interactions in the PDB</span></div><div class="casAuthors">Ferreira de Freitas, Renato; Schapira, Matthieu</div><div class="citationInfo"><span class="NLM_cas:title">MedChemComm</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1970-1981</span>CODEN:
                <span class="NLM_cas:coden">MCCEAY</span>;
        ISSN:<span class="NLM_cas:issn">2040-2503</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">As the protein databank (PDB) recently passed the cap of 123 456 structures, it stands more than ever as an important resource not only to analyze structural features of specific biol. systems, but also to study the prevalence of structural patterns obsd. in a large body of unrelated structures, that may reflect rules governing protein folding or mol. recognition.  Here, we compiled a list of 11 016 unique structures of small-mol. ligands bound to proteins - 6444 of which have exptl. binding affinity - representing 750 873 protein-ligand at. interactions, and analyzed the frequency, geometry and impact of each interaction type.  We find that hydrophobic interactions are generally enriched in high-efficiency ligands, but polar interactions are over-represented in fragment inhibitors.  While most observations extd. from the PDB will be familiar to seasoned medicinal chemists, less expected findings, such as the high no. of C-H···O hydrogen bonds or the relatively frequent amide-p stacking between the backbone amide of proteins and arom. rings of ligands, uncover underused ligand design strategies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo8iIbfKGlrqbVg90H21EOLACvtfcHk0lgZ6GRmK4CFAQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhsFOiu7nE&md5=04688488e73253f76e4ea384456f89a8</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1039%2FC7MD00381A&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC7MD00381A%26sid%3Dliteratum%253Aachs%26aulast%3DFerreira%2Bde%2BFreitas%26aufirst%3DR.%26aulast%3DSchapira%26aufirst%3DM.%26atitle%3DA%2520Systematic%2520Analysis%2520of%2520Atomic%2520Protein%25E2%2580%2593Ligand%2520Interactions%2520in%2520the%2520PDB%26jtitle%3DMedChemComm%26date%3D2017%26volume%3D8%26spage%3D1970%26epage%3D1981%26doi%3D10.1039%2FC7MD00381A" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meades, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wood, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Osnowski, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Anderson, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yuill, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thomas, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mezna, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jackson, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Midgley, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Griffiths, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fleming, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Green, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McNae, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, S.-Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McInnes, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zheleva, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Walkinshaw, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fischer, P. M.</span></span> <span> </span><span class="NLM_article-title">2-Anilino-4-(thiazol-5-yl)pyrimidine CDK Inhibitors: Synthesis, SAR Analysis, X-ray Crystallography, and Biological Activity</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>47</i></span>,  <span class="NLM_fpage">1662</span>– <span class="NLM_lpage">1675</span>, <span class="refDoi"> DOI: 10.1021/jm0309957</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm0309957" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2004&pages=1662-1675&author=S.+Wangauthor=C.+Meadesauthor=G.+Woodauthor=A.+Osnowskiauthor=S.+Andersonauthor=R.+Yuillauthor=M.+Thomasauthor=M.+Meznaauthor=W.+Jacksonauthor=C.+Midgleyauthor=G.+Griffithsauthor=I.+Flemingauthor=S.+Greenauthor=I.+McNaeauthor=S.-Y.+Wuauthor=C.+McInnesauthor=D.+Zhelevaauthor=M.+D.+Walkinshawauthor=P.+M.+Fischer&title=2-Anilino-4-%28thiazol-5-yl%29pyrimidine+CDK+Inhibitors%3A+Synthesis%2C+SAR+Analysis%2C+X-ray+Crystallography%2C+and+Biological+Activity&doi=10.1021%2Fjm0309957"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1021%2Fjm0309957&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0309957%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DS.%26aulast%3DMeades%26aufirst%3DC.%26aulast%3DWood%26aufirst%3DG.%26aulast%3DOsnowski%26aufirst%3DA.%26aulast%3DAnderson%26aufirst%3DS.%26aulast%3DYuill%26aufirst%3DR.%26aulast%3DThomas%26aufirst%3DM.%26aulast%3DMezna%26aufirst%3DM.%26aulast%3DJackson%26aufirst%3DW.%26aulast%3DMidgley%26aufirst%3DC.%26aulast%3DGriffiths%26aufirst%3DG.%26aulast%3DFleming%26aufirst%3DI.%26aulast%3DGreen%26aufirst%3DS.%26aulast%3DMcNae%26aufirst%3DI.%26aulast%3DWu%26aufirst%3DS.-Y.%26aulast%3DMcInnes%26aufirst%3DC.%26aulast%3DZheleva%26aufirst%3DD.%26aulast%3DWalkinshaw%26aufirst%3DM.%2BD.%26aulast%3DFischer%26aufirst%3DP.%2BM.%26atitle%3D2-Anilino-4-%2528thiazol-5-yl%2529pyrimidine%2520CDK%2520Inhibitors%253A%2520Synthesis%252C%2520SAR%2520Analysis%252C%2520X-ray%2520Crystallography%252C%2520and%2520Biological%2520Activity%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2004%26volume%3D47%26spage%3D1662%26epage%3D1675%26doi%3D10.1021%2Fjm0309957" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ananthan, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saini, S. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hobrath, J. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Padmalayam, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhai, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bostwick, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Antonio, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reith, M. E. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McDowell, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cho, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McAleer, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taylor, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luedtke, R. R.</span></span> <span> </span><span class="NLM_article-title">Design, Synthesis, and Structure–Activity Relationship Studies of a Series of [4-(4-Carboxamidobutyl)]-1-arylpiperazines: Insights into Structural Features Contributing to Dopamine D3 versus D2 Receptor Subtype Selectivity</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>57</i></span>,  <span class="NLM_fpage">7042</span>– <span class="NLM_lpage">7060</span>, <span class="refDoi"> DOI: 10.1021/jm500801r</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm500801r" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=7042-7060&author=S.+Ananthanauthor=S.+K.+Sainiauthor=G.+Zhouauthor=J.+V.+Hobrathauthor=I.+Padmalayamauthor=L.+Zhaiauthor=J.+R.+Bostwickauthor=T.+Antonioauthor=M.+E.+A.+Reithauthor=S.+McDowellauthor=E.+Choauthor=L.+McAleerauthor=M.+Taylorauthor=R.+R.+Luedtke&title=Design%2C+Synthesis%2C+and+Structure%E2%80%93Activity+Relationship+Studies+of+a+Series+of+%5B4-%284-Carboxamidobutyl%29%5D-1-arylpiperazines%3A+Insights+into+Structural+Features+Contributing+to+Dopamine+D3+versus+D2+Receptor+Subtype+Selectivity&doi=10.1021%2Fjm500801r"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1021%2Fjm500801r&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm500801r%26sid%3Dliteratum%253Aachs%26aulast%3DAnanthan%26aufirst%3DS.%26aulast%3DSaini%26aufirst%3DS.%2BK.%26aulast%3DZhou%26aufirst%3DG.%26aulast%3DHobrath%26aufirst%3DJ.%2BV.%26aulast%3DPadmalayam%26aufirst%3DI.%26aulast%3DZhai%26aufirst%3DL.%26aulast%3DBostwick%26aufirst%3DJ.%2BR.%26aulast%3DAntonio%26aufirst%3DT.%26aulast%3DReith%26aufirst%3DM.%2BE.%2BA.%26aulast%3DMcDowell%26aufirst%3DS.%26aulast%3DCho%26aufirst%3DE.%26aulast%3DMcAleer%26aufirst%3DL.%26aulast%3DTaylor%26aufirst%3DM.%26aulast%3DLuedtke%26aufirst%3DR.%2BR.%26atitle%3DDesign%252C%2520Synthesis%252C%2520and%2520Structure%25E2%2580%2593Activity%2520Relationship%2520Studies%2520of%2520a%2520Series%2520of%2520%255B4-%25284-Carboxamidobutyl%2529%255D-1-arylpiperazines%253A%2520Insights%2520into%2520Structural%2520Features%2520Contributing%2520to%2520Dopamine%2520D3%2520versus%2520D2%2520Receptor%2520Subtype%2520Selectivity%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26spage%3D7042%26epage%3D7060%26doi%3D10.1021%2Fjm500801r" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Michino, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Donthamsetti, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beuming, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Banala, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Duan, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roux, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Han, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Trinquet, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Newman, A. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Javitch, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shi, L.</span></span> <span> </span><span class="NLM_article-title">A Single Glycine in Extracellular Loop 1 Is the Critical Determinant for Pharmacological Specificity of Dopamine D2 and D3 Receptors</span>. <i>Mol. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>84</i></span>,  <span class="NLM_fpage">854</span>– <span class="NLM_lpage">864</span>, <span class="refDoi"> DOI: 10.1124/mol.113.087833</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00412&amp;key=10.1124%2Fmol.113.087833" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00412&amp;key=24061855" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00412&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhvVyitLvK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=84&publication_year=2013&pages=854-864&author=M.+Michinoauthor=P.+Donthamsettiauthor=T.+Beumingauthor=A.+Banalaauthor=L.+Duanauthor=T.+Rouxauthor=Y.+Hanauthor=E.+Trinquetauthor=A.+H.+Newmanauthor=J.+A.+Javitchauthor=L.+Shi&title=A+Single+Glycine+in+Extracellular+Loop+1+Is+the+Critical+Determinant+for+Pharmacological+Specificity+of+Dopamine+D2+and+D3+Receptors&doi=10.1124%2Fmol.113.087833"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">A single glycine in extracellular loop 1 is the critical determinant for pharmacological specificity of dopamine D2 and D3 receptors</span></div><div class="casAuthors">Michino, Mayako; Donthamsetti, Prashant; Beuming, Thijs; Banala, Ashwini; Duan, Lihua; Roux, Thomas; Han, Yang; Trinquet, Eric; Newman, Amy Hauck; Javitch, Jonathan A.; Shi, Lei</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Pharmacology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">84</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">854-864</span>CODEN:
                <span class="NLM_cas:coden">MOPMA3</span>;
        ISSN:<span class="NLM_cas:issn">1521-0111</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Subtype-selective agents for the dopamine D3 receptor (D3R) have been considered as potential medications for drug addiction and other neuropsychiatric disorders.  Medicinal chem. efforts have led to the discovery of 4-phenylpiperazine derivs. that are >100-fold selective for the dopamine D3 receptor over dopamine D2 receptor (D2R), despite high sequence identity (78% in the transmembrane domain).  Based on the recent crystal structure of D3R, we demonstrated that the 4-phenylpiperazine moiety in this class of D3R-selective compds. binds to the conserved orthosteric binding site, whereas the extended aryl amide moiety is oriented toward a divergent secondary binding pocket (SBP).  In an effort to further characterize mol. determinants of the selectivity of these compds., we modeled their binding modes in D3R and D2R by comparative ligand docking and mol. dynamics simulations.  We found that the aryl amide moiety in the SBP differentially induces conformational changes in transmembrane segment 2 and extracellular loop 1 (EL1), which amplify the divergence of the SBP in D3R and D2R.  Receptor chimera and site-directed mutagenesis studies were used to validate these binding modes and to identify a divergent glycine in EL1 as crit. to D3R over D2R subtype selectivity.  A better understanding of drug-dependent receptor conformations such as these is key to the rational design of compds. targeting a specific receptor among closely related homologs, and may also lead to discovery of novel chemotypes that exploit subtle differences in protein conformations.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpTHm99ZIZbabVg90H21EOLACvtfcHk0lgID9iXKKZkEQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhvVyitLvK&md5=225a4cfc272ec9897eeb010dd551c3b9</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1124%2Fmol.113.087833&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fmol.113.087833%26sid%3Dliteratum%253Aachs%26aulast%3DMichino%26aufirst%3DM.%26aulast%3DDonthamsetti%26aufirst%3DP.%26aulast%3DBeuming%26aufirst%3DT.%26aulast%3DBanala%26aufirst%3DA.%26aulast%3DDuan%26aufirst%3DL.%26aulast%3DRoux%26aufirst%3DT.%26aulast%3DHan%26aufirst%3DY.%26aulast%3DTrinquet%26aufirst%3DE.%26aulast%3DNewman%26aufirst%3DA.%2BH.%26aulast%3DJavitch%26aufirst%3DJ.%2BA.%26aulast%3DShi%26aufirst%3DL.%26atitle%3DA%2520Single%2520Glycine%2520in%2520Extracellular%2520Loop%25201%2520Is%2520the%2520Critical%2520Determinant%2520for%2520Pharmacological%2520Specificity%2520of%2520Dopamine%2520D2%2520and%2520D3%2520Receptors%26jtitle%3DMol.%2520Pharmacol.%26date%3D2013%26volume%3D84%26spage%3D854%26epage%3D864%26doi%3D10.1124%2Fmol.113.087833" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lane, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Donthamsetti, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shonberg, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Draper-Joyce, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dentry, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Michino, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shi, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">López, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scammells, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Capuano, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sexton, P. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Javitch, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Christopoulos, A.</span></span> <span> </span><span class="NLM_article-title">A New Mechanism of Allostery in a G Protein–Coupled Receptor Dimer</span>. <i>Nat. Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">745</span>– <span class="NLM_lpage">752</span>, <span class="refDoi"> DOI: 10.1038/nchembio.1593</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00412&amp;key=10.1038%2Fnchembio.1593" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00412&amp;key=25108820" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00412&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhtlahurrL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2014&pages=745-752&author=J.+R.+Laneauthor=P.+Donthamsettiauthor=J.+Shonbergauthor=C.+J.+Draper-Joyceauthor=S.+Dentryauthor=M.+Michinoauthor=L.+Shiauthor=L.+L%C3%B3pezauthor=P.+J.+Scammellsauthor=B.+Capuanoauthor=P.+M.+Sextonauthor=J.+A.+Javitchauthor=A.+Christopoulos&title=A+New+Mechanism+of+Allostery+in+a+G+Protein%E2%80%93Coupled+Receptor+Dimer&doi=10.1038%2Fnchembio.1593"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">A new mechanism of allostery in a G protein-coupled receptor dimer</span></div><div class="casAuthors">Lane, J. Robert; Donthamsetti, Prashant; Shonberg, Jeremy; Draper-Joyce, Christopher J.; Dentry, Samuel; Michino, Mayako; Shi, Lei; Lopez, Laura; Scammells, Peter J.; Capuano, Ben; Sexton, Patrick M.; Javitch, Jonathan A.; Christopoulos, Arthur</div><div class="citationInfo"><span class="NLM_cas:title">Nature Chemical Biology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">745-752</span>CODEN:
                <span class="NLM_cas:coden">NCBABT</span>;
        ISSN:<span class="NLM_cas:issn">1552-4450</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">SB269652 is to our knowledge the first drug-like allosteric modulator of the dopamine D2 receptor (D2R), but it contains structural features assocd. with orthosteric D2R antagonists.  Using a functional complementation system to control the identity of individual protomers within a dimeric D2R complex, we converted the pharmacol. of the interaction between SB269652 and dopamine from allosteric to competitive by impairing ligand binding to one of the protomers, indicating that the allostery requires D2R dimers.  Addnl. expts. identified a 'bitopic' pose for SB269652 extending from the orthosteric site into a secondary pocket at the extracellular end of the transmembrane (TM) domain, involving TM2 and TM7.  Engagement of this secondary pocket was a requirement for the allosteric pharmacol. of SB269652.  This suggests a new mechanism whereby a bitopic ligand binds in an extended pose on one G protein-coupled receptor protomer to allosterically modulate the binding of a ligand to the orthosteric site of a second protomer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpBF9SXb0jATLVg90H21EOLACvtfcHk0lgID9iXKKZkEQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhtlahurrL&md5=ececb5fc0e3e9b803807f700dc2c2cad</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1038%2Fnchembio.1593&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnchembio.1593%26sid%3Dliteratum%253Aachs%26aulast%3DLane%26aufirst%3DJ.%2BR.%26aulast%3DDonthamsetti%26aufirst%3DP.%26aulast%3DShonberg%26aufirst%3DJ.%26aulast%3DDraper-Joyce%26aufirst%3DC.%2BJ.%26aulast%3DDentry%26aufirst%3DS.%26aulast%3DMichino%26aufirst%3DM.%26aulast%3DShi%26aufirst%3DL.%26aulast%3DL%25C3%25B3pez%26aufirst%3DL.%26aulast%3DScammells%26aufirst%3DP.%2BJ.%26aulast%3DCapuano%26aufirst%3DB.%26aulast%3DSexton%26aufirst%3DP.%2BM.%26aulast%3DJavitch%26aufirst%3DJ.%2BA.%26aulast%3DChristopoulos%26aufirst%3DA.%26atitle%3DA%2520New%2520Mechanism%2520of%2520Allostery%2520in%2520a%2520G%2520Protein%25E2%2580%2593Coupled%2520Receptor%2520Dimer%26jtitle%3DNat.%2520Chem.%2520Biol.%26date%3D2014%26volume%3D10%26spage%3D745%26epage%3D752%26doi%3D10.1038%2Fnchembio.1593" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Silvano, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Millan, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">la Cour, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Han, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Duan, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Griffin, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luedtke, R. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aloisi, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rossi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zazzeroni, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Javitch, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maggio, R.</span></span> <span> </span><span class="NLM_article-title">The Tetrahydroisoquinoline Derivative SB269,652 Is an Allosteric Antagonist at Dopamine D3 and D2 Receptors</span>. <i>Mol. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>78</i></span>,  <span class="NLM_fpage">925</span>– <span class="NLM_lpage">934</span>, <span class="refDoi"> DOI: 10.1124/mol.110.065755</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00412&amp;key=10.1124%2Fmol.110.065755" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00412&amp;key=20702763" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00412&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhsVajs7zP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=78&publication_year=2010&pages=925-934&author=E.+Silvanoauthor=M.+J.+Millanauthor=C.+M.+la+Courauthor=Y.+Hanauthor=L.+Duanauthor=S.+A.+Griffinauthor=R.+R.+Luedtkeauthor=G.+Aloisiauthor=M.+Rossiauthor=F.+Zazzeroniauthor=J.+A.+Javitchauthor=R.+Maggio&title=The+Tetrahydroisoquinoline+Derivative+SB269%2C652+Is+an+Allosteric+Antagonist+at+Dopamine+D3+and+D2+Receptors&doi=10.1124%2Fmol.110.065755"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">The tetrahydroisoquinoline derivative SB269,652 is an allosteric antagonist at dopamine D3 and D2 receptors</span></div><div class="casAuthors">Silvano, Elena; Millan, Mark J.; La Cour, Clotilde Mannoury; Han, Yang; Duan, Lihua; Griffin, Suzy A.; Luedtke, Robert R.; Aloisi, Gabriella; Rossi, Mario; Zazzeroni, Francesca; Javitch, Jonathan A.; Maggio, Roberto</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Pharmacology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">78</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">925-934</span>CODEN:
                <span class="NLM_cas:coden">MOPMA3</span>;
        ISSN:<span class="NLM_cas:issn">0026-895X</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">In view of the therapeutic importance of dopamine D3 and D2 receptors, there remains considerable interest in novel ligands.  Herein, we show that the tetrahydroisoquinoline 1H-indole-2-carboxylic acid {4-[2-(cyano-3,4-dihydro-1H-isoquinolin-2-yl)-ethyl]-cyclohexyl}-amide (SB269,652) behaves as an atypical, allosteric antagonist at D3 and D2 receptors.  Accordingly, SB269,652 potently (low nanomolar range) abolished specific binding of [3H]nemanopride and [3H]spiperone to Chinese hamster ovary-transfected D3 receptors when radioligands were used at 0.2 and 0.5 nM, resp.  However, even at high concns. (5 μM), SB269,652 only submaximally inhibited the specific binding of these radioligands when they were employed at 10-fold higher concns.  By analogy, although SB269,652 potently blocked D3 receptor-mediated activation of Gαi3 and phosphorylation of extracellular-signal-regulated kinase (ERK)1/2, when concns. of dopamine were increased by 10-fold, from 1 μM to 10 μM, SB269,652 only submaximally inhibited dopamine-induced stimulation of Gαi3.  SB269,652 (up to 10 μM) only weakly and partially (by approx. 20-30%) inhibited radioligand binding to D2 receptors.  Likewise, SB269,652 only submaximally suppressed D2 receptor-mediated stimulation of Gαi3 and Gαgi5 (detected with the aequorin assay) and phosphorylation of ERK1/2 and Akt.  Furthermore, SB269,652 only partially (35%) inhibited the dopamine-induced recruitment of β-arrestin2 to D2 receptors.  Finally, Schild anal. using Gαi3 assays, and studies of radioligand assocn. and dissocn. kinetics, supported allosteric actions of SB269,652 at D3 and D2 receptors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpxX6x9JWZ0VrVg90H21EOLACvtfcHk0ljVObhHbUqrag"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhsVajs7zP&md5=ab4b8119ecda7d1ad81b61ce9e5483c1</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1124%2Fmol.110.065755&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fmol.110.065755%26sid%3Dliteratum%253Aachs%26aulast%3DSilvano%26aufirst%3DE.%26aulast%3DMillan%26aufirst%3DM.%2BJ.%26aulast%3Dla%2BCour%26aufirst%3DC.%2BM.%26aulast%3DHan%26aufirst%3DY.%26aulast%3DDuan%26aufirst%3DL.%26aulast%3DGriffin%26aufirst%3DS.%2BA.%26aulast%3DLuedtke%26aufirst%3DR.%2BR.%26aulast%3DAloisi%26aufirst%3DG.%26aulast%3DRossi%26aufirst%3DM.%26aulast%3DZazzeroni%26aufirst%3DF.%26aulast%3DJavitch%26aufirst%3DJ.%2BA.%26aulast%3DMaggio%26aufirst%3DR.%26atitle%3DThe%2520Tetrahydroisoquinoline%2520Derivative%2520SB269%252C652%2520Is%2520an%2520Allosteric%2520Antagonist%2520at%2520Dopamine%2520D3%2520and%2520D2%2520Receptors%26jtitle%3DMol.%2520Pharmacol.%26date%3D2010%26volume%3D78%26spage%3D925%26epage%3D934%26doi%3D10.1124%2Fmol.110.065755" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Christopoulos, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kenakin, T.</span></span> <span> </span><span class="NLM_article-title">G Protein-Coupled Receptor Allosterism and Complexing</span>. <i>Pharmacol. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>54</i></span>,  <span class="NLM_fpage">323</span>– <span class="NLM_lpage">374</span>, <span class="refDoi"> DOI: 10.1124/pr.54.2.323</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00412&amp;key=10.1124%2Fpr.54.2.323" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00412&amp;key=12037145" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00412&amp;key=1%3ACAS%3A528%3ADC%252BD38XltVOhsrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2002&pages=323-374&author=A.+Christopoulosauthor=T.+Kenakin&title=G+Protein-Coupled+Receptor+Allosterism+and+Complexing&doi=10.1124%2Fpr.54.2.323"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">G protein-coupled receptor allosterism and complexing</span></div><div class="casAuthors">Christopoulos, Arthur; Kenakin, Terry</div><div class="citationInfo"><span class="NLM_cas:title">Pharmacological Reviews</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">323-374</span>CODEN:
                <span class="NLM_cas:coden">PAREAQ</span>;
        ISSN:<span class="NLM_cas:issn">0031-6997</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">A review.  G protein-coupled receptors (GPCRs) represent the largest family of cell-surface receptors.  These receptors are natural allosteric proteins because agonist-mediated signaling by GPCRs requires a conformational change in the receptor protein transmitted between two topog. distinct binding sites, one for the agonist and another for the G protein.  It is now becoming increasingly recognized, however, that the agonist-bound GPCR can also form ternary complexes with other ligands or "accessory" proteins and display altered binding and/or signaling properties in relation to the binary agonist-receptor complex.  Allosteric sites on GPCRs represent novel drug targets because allosteric modulators possess a no. of theor. advantages over classic orthosteric ligands, such as a ceiling level to the allosteric effect and a potential for greater GPCR subtype-selectivity.  Because of the noncompetitive nature of allosteric phenomena, the detection and quantification of such effects often relies on a combination of equil. binding, nonequil. kinetic, and functional signaling assays.  This review discusses the development and properties of allosteric receptor models for GPCRs and the detection and quantification of allosteric effects.  Moreover, we provide an overview of the current knowledge regarding,the location of possible allosteric sites on GPCRs and candidate endogenous allosteric modulators.  Finally, we discuss the potential for allosteric effects arising from the formation of GPCR oligomers or GPCRs complexed with accessory cellular proteins.  It is proposed that the study of allosteric phenomena will become of progressively, greater import to the drug discovery process due to the advent of newer and more sensitive GPCR screening-technologies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrnSA5pRRWTILVg90H21EOLACvtfcHk0ljVObhHbUqrag"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XltVOhsrs%253D&md5=6c4895bf66778eda4778ac409c7abb70</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1124%2Fpr.54.2.323&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fpr.54.2.323%26sid%3Dliteratum%253Aachs%26aulast%3DChristopoulos%26aufirst%3DA.%26aulast%3DKenakin%26aufirst%3DT.%26atitle%3DG%2520Protein-Coupled%2520Receptor%2520Allosterism%2520and%2520Complexing%26jtitle%3DPharmacol.%2520Rev.%26date%3D2002%26volume%3D54%26spage%3D323%26epage%3D374%26doi%3D10.1124%2Fpr.54.2.323" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gerald, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Friedrich, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Elisabeth, K.</span></span> <span> </span><span class="NLM_article-title">Construction of Antagonist Dose-Response Curves for Estimation of pA2-Values by Schild-Plot Analysis and Detection of Allosteric Interactions</span>. <i>Br. J. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">1992</span>,  <span class="NLM_volume"><i>106</i></span>,  <span class="NLM_fpage">710</span>– <span class="NLM_lpage">716</span>, <span class="refDoi"> DOI: 10.1111/j.1476-5381.1992.tb14399.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00412&amp;key=10.1111%2Fj.1476-5381.1992.tb14399.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00412&amp;key=1504755" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=106&publication_year=1992&pages=710-716&author=P.+Geraldauthor=B.+Friedrichauthor=K.+Elisabeth&title=Construction+of+Antagonist+Dose-Response+Curves+for+Estimation+of+pA2-Values+by+Schild-Plot+Analysis+and+Detection+of+Allosteric+Interactions&doi=10.1111%2Fj.1476-5381.1992.tb14399.x"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1111%2Fj.1476-5381.1992.tb14399.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1476-5381.1992.tb14399.x%26sid%3Dliteratum%253Aachs%26aulast%3DGerald%26aufirst%3DP.%26aulast%3DFriedrich%26aufirst%3DB.%26aulast%3DElisabeth%26aufirst%3DK.%26atitle%3DConstruction%2520of%2520Antagonist%2520Dose-Response%2520Curves%2520for%2520Estimation%2520of%2520pA2-Values%2520by%2520Schild-Plot%2520Analysis%2520and%2520Detection%2520of%2520Allosteric%2520Interactions%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D1992%26volume%3D106%26spage%3D710%26epage%3D716%26doi%3D10.1111%2Fj.1476-5381.1992.tb14399.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kumar, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moritz, A. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Keck, T. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bonifazi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ellenberger, M. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sibley, C. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Free, R. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shi, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lane, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sibley, D. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Newman, A. H.</span></span> <span> </span><span class="NLM_article-title">Synthesis and Pharmacological Characterization of Novel trans-Cyclopropylmethyl-Linked Bivalent Ligands That Exhibit Selectivity and Allosteric Pharmacology at the Dopamine D3 Receptor (D3R)</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>60</i></span>,  <span class="NLM_fpage">1478</span>– <span class="NLM_lpage">1494</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.6b01688</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.6b01688" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00412&amp;key=1%3ACAS%3A528%3ADC%252BC2sXitlyhsLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2017&pages=1478-1494&author=V.+Kumarauthor=A.+E.+Moritzauthor=T.+M.+Keckauthor=A.+Bonifaziauthor=M.+P.+Ellenbergerauthor=C.+D.+Sibleyauthor=R.+B.+Freeauthor=L.+Shiauthor=J.+R.+Laneauthor=D.+R.+Sibleyauthor=A.+H.+Newman&title=Synthesis+and+Pharmacological+Characterization+of+Novel+trans-Cyclopropylmethyl-Linked+Bivalent+Ligands+That+Exhibit+Selectivity+and+Allosteric+Pharmacology+at+the+Dopamine+D3+Receptor+%28D3R%29&doi=10.1021%2Facs.jmedchem.6b01688"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and Pharmacological Characterization of Novel trans-Cyclopropylmethyl-Linked Bivalent Ligands That Exhibit Selectivity and Allosteric Pharmacology at the Dopamine D3 Receptor (D3R)</span></div><div class="casAuthors">Kumar, Vivek; Moritz, Amy E.; Keck, Thomas M.; Bonifazi, Alessandro; Ellenberger, Michael P.; Sibley, Christopher D.; Free, R. Benjamin; Shi, Lei; Lane, J. Robert; Sibley, David R.; Newman, Amy Hauck</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1478-1494</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The development of bitopic ligands directed toward D2-like receptors has proven to be of particular interest to improve the selectivity and/or affinity of these ligands and as an approach to modulate and bias their efficacies.  The structural similarities between dopamine D3 receptor (D3R)-selective mols. that display bitopic or allosteric pharmacol. and those that are simply competitive antagonists are subtle and intriguing.  Herein the authors synthesized a series of mols. in which the primary and secondary pharmacophores were derived from the D3R-selective antagonists SB269,652 and SB277011A whose structural similarity and pharmacol. disparity provided the perfect templates for SAR investigation.  Incorporating a trans-cyclopropylmethyl linker between pharmacophores and manipulating linker length resulted in the identification of two bivalent noncompetitive D3R-selective antagonists, I and II, which further delineates SAR assocd. with allosterism at D3R and provides leads toward novel drug development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo_PUM_XBYBsLVg90H21EOLACvtfcHk0lhE5d3XAw7sSQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXitlyhsLs%253D&md5=de385d8d9699e2d37a56974382989a19</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.6b01688&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.6b01688%26sid%3Dliteratum%253Aachs%26aulast%3DKumar%26aufirst%3DV.%26aulast%3DMoritz%26aufirst%3DA.%2BE.%26aulast%3DKeck%26aufirst%3DT.%2BM.%26aulast%3DBonifazi%26aufirst%3DA.%26aulast%3DEllenberger%26aufirst%3DM.%2BP.%26aulast%3DSibley%26aufirst%3DC.%2BD.%26aulast%3DFree%26aufirst%3DR.%2BB.%26aulast%3DShi%26aufirst%3DL.%26aulast%3DLane%26aufirst%3DJ.%2BR.%26aulast%3DSibley%26aufirst%3DD.%2BR.%26aulast%3DNewman%26aufirst%3DA.%2BH.%26atitle%3DSynthesis%2520and%2520Pharmacological%2520Characterization%2520of%2520Novel%2520trans-Cyclopropylmethyl-Linked%2520Bivalent%2520Ligands%2520That%2520Exhibit%2520Selectivity%2520and%2520Allosteric%2520Pharmacology%2520at%2520the%2520Dopamine%2520D3%2520Receptor%2520%2528D3R%2529%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2017%26volume%3D60%26spage%3D1478%26epage%3D1494%26doi%3D10.1021%2Facs.jmedchem.6b01688" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Shonberg, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Draper-Joyce, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mistry, S. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Christopoulos, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scammells, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lane, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Capuano, B.</span></span> <span> </span><span class="NLM_article-title">Structure–Activity Study of N-((trans)-4-(2-(7-Cyano-3,4-dihydroisoquinolin-2(1H)-yl)ethyl)cyclohexyl)-1<i>H</i>-indole-2-carboxamide (SB269652), a Bitopic Ligand That Acts as a Negative Allosteric Modulator of the Dopamine D2 Receptor</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>58</i></span>,  <span class="NLM_fpage">5287</span>– <span class="NLM_lpage">5307</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.5b00581</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.5b00581" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2015&pages=5287-5307&author=J.+Shonbergauthor=C.+Draper-Joyceauthor=S.+N.+Mistryauthor=A.+Christopoulosauthor=P.+J.+Scammellsauthor=J.+R.+Laneauthor=B.+Capuano&title=Structure%E2%80%93Activity+Study+of+N-%28%28trans%29-4-%282-%287-Cyano-3%2C4-dihydroisoquinolin-2%281H%29-yl%29ethyl%29cyclohexyl%29-1H-indole-2-carboxamide+%28SB269652%29%2C+a+Bitopic+Ligand+That+Acts+as+a+Negative+Allosteric+Modulator+of+the+Dopamine+D2+Receptor&doi=10.1021%2Facs.jmedchem.5b00581"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.5b00581&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.5b00581%26sid%3Dliteratum%253Aachs%26aulast%3DShonberg%26aufirst%3DJ.%26aulast%3DDraper-Joyce%26aufirst%3DC.%26aulast%3DMistry%26aufirst%3DS.%2BN.%26aulast%3DChristopoulos%26aufirst%3DA.%26aulast%3DScammells%26aufirst%3DP.%2BJ.%26aulast%3DLane%26aufirst%3DJ.%2BR.%26aulast%3DCapuano%26aufirst%3DB.%26atitle%3DStructure%25E2%2580%2593Activity%2520Study%2520of%2520N-%2528%2528trans%2529-4-%25282-%25287-Cyano-3%252C4-dihydroisoquinolin-2%25281H%2529-yl%2529ethyl%2529cyclohexyl%2529-1H-indole-2-carboxamide%2520%2528SB269652%2529%252C%2520a%2520Bitopic%2520Ligand%2520That%2520Acts%2520as%2520a%2520Negative%2520Allosteric%2520Modulator%2520of%2520the%2520Dopamine%2520D2%2520Receptor%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2015%26volume%3D58%26spage%3D5287%26epage%3D5307%26doi%3D10.1021%2Facs.jmedchem.5b00581" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="cit34"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mistry, S. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shonberg, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Draper-Joyce, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Klein Herenbrink, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Michino, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shi, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Christopoulos, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Capuano, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scammells, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lane, J. R.</span></span> <span> </span><span class="NLM_article-title">Discovery of a Novel Class of Negative Allosteric Modulator of the Dopamine D2 Receptor Through Fragmentation of a Bitopic Ligand</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>58</i></span>,  <span class="NLM_fpage">6819</span>– <span class="NLM_lpage">6843</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.5b00585</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.5b00585" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00412&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhtlSmtrjI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2015&pages=6819-6843&author=S.+N.+Mistryauthor=J.+Shonbergauthor=C.+J.+Draper-Joyceauthor=C.+Klein+Herenbrinkauthor=M.+Michinoauthor=L.+Shiauthor=A.+Christopoulosauthor=B.+Capuanoauthor=P.+J.+Scammellsauthor=J.+R.+Lane&title=Discovery+of+a+Novel+Class+of+Negative+Allosteric+Modulator+of+the+Dopamine+D2+Receptor+Through+Fragmentation+of+a+Bitopic+Ligand&doi=10.1021%2Facs.jmedchem.5b00585"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of a Novel Class of Negative Allosteric Modulator of the Dopamine D2 Receptor Through Fragmentation of a Bitopic Ligand</span></div><div class="casAuthors">Mistry, Shailesh N.; Shonberg, Jeremy; Draper-Joyce, Christopher J.; Klein Herenbrink, Carmen; Michino, Mayako; Shi, Lei; Christopoulos, Arthur; Capuano, Ben; Scammells, Peter J.; Lane, J. Robert</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">6819-6843</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Recently, the authors have demonstrated that N-((trans)-4-(2-(7-cyano-3,4-dihydroisoquinolin-2(1H)-yl)ethyl)cyclohexyl)-1H-indole-2-carboxamide (SB269652) (I) adopts a bitopic pose at one protomer of a dopamine D2 receptor (D2R) dimer to neg. modulate the binding of dopamine at the other protomer.  The 1H-indole-2-carboxamide moiety of I extends into a secondary pocket between the extracellular ends of TM2 and TM7 within the D2R protomer.  To target this putative allosteric site, the authors generated and characterized fragments that include and extend from the 1H-indole-2-carboxamide moiety of I.  N-Isopropyl-1H-indole-2-carboxamide (II) displayed allosteric pharmacol. and sensitivity to mutations of the same residues at the top of TM2 as was obsd. for I.  Using II as an "allosteric lead", the authors designed and synthesized an extensive fragment library to generate novel SAR and identify N-butyl-1H-indole-2-carboxamide, which displayed both increased neg. cooperativity and affinity for the D2R.  These data illustrate that fragmentation of extended compds. can expose fragments with purely allosteric pharmacol.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrEvPMqz8_m3bVg90H21EOLACvtfcHk0lhE5d3XAw7sSQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtlSmtrjI&md5=75991ee65b79a0131ca2e8a615694369</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.5b00585&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.5b00585%26sid%3Dliteratum%253Aachs%26aulast%3DMistry%26aufirst%3DS.%2BN.%26aulast%3DShonberg%26aufirst%3DJ.%26aulast%3DDraper-Joyce%26aufirst%3DC.%2BJ.%26aulast%3DKlein%2BHerenbrink%26aufirst%3DC.%26aulast%3DMichino%26aufirst%3DM.%26aulast%3DShi%26aufirst%3DL.%26aulast%3DChristopoulos%26aufirst%3DA.%26aulast%3DCapuano%26aufirst%3DB.%26aulast%3DScammells%26aufirst%3DP.%2BJ.%26aulast%3DLane%26aufirst%3DJ.%2BR.%26atitle%3DDiscovery%2520of%2520a%2520Novel%2520Class%2520of%2520Negative%2520Allosteric%2520Modulator%2520of%2520the%2520Dopamine%2520D2%2520Receptor%2520Through%2520Fragmentation%2520of%2520a%2520Bitopic%2520Ligand%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2015%26volume%3D58%26spage%3D6819%26epage%3D6843%26doi%3D10.1021%2Facs.jmedchem.5b00585" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref35"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref35'); return false;" data-citation="" class="refNumLink">35</a></strong><div class="NLM_citation" id="cit35"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kroeze, W. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sassano, M. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, X.-P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lansu, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McCorvy, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Giguère, P. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sciaky, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roth, B. L.</span></span> <span> </span><span class="NLM_article-title">PRESTO-Tango as an Open-Source Resource for Interrogation of the Druggable Human GPCRome</span>. <i>Nat. Struct. Mol. Biol</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>22</i></span>, <span class="NLM_elocation-id">362</span> <span class="refDoi"> DOI: 10.1038/nsmb.3014</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00412&amp;key=10.1038%2Fnsmb.3014" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00412&amp;key=25895059" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00412&amp;key=1%3ACAS%3A528%3ADC%252BC2MXnslOgtLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2015&author=W.+K.+Kroezeauthor=M.+F.+Sassanoauthor=X.-P.+Huangauthor=K.+Lansuauthor=J.+D.+McCorvyauthor=P.+M.+Gigu%C3%A8reauthor=N.+Sciakyauthor=B.+L.+Roth&title=PRESTO-Tango+as+an+Open-Source+Resource+for+Interrogation+of+the+Druggable+Human+GPCRome&doi=10.1038%2Fnsmb.3014"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">PRESTO-Tango as an open-source resource for interrogation of the druggable human GPCRome</span></div><div class="casAuthors">Kroeze, Wesley K.; Sassano, Maria F.; Huang, Xi-Ping; Lansu, Katherine; McCorvy, John D.; Giguere, Patrick M.; Sciaky, Noah; Roth, Bryan L.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Structural & Molecular Biology</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">362-369</span>CODEN:
                <span class="NLM_cas:coden">NSMBCU</span>;
        ISSN:<span class="NLM_cas:issn">1545-9993</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">G protein-coupled receptors (GPCRs) are essential mediators of cellular signaling and are important targets of drug action.  Of the approx. 350 nonolfactory human GPCRs, more than 100 are still considered to be 'orphans' because their endogenous ligands remain unknown.  Here, we describe a unique open-source resource that allows interrogation of the druggable human GPCRome via a G protein-independent β-arrestin-recruitment assay.  We validate this unique platform at more than 120 nonorphan human GPCR targets, demonstrate its utility for discovering new ligands for orphan human GPCRs and describe a method (parallel receptorome expression and screening via transcriptional output, with transcriptional activation following arrestin translocation (PRESTO-Tango)) for the simultaneous and parallel interrogation of the entire human nonolfactory GPCRome.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoVbl7caV9gUrVg90H21EOLACvtfcHk0lhODfE_8OFjfw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXnslOgtLg%253D&md5=2a78b74a5f1425fa9e8b79b730c16be6</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1038%2Fnsmb.3014&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnsmb.3014%26sid%3Dliteratum%253Aachs%26aulast%3DKroeze%26aufirst%3DW.%2BK.%26aulast%3DSassano%26aufirst%3DM.%2BF.%26aulast%3DHuang%26aufirst%3DX.-P.%26aulast%3DLansu%26aufirst%3DK.%26aulast%3DMcCorvy%26aufirst%3DJ.%2BD.%26aulast%3DGigu%25C3%25A8re%26aufirst%3DP.%2BM.%26aulast%3DSciaky%26aufirst%3DN.%26aulast%3DRoth%26aufirst%3DB.%2BL.%26atitle%3DPRESTO-Tango%2520as%2520an%2520Open-Source%2520Resource%2520for%2520Interrogation%2520of%2520the%2520Druggable%2520Human%2520GPCRome%26jtitle%3DNat.%2520Struct.%2520Mol.%2520Biol%26date%3D2015%26volume%3D22%26doi%3D10.1038%2Fnsmb.3014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref36"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref36'); return false;" data-citation="" class="refNumLink">36</a></strong><div class="NLM_citation" id="cit36"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Besnard, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ruda, G. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Setola, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abecassis, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rodriguiz, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, X.-P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Norval, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sassano, M. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shin, A. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Webster, L. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Simeons, F. R. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stojanovski, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prat, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Seidah, N. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Constam, D. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bickerton, G. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Read, K. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wetsel, W. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gilbert, I. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roth, B. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hopkins, A. L.</span></span> <span> </span><span class="NLM_article-title">Automated Design of Ligands to Polypharmacological Profiles</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>492</i></span>, <span class="NLM_elocation-id">215</span> <span class="refDoi"> DOI: 10.1038/nature11691</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00412&amp;key=10.1038%2Fnature11691" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00412&amp;key=23235874" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00412&amp;key=1%3ACAS%3A528%3ADC%252BC38XhvVamurfN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=492&publication_year=2012&author=J.+Besnardauthor=G.+F.+Rudaauthor=V.+Setolaauthor=K.+Abecassisauthor=R.+M.+Rodriguizauthor=X.-P.+Huangauthor=S.+Norvalauthor=M.+F.+Sassanoauthor=A.+I.+Shinauthor=L.+A.+Websterauthor=F.+R.+C.+Simeonsauthor=L.+Stojanovskiauthor=A.+Pratauthor=N.+G.+Seidahauthor=D.+B.+Constamauthor=G.+R.+Bickertonauthor=K.+D.+Readauthor=W.+C.+Wetselauthor=I.+H.+Gilbertauthor=B.+L.+Rothauthor=A.+L.+Hopkins&title=Automated+Design+of+Ligands+to+Polypharmacological+Profiles&doi=10.1038%2Fnature11691"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">Automated design of ligands to polypharmacological profiles</span></div><div class="casAuthors">Besnard, Jeremy; Ruda, Gian Filippo; Setola, Vincent; Abecassis, Keren; Rodriguiz, Ramona M.; Huang, Xi-Ping; Norval, Suzanne; Sassano, Maria F.; Shin, Antony I.; Webster, Lauren A.; Simeons, Frederick R. C.; Stojanovski, Laste; Prat, Annik; Seidah, Nabil G.; Constam, Daniel B.; Bickerton, G. Richard; Read, Kevin D.; Wetsel, William C.; Gilbert, Ian H.; Roth, Bryan L.; Hopkins, Andrew L.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">492</span>
        (<span class="NLM_cas:issue">7428</span>),
    <span class="NLM_cas:pages">215-220</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The clin. efficacy and safety of a drug is detd. by its activity profile across many proteins in the proteome.  However, designing drugs with a specific multi-target profile is both complex and difficult.  Therefore methods to design drugs rationally a priori against profiles of several proteins would have immense value in drug discovery.  Here is described a new approach for the automated design of ligands against profiles of multiple drug targets.  The method is demonstrated by the evolution of an approved acetylcholinesterase inhibitor drug donepezil (I) into brain-penetrable ligands with either specific polypharmacol. or exquisite selectivity profiles for G-protein-coupled receptors.  Overall, 800 ligand-target predictions of prospectively designed ligands were tested exptl., of which 75% were confirmed to be correct.  Target engagement in vivo is also demonstrated.  The approach can be a useful source of drug leads when multi-target profiles are required to achieve either selectivity over other drug targets or a desired polypharmacol.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqNu5bwrBD3tbVg90H21EOLACvtfcHk0lhODfE_8OFjfw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhvVamurfN&md5=ace6cced250cf968d327b482a5bf1798</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1038%2Fnature11691&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature11691%26sid%3Dliteratum%253Aachs%26aulast%3DBesnard%26aufirst%3DJ.%26aulast%3DRuda%26aufirst%3DG.%2BF.%26aulast%3DSetola%26aufirst%3DV.%26aulast%3DAbecassis%26aufirst%3DK.%26aulast%3DRodriguiz%26aufirst%3DR.%2BM.%26aulast%3DHuang%26aufirst%3DX.-P.%26aulast%3DNorval%26aufirst%3DS.%26aulast%3DSassano%26aufirst%3DM.%2BF.%26aulast%3DShin%26aufirst%3DA.%2BI.%26aulast%3DWebster%26aufirst%3DL.%2BA.%26aulast%3DSimeons%26aufirst%3DF.%2BR.%2BC.%26aulast%3DStojanovski%26aufirst%3DL.%26aulast%3DPrat%26aufirst%3DA.%26aulast%3DSeidah%26aufirst%3DN.%2BG.%26aulast%3DConstam%26aufirst%3DD.%2BB.%26aulast%3DBickerton%26aufirst%3DG.%2BR.%26aulast%3DRead%26aufirst%3DK.%2BD.%26aulast%3DWetsel%26aufirst%3DW.%2BC.%26aulast%3DGilbert%26aufirst%3DI.%2BH.%26aulast%3DRoth%26aufirst%3DB.%2BL.%26aulast%3DHopkins%26aufirst%3DA.%2BL.%26atitle%3DAutomated%2520Design%2520of%2520Ligands%2520to%2520Polypharmacological%2520Profiles%26jtitle%3DNature%26date%3D2012%26volume%3D492%26doi%3D10.1038%2Fnature11691" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref37"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref37'); return false;" data-citation="" class="refNumLink">37</a></strong><div class="NLM_citation" id="cit37"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Luedtke, R. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Freeman, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boundy, V. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martin, M. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mach, R. H.</span></span> <span> </span><span class="NLM_article-title">Characterization of 125I-IABN, A Novel Azabicyclononane Benzamide Selective for D2-Like Dopamine Receptors</span>. <i>Synapse</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>38</i></span>,  <span class="NLM_fpage">438</span>– <span class="NLM_lpage">449</span>, <span class="refDoi"> DOI: 10.1002/1098-2396(20001215)38:4<438::AID-SYN9>3.0.CO;2-5</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00412&amp;key=10.1002%2F1098-2396%2820001215%2938%3A4%3C438%3A%3AAID-SYN9%3E3.0.CO%3B2-5" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=38&publication_year=2000&pages=438-449&author=R.+R.+Luedtkeauthor=R.+A.+Freemanauthor=V.+A.+Boundyauthor=M.+W.+Martinauthor=Y.+Huangauthor=R.+H.+Mach&title=Characterization+of+125I-IABN%2C+A+Novel+Azabicyclononane+Benzamide+Selective+for+D2-Like+Dopamine+Receptors&doi=10.1002%2F1098-2396%2820001215%2938%3A4%3C438%3A%3AAID-SYN9%3E3.0.CO%3B2-5"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1002%2F1098-2396%2820001215%2938%3A4%3C438%3A%3AAID-SYN9%3E3.0.CO%3B2-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252F1098-2396%252820001215%252938%253A4%253C438%253A%253AAID-SYN9%253E3.0.CO%253B2-5%26sid%3Dliteratum%253Aachs%26aulast%3DLuedtke%26aufirst%3DR.%2BR.%26aulast%3DFreeman%26aufirst%3DR.%2BA.%26aulast%3DBoundy%26aufirst%3DV.%2BA.%26aulast%3DMartin%26aufirst%3DM.%2BW.%26aulast%3DHuang%26aufirst%3DY.%26aulast%3DMach%26aufirst%3DR.%2BH.%26atitle%3DCharacterization%2520of%2520125I-IABN%252C%2520A%2520Novel%2520Azabicyclononane%2520Benzamide%2520Selective%2520for%2520D2-Like%2520Dopamine%2520Receptors%26jtitle%3DSynapse%26date%3D2000%26volume%3D38%26spage%3D438%26epage%3D449%26doi%3D10.1002%2F1098-2396%2820001215%2938%3A4%3C438%3A%3AAID-SYN9%3E3.0.CO%3B2-5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref38"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref38'); return false;" data-citation="" class="refNumLink">38</a></strong><div class="NLM_citation" id="cit38"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Baker, J. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hill, S. J.</span></span> <span> </span><span class="NLM_article-title">Multiple GPCR conformations and signalling pathways: implications for antagonist affinity estimates</span>. <i>Trends Pharmacol. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>28</i></span>,  <span class="NLM_fpage">374</span>– <span class="NLM_lpage">381</span>, <span class="refDoi"> DOI: 10.1016/j.tips.2007.06.011</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00412&amp;key=10.1016%2Fj.tips.2007.06.011" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00412&amp;key=17629959" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00412&amp;key=1%3ACAS%3A528%3ADC%252BD2sXotlWltLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=2007&pages=374-381&author=J.+G.+Bakerauthor=S.+J.+Hill&title=Multiple+GPCR+conformations+and+signalling+pathways%3A+implications+for+antagonist+affinity+estimates&doi=10.1016%2Fj.tips.2007.06.011"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">Multiple GPCR conformations and signaling pathways: implications for antagonist affinity estimates</span></div><div class="casAuthors">Baker, Jillian G.; Hill, Stephen J.</div><div class="citationInfo"><span class="NLM_cas:title">Trends in Pharmacological Sciences</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">28</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">374-381</span>CODEN:
                <span class="NLM_cas:coden">TPHSDY</span>;
        ISSN:<span class="NLM_cas:issn">0165-6147</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Antagonist affinity measurements have traditionally been considered important in characterizing the cell-surface receptors present in a particular cell or tissue.  A central assumption has been that antagonist affinity is const. for a given receptor-antagonist interaction, regardless of the agonist used to stimulate that receptor or the downstream response that is measured.  As a consequence, changes in antagonist affinity values have been taken as initial evidence for the presence of novel receptor subtypes.  Emerging evidence suggests, however, that receptors can possess multiple binding sites and the same receptor can show different antagonist affinity measurements under distinct exptl. conditions.  Here, we discuss several mechanisms by which antagonists have different affinities for the same receptor as a consequence of allosterism, coupling to different G proteins, multiple (but non-interacting) receptor sites, and signal-pathway-dependent pharmacol. (where the pharmacol. obsd. varies depending on the signaling pathway measured).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrcWqdG7J1LyLVg90H21EOLACvtfcHk0lhODfE_8OFjfw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXotlWltLo%253D&md5=ac0bbf5922dd08316f502a3e981b2444</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1016%2Fj.tips.2007.06.011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.tips.2007.06.011%26sid%3Dliteratum%253Aachs%26aulast%3DBaker%26aufirst%3DJ.%2BG.%26aulast%3DHill%26aufirst%3DS.%2BJ.%26atitle%3DMultiple%2520GPCR%2520conformations%2520and%2520signalling%2520pathways%253A%2520implications%2520for%2520antagonist%2520affinity%2520estimates%26jtitle%3DTrends%2520Pharmacol.%2520Sci.%26date%3D2007%26volume%3D28%26spage%3D374%26epage%3D381%26doi%3D10.1016%2Fj.tips.2007.06.011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref39"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref39'); return false;" data-citation="" class="refNumLink">39</a></strong><div class="NLM_citation" id="cit39"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Boateng, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bakare, O. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhan, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Banala, A. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burzynski, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pommier, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Keck, T. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Donthamsetti, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Javitch, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rais, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Slusher, B. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xi, Z.-X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Newman, A. H.</span></span> <span> </span><span class="NLM_article-title">High Affinity Dopamine D3 Receptor (D3R)-Selective Antagonists Attenuate Heroin Self-Administration in Wild-Type but not D3R Knockout Mice</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>58</i></span>,  <span class="NLM_fpage">6195</span>– <span class="NLM_lpage">6213</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.5b00776</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.5b00776" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00412&amp;key=1%3ACAS%3A528%3ADC%252BC2MXht1alur%252FK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2015&pages=6195-6213&author=C.+A.+Boatengauthor=O.+M.+Bakareauthor=J.+Zhanauthor=A.+K.+Banalaauthor=C.+Burzynskiauthor=E.+Pommierauthor=T.+M.+Keckauthor=P.+Donthamsettiauthor=J.+A.+Javitchauthor=R.+Raisauthor=B.+S.+Slusherauthor=Z.-X.+Xiauthor=A.+H.+Newman&title=High+Affinity+Dopamine+D3+Receptor+%28D3R%29-Selective+Antagonists+Attenuate+Heroin+Self-Administration+in+Wild-Type+but+not+D3R+Knockout+Mice&doi=10.1021%2Facs.jmedchem.5b00776"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">High Affinity Dopamine D3 Receptor (D3R)-Selective Antagonists Attenuate Heroin Self-Administration in Wild-Type but not D3R Knockout Mice</span></div><div class="casAuthors">Boateng, Comfort A.; Bakare, Oluyomi M.; Zhan, Jia; Banala, Ashwini K.; Burzynski, Caitlin; Pommier, Elie; Keck, Thomas M.; Donthamsetti, Prashant; Javitch, Jonathan A.; Rais, Rana; Slusher, Barbara S.; Xi, Zheng-Xiong; Newman, Amy Hauck</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">6195-6213</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The dopamine D3 receptor (D3R) is a promising target for the development of pharmacotherapeutics to treat substance use disorders.  Several D3R-selective antagonists are effective in animal models of drug abuse, esp. in models of relapse.  Nevertheless, poor bioavailability, metabolic instability, and/or predicted toxicity have impeded success in translating these drug candidates to clin. use.  Herein, the authors report a series of D3R-selective 4-phenylpiperazines with improved metabolic stability.  A subset of these compds. was evaluated for D3R functional efficacy and off-target binding at selected 5-HT receptor subtypes, where significant overlap in SAR with D3R has been obsd.  Several high affinity D3R antagonists, including compds. I (Ki = 0.12 nM) and II (Ki = 0.35 nM), showed improved metabolic stability compared to the parent compd., PG648.  Notably, I and the classic D3R antagonist SB277011A were effective in reducing self-administration of heroin in wild-type but not D3R knockout mice.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoagzWQU_gPV7Vg90H21EOLACvtfcHk0lge_JuzzqmUrg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXht1alur%252FK&md5=1724065cac8ac51295cf4660a20ed734</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.5b00776&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.5b00776%26sid%3Dliteratum%253Aachs%26aulast%3DBoateng%26aufirst%3DC.%2BA.%26aulast%3DBakare%26aufirst%3DO.%2BM.%26aulast%3DZhan%26aufirst%3DJ.%26aulast%3DBanala%26aufirst%3DA.%2BK.%26aulast%3DBurzynski%26aufirst%3DC.%26aulast%3DPommier%26aufirst%3DE.%26aulast%3DKeck%26aufirst%3DT.%2BM.%26aulast%3DDonthamsetti%26aufirst%3DP.%26aulast%3DJavitch%26aufirst%3DJ.%2BA.%26aulast%3DRais%26aufirst%3DR.%26aulast%3DSlusher%26aufirst%3DB.%2BS.%26aulast%3DXi%26aufirst%3DZ.-X.%26aulast%3DNewman%26aufirst%3DA.%2BH.%26atitle%3DHigh%2520Affinity%2520Dopamine%2520D3%2520Receptor%2520%2528D3R%2529-Selective%2520Antagonists%2520Attenuate%2520Heroin%2520Self-Administration%2520in%2520Wild-Type%2520but%2520not%2520D3R%2520Knockout%2520Mice%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2015%26volume%3D58%26spage%3D6195%26epage%3D6213%26doi%3D10.1021%2Facs.jmedchem.5b00776" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref40"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref40'); return false;" data-citation="" class="refNumLink">40</a></strong><div class="NLM_citation" id="cit40"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mach, R. H.</span></span> <span> </span><span class="NLM_article-title">Small Molecule Receptor Ligands for PET Studies of the Central Nervous System—Focus on G Protein Coupled Receptors</span>. <i>Semin. Nucl. Med.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>47</i></span>,  <span class="NLM_fpage">524</span>– <span class="NLM_lpage">535</span>, <span class="refDoi"> DOI: 10.1053/j.semnuclmed.2017.05.002</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00412&amp;key=10.1053%2Fj.semnuclmed.2017.05.002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00412&amp;key=28826524" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00412&amp;key=1%3ACAS%3A280%3ADC%252BC1cbgt1Siuw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2017&pages=524-535&author=R.+H.+Mach&title=Small+Molecule+Receptor+Ligands+for+PET+Studies+of+the+Central+Nervous+System%E2%80%94Focus+on+G+Protein+Coupled+Receptors&doi=10.1053%2Fj.semnuclmed.2017.05.002"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">Small Molecule Receptor Ligands for PET Studies of the Central Nervous System-Focus on G Protein Coupled Receptors</span></div><div class="casAuthors">Mach Robert H</div><div class="citationInfo"><span class="NLM_cas:title">Seminars in nuclear medicine</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">47</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">524-535</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">G protein-coupled receptors (GPRCs) are a class of proteins that are expressed in high abundance and are responsible for numerous signal transduction pathways in the central nervous system.  Consequently, alterations in GPRC function have been associated with a wide variety of neurologic and neuropsychiatric disorders.  The development of PET probes for imaging GPRCs has served as a major emphasis of PET radiotracer development and PET imaging studies over the past 30 years.  In this review, a basic description of the biology of G proteins and GPRCs is provided.  This includes recent evidence of the existence of dimeric and multimeric species of GPRCs that have been termed "receptor mosaics," with an emphasis on the different GPRCs that form complexes with the dopamine D2 receptor.  An overview of the different PET radiotracers for imaging the component GPRC within these different multimeric complexes of the D2 receptor is also provided.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTaZEK7fnupmfx2phytoz6_fW6udTcc2eZ9-s3i-pWyOrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC1cbgt1Siuw%253D%253D&md5=a863ca1c89efd2f16a6a18b8a6c14314</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1053%2Fj.semnuclmed.2017.05.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1053%252Fj.semnuclmed.2017.05.002%26sid%3Dliteratum%253Aachs%26aulast%3DMach%26aufirst%3DR.%2BH.%26atitle%3DSmall%2520Molecule%2520Receptor%2520Ligands%2520for%2520PET%2520Studies%2520of%2520the%2520Central%2520Nervous%2520System%25E2%2580%2594Focus%2520on%2520G%2520Protein%2520Coupled%2520Receptors%26jtitle%3DSemin.%2520Nucl.%2520Med.%26date%3D2017%26volume%3D47%26spage%3D524%26epage%3D535%26doi%3D10.1053%2Fj.semnuclmed.2017.05.002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref41"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref41'); return false;" data-citation="" class="refNumLink">41</a></strong><div class="NLM_citation" id="cit41"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mach, R. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luedtke, R. R.</span></span> <span> </span><span class="NLM_article-title">Challenges in the Development of Dopamine D2- and D3-Selective Radiotracers for PET Imaging Studies</span>. <i>J. Labelled Compd. Radiopharm.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>61</i></span>,  <span class="NLM_fpage">291</span>– <span class="NLM_lpage">298</span>, <span class="refDoi"> DOI: 10.1002/jlcr.3558</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00412&amp;key=10.1002%2Fjlcr.3558" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00412&amp;key=28857231" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00412&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhsFOitbjN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2018&pages=291-298&author=R.+H.+Machauthor=R.+R.+Luedtke&title=Challenges+in+the+Development+of+Dopamine+D2-+and+D3-Selective+Radiotracers+for+PET+Imaging+Studies&doi=10.1002%2Fjlcr.3558"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">Challenges in the development of dopamine D2- and D3-selective radiotracers for PET imaging studies</span></div><div class="casAuthors">Mach, Robert H.; Luedtke, Robert R.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Labelled Compounds and Radiopharmaceuticals</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">61</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">291-298</span>CODEN:
                <span class="NLM_cas:coden">JLCRD4</span>;
        ISSN:<span class="NLM_cas:issn">0362-4803</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons Ltd.</span>)
        </div><div class="casAbstract">The dopamine D2-like receptors (ie, D2/3 receptors) have been the most extensively studied CNS receptor with Positron Emission Tomog. (PET).  The 3 different radiotracers that have been used in these studies are [11C]raclopride, [18F]fallypride, and [11C]PHNO.  Because these radiotracers have a high affinity for both dopamine D2 and D3 receptors, the d. of dopamine receptors in the CNS is reported as the D2/3 binding potential, which reflects a measure of the d. of both receptor subtypes.  Although the development of D2- and D3-selective PET radiotracers has been an active area of research for many years, this by and large presents an unmet need in the area of translational PET imaging studies.  This article discusses some of the challenges that have inhibited progress in this area of research and the current status of the development of subtype selective radiotracers for imaging D3 and D2 dopamine receptors with PET.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr8JZoIikHgU7Vg90H21EOLACvtfcHk0lge_JuzzqmUrg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhsFOitbjN&md5=4158425b26582cc514b994c264c5da04</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1002%2Fjlcr.3558&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjlcr.3558%26sid%3Dliteratum%253Aachs%26aulast%3DMach%26aufirst%3DR.%2BH.%26aulast%3DLuedtke%26aufirst%3DR.%2BR.%26atitle%3DChallenges%2520in%2520the%2520Development%2520of%2520Dopamine%2520D2-%2520and%2520D3-Selective%2520Radiotracers%2520for%2520PET%2520Imaging%2520Studies%26jtitle%3DJ.%2520Labelled%2520Compd.%2520Radiopharm.%26date%3D2018%26volume%3D61%26spage%3D291%26epage%3D298%26doi%3D10.1002%2Fjlcr.3558" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref42"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref42'); return false;" data-citation="" class="refNumLink">42</a></strong><div class="NLM_citation" id="cit42"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sóvágó, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Farde, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Halldin, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Langer, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Laszlovszky, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kiss, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gulyás, B.</span></span> <span> </span><span class="NLM_article-title">Positron Emission Tomographic Evaluation of the Putative Dopamine-D3 Receptor Ligand, [11C]RGH-1756 in the Monkey Brain</span>. <i>Neurochem. Int.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>45</i></span>,  <span class="NLM_fpage">609</span>– <span class="NLM_lpage">617</span>, <span class="refDoi"> DOI: 10.1016/j.neuint.2004.04.004</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00412&amp;key=10.1016%2Fj.neuint.2004.04.004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00412&amp;key=15234102" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00412&amp;key=1%3ACAS%3A528%3ADC%252BD2cXlsVartr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=2004&pages=609-617&author=J.+S%C3%B3v%C3%A1g%C3%B3author=L.+Fardeauthor=C.+Halldinauthor=O.+Langerauthor=I.+Laszlovszkyauthor=B.+Kissauthor=B.+Guly%C3%A1s&title=Positron+Emission+Tomographic+Evaluation+of+the+Putative+Dopamine-D3+Receptor+Ligand%2C+%5B11C%5DRGH-1756+in+the+Monkey+Brain&doi=10.1016%2Fj.neuint.2004.04.004"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit42R"><div class="casContent"><span class="casTitleNuber">42</span><div class="casTitle"><span class="NLM_cas:atitle">Positron emission tomographic evaluation of the putative dopamine-D3 receptor ligand, [11C]RGH-1756 in the monkey brain</span></div><div class="casAuthors">Sovago, Judit; Farde, Lars; Halldin, Christer; Langer, Oliver; Laszlovszky, Istvan; Kiss, Bela; Gulyas, Balazs</div><div class="citationInfo"><span class="NLM_cas:title">Neurochemistry International</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">45</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">609-617</span>CODEN:
                <span class="NLM_cas:coden">NEUIDS</span>;
        ISSN:<span class="NLM_cas:issn">0197-0186</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science B.V.</span>)
        </div><div class="casAbstract">The dopamine-D3 receptor is of special interest due to its postulated role in the pathophysiol. and treatment of schizophrenia and Parkinson's Disease.  Increasing evidences support the assumption that the D3 receptors are occupied to a high degree by dopamine at physiol. conditions.  Research on the functional role of the D3 receptors in brain has however been hampered by the lack of D3 selective ligands.  In the present Positron Emission Tomog. (PET) study the binding of the novel, putative dopamine-D3 receptor ligand, [11C]RGH-1756 was characterized in the cynomolgus monkey brain.  [11C]RGH-1756 was rather homogenously distributed in brain and the regional binding potential (BP) values ranged between 0.17 and 0.48.  Pretreatment with unlabeled RGH-1756 decreased radioligand binding to the level of the cerebellum in most brain areas.  The regional BP values were lower after i.v. injection of a higher mass of RGH-1756, indicating saturable binding of [11C]RGH-1756.  The D2/D3 antagonist raclopride partly inhibited the binding of [11C]RGH-1756 in several brain areas, including the striatum, mesencephalon and neocortex, whereas the 5HT1A antagonist WAY-100635 had no evident effect on [11C]RGH-1756 binding.  Despite the promising binding characteristics of RGH-1756 in vitro the present PET-study indicates that [11C]RGH-1756 provides a low signal for specific binding to the D3 receptor in vivo.  One explanation is that the favorable binding characteristics of RGH-1756 in vitro are not manifested in vivo.  Alternatively, the results may support the hypothesis that the dopamine-D3 receptors are indeed occupied to a high extent by dopamine in vivo and thus not available for radioligand binding.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp1rtfx7fQFvrVg90H21EOLACvtfcHk0lj1rnkw1bPWPA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXlsVartr0%253D&md5=79472e54e607a024844afc5d606fe210</span></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1016%2Fj.neuint.2004.04.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.neuint.2004.04.004%26sid%3Dliteratum%253Aachs%26aulast%3DS%25C3%25B3v%25C3%25A1g%25C3%25B3%26aufirst%3DJ.%26aulast%3DFarde%26aufirst%3DL.%26aulast%3DHalldin%26aufirst%3DC.%26aulast%3DLanger%26aufirst%3DO.%26aulast%3DLaszlovszky%26aufirst%3DI.%26aulast%3DKiss%26aufirst%3DB.%26aulast%3DGuly%25C3%25A1s%26aufirst%3DB.%26atitle%3DPositron%2520Emission%2520Tomographic%2520Evaluation%2520of%2520the%2520Putative%2520Dopamine-D3%2520Receptor%2520Ligand%252C%2520%255B11C%255DRGH-1756%2520in%2520the%2520Monkey%2520Brain%26jtitle%3DNeurochem.%2520Int.%26date%3D2004%26volume%3D45%26spage%3D609%26epage%3D617%26doi%3D10.1016%2Fj.neuint.2004.04.004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref43"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref43'); return false;" data-citation="" class="refNumLink">43</a></strong><div class="NLM_citation" id="cit43"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kuhnast, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Valette, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Besret, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Demphel, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Coulon, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ottaviani, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guillermier, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bottlaender, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dollé, F.</span></span> <span> </span><span class="NLM_article-title">Synthesis and Radiolabeling of N-[4-[4-(2-[11C]Methoxyphenyl)piperazin-1-yl]butyl]benzo[b]thiophene-2-carboxamide — a Potential Radiotracer for D3 Receptor Imaging with PET</span>. <i>Nucl. Med. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>33</i></span>,  <span class="NLM_fpage">785</span>– <span class="NLM_lpage">795</span>, <span class="refDoi"> DOI: 10.1016/j.nucmedbio.2006.05.007</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00412&amp;key=10.1016%2Fj.nucmedbio.2006.05.007" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00412&amp;key=16934697" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00412&amp;key=1%3ACAS%3A528%3ADC%252BD28Xoslyqurs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=2006&pages=785-795&author=B.+Kuhnastauthor=H.+Valetteauthor=L.+Besretauthor=S.+Demphelauthor=C.+Coulonauthor=M.+Ottavianiauthor=M.+Guillermierauthor=M.+Bottlaenderauthor=F.+Doll%C3%A9&title=Synthesis+and+Radiolabeling+of+N-%5B4-%5B4-%282-%5B11C%5DMethoxyphenyl%29piperazin-1-yl%5Dbutyl%5Dbenzo%5Bb%5Dthiophene-2-carboxamide+%E2%80%94+a+Potential+Radiotracer+for+D3+Receptor+Imaging+with+PET&doi=10.1016%2Fj.nucmedbio.2006.05.007"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit43R"><div class="casContent"><span class="casTitleNuber">43</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and radiolabeling of N-[4-[4-(2-[11C]methoxyphenyl)piperazin-1-yl]butyl]benzo[b]thiophene-2-carboxamide - a potential radiotracer for D3 receptor imaging with PET</span></div><div class="casAuthors">Kuhnast, Bertrand; Valette, Heric; Besret, Laurent; Demphel, Stephane; Coulon, Christine; Ottaviani, Michele; Guillermier, Martine; Bottlaender, Michel; Dolle, Frederic</div><div class="citationInfo"><span class="NLM_cas:title">Nuclear Medicine and Biology</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">33</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">785-795</span>CODEN:
                <span class="NLM_cas:coden">NMBIEO</span>;
        ISSN:<span class="NLM_cas:issn">0969-8051</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">FAUC346 (N-[4-[4-(2-methoxyphenyl)piperazin-1-yl]butyl]benzo[b]thiophene-2-carboxamide),an in vitro D3-selective ligand, and its normethyl deriv. have been synthesized from com. available 1-(2-substituted-phenyl)piperazines.  FAUC346 has been labeled using [11C]methyl triflate in acetone contg. aq. NaOH (5 Equiv) at -10 °C for 1 min, purified on semipreparative reverse-phase high-performance liq. chromatog. (HPLC) and formulated as an i.v. injectable soln. using a Sep-Pak Plus C18 device.  Up to 5.5 GBq of [11C]FAUC346 (N-[4-[4-(2-[methyl-11C]methoxyphenyl)piperazin-1-yl]butyl]benzo[b]thiophene-2-carboxamide), with a specific radioactivity of 45-75 GBq/μmol, could be obtained in 30-35 min, including HPLC purifn. and formulation starting from 44.4 GBq of [11C]carbon dioxide.  Preliminary pharmacol. evaluation of [11C]FAUC346 in rat brain clearly demonstrated in vivo selectivity for D3 receptors and the absence of radiolabeled metabolite within the brain.  These encouraging results, however, could not be confirmed in nonhuman primates; therefore, this radioligand does not appear to have the required pharmacol. profile for a positron emission tomog. probe for imaging D3 receptors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrx0NTdR3DKMrVg90H21EOLACvtfcHk0lj1rnkw1bPWPA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xoslyqurs%253D&md5=4f3a8d6fce9e174298570fa0a7dd8c11</span></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1016%2Fj.nucmedbio.2006.05.007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.nucmedbio.2006.05.007%26sid%3Dliteratum%253Aachs%26aulast%3DKuhnast%26aufirst%3DB.%26aulast%3DValette%26aufirst%3DH.%26aulast%3DBesret%26aufirst%3DL.%26aulast%3DDemphel%26aufirst%3DS.%26aulast%3DCoulon%26aufirst%3DC.%26aulast%3DOttaviani%26aufirst%3DM.%26aulast%3DGuillermier%26aufirst%3DM.%26aulast%3DBottlaender%26aufirst%3DM.%26aulast%3DDoll%25C3%25A9%26aufirst%3DF.%26atitle%3DSynthesis%2520and%2520Radiolabeling%2520of%2520N-%255B4-%255B4-%25282-%255B11C%255DMethoxyphenyl%2529piperazin-1-yl%255Dbutyl%255Dbenzo%255Bb%255Dthiophene-2-carboxamide%2520%25E2%2580%2594%2520a%2520Potential%2520Radiotracer%2520for%2520D3%2520Receptor%2520Imaging%2520with%2520PET%26jtitle%3DNucl.%2520Med.%2520Biol.%26date%3D2006%26volume%3D33%26spage%3D785%26epage%3D795%26doi%3D10.1016%2Fj.nucmedbio.2006.05.007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref44"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref44'); return false;" data-citation="" class="refNumLink">44</a></strong><div class="NLM_citation" id="cit44"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Reid, J. L.</span></span> <span> </span><span class="NLM_article-title">Alpha-Adrenergic Receptors and Blood Pressure Control</span>. <i>Am. J. Cardiol.</i> <span class="NLM_year" style="font-weight: bold;">1986</span>,  <span class="NLM_volume"><i>57</i></span>,  <span class="NLM_fpage">E6</span>– <span class="NLM_lpage">E12</span>, <span class="refDoi"> DOI: 10.1016/0002-9149(86)90716-2</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00412&amp;key=10.1016%2F0002-9149%2886%2990716-2" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=1986&pages=E6-E12&author=J.+L.+Reid&title=Alpha-Adrenergic+Receptors+and+Blood+Pressure+Control&doi=10.1016%2F0002-9149%2886%2990716-2"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1016%2F0002-9149%2886%2990716-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0002-9149%252886%252990716-2%26sid%3Dliteratum%253Aachs%26aulast%3DReid%26aufirst%3DJ.%2BL.%26atitle%3DAlpha-Adrenergic%2520Receptors%2520and%2520Blood%2520Pressure%2520Control%26jtitle%3DAm.%2520J.%2520Cardiol.%26date%3D1986%26volume%3D57%26spage%3DE6%26epage%3DE12%26doi%3D10.1016%2F0002-9149%2886%2990716-2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref45"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref45'); return false;" data-citation="" class="refNumLink">45</a></strong><div class="NLM_citation" id="cit45"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Newman, A. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grundt, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nader, M. A.</span></span> <span> </span><span class="NLM_article-title">Dopamine D3 Receptor Partial Agonists and Antagonists as Potential Drug Abuse Therapeutic Agents</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>48</i></span>,  <span class="NLM_fpage">3663</span>– <span class="NLM_lpage">3679</span>, <span class="refDoi"> DOI: 10.1021/jm040190e</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm040190e" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00412&amp;key=1%3ACAS%3A528%3ADC%252BD2MXjtl2nur0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2005&pages=3663-3679&author=A.+H.+Newmanauthor=P.+Grundtauthor=M.+A.+Nader&title=Dopamine+D3+Receptor+Partial+Agonists+and+Antagonists+as+Potential+Drug+Abuse+Therapeutic+Agents&doi=10.1021%2Fjm040190e"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit45R"><div class="casContent"><span class="casTitleNuber">45</span><div class="casTitle"><span class="NLM_cas:atitle">Dopamine D3 Receptor Partial Agonists and Antagonists as Potential Drug Abuse Therapeutic Agents</span></div><div class="casAuthors">Newman, Amy Hauck; Grundt, Peter; Nader, Michael A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">48</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">3663-3679</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  This report is limited to discussions of potential dopamine D3 receptor agents, currently being developed as medications for drug abuse and other neuropsychiatric disorders, to partial agonists and antagonists.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrqHXSFV83KfLVg90H21EOLACvtfcHk0lj1rnkw1bPWPA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXjtl2nur0%253D&md5=4244539d9e8038e2027dba1e21497cdd</span></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1021%2Fjm040190e&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm040190e%26sid%3Dliteratum%253Aachs%26aulast%3DNewman%26aufirst%3DA.%2BH.%26aulast%3DGrundt%26aufirst%3DP.%26aulast%3DNader%26aufirst%3DM.%2BA.%26atitle%3DDopamine%2520D3%2520Receptor%2520Partial%2520Agonists%2520and%2520Antagonists%2520as%2520Potential%2520Drug%2520Abuse%2520Therapeutic%2520Agents%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2005%26volume%3D48%26spage%3D3663%26epage%3D3679%26doi%3D10.1021%2Fjm040190e" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref46"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref46'); return false;" data-citation="" class="refNumLink">46</a></strong><div class="NLM_citation" id="cit46"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pilla, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perachon, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sautel, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garrido, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mann, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wermuth, C. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schwartz, J.-C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Everitt, B. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sokoloff, P.</span></span> <span> </span><span class="NLM_article-title">Selective Inhibition of Cocaine-Seeking Behaviour by a Partial Dopamine D3 Receptor Agonist</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">1999</span>,  <span class="NLM_volume"><i>400</i></span>,  <span class="NLM_fpage">371</span>– <span class="NLM_lpage">375</span>, <span class="refDoi"> DOI: 10.1038/22560</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00412&amp;key=10.1038%2F22560" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00412&amp;key=10432116" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00412&amp;key=1%3ACAS%3A528%3ADyaK1MXkvFOntr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=400&publication_year=1999&pages=371-375&author=M.+Pillaauthor=S.+Perachonauthor=F.+Sautelauthor=F.+Garridoauthor=A.+Mannauthor=C.+G.+Wermuthauthor=J.-C.+Schwartzauthor=B.+J.+Everittauthor=P.+Sokoloff&title=Selective+Inhibition+of+Cocaine-Seeking+Behaviour+by+a+Partial+Dopamine+D3+Receptor+Agonist&doi=10.1038%2F22560"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit46R"><div class="casContent"><span class="casTitleNuber">46</span><div class="casTitle"><span class="NLM_cas:atitle">Selective inhibition of cocaine-seeking behavior by a partial dopamine D3 receptor agonist</span></div><div class="casAuthors">Pilla, Maria; Perachon, Sylvie; Sautel, Francois; Garrido, Fabrice; Mann, Andre; Wermuth, Camille G.; Schwartz, Jean-Charles; Everitt, Barry J.; Sokoloff, Pierre</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London)</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">400</span>
        (<span class="NLM_cas:issue">6742</span>),
    <span class="NLM_cas:pages">371-375</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Macmillan Magazines</span>)
        </div><div class="casAbstract">Environmental stimuli that are reliably assocd. with the effects of many abused drugs, esp. stimulants such as cocaine, can produce craving and relapse in abstinent human substance abusers.  In animals, such cues can induce and maintain drug-seeking behavior and also reinstate drug-seeking after extinction.  Reducing the motivational effects of drug-related cues might therefore be useful in the treatment of addiction.  Converging pharmacol., human post-mortem and genetic studies implicate the dopamine D3 receptor in drug addiction.  Here we have designed BP 897, the first D3-receptor-selective agonist, as assessed in vitro with recombinant receptors and in vivo with mice bearing disrupted D3-receptor genes.  BP 897 is a partial agonist in vitro and acts in vivo as either an agonist or an antagonist.  We show that BP 897 inhibits cocaine-seeking behavior that depends upon the presentation of drug-assocd. cues, without having any intrinsic, primary rewarding effects.  Our data indicate that compds. like BP 897 could be used for reducing the drug craving and vulnerability to relapse that are elicited by drug-assocd. environmental stimuli.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp6SwJsmcTSCLVg90H21EOLACvtfcHk0ljPGWyy2QR5xg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXkvFOntr0%253D&md5=3f4055a4cd1b6cee7e890ff1b96b21b6</span></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1038%2F22560&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F22560%26sid%3Dliteratum%253Aachs%26aulast%3DPilla%26aufirst%3DM.%26aulast%3DPerachon%26aufirst%3DS.%26aulast%3DSautel%26aufirst%3DF.%26aulast%3DGarrido%26aufirst%3DF.%26aulast%3DMann%26aufirst%3DA.%26aulast%3DWermuth%26aufirst%3DC.%2BG.%26aulast%3DSchwartz%26aufirst%3DJ.-C.%26aulast%3DEveritt%26aufirst%3DB.%2BJ.%26aulast%3DSokoloff%26aufirst%3DP.%26atitle%3DSelective%2520Inhibition%2520of%2520Cocaine-Seeking%2520Behaviour%2520by%2520a%2520Partial%2520Dopamine%2520D3%2520Receptor%2520Agonist%26jtitle%3DNature%26date%3D1999%26volume%3D400%26spage%3D371%26epage%3D375%26doi%3D10.1038%2F22560" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref47"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref47'); return false;" data-citation="" class="refNumLink">47</a></strong><div class="NLM_citation" id="cit47"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sánchez-Soto, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Casadó-Anguera, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yano, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bender, B. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cai, N.-S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moreno, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Canela, E. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cortés, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meiler, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Casadó, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ferré, S.</span></span> <span> </span><span class="NLM_article-title">α2A- and α2C-Adrenoceptors as Potential Targets for Dopamine and Dopamine Receptor Ligands</span>. <i>Mol. Neurobiol.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>55</i></span>,  <span class="NLM_fpage">8438</span>– <span class="NLM_lpage">8454</span>, <span class="refDoi"> DOI: 10.1007/s12035-018-1004-1</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00412&amp;key=10.1007%2Fs12035-018-1004-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00412&amp;key=29552726" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00412&amp;key=1%3ACAS%3A528%3ADC%252BC1cXltVynsrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2018&pages=8438-8454&author=M.+S%C3%A1nchez-Sotoauthor=V.+Casad%C3%B3-Angueraauthor=H.+Yanoauthor=B.+J.+Benderauthor=N.-S.+Caiauthor=E.+Morenoauthor=E.+I.+Canelaauthor=A.+Cort%C3%A9sauthor=J.+Meilerauthor=V.+Casad%C3%B3author=S.+Ferr%C3%A9&title=%CE%B12A-+and+%CE%B12C-Adrenoceptors+as+Potential+Targets+for+Dopamine+and+Dopamine+Receptor+Ligands&doi=10.1007%2Fs12035-018-1004-1"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit47R"><div class="casContent"><span class="casTitleNuber">47</span><div class="casTitle"><span class="NLM_cas:atitle">α2A- and α2C-Adrenoceptors as Potential Targets for Dopamine and Dopamine Receptor Ligands</span></div><div class="casAuthors">Sanchez-Soto, Marta; Casado-Anguera, Veronica; Yano, Hideaki; Bender, Brian Joseph; Cai, Ning-Sheng; Moreno, Estefania; Canela, Enric I.; Cortes, Antoni; Meiler, Jens; Casado, Vicent; Ferre, Sergi</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Neurobiology</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">8438-8454</span>CODEN:
                <span class="NLM_cas:coden">MONBEW</span>;
        ISSN:<span class="NLM_cas:issn">0893-7648</span>.
    
            (<span class="NLM_cas:orgname">Humana Press Inc.</span>)
        </div><div class="casAbstract">The poor norepinephrine innervation and high d. of Gi/o-coupled α2A- and α2C-adrenoceptors in the striatum and the dense striatal dopamine innervation have prompted the possibility that dopamine could be an effective adrenoceptor ligand.  Nevertheless, the reported adrenoceptor agonistic properties of dopamine are still inconclusive.  In this study, we analyzed the binding of norepinephrine, dopamine, and several compds. reported as selective dopamine D2-like receptor ligands, such as the D3 receptor agonist 7-OH-PIPAT and the D4 receptor agonist RO-105824, to α2-adrenoceptors in cortical and striatal tissue, which express α2A-adrenoceptors and both α2A- and α2C-adrenoceptors, resp.  The affinity of dopamine for α2-adrenoceptors was found to be similar to that for D1-like and D2-like receptors.  Moreover, the exogenous dopamine receptor ligands also showed high affinity for α2A- and α2C-adrenoceptors.  Their ability to activate Gi/o proteins through α2A- and α2C-adrenoceptors was also analyzed in transfected cells with bioluminescent resonance energy transfer techniques.  The relative ligand potencies and efficacies were dependent on the Gi/o protein subtype.  Furthermore, dopamine binding to α2-adrenoceptors was functional, inducing changes in dynamic mass redistribution, adenylyl cyclase activity, and ERK1/2 phosphorylation.  Binding events were further studied with computer modeling of ligand docking.  Docking of dopamine at α2A- and α2C-adrenoceptors was nearly identical to its binding to the crystd. D3 receptor.  Therefore, we provide conclusive evidence that α2A- and α2C-adrenoceptors are functional receptors for norepinephrine, dopamine, and other previously assumed selective D2-like receptor ligands, which calls for revisiting previous studies with those ligands.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrGdXKvwK7HTLVg90H21EOLACvtfcHk0ljPGWyy2QR5xg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXltVynsrw%253D&md5=307c9e1dfa5a39a0bca6c137034c1216</span></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.1007%2Fs12035-018-1004-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs12035-018-1004-1%26sid%3Dliteratum%253Aachs%26aulast%3DS%25C3%25A1nchez-Soto%26aufirst%3DM.%26aulast%3DCasad%25C3%25B3-Anguera%26aufirst%3DV.%26aulast%3DYano%26aufirst%3DH.%26aulast%3DBender%26aufirst%3DB.%2BJ.%26aulast%3DCai%26aufirst%3DN.-S.%26aulast%3DMoreno%26aufirst%3DE.%26aulast%3DCanela%26aufirst%3DE.%2BI.%26aulast%3DCort%25C3%25A9s%26aufirst%3DA.%26aulast%3DMeiler%26aufirst%3DJ.%26aulast%3DCasad%25C3%25B3%26aufirst%3DV.%26aulast%3DFerr%25C3%25A9%26aufirst%3DS.%26atitle%3D%25CE%25B12A-%2520and%2520%25CE%25B12C-Adrenoceptors%2520as%2520Potential%2520Targets%2520for%2520Dopamine%2520and%2520Dopamine%2520Receptor%2520Ligands%26jtitle%3DMol.%2520Neurobiol.%26date%3D2018%26volume%3D55%26spage%3D8438%26epage%3D8454%26doi%3D10.1007%2Fs12035-018-1004-1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref48"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref48'); return false;" data-citation="" class="refNumLink">48</a></strong><div class="NLM_citation" id="cit48"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Appel, N. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, S. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Holmes, T. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Acri, J. B.</span></span> <span> </span><span class="NLM_article-title">Dopamine D3 Receptor Antagonist (GSK598809) Potentiates the Hypertensive Effects of Cocaine in Conscious, Freely-Moving Dogs</span>. <i>J. Pharmacol. Exp. Ther.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>354</i></span>,  <span class="NLM_fpage">484</span>– <span class="NLM_lpage">492</span>, <span class="refDoi"> DOI: 10.1124/jpet.115.224121</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00412&amp;key=10.1124%2Fjpet.115.224121" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00412&amp;key=26177654" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00412&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhsV2rsbvJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=354&publication_year=2015&pages=484-492&author=N.+M.+Appelauthor=S.+H.+Liauthor=T.+H.+Holmesauthor=J.+B.+Acri&title=Dopamine+D3+Receptor+Antagonist+%28GSK598809%29+Potentiates+the+Hypertensive+Effects+of+Cocaine+in+Conscious%2C+Freely-Moving+Dogs&doi=10.1124%2Fjpet.115.224121"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit48R"><div class="casContent"><span class="casTitleNuber">48</span><div class="casTitle"><span class="NLM_cas:atitle">Dopamine D3 receptor antagonist (GSK598809) potentiates the hypertensive effects of cocaine in conscious, freely-moving dogs</span></div><div class="casAuthors">Appel, Nathan M.; Li, Shou-Hua; Holmes, Tyson H.; Acri, Jane B.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">354</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">484-492</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">1521-0103</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">The chronic and relapsing nature of addiction presents unique challenges for ensuring the safety of a potential medication.  A patient may use cocaine, for example, while taking the medication or take more medication than prescribed.  Thus, a potential medication must be safe and not exacerbate the effects of cocaine.  Multiple published studies support antagonism of brain dopamine D3 receptor function as a potential mechanism of action for an anti-addiction medication.  Dopamine D3 receptors are widely distributed outside the central nervous system, however; for example, dopamine D3 receptors in the kidneys are implicated in regulating blood pressure.  The selective dopamine D3 receptor antagonist GSK598809 [1-(2-fluoro-4- trifluoromethyl-phenyl)-3-{3-[4-methyl-5-(4-methyl-oxazol-5- yl)-4H-[1,2,4]triazol-3-ylsulfanyl]-propyl}-3-aza-bicyclo[3.1.0] hexane] has been proposed as a medication to treat cocaine and other substance use disorders.  The US Food and Drug Administration has established guidelines recommending safety studies to investigate potential undesirable pharmacodynamic effects of a substance in relation to exposure in the therapeutic range and above.  Hence, we assessed the interaction between this selective dopamine D3 receptor antagonist and cocaine on hemodynamics and cardiac function in freely-moving, telemetered dogs before conducting a clin. trial.  GSK598809 increased the hemodynamic effect of cocaine in this model.  Thus, the increase in blood pressure after i.v. cocaine was greater in animals that had been pretreated with GSK598809 compared with vehicle.  This finding suggests that GSK598809 in particular, and perhaps dopamine D3 receptor antagonists as a class, may produce unacceptable cardiovascular risks as medications to treat cocaine use disorder.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoWWq20sTq43bVg90H21EOLACvtfcHk0ljtfcvmCi1tpA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhsV2rsbvJ&md5=6fd994c95c5bee2dd486b4c340564c73</span></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.1124%2Fjpet.115.224121&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.115.224121%26sid%3Dliteratum%253Aachs%26aulast%3DAppel%26aufirst%3DN.%2BM.%26aulast%3DLi%26aufirst%3DS.%2BH.%26aulast%3DHolmes%26aufirst%3DT.%2BH.%26aulast%3DAcri%26aufirst%3DJ.%2BB.%26atitle%3DDopamine%2520D3%2520Receptor%2520Antagonist%2520%2528GSK598809%2529%2520Potentiates%2520the%2520Hypertensive%2520Effects%2520of%2520Cocaine%2520in%2520Conscious%252C%2520Freely-Moving%2520Dogs%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2015%26volume%3D354%26spage%3D484%26epage%3D492%26doi%3D10.1124%2Fjpet.115.224121" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref49"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref49'); return false;" data-citation="" class="refNumLink">49</a></strong><div class="NLM_citation" id="cit49"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Galaj, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ewing, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ranaldi, R.</span></span> <span> </span><span class="NLM_article-title">Dopamine D1 and D3 Receptor Polypharmacology as a Potential Treatment Approach for Substance use Disorder</span>. <i>Neurosci. Biobehav. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>89</i></span>,  <span class="NLM_fpage">13</span>– <span class="NLM_lpage">28</span>, <span class="refDoi"> DOI: 10.1016/j.neubiorev.2018.03.020</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00412&amp;key=10.1016%2Fj.neubiorev.2018.03.020" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=89&publication_year=2018&pages=13-28&author=E.+Galajauthor=S.+Ewingauthor=R.+Ranaldi&title=Dopamine+D1+and+D3+Receptor+Polypharmacology+as+a+Potential+Treatment+Approach+for+Substance+use+Disorder&doi=10.1016%2Fj.neubiorev.2018.03.020"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=10.1016%2Fj.neubiorev.2018.03.020&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.neubiorev.2018.03.020%26sid%3Dliteratum%253Aachs%26aulast%3DGalaj%26aufirst%3DE.%26aulast%3DEwing%26aufirst%3DS.%26aulast%3DRanaldi%26aufirst%3DR.%26atitle%3DDopamine%2520D1%2520and%2520D3%2520Receptor%2520Polypharmacology%2520as%2520a%2520Potential%2520Treatment%2520Approach%2520for%2520Substance%2520use%2520Disorder%26jtitle%3DNeurosci.%2520Biobehav.%2520Rev.%26date%3D2018%26volume%3D89%26spage%3D13%26epage%3D28%26doi%3D10.1016%2Fj.neubiorev.2018.03.020" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref50"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref50'); return false;" data-citation="" class="refNumLink">50</a></strong><div class="NLM_citation" id="cit50"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hayatshahi, H. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Griffin, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taylor, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mach, R. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luedtke, R. R.</span></span> <span> </span><span class="NLM_article-title">Analogues of Arylamide Phenylpiperazine Ligands To Investigate the Factors Influencing D3 Dopamine Receptor Bitropic Binding and Receptor Subtype Selectivity</span>. <i>ACS Chem. Neurosci.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">2972</span>– <span class="NLM_lpage">2983</span>, <span class="refDoi"> DOI: 10.1021/acschemneuro.8b00142</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acschemneuro.8b00142" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00412&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhtlWrt77J" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2018&pages=2972-2983&author=H.+S.+Hayatshahiauthor=K.+Xuauthor=S.+A.+Griffinauthor=M.+Taylorauthor=R.+H.+Machauthor=J.+Liuauthor=R.+R.+Luedtke&title=Analogues+of+Arylamide+Phenylpiperazine+Ligands+To+Investigate+the+Factors+Influencing+D3+Dopamine+Receptor+Bitropic+Binding+and+Receptor+Subtype+Selectivity&doi=10.1021%2Facschemneuro.8b00142"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit50R"><div class="casContent"><span class="casTitleNuber">50</span><div class="casTitle"><span class="NLM_cas:atitle">Analogues of Arylamide Phenylpiperazine Ligands To Investigate the Factors Influencing D3 Dopamine Receptor Bitropic Binding and Receptor Subtype Selectivity</span></div><div class="casAuthors">Hayatshahi, Hamed S.; Xu, Kuiying; Griffin, Suzy A.; Taylor, Michelle; Mach, Robert H.; Liu, Jin; Luedtke, Robert R.</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Neuroscience</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">2972-2983</span>CODEN:
                <span class="NLM_cas:coden">ACNCDM</span>;
        ISSN:<span class="NLM_cas:issn">1948-7193</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The authors have previously reported on the ability of arylamide phenylpiperazines to bind selectively to the D3 vs. the D2 dopamine receptor subtype.  For these studies, the authors used LS-3-134 as the prototypic arylamide phenylpiperazine ligand because it binds with high affinity at D3 dopamine receptor (0.17 nM) and exhibits >150-fold D3 vs. D2 receptor binding selectivity.  The authors' goal was to investigate how the compn. and size of the nonarom. ring structure at the piperazine position of substituted phenylpiperazine analogs might influence binding affinity at the human D2 and D3 dopamine receptors.  Two factors were identified as being important for detg. the binding affinity of bitropic arylamide phenylpiperazines at the dopamine D3 receptor subtype.  One factor was the strength of the salt bridge between the highly conserved residue Asp3.32 with the protonated nitrogen of the nonarom. ring at the piperazine position.  The second factor was the configuration of the unbound ligand in an aq. soln.  These two factors were found to be related to the logarithm of the affinities using a simple correlation model, which could be useful when designing high affinity subtype selective bitropic ligands.  While this model is based upon the interaction of arylamide phenylpiperazines with the D2 and D3 D2-like dopamine receptor subtypes, it provides insights into the complexity of the factors that define a bitropic mode of the binding at GPCRs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo2bY8O70GE2LVg90H21EOLACvtfcHk0ljtfcvmCi1tpA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhtlWrt77J&md5=1ed0ee59eef51b7e1c2e1b4b8fad8537</span></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=10.1021%2Facschemneuro.8b00142&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facschemneuro.8b00142%26sid%3Dliteratum%253Aachs%26aulast%3DHayatshahi%26aufirst%3DH.%2BS.%26aulast%3DXu%26aufirst%3DK.%26aulast%3DGriffin%26aufirst%3DS.%2BA.%26aulast%3DTaylor%26aufirst%3DM.%26aulast%3DMach%26aufirst%3DR.%2BH.%26aulast%3DLiu%26aufirst%3DJ.%26aulast%3DLuedtke%26aufirst%3DR.%2BR.%26atitle%3DAnalogues%2520of%2520Arylamide%2520Phenylpiperazine%2520Ligands%2520To%2520Investigate%2520the%2520Factors%2520Influencing%2520D3%2520Dopamine%2520Receptor%2520Bitropic%2520Binding%2520and%2520Receptor%2520Subtype%2520Selectivity%26jtitle%3DACS%2520Chem.%2520Neurosci.%26date%3D2018%26volume%3D9%26spage%3D2972%26epage%3D2983%26doi%3D10.1021%2Facschemneuro.8b00142" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref51"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref51'); return false;" data-citation="" class="refNumLink">51</a></strong><div class="NLM_citation" id="cit51"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yung-Chi, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prusoff, W. H.</span></span> <span> </span><span class="NLM_article-title">Relationship Between the Inhibition Constant (KI) and the Concentration of Inhibitor Which Causes 50 Percent Inhibition (I50) of an Enzymatic Reaction</span>. <i>Biochem. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">1973</span>,  <span class="NLM_volume"><i>22</i></span>,  <span class="NLM_fpage">3099</span>– <span class="NLM_lpage">3108</span>, <span class="refDoi"> DOI: 10.1016/0006-2952(73)90196-2</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00412&amp;key=10.1016%2F0006-2952%2873%2990196-2" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00412&amp;key=4202581" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=1973&pages=3099-3108&author=C.+Yung-Chiauthor=W.+H.+Prusoff&title=Relationship+Between+the+Inhibition+Constant+%28KI%29+and+the+Concentration+of+Inhibitor+Which+Causes+50+Percent+Inhibition+%28I50%29+of+an+Enzymatic+Reaction&doi=10.1016%2F0006-2952%2873%2990196-2"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=10.1016%2F0006-2952%2873%2990196-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0006-2952%252873%252990196-2%26sid%3Dliteratum%253Aachs%26aulast%3DYung-Chi%26aufirst%3DC.%26aulast%3DPrusoff%26aufirst%3DW.%2BH.%26atitle%3DRelationship%2520Between%2520the%2520Inhibition%2520Constant%2520%2528KI%2529%2520and%2520the%2520Concentration%2520of%2520Inhibitor%2520Which%2520Causes%252050%2520Percent%2520Inhibition%2520%2528I50%2529%2520of%2520an%2520Enzymatic%2520Reaction%26jtitle%3DBiochem.%2520Pharmacol.%26date%3D1973%26volume%3D22%26spage%3D3099%26epage%3D3108%26doi%3D10.1016%2F0006-2952%2873%2990196-2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref52"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref52'); return false;" data-citation="" class="refNumLink">52</a></strong><div class="NLM_citation" id="cit52"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Reilly, S. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Puentes, L. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wilson, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hsieh, C.-J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weng, C.-C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Makvandi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mach, R. H.</span></span> <span> </span><span class="NLM_article-title">Examination of Diazaspiro Cores as Piperazine Bioisosteres in the Olaparib Framework Shows Reduced DNA Damage and Cytotoxicity</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>61</i></span>,  <span class="NLM_fpage">5367</span>– <span class="NLM_lpage">5379</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.8b00576</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.8b00576" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00412&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhtVKktbzE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2018&pages=5367-5379&author=S.+W.+Reillyauthor=L.+N.+Puentesauthor=K.+Wilsonauthor=C.-J.+Hsiehauthor=C.-C.+Wengauthor=M.+Makvandiauthor=R.+H.+Mach&title=Examination+of+Diazaspiro+Cores+as+Piperazine+Bioisosteres+in+the+Olaparib+Framework+Shows+Reduced+DNA+Damage+and+Cytotoxicity&doi=10.1021%2Facs.jmedchem.8b00576"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit52R"><div class="casContent"><span class="casTitleNuber">52</span><div class="casTitle"><span class="NLM_cas:atitle">Examination of Diazaspiro Cores as Piperazine Bioisosteres in the Olaparib Framework Shows Reduced DNA Damage and Cytotoxicity</span></div><div class="casAuthors">Reilly, Sean W.; Puentes, Laura N.; Wilson, Khadija; Hsieh, Chia-Ju; Weng, Chi-Chang; Makvandi, Mehran; Mach, Robert H.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">61</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">5367-5379</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Development of poly(ADP-ribose) polymerase inhibitors (PARPi's) continues to be an attractive area of research due to synthetic lethality in DNA repair deficient cancers; however, PARPi's also have potential as therapeutics to prevent harmful inflammation.  We investigated the pharmacol. impact of incorporating spirodiamine motifs into the phthalazine architecture of FDA approved PARPi olaparib.  Synthesized analogs were screened for PARP-1 affinity, enzyme specificity, catalytic inhibition, DNA damage, and cytotoxicity.  This work led to the identification of 10e (12.6 ± 1.1 nM), which did not induce DNA damage at similar drug concns. as olaparib.  Interestingly, several worst in class compds. with low PARP-1 affinity, including 15b (4397 ± 1.1 nM), induced DNA damage at micromolar concns., which can explain the cytotoxicity obsd. in vitro.  This work provides further evidence that high affinity PARPi's can be developed without DNA damaging properties offering potential new drugs for treating inflammatory related diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrnTC4dTcUAdrVg90H21EOLACvtfcHk0lgPY-IsEnY7ow"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhtVKktbzE&md5=e352b0777c5f53f2c126288a1c5ff4c1</span></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.8b00576&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.8b00576%26sid%3Dliteratum%253Aachs%26aulast%3DReilly%26aufirst%3DS.%2BW.%26aulast%3DPuentes%26aufirst%3DL.%2BN.%26aulast%3DWilson%26aufirst%3DK.%26aulast%3DHsieh%26aufirst%3DC.-J.%26aulast%3DWeng%26aufirst%3DC.-C.%26aulast%3DMakvandi%26aufirst%3DM.%26aulast%3DMach%26aufirst%3DR.%2BH.%26atitle%3DExamination%2520of%2520Diazaspiro%2520Cores%2520as%2520Piperazine%2520Bioisosteres%2520in%2520the%2520Olaparib%2520Framework%2520Shows%2520Reduced%2520DNA%2520Damage%2520and%2520Cytotoxicity%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2018%26volume%3D61%26spage%3D5367%26epage%3D5379%26doi%3D10.1021%2Facs.jmedchem.8b00576" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref53"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref53'); return false;" data-citation="" class="refNumLink">53</a></strong><div class="NLM_citation" id="cit53"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Morris, G. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huey, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lindstrom, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sanner, M. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Belew, R. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goodsell, D. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Olson, A. J.</span></span> <span> </span><span class="NLM_article-title">AutoDock4 and AutoDockTools4: Automated Docking with Selective Receptor Flexibility</span>. <i>J. Comput. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>30</i></span>,  <span class="NLM_fpage">2785</span>– <span class="NLM_lpage">2791</span>, <span class="refDoi"> DOI: 10.1002/jcc.21256</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00412&amp;key=10.1002%2Fjcc.21256" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00412&amp;key=19399780" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00412&amp;key=1%3ACAS%3A528%3ADC%252BD1MXht1GitrnK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=2009&pages=2785-2791&author=G.+M.+Morrisauthor=R.+Hueyauthor=W.+Lindstromauthor=M.+F.+Sannerauthor=R.+K.+Belewauthor=D.+S.+Goodsellauthor=A.+J.+Olson&title=AutoDock4+and+AutoDockTools4%3A+Automated+Docking+with+Selective+Receptor+Flexibility&doi=10.1002%2Fjcc.21256"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit53R"><div class="casContent"><span class="casTitleNuber">53</span><div class="casTitle"><span class="NLM_cas:atitle">AutoDock and AutoDockTools: Automated docking with selective receptor flexibility</span></div><div class="casAuthors">Morris, Garrett M.; Huey, Ruth; Lindstrom, William; Sanner, Michel F.; Belew, Richard K.; Goodsell, David S.; Olson, Arthur J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Computational Chemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">30</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">2785-2791</span>CODEN:
                <span class="NLM_cas:coden">JCCHDD</span>;
        ISSN:<span class="NLM_cas:issn">0192-8651</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">We describe the testing and release of AutoDock4 and the accompanying graphical user interface AutoDockTools.  AutoDock4 incorporates limited flexibility in the receptor.  Several tests are reported here, including a redocking expt. with 188 diverse ligand-protein complexes and a cross-docking expt. using flexible sidechains in 87 HIV protease complexes.  We also report its utility in anal. of covalently bound ligands, using both a grid-based docking method and a modification of the flexible sidechain technique. © 2009 Wiley Periodicals, Inc.  J Comput Chem, 2009.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqktE6WAo4GEbVg90H21EOLACvtfcHk0lgPY-IsEnY7ow"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXht1GitrnK&md5=679ce22fc50e9291c9aa16e7a1855845</span></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=10.1002%2Fjcc.21256&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjcc.21256%26sid%3Dliteratum%253Aachs%26aulast%3DMorris%26aufirst%3DG.%2BM.%26aulast%3DHuey%26aufirst%3DR.%26aulast%3DLindstrom%26aufirst%3DW.%26aulast%3DSanner%26aufirst%3DM.%2BF.%26aulast%3DBelew%26aufirst%3DR.%2BK.%26aulast%3DGoodsell%26aufirst%3DD.%2BS.%26aulast%3DOlson%26aufirst%3DA.%2BJ.%26atitle%3DAutoDock4%2520and%2520AutoDockTools4%253A%2520Automated%2520Docking%2520with%2520Selective%2520Receptor%2520Flexibility%26jtitle%3DJ.%2520Comput.%2520Chem.%26date%3D2009%26volume%3D30%26spage%3D2785%26epage%3D2791%26doi%3D10.1002%2Fjcc.21256" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31'],'ref32':['cit32'],'ref33':['cit33'],'ref34':['cit34'],'ref35':['cit35'],'ref36':['cit36'],'ref37':['cit37'],'ref38':['cit38'],'ref39':['cit39'],'ref40':['cit40'],'ref41':['cit41'],'ref42':['cit42'],'ref43':['cit43'],'ref44':['cit44'],'ref45':['cit45'],'ref46':['cit46'],'ref47':['cit47'],'ref48':['cit48'],'ref49':['cit49'],'ref50':['cit50'],'ref51':['cit51'],'ref52':['cit52'],'ref53':['cit53']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 4 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Kerstin Hiesinger, Dmitry Dar’in, Ewgenij Proschak, <span class="NLM_string-name hlFld-ContribAuthor">Mikhail Krasavin</span>. </span><span class="cited-content_cbyCitation_article-title">Spirocyclic Scaffolds in Medicinal Chemistry. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>64 </em>
                                    (1)
                                     , 150-183. <a href="https://doi.org/10.1021/acs.jmedchem.0c01473" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.0c01473</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.0c01473&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.0c01473%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DSpirocyclic%252BScaffolds%252Bin%252BMedicinal%252BChemistry%26aulast%3DHiesinger%26aufirst%3DKerstin%26date%3D2021%26date%3D2020%26date%3D2020%26date%3D24082020%26date%3D31122020%26volume%3D64%26issue%3D1%26spage%3D150%26epage%3D183" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Rachel D. Slack, Therese C. Ku, Jianjing Cao, JoLynn B. Giancola, Alessandro Bonifazi, Claus J. Loland, Alexandra Gadiano, Jenny Lam, Rana Rais, Barbara S. Slusher, Mark Coggiano, Gianluigi Tanda, <span class="NLM_string-name hlFld-ContribAuthor">Amy Hauck Newman</span>. </span><span class="cited-content_cbyCitation_article-title">Structure–Activity Relationships for a Series of (Bis(4-fluorophenyl)methyl)sulfinyl Alkyl Alicyclic Amines at the Dopamine Transporter: Functionalizing the Terminal Nitrogen Affects Affinity, Selectivity, and Metabolic Stability. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>63 </em>
                                    (5)
                                     , 2343-2357. <a href="https://doi.org/10.1021/acs.jmedchem.9b01188" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.9b01188</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.9b01188&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.9b01188%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DStructure%2525E2%252580%252593Activity%252BRelationships%252Bfor%252Ba%252BSeries%252Bof%252B%252528Bis%2525284-fluorophenyl%252529methyl%252529sulfinyl%252BAlkyl%252BAlicyclic%252BAmines%252Bat%252Bthe%252BDopamine%252BTransporter%25253A%252BFunctionalizing%252Bthe%252BTerminal%252BNitrogen%252BAffects%252BAffinity%25252C%252BSelectivity%25252C%252Band%252BMetabolic%252BStability%26aulast%3DSlack%26aufirst%3DRachel%2BD.%26date%3D2020%26date%3D2019%26date%3D2019%26date%3D23072019%26date%3D14112019%26date%3D29102019%26volume%3D63%26issue%3D5%26spage%3D2343%26epage%3D2357" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Chia-Ju  Hsieh</span>, <span class="hlFld-ContribAuthor ">Aladdin  Riad</span>, <span class="hlFld-ContribAuthor ">Ji Youn  Lee</span>, <span class="hlFld-ContribAuthor ">Kristoffer  Sahlholm</span>, <span class="hlFld-ContribAuthor ">Kuiying  Xu</span>, <span class="hlFld-ContribAuthor ">Robert R.  Luedtke</span>, <span class="hlFld-ContribAuthor ">Robert H.  Mach</span>. </span><span class="cited-content_cbyCitation_article-title">Interaction of Ligands for PET with the Dopamine D3 Receptor: In Silico and In Vitro Methods. </span><span class="cited-content_cbyCitation_journal-name">Biomolecules</span><span> <strong>2021,</strong> <em>11 </em>
                                    (4)
                                     , 529. <a href="https://doi.org/10.3390/biom11040529" title="DOI URL">https://doi.org/10.3390/biom11040529</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/biom11040529&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fbiom11040529%26sid%3Dliteratum%253Aachs%26jtitle%3DBiomolecules%26atitle%3DInteraction%252Bof%252BLigands%252Bfor%252BPET%252Bwith%252Bthe%252BDopamine%252BD3%252BReceptor%25253A%252BIn%252BSilico%252Band%252BIn%252BVitro%252BMethods%26aulast%3DHsieh%26aufirst%3DChia-Ju%26date%3D2021%26date%3D2021%26volume%3D11%26issue%3D4%26spage%3D529" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Tomas  Opsomer</span>, <span class="hlFld-ContribAuthor ">Wim  Dehaen</span>. </span><span class="cited-content_cbyCitation_article-title">1,2,4-Triazoles. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2020,</strong>,<a href="https://doi.org/10.1016/B978-0-12-409547-2.14854-1" title="DOI URL">https://doi.org/10.1016/B978-0-12-409547-2.14854-1</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/B978-0-12-409547-2.14854-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2FB978-0-12-409547-2.14854-1%26sid%3Dliteratum%253Aachs%26atitle%3D1%25252C2%25252C4-Triazoles%26aulast%3DOpsomer%26aufirst%3DTomas%26date%3D2020%26pub%3DElsevier%26atitle%3DReference%252BModule%252Bin%252BChemistry%25252C%252BMolecular%252BSciences%252Band%252BChemical%252BEngineering%26date%3D2020%26volume%3Dvol.%25205" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="_i1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-10/acs.jmedchem.9b00412/20190516/images/medium/jm-2019-004124_0014.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-10/acs.jmedchem.9b00412/20190516/images/large/jm-2019-004124_0014.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00412&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-10/acs.jmedchem.9b00412/20190516/images/medium/jm-2019-004124_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-10/acs.jmedchem.9b00412/20190516/images/large/jm-2019-004124_0001.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Lead compounds identified with diazaspiro amino systems.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-10/acs.jmedchem.9b00412/20190516/images/large/jm-2019-004124_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00412&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-10/acs.jmedchem.9b00412/20190516/images/medium/jm-2019-004124_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-10/acs.jmedchem.9b00412/20190516/images/large/jm-2019-004124_0005.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthesis of Fragmented Synthons<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-10/acs.jmedchem.9b00412/20190516/images/large/jm-2019-004124_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00412&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (i) Pd<sub>2</sub>(dba)<sub>3</sub>, RuPhos, aryl halide, diazaspiro reagent, NaO<i>t</i>-Bu, dioxane, 100 °C, 20 min; (ii) TFA, CH<sub>2</sub>Cl<sub>2</sub>, rt, 3 h; (iii) 1-bromobutane, K<sub>2</sub>CO<sub>3</sub>, acetone, rt, 12 h; (iv) alkylating reagent, K<sub>2</sub>CO<sub>3</sub>, acetone, rt, 12 h; (v) amine, Cs<sub>2</sub>CO<sub>3</sub>, acetonitrile (ACN), 70 °C, 8 h.</p></p></figure><figure data-id="sch2" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-10/acs.jmedchem.9b00412/20190516/images/medium/jm-2019-004124_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-10/acs.jmedchem.9b00412/20190516/images/large/jm-2019-004124_0006.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. General Synthesis of Compounds <b>1</b>–<b>3</b> and <b>7</b>-<b>37</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-10/acs.jmedchem.9b00412/20190516/images/large/jm-2019-004124_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00412&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (i) (A) TFA, CH<sub>2</sub>Cl<sub>2</sub>, rt, 3 h; (ii) (B) alkylating reagent, K<sub>2</sub>CO<sub>3</sub>, acetone, rt, 12 h; (iii) (<b>C</b>, <b>D</b>) TEA, EtOH, 75 °C, 12 h; (iv) <b>4b′</b>, 2-(4-bromobutyl)isoindoline-1,3-dione, KI and Cs<sub>2</sub>CO<sub>3</sub>, ACN, 75 °C for 3 h; (v) (E), hydrazine, EtOH, 75 °C for 2 h; (vi) (F), benzoic acid, HOBt, EDC, CH<sub>2</sub>Cl<sub>2</sub>, rt, 2 h; (vii) (G), KI, and K<sub>2</sub>CO<sub>3</sub>, ACN, 90 °C for 12 h.</p></p></figure><figure data-id="fig2" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-10/acs.jmedchem.9b00412/20190516/images/medium/jm-2019-004124_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-10/acs.jmedchem.9b00412/20190516/images/large/jm-2019-004124_0002.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. (A) Predicted binding modes of compound <b>1</b> derivatives in complex with the D<sub>3</sub>R (3PBL). Predicted polar (yellow, 3.0 Å cut-off), weak hydrogen bonding (magenta, 3.6 Å cut-off), π–π stacking (purple, 5.5 Å cut-off), and hydrophobic (black, 4.0 Å cut-off) residue interactions with compounds <b>1</b> (B), <b>17</b> (C), <b>19</b> (D), <b>31</b> (E), and <b>32</b> (F) within the binding pocket of the receptor. Interaction between the Asp110 [3.32] residue and the ionizable nitrogen of the ligand scaffold is shown in red.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-10/acs.jmedchem.9b00412/20190516/images/large/jm-2019-004124_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00412&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-10/acs.jmedchem.9b00412/20190516/images/medium/jm-2019-004124_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-10/acs.jmedchem.9b00412/20190516/images/large/jm-2019-004124_0003.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Curve shift analysis of <b>1</b> (A), <b>31</b> (B), and SB269,625 (C) using a dopamine (DA)-mediated β-arrestin 2 recruitment assay. The receptor was stimulated with the indicated concentration of DA along with and without concentrations of the test compound. Data points represent the mean ± SEM of dopamine-induced luminescence response obtained from 7 to 16 replicates.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-10/acs.jmedchem.9b00412/20190516/images/large/jm-2019-004124_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00412&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-10/acs.jmedchem.9b00412/20190516/images/medium/jm-2019-004124_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-10/acs.jmedchem.9b00412/20190516/images/large/jm-2019-004124_0004.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Agonist and antagonist selectivity profiling with G-protein-independent β-arrestin recruitment Tango assays at human D<sub>1</sub>- and D<sub>2</sub>-like receptors. (A) Concentration–response to varying doses of D<sub>1</sub>R agonists and control SKF81297. (B) Response to varying doses of D<sub>1</sub>R antagonists and control SCH23390, added 30 min before the addition of a final EC<sub>80</sub> concentration (3 μM) of a reference agonist SKF81297. (C) Concentration–response to varying doses of D<sub>2</sub>R agonists and control quinpirole. (D) Concentration–response to varying doses of D<sub>2</sub>R antagonists and control haloperidol, added 30 min before the addition of a final EC<sub>80</sub> concentration (3 nM) of reference agonist quinpirole. (E) Concentration–response to varying doses of D<sub>3</sub>R agonists and control quinpirole. (F) Concentration–response to varying doses of D<sub>3</sub>R antagonists and control haloperidol, added 30 min before the addition of a final EC<sub>80</sub> concentration (3 nM) of the reference agonist quinpirole. (G) Concentration–response to varying doses of D<sub>4</sub>R agonists and control lisuride. (H) Concentration–response to varying doses of D<sub>4</sub>R antagonists and control nemonapride, added 30 min before the addition of a final EC<sub>80</sub> concentration (100 nM) of reference agonist lisuride. Data are shown as mean ± SEM of three independent experiments. N/A, not active. N/C, data not converged.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-10/acs.jmedchem.9b00412/20190516/images/large/jm-2019-004124_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00412&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i70">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_03118" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_03118" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 53 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Leggio, G. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bucolo, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Platania, C. B. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Salomone, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Drago, F.</span></span> <span> </span><span class="NLM_article-title">Current Drug Treatments Targeting Dopamine D3 Receptor</span>. <i>Pharmacol. Ther.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>165</i></span>,  <span class="NLM_fpage">164</span>– <span class="NLM_lpage">177</span>, <span class="refDoi"> DOI: 10.1016/j.pharmthera.2016.06.007</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00412&amp;key=10.1016%2Fj.pharmthera.2016.06.007" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00412&amp;key=27343365" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00412&amp;key=1%3ACAS%3A528%3ADC%252BC28XhtVGisbfF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=165&publication_year=2016&pages=164-177&author=G.+M.+Leggioauthor=C.+Bucoloauthor=C.+B.+M.+Plataniaauthor=S.+Salomoneauthor=F.+Drago&title=Current+Drug+Treatments+Targeting+Dopamine+D3+Receptor&doi=10.1016%2Fj.pharmthera.2016.06.007"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Current drug treatments targeting dopamine D3 receptor</span></div><div class="casAuthors">Leggio, Gian Marco; Bucolo, Claudio; Platania, Chiara Bianca Maria; Salomone, Salvatore; Drago, Filippo</div><div class="citationInfo"><span class="NLM_cas:title">Pharmacology & Therapeutics</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">165</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">164-177</span>CODEN:
                <span class="NLM_cas:coden">PHTHDT</span>;
        ISSN:<span class="NLM_cas:issn">0163-7258</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">Dopamine receptors (DR) have been extensively studied, but only in recent years they became object of investigation to elucidate the specific role of different subtypes (D1R, D2R, D3R, D4R, D5R) in neural transmission and circuitry.  D1-like receptors (D1R and D5R) and D2-like receptors (D2R, D2R and D4R) differ in signal transduction, binding profile, localization in the central nervous system and physiol. effects.  D3R is involved in a no. of pathol. conditions, including schizophrenia, Parkinson's disease, addiction, anxiety, depression and glaucoma.  Development of selective D3R ligands has been so far challenging, due to the high sequence identity and homol. shared by D2R and D3R.  As a consequence, despite a rational design of selective DR ligands has been carried out, none of currently available medicines selectively target a given D2-like receptor subtype.  The availability of the D3R ligand [11C]-(+)-PHNO for positron emission tomog. studies in animal models as well as in humans, allows researchers to est. the expression of D3R in vivo; displacement of [11C]-(+)-PHNO binding by concurrent drug treatments is used to est. the in vivo occupancy of D3R.  Here we provide an overview of studies indicating D3R as a target for pharmacol. therapy, and a review of market approved drugs endowed with significant affinity at D3R that are used to treat disorders where D3R plays a relevant role.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGripJ2xDVYRubVg90H21EOLACvtfcHk0lhnRYXl2MkDhA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhtVGisbfF&md5=e29dffe5b17b48f68d33ec838ece35dc</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1016%2Fj.pharmthera.2016.06.007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.pharmthera.2016.06.007%26sid%3Dliteratum%253Aachs%26aulast%3DLeggio%26aufirst%3DG.%2BM.%26aulast%3DBucolo%26aufirst%3DC.%26aulast%3DPlatania%26aufirst%3DC.%2BB.%2BM.%26aulast%3DSalomone%26aufirst%3DS.%26aulast%3DDrago%26aufirst%3DF.%26atitle%3DCurrent%2520Drug%2520Treatments%2520Targeting%2520Dopamine%2520D3%2520Receptor%26jtitle%3DPharmacol.%2520Ther.%26date%3D2016%26volume%3D165%26spage%3D164%26epage%3D177%26doi%3D10.1016%2Fj.pharmthera.2016.06.007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Keck, T. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">John, W. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Czoty, P. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nader, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Newman, A. H.</span></span> <span> </span><span class="NLM_article-title">Identifying Medication Targets for Psychostimulant Addiction: Unraveling the Dopamine D3 Receptor Hypothesis</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>58</i></span>,  <span class="NLM_fpage">5361</span>– <span class="NLM_lpage">5380</span>, <span class="refDoi"> DOI: 10.1021/jm501512b</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm501512b" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00412&amp;key=1%3ACAS%3A528%3ADC%252BC2MXlsFGgu74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2015&pages=5361-5380&author=T.+M.+Keckauthor=W.+S.+Johnauthor=P.+W.+Czotyauthor=M.+A.+Naderauthor=A.+H.+Newman&title=Identifying+Medication+Targets+for+Psychostimulant+Addiction%3A+Unraveling+the+Dopamine+D3+Receptor+Hypothesis&doi=10.1021%2Fjm501512b"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Identifying Medication Targets for Psychostimulant Addiction: Unraveling the Dopamine D3 Receptor Hypothesis</span></div><div class="casAuthors">Keck, Thomas M.; John, William S.; Czoty, Paul W.; Nader, Michael A.; Newman, Amy Hauck</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">5361-5380</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The dopamine D3 receptor (D3R) is a target for developing medications to treat substance use disorders.  D3R-selective compds. with high affinity and varying efficacies have been discovered, providing crit. research tools for cell-based studies that have been translated to in vivo models of drug abuse.  D3R antagonists and partial agonists have shown esp. promising results in rodent models of relapse-like behavior, including stress-, drug-, and cue-induced reinstatement of drug seeking.  However, to date, translation to human studies has been limited.  Herein, we present an overview and illustrate some of the pitfalls and challenges of developing novel D3R-selective compds. toward clin. utility, esp. for treatment of cocaine abuse.  Future research and development of D3R-selective antagonists and partial agonists for substance abuse remains critically important but will also require further evaluation and development of translational animal models to det. the best time in the addiction cycle to target D3Rs for optimal therapeutic efficacy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpKVPGvcTvN87Vg90H21EOLACvtfcHk0lhnRYXl2MkDhA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXlsFGgu74%253D&md5=99f531d840ad7f94d0eeadeb6fd48100</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1021%2Fjm501512b&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm501512b%26sid%3Dliteratum%253Aachs%26aulast%3DKeck%26aufirst%3DT.%2BM.%26aulast%3DJohn%26aufirst%3DW.%2BS.%26aulast%3DCzoty%26aufirst%3DP.%2BW.%26aulast%3DNader%26aufirst%3DM.%2BA.%26aulast%3DNewman%26aufirst%3DA.%2BH.%26atitle%3DIdentifying%2520Medication%2520Targets%2520for%2520Psychostimulant%2520Addiction%253A%2520Unraveling%2520the%2520Dopamine%2520D3%2520Receptor%2520Hypothesis%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2015%26volume%3D58%26spage%3D5361%26epage%3D5380%26doi%3D10.1021%2Fjm501512b" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Strange, P. G.</span></span> <span> </span><span class="NLM_article-title">Antipsychotic Drug Action: Antagonism, Inverse Agonism or Partial Agonism</span>. <i>Trends Pharmacol. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>29</i></span>,  <span class="NLM_fpage">314</span>– <span class="NLM_lpage">321</span>, <span class="refDoi"> DOI: 10.1016/j.tips.2008.03.009</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00412&amp;key=10.1016%2Fj.tips.2008.03.009" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=2008&pages=314-321&author=P.+G.+Strange&title=Antipsychotic+Drug+Action%3A+Antagonism%2C+Inverse+Agonism+or+Partial+Agonism&doi=10.1016%2Fj.tips.2008.03.009"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1016%2Fj.tips.2008.03.009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.tips.2008.03.009%26sid%3Dliteratum%253Aachs%26aulast%3DStrange%26aufirst%3DP.%2BG.%26atitle%3DAntipsychotic%2520Drug%2520Action%253A%2520Antagonism%252C%2520Inverse%2520Agonism%2520or%2520Partial%2520Agonism%26jtitle%3DTrends%2520Pharmacol.%2520Sci.%26date%3D2008%26volume%3D29%26spage%3D314%26epage%3D321%26doi%3D10.1016%2Fj.tips.2008.03.009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Murray, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ryoo, H. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gurevich, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Joyce, J. N.</span></span> <span> </span><span class="NLM_article-title">Localization of Dopamine D3 Receptors to Mesolimbic and D2 Receptors to Mesostriatal Regions of Human Forebrain</span>. <i>Proc. Natl. Acad. Sci. U.S.A.</i> <span class="NLM_year" style="font-weight: bold;">1994</span>,  <span class="NLM_volume"><i>91</i></span>,  <span class="NLM_fpage">11271</span>– <span class="NLM_lpage">11275</span>, <span class="refDoi"> DOI: 10.1073/pnas.91.23.11271</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00412&amp;key=10.1073%2Fpnas.91.23.11271" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00412&amp;key=7972046" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00412&amp;key=1%3ACAS%3A528%3ADyaK2cXmvFems70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=91&publication_year=1994&pages=11271-11275&author=A.+M.+Murrayauthor=H.+L.+Ryooauthor=E.+Gurevichauthor=J.+N.+Joyce&title=Localization+of+Dopamine+D3+Receptors+to+Mesolimbic+and+D2+Receptors+to+Mesostriatal+Regions+of+Human+Forebrain&doi=10.1073%2Fpnas.91.23.11271"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Localization of dopamine D3 receptors to mesolimbic and D2 receptors to mesostriatal regions of human forebrain</span></div><div class="casAuthors">Murray, Angela M.; Ryoo, Han L.; Gurevich, Eugenia; Joyce, Jeffrey N.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">1994</span>),
    <span class="NLM_cas:volume">91</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">11271-5</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">We characterized the binding of [125I]epidepride to dopamine D2-like and D3-like receptors in tissue sections of human striatum.  The competition for binding of [125I]epidepride by domperidone, quinpirole, and 7-hydroxy-N,N-di(1-propyl)-2-aminotetralin (7-OH-DPAT) was best fit by assuming one site in the caudate but two sites in nucleus accumbens.  Guanosine 5'-[β,γ-imido]triphosphate showed a large modulatory influence in agonist inhibition of [125I]epidepride binding in caudate but not in nucleus accumbens.  The binding of [125I]epidepride in the presence of 7-OH-DPAT (1000-fold selective for D3-like vs. D2-like sites) and domperidone (20-fold selective for D2 vs. D3-like sites) was used to quantify the nos. of D2-like and D3-like receptors in areas of human brain.  The distribution of D2-like and D3-like receptors was largely nonoverlapping.  Binding of [125I]epidepride to D3-like receptors was negligible in the dorsal striatum but was concd. in islands of dense binding in the nucleus accumbens and ventral putamen that aligned with acetylcholinesterase-poor striosomes.  Binding to D3-like receptors was also enriched in the internal globus pallidus, ventral palladium, septum, islands of Calleja, nucleus basalis, amygdalostriatal transition nucleus of the amygdala, central nucleus of the amygdala, and ventral tegmental area.  Binding of [125I]epidepride to D2 but not D3 receptors was detected in cortex and hippocampus.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqXhwrtC4swVrVg90H21EOLACvtfcHk0ljJi8VZRyO47g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2cXmvFems70%253D&md5=229c93d0b8695eb673e9c7265a1d574f</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1073%2Fpnas.91.23.11271&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.91.23.11271%26sid%3Dliteratum%253Aachs%26aulast%3DMurray%26aufirst%3DA.%2BM.%26aulast%3DRyoo%26aufirst%3DH.%2BL.%26aulast%3DGurevich%26aufirst%3DE.%26aulast%3DJoyce%26aufirst%3DJ.%2BN.%26atitle%3DLocalization%2520of%2520Dopamine%2520D3%2520Receptors%2520to%2520Mesolimbic%2520and%2520D2%2520Receptors%2520to%2520Mesostriatal%2520Regions%2520of%2520Human%2520Forebrain%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D1994%26volume%3D91%26spage%3D11271%26epage%3D11275%26doi%3D10.1073%2Fpnas.91.23.11271" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Heidbreder, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Newman, A. H.</span></span> <span> </span><span class="NLM_article-title">Current Perspectives on Selective Dopamine D3 Receptor Antagonists as Pharmacotherapeutics for Addictions and Related Disorders</span>. <i>Ann. N. Y. Acad. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>1187</i></span>,  <span class="NLM_fpage">4</span>– <span class="NLM_lpage">34</span>, <span class="refDoi"> DOI: 10.1111/j.1749-6632.2009.05149.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00412&amp;key=10.1111%2Fj.1749-6632.2009.05149.x" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1187&publication_year=2010&pages=4-34&author=C.+A.+Heidbrederauthor=A.+H.+Newman&title=Current+Perspectives+on+Selective+Dopamine+D3+Receptor+Antagonists+as+Pharmacotherapeutics+for+Addictions+and+Related+Disorders&doi=10.1111%2Fj.1749-6632.2009.05149.x"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1111%2Fj.1749-6632.2009.05149.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1749-6632.2009.05149.x%26sid%3Dliteratum%253Aachs%26aulast%3DHeidbreder%26aufirst%3DC.%2BA.%26aulast%3DNewman%26aufirst%3DA.%2BH.%26atitle%3DCurrent%2520Perspectives%2520on%2520Selective%2520Dopamine%2520D3%2520Receptor%2520Antagonists%2520as%2520Pharmacotherapeutics%2520for%2520Addictions%2520and%2520Related%2520Disorders%26jtitle%3DAnn.%2520N.%2520Y.%2520Acad.%2520Sci.%26date%3D2010%26volume%3D1187%26spage%3D4%26epage%3D34%26doi%3D10.1111%2Fj.1749-6632.2009.05149.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Slifstein, M.</span>; <span class="NLM_string-name">Rabiner, E. A.</span>; <span class="NLM_string-name">Gunn, R. N.</span></span> <span> </span><span class="NLM_article-title">Imaging the Dopamine D3 Receptor In Vivo</span>. In  <i>Imaging of the Human Brain in Health and Disease</i>; <span class="NLM_publisher-name">Academic Press</span>: <span class="NLM_publisher-loc">Boston</span>, <span class="NLM_year">2014</span>; Chapter 11, pp  <span class="NLM_fpage">265</span>– <span class="NLM_lpage">287</span>.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00412&amp;key=10.1016%2FB978-0-12-418677-4.00011-7" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2014&pages=265-287&author=M.+Slifstein&author=E.+A.+Rabiner&author=R.+N.+Gunn&title=Imaging+of+the+Human+Brain+in+Health+and+Disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1016%2FB978-0-12-418677-4.00011-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26id%3Ddoi%3A10.1016%252FB978-0-12-418677-4.00011-7%26sid%3Dliteratum%253Aachs%26aulast%3DSlifstein%26aufirst%3DM.%26atitle%3DImaging%2520the%2520Dopamine%2520D3%2520Receptor%2520In%2520Vivo%26btitle%3DImaging%2520of%2520the%2520Human%2520Brain%2520in%2520Health%2520and%2520Disease%26pub%3DAcademic%2520Press%26date%3D2014%26spage%3D265%26epage%3D287" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Searle, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beaver, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Comley, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bani, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tziortzi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Slifstein, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mugnaini, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Griffante, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wilson, A. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Merlo-Pich, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Houle, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gunn, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rabiner, E. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Laruelle, M.</span></span> <span> </span><span class="NLM_article-title">Imaging Dopamine D<sub>3</sub> Receptors in the Human Brain with Positron Emission Tomography, [<sup>11</sup>C]PHNO, and a Selective D<sub>3</sub> Receptor Antagonist</span>. <i>Biol. Psychiatry</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>68</i></span>,  <span class="NLM_fpage">392</span>– <span class="NLM_lpage">399</span>, <span class="refDoi"> DOI: 10.1016/j.biopsych.2010.04.038</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00412&amp;key=10.1016%2Fj.biopsych.2010.04.038" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00412&amp;key=20599188" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00412&amp;key=1%3ACAS%3A528%3ADC%252BC3cXps1eitrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=68&publication_year=2010&pages=392-399&author=G.+Searleauthor=J.+D.+Beaverauthor=R.+A.+Comleyauthor=M.+Baniauthor=A.+Tziortziauthor=M.+Slifsteinauthor=M.+Mugnainiauthor=C.+Griffanteauthor=A.+A.+Wilsonauthor=E.+Merlo-Pichauthor=S.+Houleauthor=R.+Gunnauthor=E.+A.+Rabinerauthor=M.+Laruelle&title=Imaging+Dopamine+D3+Receptors+in+the+Human+Brain+with+Positron+Emission+Tomography%2C+%5B11C%5DPHNO%2C+and+a+Selective+D3+Receptor+Antagonist&doi=10.1016%2Fj.biopsych.2010.04.038"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Imaging dopamine D3 receptors in the human brain with positron emission tomography, [11C]PHNO, and a selective D3 receptor antagonist</span></div><div class="casAuthors">Searle, Graham; Beaver, John D.; Comley, Robert A.; Bani, Massimo; Tziortzi, Andri; Slifstein, Mark; Mugnaini, Manolo; Griffante, Cristiana; Wilson, Alan A.; Merlo-Pich, Emilio; Houle, Sylvain; Gunn, Roger; Rabiner, Eugenii A.; Laruelle, Marc</div><div class="citationInfo"><span class="NLM_cas:title">Biological Psychiatry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">68</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">392-399</span>CODEN:
                <span class="NLM_cas:coden">BIPCBF</span>;
        ISSN:<span class="NLM_cas:issn">0006-3223</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">Dopamine D3 receptors are involved in the pathophysiol. of several neuropsychiatric conditions. [11C]-(+)-PHNO is a radiolabeled D2 and D3 agonist, suitable for imaging the agonist binding sites (denoted D2HIGH and D3) of these receptors with positron emission tomog. (PET).  PET studies in nonhuman primates documented that, in vivo, [11C]-(+)-PHNO displays a relative selectivity for D3 compared with D2HIGH receptor sites and that the [11C]-(+)-PHNO signal is enriched in D3 contribution compared with conventional ligands such as [11C] raclopride.  To define the D3 contribution (fPHNOD3) to [11C]-(+)-PHNO binding potential (BPND) in healthy humans, 52 PET scans were obtained in 19 healthy volunteers at baseline and following oral administration of various doses of the selective D3 receptor antagonist, GSK598809.  The impact of GSK598809 on [11C]-(+)-PHNO was regionally selective.  In dorsal regions of the striatum, GSK598809 did not significantly affect [11C]-(+)-PHNO BPND (fPHNOD3 ≈ 0%).  Conversely, in the substantia nigra, GSK598809 dose-dependently reduced [11C]-(+)-PHNO binding to nonspecific level (fPHNOD3 ≈ 100%).  In ventral striatum (VST), globus pallidus and thalamus (THA), [11C]-(+)-PHNO BPND was attributable to a combination of D2HIGH and D3 receptor sites, with fPHNOD3 of 26%, 67% and 46%, resp.  D3 receptor binding potential (BPNDD3) was highest in globus pallidus (1.90) and substantial nigra (1.39), with lower levels in VST (.77) and THA (.18) and negligible levels in dorsal striatum.  This study elucidated the pharmacol. nature of the [11C]-(+)-PHNO signal in healthy subjects and provided the first quantification of D3 receptor availability with PET in the living human brain.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqEJHz3sXsWDrVg90H21EOLACvtfcHk0liGrLzuPWpcBg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXps1eitrc%253D&md5=dbb2800b668a23be61f9b0c90f2725c3</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1016%2Fj.biopsych.2010.04.038&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.biopsych.2010.04.038%26sid%3Dliteratum%253Aachs%26aulast%3DSearle%26aufirst%3DG.%26aulast%3DBeaver%26aufirst%3DJ.%2BD.%26aulast%3DComley%26aufirst%3DR.%2BA.%26aulast%3DBani%26aufirst%3DM.%26aulast%3DTziortzi%26aufirst%3DA.%26aulast%3DSlifstein%26aufirst%3DM.%26aulast%3DMugnaini%26aufirst%3DM.%26aulast%3DGriffante%26aufirst%3DC.%26aulast%3DWilson%26aufirst%3DA.%2BA.%26aulast%3DMerlo-Pich%26aufirst%3DE.%26aulast%3DHoule%26aufirst%3DS.%26aulast%3DGunn%26aufirst%3DR.%26aulast%3DRabiner%26aufirst%3DE.%2BA.%26aulast%3DLaruelle%26aufirst%3DM.%26atitle%3DImaging%2520Dopamine%2520D3%2520Receptors%2520in%2520the%2520Human%2520Brain%2520with%2520Positron%2520Emission%2520Tomography%252C%2520%255B11C%255DPHNO%252C%2520and%2520a%2520Selective%2520D3%2520Receptor%2520Antagonist%26jtitle%3DBiol.%2520Psychiatry%26date%3D2010%26volume%3D68%26spage%3D392%26epage%3D399%26doi%3D10.1016%2Fj.biopsych.2010.04.038" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Nebel, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maschauer, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuwert, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hocke, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prante, O.</span></span> <span> </span><span class="NLM_article-title">In Vitro and In Vivo Characterization of Selected Fluorine-18 Labeled Radioligands for PET Imaging of the Dopamine D3 Receptor</span>. <i>Molecules</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>21</i></span>, <span class="NLM_elocation-id">1144</span> <span class="refDoi"> DOI: 10.3390/molecules21091144</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00412&amp;key=10.3390%2Fmolecules21091144" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2016&author=N.+Nebelauthor=S.+Maschauerauthor=T.+Kuwertauthor=C.+Hockeauthor=O.+Prante&title=In+Vitro+and+In+Vivo+Characterization+of+Selected+Fluorine-18+Labeled+Radioligands+for+PET+Imaging+of+the+Dopamine+D3+Receptor&doi=10.3390%2Fmolecules21091144"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.3390%2Fmolecules21091144&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3390%252Fmolecules21091144%26sid%3Dliteratum%253Aachs%26aulast%3DNebel%26aufirst%3DN.%26aulast%3DMaschauer%26aufirst%3DS.%26aulast%3DKuwert%26aufirst%3DT.%26aulast%3DHocke%26aufirst%3DC.%26aulast%3DPrante%26aufirst%3DO.%26atitle%3DIn%2520Vitro%2520and%2520In%2520Vivo%2520Characterization%2520of%2520Selected%2520Fluorine-18%2520Labeled%2520Radioligands%2520for%2520PET%2520Imaging%2520of%2520the%2520Dopamine%2520D3%2520Receptor%26jtitle%3DMolecules%26date%3D2016%26volume%3D21%26doi%3D10.3390%2Fmolecules21091144" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Boileau, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nakajima, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Payer, D.</span></span> <span> </span><span class="NLM_article-title">Imaging the D3 Dopamine Receptor Across Behavioral and Drug Addictions: Positron Emission Tomography Studies with [11C]-(+)-PHNO</span>. <i>Eur. Neuropsychopharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>25</i></span>,  <span class="NLM_fpage">1410</span>– <span class="NLM_lpage">1420</span>, <span class="refDoi"> DOI: 10.1016/j.euroneuro.2015.06.002</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00412&amp;key=10.1016%2Fj.euroneuro.2015.06.002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00412&amp;key=26141509" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00412&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhtV2lsrbP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2015&pages=1410-1420&author=I.+Boileauauthor=S.+Nakajimaauthor=D.+Payer&title=Imaging+the+D3+Dopamine+Receptor+Across+Behavioral+and+Drug+Addictions%3A+Positron+Emission+Tomography+Studies+with+%5B11C%5D-%28%2B%29-PHNO&doi=10.1016%2Fj.euroneuro.2015.06.002"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Imaging the D3 dopamine receptor across behavioral and drug addictions: Positron emission tomography studies with [11C]-(+)-PHNO</span></div><div class="casAuthors">Boileau, Isabelle; Nakajima, Shinichiro; Payer, Doris</div><div class="citationInfo"><span class="NLM_cas:title">European Neuropsychopharmacology</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1410-1420</span>CODEN:
                <span class="NLM_cas:coden">EURNE8</span>;
        ISSN:<span class="NLM_cas:issn">0924-977X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Chronic drug use has been assocd. with dopaminergic abnormalities, detectable in humans with positron emission tomog. (PET).  Among these, a hallmark feature is low D2 dopamine receptor availability, which has been linked to clin. outcomes, but has not yet translated into a therapeutic strategy.  The D3 dopamine receptor on the other hand has gained increasing attention, as, in contrast to D2, chronic exposure to drugs has been shown to up-regulate this receptor subtype in preclin. models of addiction-a phenomenon linked to dopamine system sensitization and drug-seeking.  The present article summarizes the literature to date in humans, suggesting that the D3 receptor may indeed contribute to core features of addiction such as impulsiveness and cognitive impairment.  A particularly useful tool in investigating this question is the PET imaging probe [11C]-(+)-PHNO, which binds to D2/3 dopamine receptors but has preferential affinity for D3.  This technique has been used to demonstrate D3 up-regulation in humans, and can be applied to assess pharmacol. interventions for development of D3-targeted strategies in addiction treatment.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpW6zsdhIO0K7Vg90H21EOLACvtfcHk0liGrLzuPWpcBg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtV2lsrbP&md5=c6ceb2674c5f29987418ada62ca80f38</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1016%2Fj.euroneuro.2015.06.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.euroneuro.2015.06.002%26sid%3Dliteratum%253Aachs%26aulast%3DBoileau%26aufirst%3DI.%26aulast%3DNakajima%26aufirst%3DS.%26aulast%3DPayer%26aufirst%3DD.%26atitle%3DImaging%2520the%2520D3%2520Dopamine%2520Receptor%2520Across%2520Behavioral%2520and%2520Drug%2520Addictions%253A%2520Positron%2520Emission%2520Tomography%2520Studies%2520with%2520%255B11C%255D-%2528%252B%2529-PHNO%26jtitle%3DEur.%2520Neuropsychopharmacol.%26date%3D2015%26volume%3D25%26spage%3D1410%26epage%3D1420%26doi%3D10.1016%2Fj.euroneuro.2015.06.002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mach, R. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luedtke, R. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reichert, D. E.</span></span> <span> </span><span class="NLM_article-title">Subtype Selectivity of Dopamine Receptor Ligands: Insights from Structure and Ligand-Based Methods</span>. <i>J. Chem. Inf. Model.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>50</i></span>,  <span class="NLM_fpage">1970</span>– <span class="NLM_lpage">1985</span>, <span class="refDoi"> DOI: 10.1021/ci1002747</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ci1002747" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00412&amp;key=1%3ACAS%3A528%3ADC%252BC3cXht1OisrzJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2010&pages=1970-1985&author=Q.+Wangauthor=R.+H.+Machauthor=R.+R.+Luedtkeauthor=D.+E.+Reichert&title=Subtype+Selectivity+of+Dopamine+Receptor+Ligands%3A+Insights+from+Structure+and+Ligand-Based+Methods&doi=10.1021%2Fci1002747"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Subtype selectivity of dopamine receptor ligands: insights from structure and ligand-based methods</span></div><div class="casAuthors">Wang, Qi; Mach, Robert H.; Luedtke, Robert R.; Reichert, David E.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Chemical Information and Modeling</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">50</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1970-1985</span>CODEN:
                <span class="NLM_cas:coden">JCISD8</span>;
        ISSN:<span class="NLM_cas:issn">1549-9596</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Subtype selective dopamine receptor ligands have long been sought after as therapeutic and/or imaging agents for the treatment and monitoring of neurol. disorders.  We report herein on a combined structure- and ligand-based approach to explore the mol. mechanism of the subtype selectivity for a large class of D2-like dopamine receptor ligands (163 ligands in total).  Homol. models were built for both human D2L and D3 receptors in complex with haloperidol.  Other ligands, which included multiple examples of substituted phenylpiperazines, were aligned against the binding conformations of haloperidol, and three-dimensional quant. structure activity relationship (3D-QSAR) analyses were carried out.  The receptor models show that although D2 and D3 share highly similar folds and 3D conformations, the slight sequence differences at their extracellular loop regions result in the binding cavity in D2 being comparably shallower than in D3, which may explain why some larger ligands bind with greater affinity at D3 compared to D2 receptors.  The QSAR models show excellent correlation and high predictive power even when evaluated by the most stringent criteria.  They confirm that the origins of subtype selectivity for the ligands arise primarily due to differences in the contours of the two binding sites.  The predictive models suggest that while both steric and electrostatic interactions contribute to the compds.' binding affinity, the major contribution arises from hydrophobic interactions, with hydrogen bonding conferring binding specificity.  The current work provides clues for the development of more subtype selective dopamine receptor ligands.  Furthermore, it demonstrates the possibility of being able to apply similar modeling methods to other subtypes or classes of receptors to study GPCR receptor-ligand interactions at a mol. level.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGokZTtMqvRrXbVg90H21EOLACvtfcHk0liT99xdi-8ZXQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXht1OisrzJ&md5=7c923cdaa5e10b1089c7152cedcd9cb0</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1021%2Fci1002747&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fci1002747%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DQ.%26aulast%3DMach%26aufirst%3DR.%2BH.%26aulast%3DLuedtke%26aufirst%3DR.%2BR.%26aulast%3DReichert%26aufirst%3DD.%2BE.%26atitle%3DSubtype%2520Selectivity%2520of%2520Dopamine%2520Receptor%2520Ligands%253A%2520Insights%2520from%2520Structure%2520and%2520Ligand-Based%2520Methods%26jtitle%3DJ.%2520Chem.%2520Inf.%2520Model.%26date%3D2010%26volume%3D50%26spage%3D1970%26epage%3D1985%26doi%3D10.1021%2Fci1002747" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Newman, A. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beuming, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Banala, A. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Donthamsetti, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pongetti, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">LaBounty, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Levy, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cao, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Michino, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luedtke, R. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Javitch, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shi, L.</span></span> <span> </span><span class="NLM_article-title">Molecular Determinants of Selectivity and Efficacy at the Dopamine D3 Receptor</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>55</i></span>,  <span class="NLM_fpage">6689</span>– <span class="NLM_lpage">6699</span>, <span class="refDoi"> DOI: 10.1021/jm300482h</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm300482h" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00412&amp;key=1%3ACAS%3A528%3ADC%252BC38XnsFCkt7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=6689-6699&author=A.+H.+Newmanauthor=T.+Beumingauthor=A.+K.+Banalaauthor=P.+Donthamsettiauthor=K.+Pongettiauthor=A.+LaBountyauthor=B.+Levyauthor=J.+Caoauthor=M.+Michinoauthor=R.+R.+Luedtkeauthor=J.+A.+Javitchauthor=L.+Shi&title=Molecular+Determinants+of+Selectivity+and+Efficacy+at+the+Dopamine+D3+Receptor&doi=10.1021%2Fjm300482h"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular Determinants of Selectivity and Efficacy at the Dopamine D3 Receptor</span></div><div class="casAuthors">Newman, Amy Hauck; Beuming, Thijs; Banala, Ashwini K.; Donthamsetti, Prashant; Pongetti, Katherine; LaBounty, Alex; Levy, Benjamin; Cao, Jianjing; Michino, Mayako; Luedtke, Robert R.; Javitch, Jonathan A.; Shi, Lei</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">6689-6699</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The dopamine D3 receptor (D3R) has been implicated in substance abuse and other neuropsychiatric disorders.  The high sequence homol. between the D3R and D2R, esp. within the orthosteric binding site (OBS) that binds dopamine, has made the development of D3R-selective compds. challenging.  Here, we deconstruct into pharmacophoric elements a series of D3R-selective substituted-4-phenylpiperazine compds. and use computational simulations and binding and activation studies to dissect the structural bases for D3R selectivity and efficacy.  We find that selectivity arises from divergent interactions within a second binding pocket (SBP) sep. from the OBS, whereas efficacy depends on the binding mode in the OBS.  Our findings reveal structural features of the receptor that are crit. to selectivity and efficacy that can be used to design highly D3R-selective ligands with targeted efficacies.  These findings are generalizable to other GPCRs in which the SBP can be targeted by bitopic or allosteric ligands.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqmBJU7uyvVg7Vg90H21EOLACvtfcHk0liT99xdi-8ZXQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XnsFCkt7c%253D&md5=033dd49282723650828a3ec0a31211e5</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1021%2Fjm300482h&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm300482h%26sid%3Dliteratum%253Aachs%26aulast%3DNewman%26aufirst%3DA.%2BH.%26aulast%3DBeuming%26aufirst%3DT.%26aulast%3DBanala%26aufirst%3DA.%2BK.%26aulast%3DDonthamsetti%26aufirst%3DP.%26aulast%3DPongetti%26aufirst%3DK.%26aulast%3DLaBounty%26aufirst%3DA.%26aulast%3DLevy%26aufirst%3DB.%26aulast%3DCao%26aufirst%3DJ.%26aulast%3DMichino%26aufirst%3DM.%26aulast%3DLuedtke%26aufirst%3DR.%2BR.%26aulast%3DJavitch%26aufirst%3DJ.%2BA.%26aulast%3DShi%26aufirst%3DL.%26atitle%3DMolecular%2520Determinants%2520of%2520Selectivity%2520and%2520Efficacy%2520at%2520the%2520Dopamine%2520D3%2520Receptor%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D6689%26epage%3D6699%26doi%3D10.1021%2Fjm300482h" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chien, E. Y.
T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Katritch, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Won Han, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hanson, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shi, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Newman, A. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Javitch, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cherezov, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stevens, R. C.</span></span> <span> </span><span class="NLM_article-title">Structure of the Human Dopamine D3 Receptor in Complex with a D2/D3 Selective Antagonist</span>. <i>Science</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>330</i></span>,  <span class="NLM_fpage">1091</span>– <span class="NLM_lpage">1095</span>, <span class="refDoi"> DOI: 10.1126/science.1197410</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00412&amp;key=10.1126%2Fscience.1197410" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00412&amp;key=21097933" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00412&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhsVahurvM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=330&publication_year=2010&pages=1091-1095&author=E.+Y.%0AT.+Chienauthor=W.+Liuauthor=Q.+Zhaoauthor=V.+Katritchauthor=G.+Won+Hanauthor=M.+A.+Hansonauthor=L.+Shiauthor=A.+H.+Newmanauthor=J.+A.+Javitchauthor=V.+Cherezovauthor=R.+C.+Stevens&title=Structure+of+the+Human+Dopamine+D3+Receptor+in+Complex+with+a+D2%2FD3+Selective+Antagonist&doi=10.1126%2Fscience.1197410"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Structure of the Human Dopamine D3 Receptor in Complex with a D2/D3 Selective Antagonist</span></div><div class="casAuthors">Chien, Ellen Y. T.; Liu, Wei; Zhao, Qiang; Katritch, Vsevolod; Won Han, Gye; Hanson, Michael A.; Shi, Lei; Newman, Amy Hauck; Javitch, Jonathan A.; Cherezov, Vadim; Stevens, Raymond C.</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">330</span>
        (<span class="NLM_cas:issue">6007</span>),
    <span class="NLM_cas:pages">1091-1095</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">Dopamine modulates movement, cognition, and emotion through activation of dopamine G protein-coupled receptors in the brain.  The crystal structure of the human dopamine D3 receptor (D3R) in complex with the small mol. D2R/D3R-specific antagonist eticlopride reveals important features of the ligand binding pocket and extracellular loops.  On the intracellular side of the receptor, a locked conformation of the ionic lock and two distinctly different conformations of intracellular loop 2 are obsd.  Docking of R-22, a D3R-selective antagonist, reveals an extracellular extension of the eticlopride binding site that comprises a second binding pocket for the aryl amide of R-22, which differs between the highly homologous D2R and D3R.  This difference provides direction to the design of D3R-selective agents for treating drug abuse and other neuropsychiatric indications.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoOEcfSdjMm-7Vg90H21EOLACvtfcHk0lhP8cPMgrgGAQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhsVahurvM&md5=12c6f343daea9fb14ca605a092f28533</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1126%2Fscience.1197410&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.1197410%26sid%3Dliteratum%253Aachs%26aulast%3DChien%26aufirst%3DE.%2BY.%2BT.%26aulast%3DLiu%26aufirst%3DW.%26aulast%3DZhao%26aufirst%3DQ.%26aulast%3DKatritch%26aufirst%3DV.%26aulast%3DWon%2BHan%26aufirst%3DG.%26aulast%3DHanson%26aufirst%3DM.%2BA.%26aulast%3DShi%26aufirst%3DL.%26aulast%3DNewman%26aufirst%3DA.%2BH.%26aulast%3DJavitch%26aufirst%3DJ.%2BA.%26aulast%3DCherezov%26aufirst%3DV.%26aulast%3DStevens%26aufirst%3DR.%2BC.%26atitle%3DStructure%2520of%2520the%2520Human%2520Dopamine%2520D3%2520Receptor%2520in%2520Complex%2520with%2520a%2520D2%252FD3%2520Selective%2520Antagonist%26jtitle%3DScience%26date%3D2010%26volume%3D330%26spage%3D1091%26epage%3D1095%26doi%3D10.1126%2Fscience.1197410" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Michino, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beuming, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Donthamsetti, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Newman, A. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Javitch, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shi, L.</span></span> <span> </span><span class="NLM_article-title">What Can Crystal Structures of Aminergic Receptors Tell Us about Designing Subtype-Selective Ligands?</span>. <i>Pharmacol. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>67</i></span>,  <span class="NLM_fpage">198</span>– <span class="NLM_lpage">213</span>, <span class="refDoi"> DOI: 10.1124/pr.114.009944</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00412&amp;key=10.1124%2Fpr.114.009944" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00412&amp;key=25527701" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00412&amp;key=1%3ACAS%3A528%3ADC%252BC2MXisVWqu7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=67&publication_year=2015&pages=198-213&author=M.+Michinoauthor=T.+Beumingauthor=P.+Donthamsettiauthor=A.+H.+Newmanauthor=J.+A.+Javitchauthor=L.+Shi&title=What+Can+Crystal+Structures+of+Aminergic+Receptors+Tell+Us+about+Designing+Subtype-Selective+Ligands%3F&doi=10.1124%2Fpr.114.009944"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">What can crystal structures of aminergic receptors tell us about designing subtype-selective ligands?</span></div><div class="casAuthors">Michino, Mayako; Beuming, Thijs; Donthamsetti, Prashant; Newman, Amy Hauck; Javitch, Jonathan A.; Shi, Lei</div><div class="citationInfo"><span class="NLM_cas:title">Pharmacological Reviews</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">67</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">198-213</span>CODEN:
                <span class="NLM_cas:coden">PAREAQ</span>;
        ISSN:<span class="NLM_cas:issn">1521-0081</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">A review.  G protein-coupled receptors (GPCRs) are integral membrane proteins that represent an important class of drug targets.  In particular, aminergic GPCRs interact with a significant portion of drugs currently on the market.  However, most drugs that target these receptors are assocd. with undesirable side effects, which are due in part to promiscuous interactions with close homologs of the intended target receptors.  Here, based on a systematic anal. of all 37 of the currently available high-resoln. crystal structures of aminergic GPCRs, we review structural elements that contribute to and can be exploited for designing subtype-selective compds.  We describe the roles of secondary binding pockets (SBPs), as well as differences in ligand entry pathways to the orthosteric binding site, in detg. selectivity.  In addn., using the available crystal structures, we have identified conformational changes in the SBPs that are assocd. with receptor activation and explore the implications of these changes for the rational development of selective ligands with tailored efficacy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp88D-c63Tm3LVg90H21EOLACvtfcHk0lhP8cPMgrgGAQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXisVWqu7s%253D&md5=7ed6698fae95a5e045a8d4e12b18fef5</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1124%2Fpr.114.009944&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fpr.114.009944%26sid%3Dliteratum%253Aachs%26aulast%3DMichino%26aufirst%3DM.%26aulast%3DBeuming%26aufirst%3DT.%26aulast%3DDonthamsetti%26aufirst%3DP.%26aulast%3DNewman%26aufirst%3DA.%2BH.%26aulast%3DJavitch%26aufirst%3DJ.%2BA.%26aulast%3DShi%26aufirst%3DL.%26atitle%3DWhat%2520Can%2520Crystal%2520Structures%2520of%2520Aminergic%2520Receptors%2520Tell%2520Us%2520about%2520Designing%2520Subtype-Selective%2520Ligands%253F%26jtitle%3DPharmacol.%2520Rev.%26date%3D2015%26volume%3D67%26spage%3D198%26epage%3D213%26doi%3D10.1124%2Fpr.114.009944" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Reilly, S. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Griffin, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taylor, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sahlholm, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weng, C.-C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jacome, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luedtke, R. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mach, R. H.</span></span> <span> </span><span class="NLM_article-title">Highly Selective Dopamine D3 Receptor Antagonists with Arylated Diazaspiro Alkane Cores</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>60</i></span>,  <span class="NLM_fpage">9905</span>– <span class="NLM_lpage">9910</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.7b01248</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.7b01248" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00412&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhsl2gsbjL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2017&pages=9905-9910&author=S.+W.+Reillyauthor=S.+Griffinauthor=M.+Taylorauthor=K.+Sahlholmauthor=C.-C.+Wengauthor=K.+Xuauthor=D.+A.+Jacomeauthor=R.+R.+Luedtkeauthor=R.+H.+Mach&title=Highly+Selective+Dopamine+D3+Receptor+Antagonists+with+Arylated+Diazaspiro+Alkane+Cores&doi=10.1021%2Facs.jmedchem.7b01248"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Highly Selective Dopamine D3 Receptor Antagonists with Arylated Diazaspiro Alkane Cores</span></div><div class="casAuthors">Reilly, Sean W.; Griffin, Suzy; Taylor, Michelle; Sahlholm, Kristoffer; Weng, Chi-Chang; Xu, Kuiying; Jacome, Daniel A.; Luedtke, Robert R.; Mach, Robert H.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">9905-9910</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Aryldiazaspirocyclylpropyl phenyltriazolyl thioethers such as I (R = 2-MeOC6H4, 4-FC6H4, 4-MeOC6H4, 2-pyridinyl, 3-NCC6H4, 2,3-Cl2C6H3) were prepd. as selective dopamine D3 receptor (D3R) antagonists; their selectivities for D3R over D2R and for selected compds. over 5-HT1a, 5-HT2a, and 5-HT2c receptors and adenylyl cyclase were detd.  I (R = 2-MeOC6H4, 4-FC6H4) showed favorable D3R affinities (Ki = 12-25.6 nM) and were 264- to 905-fold selective for D3R vs D2R.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpHLC1nn5_14LVg90H21EOLACvtfcHk0liRBtrU9CS0TQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhsl2gsbjL&md5=a60ed8b0524189901b7155e11025d3c6</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.7b01248&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.7b01248%26sid%3Dliteratum%253Aachs%26aulast%3DReilly%26aufirst%3DS.%2BW.%26aulast%3DGriffin%26aufirst%3DS.%26aulast%3DTaylor%26aufirst%3DM.%26aulast%3DSahlholm%26aufirst%3DK.%26aulast%3DWeng%26aufirst%3DC.-C.%26aulast%3DXu%26aufirst%3DK.%26aulast%3DJacome%26aufirst%3DD.%2BA.%26aulast%3DLuedtke%26aufirst%3DR.%2BR.%26aulast%3DMach%26aufirst%3DR.%2BH.%26atitle%3DHighly%2520Selective%2520Dopamine%2520D3%2520Receptor%2520Antagonists%2520with%2520Arylated%2520Diazaspiro%2520Alkane%2520Cores%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2017%26volume%3D60%26spage%3D9905%26epage%3D9910%26doi%3D10.1021%2Facs.jmedchem.7b01248" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Reilly, S. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bryan, N. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mach, R. H.</span></span> <span> </span><span class="NLM_article-title">Pd-catalyzed arylation of linear and angular spirodiamine salts under aerobic conditions</span>. <i>Tetrahedron Lett.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>58</i></span>,  <span class="NLM_fpage">466</span>– <span class="NLM_lpage">469</span>, <span class="refDoi"> DOI: 10.1016/j.tetlet.2016.12.063</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00412&amp;key=10.1016%2Fj.tetlet.2016.12.063" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2017&pages=466-469&author=S.+W.+Reillyauthor=N.+W.+Bryanauthor=R.+H.+Mach&title=Pd-catalyzed+arylation+of+linear+and+angular+spirodiamine+salts+under+aerobic+conditions&doi=10.1016%2Fj.tetlet.2016.12.063"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1016%2Fj.tetlet.2016.12.063&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.tetlet.2016.12.063%26sid%3Dliteratum%253Aachs%26aulast%3DReilly%26aufirst%3DS.%2BW.%26aulast%3DBryan%26aufirst%3DN.%2BW.%26aulast%3DMach%26aufirst%3DR.%2BH.%26atitle%3DPd-catalyzed%2520arylation%2520of%2520linear%2520and%2520angular%2520spirodiamine%2520salts%2520under%2520aerobic%2520conditions%26jtitle%3DTetrahedron%2520Lett.%26date%3D2017%26volume%3D58%26spage%3D466%26epage%3D469%26doi%3D10.1016%2Fj.tetlet.2016.12.063" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Reilly, S. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mach, R. H.</span></span> <span> </span><span class="NLM_article-title">Pd-Catalyzed Synthesis of Piperazine Scaffolds Under Aerobic and Solvent-Free Conditions</span>. <i>Org. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>18</i></span>,  <span class="NLM_fpage">5272</span>– <span class="NLM_lpage">5275</span>, <span class="refDoi"> DOI: 10.1021/acs.orglett.6b02591</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.orglett.6b02591" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00412&amp;key=1%3ACAS%3A528%3ADC%252BC28Xhs1GmtrnL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2016&pages=5272-5275&author=S.+W.+Reillyauthor=R.+H.+Mach&title=Pd-Catalyzed+Synthesis+of+Piperazine+Scaffolds+Under+Aerobic+and+Solvent-Free+Conditions&doi=10.1021%2Facs.orglett.6b02591"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Pd-Catalyzed Synthesis of Piperazine Scaffolds Under Aerobic and Solvent-Free Conditions</span></div><div class="casAuthors">Reilly, Sean W.; Mach, Robert H.</div><div class="citationInfo"><span class="NLM_cas:title">Organic Letters</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">20</span>),
    <span class="NLM_cas:pages">5272-5275</span>CODEN:
                <span class="NLM_cas:coden">ORLEF7</span>;
        ISSN:<span class="NLM_cas:issn">1523-7052</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A facile Pd-catalyzed methodol. providing an efficient synthetic route to biol. relevant arylpiperazines under aerobic conditions is reported.  Electron donating and sterically hindered aryl chlorides were aminated to afford yields up to 97%, with examples using piperazine as solvent, illustrating an ecofriendly, cost-effective synthesis of these privileged structures.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqXeVVzuPjiTrVg90H21EOLACvtfcHk0liRBtrU9CS0TQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xhs1GmtrnL&md5=4ef3b43051bc8bd715b31ee464921efa</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1021%2Facs.orglett.6b02591&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.orglett.6b02591%26sid%3Dliteratum%253Aachs%26aulast%3DReilly%26aufirst%3DS.%2BW.%26aulast%3DMach%26aufirst%3DR.%2BH.%26atitle%3DPd-Catalyzed%2520Synthesis%2520of%2520Piperazine%2520Scaffolds%2520Under%2520Aerobic%2520and%2520Solvent-Free%2520Conditions%26jtitle%3DOrg.%2520Lett.%26date%3D2016%26volume%3D18%26spage%3D5272%26epage%3D5275%26doi%3D10.1021%2Facs.orglett.6b02591" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Vangveravong, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taylor, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bearden, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cui, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luedtke, R. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mach, R. H.</span></span> <span> </span><span class="NLM_article-title">Synthesis and Characterization of Selective Dopamine D2 Receptor Ligands Using Aripiprazole as the Lead Compound</span>. <i>Bioorg. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>19</i></span>,  <span class="NLM_fpage">3502</span>– <span class="NLM_lpage">3511</span>, <span class="refDoi"> DOI: 10.1016/j.bmc.2011.04.021</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00412&amp;key=10.1016%2Fj.bmc.2011.04.021" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00412&amp;key=21536445" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00412&amp;key=1%3ACAS%3A528%3ADC%252BC3MXmvFWmt7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2011&pages=3502-3511&author=S.+Vangveravongauthor=Z.+Zhangauthor=M.+Taylorauthor=M.+Beardenauthor=J.+Xuauthor=J.+Cuiauthor=W.+Wangauthor=R.+R.+Luedtkeauthor=R.+H.+Mach&title=Synthesis+and+Characterization+of+Selective+Dopamine+D2+Receptor+Ligands+Using+Aripiprazole+as+the+Lead+Compound&doi=10.1016%2Fj.bmc.2011.04.021"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and characterization of selective dopamine D2 receptor ligands using aripiprazole as the lead compound</span></div><div class="casAuthors">Vangveravong, Suwanna; Zhang, Zhanbin; Taylor, Michelle; Bearden, Melissa; Xu, Jinbin; Cui, Jinquan; Wang, Wei; Luedtke, Robert R.; Mach, Robert H.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">3502-3511</span>CODEN:
                <span class="NLM_cas:coden">BMECEP</span>;
        ISSN:<span class="NLM_cas:issn">0968-0896</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A series of compds. structurally related to aripiprazole (1), an atypical antipsychotic and antidepressant used clin. for the treatment of schizophrenia, bipolar disorder, and depression, have been prepd. and evaluated for affinity at D2-like dopamine receptors.  These compds. also share structural elements with the classical D2-like dopamine receptor antagonists, haloperidol, N-methylspiperone, domperidone and benperidol.  Two new compds., 7-(4-(4-(2-methoxyphenyl)piperazin-1-yl)butoxy)-3,4-dihydroquinolin-2(1H)-one oxalate (6) and 7-(4-(4-(2-(2-fluoroethoxy)phenyl)piperazin-1-yl)butoxy)-3,4-dihydroquinolin-2(1H)-one oxalate (7) were found to (a) bind to the D2 receptor subtype with high affinity (K i values <0.3 nM), (b) exhibit >50-fold D2 vs. D3 receptor binding selectivity and (c) be partial agonists at both the D2 and D3 receptor subtype.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGopvLSFYukyzrVg90H21EOLACvtfcHk0lg8OEP7nq90SQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXmvFWmt7o%253D&md5=4b71878d8f8e2dc6cbbb4c59c2b5872d</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2011.04.021&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2011.04.021%26sid%3Dliteratum%253Aachs%26aulast%3DVangveravong%26aufirst%3DS.%26aulast%3DZhang%26aufirst%3DZ.%26aulast%3DTaylor%26aufirst%3DM.%26aulast%3DBearden%26aufirst%3DM.%26aulast%3DXu%26aufirst%3DJ.%26aulast%3DCui%26aufirst%3DJ.%26aulast%3DWang%26aufirst%3DW.%26aulast%3DLuedtke%26aufirst%3DR.%2BR.%26aulast%3DMach%26aufirst%3DR.%2BH.%26atitle%3DSynthesis%2520and%2520Characterization%2520of%2520Selective%2520Dopamine%2520D2%2520Receptor%2520Ligands%2520Using%2520Aripiprazole%2520as%2520the%2520Lead%2520Compound%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2011%26volume%3D19%26spage%3D3502%26epage%3D3511%26doi%3D10.1016%2Fj.bmc.2011.04.021" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Micheli, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bacchi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Braggio, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Castelletti, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cavallini, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cavanni, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cremonesi, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dal Cin, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feriani, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gehanne, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kajbaf, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marchió, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nola, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oliosi, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pellacani, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perdonà, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sava, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Semeraro, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tarsi, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tomelleri, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wong, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Visentini, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zonzini, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heidbreder, C.</span></span> <span> </span><span class="NLM_article-title">1,2,4-Triazolyl 5-Azaspiro[2.4]heptanes: Lead Identification and Early Lead Optimization of a New Series of Potent and Selective Dopamine D3 Receptor Antagonists</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>59</i></span>,  <span class="NLM_fpage">8549</span>– <span class="NLM_lpage">8576</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.6b00972</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.6b00972" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00412&amp;key=1%3ACAS%3A528%3ADC%252BC28XhsVWltrjN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2016&pages=8549-8576&author=F.+Micheliauthor=A.+Bacchiauthor=S.+Braggioauthor=L.+Castellettiauthor=P.+Cavalliniauthor=P.+Cavanniauthor=S.+Cremonesiauthor=M.+Dal+Cinauthor=A.+Ferianiauthor=S.+Gehanneauthor=M.+Kajbafauthor=L.+Marchi%C3%B3author=S.+Nolaauthor=B.+Oliosiauthor=A.+Pellacaniauthor=E.+Perdon%C3%A0author=A.+Savaauthor=T.+Semeraroauthor=L.+Tarsiauthor=S.+Tomelleriauthor=A.+Wongauthor=F.+Visentiniauthor=L.+Zonziniauthor=C.+Heidbreder&title=1%2C2%2C4-Triazolyl+5-Azaspiro%5B2.4%5Dheptanes%3A+Lead+Identification+and+Early+Lead+Optimization+of+a+New+Series+of+Potent+and+Selective+Dopamine+D3+Receptor+Antagonists&doi=10.1021%2Facs.jmedchem.6b00972"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">1,2,4-Triazolyl 5-Azaspiro[2.4]heptanes: Lead Identification and Early Lead Optimization of a New Series of Potent and Selective Dopamine D3 Receptor Antagonists</span></div><div class="casAuthors">Micheli, Fabrizio; Bacchi, Alessia; Braggio, Simone; Castelletti, Laura; Cavallini, Palmina; Cavanni, Paolo; Cremonesi, Susanna; Dal Cin, Michele; Feriani, Aldo; Gehanne, Sylvie; Kajbaf, Mahmud; Marchio, Luciano; Nola, Selena; Oliosi, Beatrice; Pellacani, Annalisa; Perdona, Elisabetta; Sava, Anna; Semeraro, Teresa; Tarsi, Luca; Tomelleri, Silvia; Wong, Andrea; Visentini, Filippo; Zonzini, Laura; Heidbreder, Christian</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">8549-8576</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A novel series of 1,2,4-triazolyl 5-azaspiro[2.4]heptanes with high affinity and selectivity at the dopamine (DA) D3 receptor (D3R) is described.  Some of these compds. also have high selectivity over the hERG channel and were characterized with respect to their pharmacokinetic properties both in vitro and in vivo during lead identification and early lead optimization phases.  A few derivs. with overall favorable developability characteristics were selected for further late lead optimization studies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqCKMOaVTpugrVg90H21EOLACvtfcHk0ljLQzmVgaOVlg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhsVWltrjN&md5=9588db3bf4e320c6d082b4318a8143a4</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.6b00972&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.6b00972%26sid%3Dliteratum%253Aachs%26aulast%3DMicheli%26aufirst%3DF.%26aulast%3DBacchi%26aufirst%3DA.%26aulast%3DBraggio%26aufirst%3DS.%26aulast%3DCastelletti%26aufirst%3DL.%26aulast%3DCavallini%26aufirst%3DP.%26aulast%3DCavanni%26aufirst%3DP.%26aulast%3DCremonesi%26aufirst%3DS.%26aulast%3DDal%2BCin%26aufirst%3DM.%26aulast%3DFeriani%26aufirst%3DA.%26aulast%3DGehanne%26aufirst%3DS.%26aulast%3DKajbaf%26aufirst%3DM.%26aulast%3DMarchi%25C3%25B3%26aufirst%3DL.%26aulast%3DNola%26aufirst%3DS.%26aulast%3DOliosi%26aufirst%3DB.%26aulast%3DPellacani%26aufirst%3DA.%26aulast%3DPerdon%25C3%25A0%26aufirst%3DE.%26aulast%3DSava%26aufirst%3DA.%26aulast%3DSemeraro%26aufirst%3DT.%26aulast%3DTarsi%26aufirst%3DL.%26aulast%3DTomelleri%26aufirst%3DS.%26aulast%3DWong%26aufirst%3DA.%26aulast%3DVisentini%26aufirst%3DF.%26aulast%3DZonzini%26aufirst%3DL.%26aulast%3DHeidbreder%26aufirst%3DC.%26atitle%3D1%252C2%252C4-Triazolyl%25205-Azaspiro%255B2.4%255Dheptanes%253A%2520Lead%2520Identification%2520and%2520Early%2520Lead%2520Optimization%2520of%2520a%2520New%2520Series%2520of%2520Potent%2520and%2520Selective%2520Dopamine%2520D3%2520Receptor%2520Antagonists%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2016%26volume%3D59%26spage%3D8549%26epage%3D8576%26doi%3D10.1021%2Facs.jmedchem.6b00972" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Micheli, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arista, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bertani, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Braggio, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Capelli, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cremonesi, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Di-Fabio, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gelardi, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gentile, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marchioro, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pasquarello, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Provera, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tedesco, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tarsi, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Terreni, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Worby, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heidbreder, C.</span></span> <span> </span><span class="NLM_article-title">Exploration of the Amine Terminus in a Novel Series of 1,2,4-Triazolo-3-yl-azabicyclo[3.1.0]hexanes as Selective Dopamine D3 Receptor Antagonists</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>53</i></span>,  <span class="NLM_fpage">7129</span>– <span class="NLM_lpage">7139</span>, <span class="refDoi"> DOI: 10.1021/jm100832d</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm100832d" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=7129-7139&author=F.+Micheliauthor=L.+Aristaauthor=B.+Bertaniauthor=S.+Braggioauthor=A.+M.+Capelliauthor=S.+Cremonesiauthor=R.+Di-Fabioauthor=G.+Gelardiauthor=G.+Gentileauthor=C.+Marchioroauthor=A.+Pasquarelloauthor=S.+Proveraauthor=G.+Tedescoauthor=L.+Tarsiauthor=S.+Terreniauthor=A.+Worbyauthor=C.+Heidbreder&title=Exploration+of+the+Amine+Terminus+in+a+Novel+Series+of+1%2C2%2C4-Triazolo-3-yl-azabicyclo%5B3.1.0%5Dhexanes+as+Selective+Dopamine+D3+Receptor+Antagonists&doi=10.1021%2Fjm100832d"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1021%2Fjm100832d&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm100832d%26sid%3Dliteratum%253Aachs%26aulast%3DMicheli%26aufirst%3DF.%26aulast%3DArista%26aufirst%3DL.%26aulast%3DBertani%26aufirst%3DB.%26aulast%3DBraggio%26aufirst%3DS.%26aulast%3DCapelli%26aufirst%3DA.%2BM.%26aulast%3DCremonesi%26aufirst%3DS.%26aulast%3DDi-Fabio%26aufirst%3DR.%26aulast%3DGelardi%26aufirst%3DG.%26aulast%3DGentile%26aufirst%3DG.%26aulast%3DMarchioro%26aufirst%3DC.%26aulast%3DPasquarello%26aufirst%3DA.%26aulast%3DProvera%26aufirst%3DS.%26aulast%3DTedesco%26aufirst%3DG.%26aulast%3DTarsi%26aufirst%3DL.%26aulast%3DTerreni%26aufirst%3DS.%26aulast%3DWorby%26aufirst%3DA.%26aulast%3DHeidbreder%26aufirst%3DC.%26atitle%3DExploration%2520of%2520the%2520Amine%2520Terminus%2520in%2520a%2520Novel%2520Series%2520of%25201%252C2%252C4-Triazolo-3-yl-azabicyclo%255B3.1.0%255Dhexanes%2520as%2520Selective%2520Dopamine%2520D3%2520Receptor%2520Antagonists%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26spage%3D7129%26epage%3D7139%26doi%3D10.1021%2Fjm100832d" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cremonesi, S.</span>; <span class="NLM_string-name">Micheli, F.</span>; <span class="NLM_string-name">Semeraro, T.</span>; <span class="NLM_string-name">Tarsi, L.</span></span> <span> </span><span class="NLM_article-title">Azaspirocyclic Compounds as Dopamine D3 Receptor Antagonists and their Preparation</span>. WO Patent <span class="NLM_patent">WO2016067043A1</span>, <span class="NLM_year">2016</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2016&author=S.+Cremonesi&author=F.+Micheli&author=T.+Semeraro&author=L.+Tarsi&title=Azaspirocyclic+Compounds+as+Dopamine+D3+Receptor+Antagonists+and+their+Preparation"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DCremonesi%26aufirst%3DS.%26atitle%3DAzaspirocyclic%2520Compounds%2520as%2520Dopamine%2520D3%2520Receptor%2520Antagonists%2520and%2520their%2520Preparation%26date%3D2016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tu, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cui, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taylor, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ho, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luedtke, R. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mach, R. H.</span></span> <span> </span><span class="NLM_article-title">Synthesis and Pharmacological Evaluation of Fluorine-Containing D3 Dopamine Receptor Ligands</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>54</i></span>,  <span class="NLM_fpage">1555</span>– <span class="NLM_lpage">1564</span>, <span class="refDoi"> DOI: 10.1021/jm101323b</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm101323b" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00412&amp;key=1%3ACAS%3A528%3ADC%252BC3MXisFWntrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2011&pages=1555-1564&author=Z.+Tuauthor=S.+Liauthor=J.+Cuiauthor=J.+Xuauthor=M.+Taylorauthor=D.+Hoauthor=R.+R.+Luedtkeauthor=R.+H.+Mach&title=Synthesis+and+Pharmacological+Evaluation+of+Fluorine-Containing+D3+Dopamine+Receptor+Ligands&doi=10.1021%2Fjm101323b"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and Pharmacological Evaluation of Fluorine-Containing D3 Dopamine Receptor Ligands</span></div><div class="casAuthors">Tu, Zhu-De; Li, Shi-Hong; Cui, Jin-Quan; Xu, Jin-Bin; Taylor, Michelle; Ho, David; Luedtke, Robert R.; Mach, Robert H.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1555-1564</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A series of fluorine-contg. N-(2-methoxyphenyl)piperazine and N-(2-fluoroethoxy)piperazine analogs, e. g. I, were synthesized, and their affinities for human dopamine D2, D3, and D4 receptors were detd.  Radioligand binding studies identified five compds., 18a, 20a, 20c, 20e, and 21e, which bind with high affinity at D3 (Ki = 0.17-5 nM) and moderate to high selectivity for D3 vs D2 receptors (ranging from ∼25- to 163-fold).  These compds. were also evaluated for intrinsic activity at D2 and D3 receptors using a forskolin-dependent adenylyl cyclase assay.  This panel of compds. exhibits varying receptor subtype binding selectivity and intrinsic activity at D2 vs D3 receptors.  These compds. may be useful for behavioral pharmacol. studies on the role of D2-like dopamine receptors in neuropsychiatric and neurol. disorders.  Furthermore, compd. 20e, which has the highest binding affinity and selectivity for the D3 receptor (Ki = 0.17 nM for D3, 163-fold selectivity for D3 vs D2 receptors), represents a candidate fluorine-18 radiotracer for in vivo PET imaging studies on the regulation of D3 receptor expression.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp_lRIZaeiUnbVg90H21EOLACvtfcHk0lix8Iyv2Ybp_Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXisFWntrY%253D&md5=138e7cf0e434cd726af353d75f99b0f6</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1021%2Fjm101323b&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm101323b%26sid%3Dliteratum%253Aachs%26aulast%3DTu%26aufirst%3DZ.%26aulast%3DLi%26aufirst%3DS.%26aulast%3DCui%26aufirst%3DJ.%26aulast%3DXu%26aufirst%3DJ.%26aulast%3DTaylor%26aufirst%3DM.%26aulast%3DHo%26aufirst%3DD.%26aulast%3DLuedtke%26aufirst%3DR.%2BR.%26aulast%3DMach%26aufirst%3DR.%2BH.%26atitle%3DSynthesis%2520and%2520Pharmacological%2520Evaluation%2520of%2520Fluorine-Containing%2520D3%2520Dopamine%2520Receptor%2520Ligands%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2011%26volume%3D54%26spage%3D1555%26epage%3D1564%26doi%3D10.1021%2Fjm101323b" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chu, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tu, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McElveen, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taylor, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luedtke, R. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mach, R. H.</span></span> <span> </span><span class="NLM_article-title">Synthesis and In Vitro Binding of <i>N</i>-Phenyl Piperazine Analogs as Potential Dopamine D3 Receptor Ligands</span>. <i>Bioorg. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>13</i></span>,  <span class="NLM_fpage">77</span>– <span class="NLM_lpage">87</span>, <span class="refDoi"> DOI: 10.1016/j.bmc.2004.09.054</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00412&amp;key=10.1016%2Fj.bmc.2004.09.054" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2005&pages=77-87&author=W.+Chuauthor=Z.+Tuauthor=E.+McElveenauthor=J.+Xuauthor=M.+Taylorauthor=R.+R.+Luedtkeauthor=R.+H.+Mach&title=Synthesis+and+In+Vitro+Binding+of+N-Phenyl+Piperazine+Analogs+as+Potential+Dopamine+D3+Receptor+Ligands&doi=10.1016%2Fj.bmc.2004.09.054"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2004.09.054&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2004.09.054%26sid%3Dliteratum%253Aachs%26aulast%3DChu%26aufirst%3DW.%26aulast%3DTu%26aufirst%3DZ.%26aulast%3DMcElveen%26aufirst%3DE.%26aulast%3DXu%26aufirst%3DJ.%26aulast%3DTaylor%26aufirst%3DM.%26aulast%3DLuedtke%26aufirst%3DR.%2BR.%26aulast%3DMach%26aufirst%3DR.%2BH.%26atitle%3DSynthesis%2520and%2520In%2520Vitro%2520Binding%2520of%2520N-Phenyl%2520Piperazine%2520Analogs%2520as%2520Potential%2520Dopamine%2520D3%2520Receptor%2520Ligands%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2005%26volume%3D13%26spage%3D77%26epage%3D87%26doi%3D10.1016%2Fj.bmc.2004.09.054" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mach, R. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tu, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jones, L. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taylor, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luedtke, R. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Derdeyn, C. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perlmutter, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mintun, M. A.</span></span> <span> </span><span class="NLM_article-title">Endogenous Dopamine (DA) Competes with the Binding of a Radiolabeled D(3) Receptor Partial Agonist In Vivo: A Positron Emission Tomography Study</span>. <i>Synapse</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>65</i></span>,  <span class="NLM_fpage">724</span>– <span class="NLM_lpage">732</span>, <span class="refDoi"> DOI: 10.1002/syn.20891</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00412&amp;key=10.1002%2Fsyn.20891" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=65&publication_year=2011&pages=724-732&author=R.+H.+Machauthor=Z.+Tuauthor=J.+Xuauthor=S.+Liauthor=L.+A.+Jonesauthor=M.+Taylorauthor=R.+R.+Luedtkeauthor=C.+P.+Derdeynauthor=J.+S.+Perlmutterauthor=M.+A.+Mintun&title=Endogenous+Dopamine+%28DA%29+Competes+with+the+Binding+of+a+Radiolabeled+D%283%29+Receptor+Partial+Agonist+In+Vivo%3A+A+Positron+Emission+Tomography+Study&doi=10.1002%2Fsyn.20891"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1002%2Fsyn.20891&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fsyn.20891%26sid%3Dliteratum%253Aachs%26aulast%3DMach%26aufirst%3DR.%2BH.%26aulast%3DTu%26aufirst%3DZ.%26aulast%3DXu%26aufirst%3DJ.%26aulast%3DLi%26aufirst%3DS.%26aulast%3DJones%26aufirst%3DL.%2BA.%26aulast%3DTaylor%26aufirst%3DM.%26aulast%3DLuedtke%26aufirst%3DR.%2BR.%26aulast%3DDerdeyn%26aufirst%3DC.%2BP.%26aulast%3DPerlmutter%26aufirst%3DJ.%2BS.%26aulast%3DMintun%26aufirst%3DM.%2BA.%26atitle%3DEndogenous%2520Dopamine%2520%2528DA%2529%2520Competes%2520with%2520the%2520Binding%2520of%2520a%2520Radiolabeled%2520D%25283%2529%2520Receptor%2520Partial%2520Agonist%2520In%2520Vivo%253A%2520A%2520Positron%2520Emission%2520Tomography%2520Study%26jtitle%3DSynapse%26date%3D2011%26volume%3D65%26spage%3D724%26epage%3D732%26doi%3D10.1002%2Fsyn.20891" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ferreira
de Freitas, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schapira, M.</span></span> <span> </span><span class="NLM_article-title">A Systematic Analysis of Atomic Protein–Ligand Interactions in the PDB</span>. <i>MedChemComm</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">1970</span>– <span class="NLM_lpage">1981</span>, <span class="refDoi"> DOI: 10.1039/C7MD00381A</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00412&amp;key=10.1039%2FC7MD00381A" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00412&amp;key=29308120" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00412&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhsFOiu7nE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2017&pages=1970-1981&author=R.+Ferreira%0Ade+Freitasauthor=M.+Schapira&title=A+Systematic+Analysis+of+Atomic+Protein%E2%80%93Ligand+Interactions+in+the+PDB&doi=10.1039%2FC7MD00381A"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">A systematic analysis of atomic protein-ligand interactions in the PDB</span></div><div class="casAuthors">Ferreira de Freitas, Renato; Schapira, Matthieu</div><div class="citationInfo"><span class="NLM_cas:title">MedChemComm</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1970-1981</span>CODEN:
                <span class="NLM_cas:coden">MCCEAY</span>;
        ISSN:<span class="NLM_cas:issn">2040-2503</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">As the protein databank (PDB) recently passed the cap of 123 456 structures, it stands more than ever as an important resource not only to analyze structural features of specific biol. systems, but also to study the prevalence of structural patterns obsd. in a large body of unrelated structures, that may reflect rules governing protein folding or mol. recognition.  Here, we compiled a list of 11 016 unique structures of small-mol. ligands bound to proteins - 6444 of which have exptl. binding affinity - representing 750 873 protein-ligand at. interactions, and analyzed the frequency, geometry and impact of each interaction type.  We find that hydrophobic interactions are generally enriched in high-efficiency ligands, but polar interactions are over-represented in fragment inhibitors.  While most observations extd. from the PDB will be familiar to seasoned medicinal chemists, less expected findings, such as the high no. of C-H···O hydrogen bonds or the relatively frequent amide-p stacking between the backbone amide of proteins and arom. rings of ligands, uncover underused ligand design strategies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo8iIbfKGlrqbVg90H21EOLACvtfcHk0li_Q_xfwGTbWQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhsFOiu7nE&md5=04688488e73253f76e4ea384456f89a8</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1039%2FC7MD00381A&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC7MD00381A%26sid%3Dliteratum%253Aachs%26aulast%3DFerreira%2Bde%2BFreitas%26aufirst%3DR.%26aulast%3DSchapira%26aufirst%3DM.%26atitle%3DA%2520Systematic%2520Analysis%2520of%2520Atomic%2520Protein%25E2%2580%2593Ligand%2520Interactions%2520in%2520the%2520PDB%26jtitle%3DMedChemComm%26date%3D2017%26volume%3D8%26spage%3D1970%26epage%3D1981%26doi%3D10.1039%2FC7MD00381A" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meades, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wood, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Osnowski, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Anderson, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yuill, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thomas, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mezna, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jackson, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Midgley, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Griffiths, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fleming, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Green, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McNae, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, S.-Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McInnes, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zheleva, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Walkinshaw, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fischer, P. M.</span></span> <span> </span><span class="NLM_article-title">2-Anilino-4-(thiazol-5-yl)pyrimidine CDK Inhibitors: Synthesis, SAR Analysis, X-ray Crystallography, and Biological Activity</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>47</i></span>,  <span class="NLM_fpage">1662</span>– <span class="NLM_lpage">1675</span>, <span class="refDoi"> DOI: 10.1021/jm0309957</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm0309957" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2004&pages=1662-1675&author=S.+Wangauthor=C.+Meadesauthor=G.+Woodauthor=A.+Osnowskiauthor=S.+Andersonauthor=R.+Yuillauthor=M.+Thomasauthor=M.+Meznaauthor=W.+Jacksonauthor=C.+Midgleyauthor=G.+Griffithsauthor=I.+Flemingauthor=S.+Greenauthor=I.+McNaeauthor=S.-Y.+Wuauthor=C.+McInnesauthor=D.+Zhelevaauthor=M.+D.+Walkinshawauthor=P.+M.+Fischer&title=2-Anilino-4-%28thiazol-5-yl%29pyrimidine+CDK+Inhibitors%3A+Synthesis%2C+SAR+Analysis%2C+X-ray+Crystallography%2C+and+Biological+Activity&doi=10.1021%2Fjm0309957"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1021%2Fjm0309957&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0309957%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DS.%26aulast%3DMeades%26aufirst%3DC.%26aulast%3DWood%26aufirst%3DG.%26aulast%3DOsnowski%26aufirst%3DA.%26aulast%3DAnderson%26aufirst%3DS.%26aulast%3DYuill%26aufirst%3DR.%26aulast%3DThomas%26aufirst%3DM.%26aulast%3DMezna%26aufirst%3DM.%26aulast%3DJackson%26aufirst%3DW.%26aulast%3DMidgley%26aufirst%3DC.%26aulast%3DGriffiths%26aufirst%3DG.%26aulast%3DFleming%26aufirst%3DI.%26aulast%3DGreen%26aufirst%3DS.%26aulast%3DMcNae%26aufirst%3DI.%26aulast%3DWu%26aufirst%3DS.-Y.%26aulast%3DMcInnes%26aufirst%3DC.%26aulast%3DZheleva%26aufirst%3DD.%26aulast%3DWalkinshaw%26aufirst%3DM.%2BD.%26aulast%3DFischer%26aufirst%3DP.%2BM.%26atitle%3D2-Anilino-4-%2528thiazol-5-yl%2529pyrimidine%2520CDK%2520Inhibitors%253A%2520Synthesis%252C%2520SAR%2520Analysis%252C%2520X-ray%2520Crystallography%252C%2520and%2520Biological%2520Activity%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2004%26volume%3D47%26spage%3D1662%26epage%3D1675%26doi%3D10.1021%2Fjm0309957" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ananthan, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saini, S. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hobrath, J. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Padmalayam, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhai, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bostwick, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Antonio, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reith, M. E. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McDowell, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cho, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McAleer, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taylor, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luedtke, R. R.</span></span> <span> </span><span class="NLM_article-title">Design, Synthesis, and Structure–Activity Relationship Studies of a Series of [4-(4-Carboxamidobutyl)]-1-arylpiperazines: Insights into Structural Features Contributing to Dopamine D3 versus D2 Receptor Subtype Selectivity</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>57</i></span>,  <span class="NLM_fpage">7042</span>– <span class="NLM_lpage">7060</span>, <span class="refDoi"> DOI: 10.1021/jm500801r</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm500801r" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=7042-7060&author=S.+Ananthanauthor=S.+K.+Sainiauthor=G.+Zhouauthor=J.+V.+Hobrathauthor=I.+Padmalayamauthor=L.+Zhaiauthor=J.+R.+Bostwickauthor=T.+Antonioauthor=M.+E.+A.+Reithauthor=S.+McDowellauthor=E.+Choauthor=L.+McAleerauthor=M.+Taylorauthor=R.+R.+Luedtke&title=Design%2C+Synthesis%2C+and+Structure%E2%80%93Activity+Relationship+Studies+of+a+Series+of+%5B4-%284-Carboxamidobutyl%29%5D-1-arylpiperazines%3A+Insights+into+Structural+Features+Contributing+to+Dopamine+D3+versus+D2+Receptor+Subtype+Selectivity&doi=10.1021%2Fjm500801r"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1021%2Fjm500801r&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm500801r%26sid%3Dliteratum%253Aachs%26aulast%3DAnanthan%26aufirst%3DS.%26aulast%3DSaini%26aufirst%3DS.%2BK.%26aulast%3DZhou%26aufirst%3DG.%26aulast%3DHobrath%26aufirst%3DJ.%2BV.%26aulast%3DPadmalayam%26aufirst%3DI.%26aulast%3DZhai%26aufirst%3DL.%26aulast%3DBostwick%26aufirst%3DJ.%2BR.%26aulast%3DAntonio%26aufirst%3DT.%26aulast%3DReith%26aufirst%3DM.%2BE.%2BA.%26aulast%3DMcDowell%26aufirst%3DS.%26aulast%3DCho%26aufirst%3DE.%26aulast%3DMcAleer%26aufirst%3DL.%26aulast%3DTaylor%26aufirst%3DM.%26aulast%3DLuedtke%26aufirst%3DR.%2BR.%26atitle%3DDesign%252C%2520Synthesis%252C%2520and%2520Structure%25E2%2580%2593Activity%2520Relationship%2520Studies%2520of%2520a%2520Series%2520of%2520%255B4-%25284-Carboxamidobutyl%2529%255D-1-arylpiperazines%253A%2520Insights%2520into%2520Structural%2520Features%2520Contributing%2520to%2520Dopamine%2520D3%2520versus%2520D2%2520Receptor%2520Subtype%2520Selectivity%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26spage%3D7042%26epage%3D7060%26doi%3D10.1021%2Fjm500801r" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Michino, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Donthamsetti, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beuming, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Banala, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Duan, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roux, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Han, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Trinquet, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Newman, A. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Javitch, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shi, L.</span></span> <span> </span><span class="NLM_article-title">A Single Glycine in Extracellular Loop 1 Is the Critical Determinant for Pharmacological Specificity of Dopamine D2 and D3 Receptors</span>. <i>Mol. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>84</i></span>,  <span class="NLM_fpage">854</span>– <span class="NLM_lpage">864</span>, <span class="refDoi"> DOI: 10.1124/mol.113.087833</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00412&amp;key=10.1124%2Fmol.113.087833" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00412&amp;key=24061855" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00412&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhvVyitLvK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=84&publication_year=2013&pages=854-864&author=M.+Michinoauthor=P.+Donthamsettiauthor=T.+Beumingauthor=A.+Banalaauthor=L.+Duanauthor=T.+Rouxauthor=Y.+Hanauthor=E.+Trinquetauthor=A.+H.+Newmanauthor=J.+A.+Javitchauthor=L.+Shi&title=A+Single+Glycine+in+Extracellular+Loop+1+Is+the+Critical+Determinant+for+Pharmacological+Specificity+of+Dopamine+D2+and+D3+Receptors&doi=10.1124%2Fmol.113.087833"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">A single glycine in extracellular loop 1 is the critical determinant for pharmacological specificity of dopamine D2 and D3 receptors</span></div><div class="casAuthors">Michino, Mayako; Donthamsetti, Prashant; Beuming, Thijs; Banala, Ashwini; Duan, Lihua; Roux, Thomas; Han, Yang; Trinquet, Eric; Newman, Amy Hauck; Javitch, Jonathan A.; Shi, Lei</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Pharmacology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">84</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">854-864</span>CODEN:
                <span class="NLM_cas:coden">MOPMA3</span>;
        ISSN:<span class="NLM_cas:issn">1521-0111</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Subtype-selective agents for the dopamine D3 receptor (D3R) have been considered as potential medications for drug addiction and other neuropsychiatric disorders.  Medicinal chem. efforts have led to the discovery of 4-phenylpiperazine derivs. that are >100-fold selective for the dopamine D3 receptor over dopamine D2 receptor (D2R), despite high sequence identity (78% in the transmembrane domain).  Based on the recent crystal structure of D3R, we demonstrated that the 4-phenylpiperazine moiety in this class of D3R-selective compds. binds to the conserved orthosteric binding site, whereas the extended aryl amide moiety is oriented toward a divergent secondary binding pocket (SBP).  In an effort to further characterize mol. determinants of the selectivity of these compds., we modeled their binding modes in D3R and D2R by comparative ligand docking and mol. dynamics simulations.  We found that the aryl amide moiety in the SBP differentially induces conformational changes in transmembrane segment 2 and extracellular loop 1 (EL1), which amplify the divergence of the SBP in D3R and D2R.  Receptor chimera and site-directed mutagenesis studies were used to validate these binding modes and to identify a divergent glycine in EL1 as crit. to D3R over D2R subtype selectivity.  A better understanding of drug-dependent receptor conformations such as these is key to the rational design of compds. targeting a specific receptor among closely related homologs, and may also lead to discovery of novel chemotypes that exploit subtle differences in protein conformations.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpTHm99ZIZbabVg90H21EOLACvtfcHk0lgVOwxK1W5cuw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhvVyitLvK&md5=225a4cfc272ec9897eeb010dd551c3b9</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1124%2Fmol.113.087833&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fmol.113.087833%26sid%3Dliteratum%253Aachs%26aulast%3DMichino%26aufirst%3DM.%26aulast%3DDonthamsetti%26aufirst%3DP.%26aulast%3DBeuming%26aufirst%3DT.%26aulast%3DBanala%26aufirst%3DA.%26aulast%3DDuan%26aufirst%3DL.%26aulast%3DRoux%26aufirst%3DT.%26aulast%3DHan%26aufirst%3DY.%26aulast%3DTrinquet%26aufirst%3DE.%26aulast%3DNewman%26aufirst%3DA.%2BH.%26aulast%3DJavitch%26aufirst%3DJ.%2BA.%26aulast%3DShi%26aufirst%3DL.%26atitle%3DA%2520Single%2520Glycine%2520in%2520Extracellular%2520Loop%25201%2520Is%2520the%2520Critical%2520Determinant%2520for%2520Pharmacological%2520Specificity%2520of%2520Dopamine%2520D2%2520and%2520D3%2520Receptors%26jtitle%3DMol.%2520Pharmacol.%26date%3D2013%26volume%3D84%26spage%3D854%26epage%3D864%26doi%3D10.1124%2Fmol.113.087833" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lane, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Donthamsetti, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shonberg, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Draper-Joyce, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dentry, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Michino, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shi, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">López, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scammells, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Capuano, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sexton, P. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Javitch, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Christopoulos, A.</span></span> <span> </span><span class="NLM_article-title">A New Mechanism of Allostery in a G Protein–Coupled Receptor Dimer</span>. <i>Nat. Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">745</span>– <span class="NLM_lpage">752</span>, <span class="refDoi"> DOI: 10.1038/nchembio.1593</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00412&amp;key=10.1038%2Fnchembio.1593" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00412&amp;key=25108820" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00412&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhtlahurrL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2014&pages=745-752&author=J.+R.+Laneauthor=P.+Donthamsettiauthor=J.+Shonbergauthor=C.+J.+Draper-Joyceauthor=S.+Dentryauthor=M.+Michinoauthor=L.+Shiauthor=L.+L%C3%B3pezauthor=P.+J.+Scammellsauthor=B.+Capuanoauthor=P.+M.+Sextonauthor=J.+A.+Javitchauthor=A.+Christopoulos&title=A+New+Mechanism+of+Allostery+in+a+G+Protein%E2%80%93Coupled+Receptor+Dimer&doi=10.1038%2Fnchembio.1593"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">A new mechanism of allostery in a G protein-coupled receptor dimer</span></div><div class="casAuthors">Lane, J. Robert; Donthamsetti, Prashant; Shonberg, Jeremy; Draper-Joyce, Christopher J.; Dentry, Samuel; Michino, Mayako; Shi, Lei; Lopez, Laura; Scammells, Peter J.; Capuano, Ben; Sexton, Patrick M.; Javitch, Jonathan A.; Christopoulos, Arthur</div><div class="citationInfo"><span class="NLM_cas:title">Nature Chemical Biology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">745-752</span>CODEN:
                <span class="NLM_cas:coden">NCBABT</span>;
        ISSN:<span class="NLM_cas:issn">1552-4450</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">SB269652 is to our knowledge the first drug-like allosteric modulator of the dopamine D2 receptor (D2R), but it contains structural features assocd. with orthosteric D2R antagonists.  Using a functional complementation system to control the identity of individual protomers within a dimeric D2R complex, we converted the pharmacol. of the interaction between SB269652 and dopamine from allosteric to competitive by impairing ligand binding to one of the protomers, indicating that the allostery requires D2R dimers.  Addnl. expts. identified a 'bitopic' pose for SB269652 extending from the orthosteric site into a secondary pocket at the extracellular end of the transmembrane (TM) domain, involving TM2 and TM7.  Engagement of this secondary pocket was a requirement for the allosteric pharmacol. of SB269652.  This suggests a new mechanism whereby a bitopic ligand binds in an extended pose on one G protein-coupled receptor protomer to allosterically modulate the binding of a ligand to the orthosteric site of a second protomer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpBF9SXb0jATLVg90H21EOLACvtfcHk0lgVOwxK1W5cuw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhtlahurrL&md5=ececb5fc0e3e9b803807f700dc2c2cad</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1038%2Fnchembio.1593&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnchembio.1593%26sid%3Dliteratum%253Aachs%26aulast%3DLane%26aufirst%3DJ.%2BR.%26aulast%3DDonthamsetti%26aufirst%3DP.%26aulast%3DShonberg%26aufirst%3DJ.%26aulast%3DDraper-Joyce%26aufirst%3DC.%2BJ.%26aulast%3DDentry%26aufirst%3DS.%26aulast%3DMichino%26aufirst%3DM.%26aulast%3DShi%26aufirst%3DL.%26aulast%3DL%25C3%25B3pez%26aufirst%3DL.%26aulast%3DScammells%26aufirst%3DP.%2BJ.%26aulast%3DCapuano%26aufirst%3DB.%26aulast%3DSexton%26aufirst%3DP.%2BM.%26aulast%3DJavitch%26aufirst%3DJ.%2BA.%26aulast%3DChristopoulos%26aufirst%3DA.%26atitle%3DA%2520New%2520Mechanism%2520of%2520Allostery%2520in%2520a%2520G%2520Protein%25E2%2580%2593Coupled%2520Receptor%2520Dimer%26jtitle%3DNat.%2520Chem.%2520Biol.%26date%3D2014%26volume%3D10%26spage%3D745%26epage%3D752%26doi%3D10.1038%2Fnchembio.1593" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Silvano, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Millan, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">la Cour, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Han, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Duan, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Griffin, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luedtke, R. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aloisi, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rossi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zazzeroni, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Javitch, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maggio, R.</span></span> <span> </span><span class="NLM_article-title">The Tetrahydroisoquinoline Derivative SB269,652 Is an Allosteric Antagonist at Dopamine D3 and D2 Receptors</span>. <i>Mol. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>78</i></span>,  <span class="NLM_fpage">925</span>– <span class="NLM_lpage">934</span>, <span class="refDoi"> DOI: 10.1124/mol.110.065755</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00412&amp;key=10.1124%2Fmol.110.065755" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00412&amp;key=20702763" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00412&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhsVajs7zP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=78&publication_year=2010&pages=925-934&author=E.+Silvanoauthor=M.+J.+Millanauthor=C.+M.+la+Courauthor=Y.+Hanauthor=L.+Duanauthor=S.+A.+Griffinauthor=R.+R.+Luedtkeauthor=G.+Aloisiauthor=M.+Rossiauthor=F.+Zazzeroniauthor=J.+A.+Javitchauthor=R.+Maggio&title=The+Tetrahydroisoquinoline+Derivative+SB269%2C652+Is+an+Allosteric+Antagonist+at+Dopamine+D3+and+D2+Receptors&doi=10.1124%2Fmol.110.065755"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">The tetrahydroisoquinoline derivative SB269,652 is an allosteric antagonist at dopamine D3 and D2 receptors</span></div><div class="casAuthors">Silvano, Elena; Millan, Mark J.; La Cour, Clotilde Mannoury; Han, Yang; Duan, Lihua; Griffin, Suzy A.; Luedtke, Robert R.; Aloisi, Gabriella; Rossi, Mario; Zazzeroni, Francesca; Javitch, Jonathan A.; Maggio, Roberto</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Pharmacology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">78</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">925-934</span>CODEN:
                <span class="NLM_cas:coden">MOPMA3</span>;
        ISSN:<span class="NLM_cas:issn">0026-895X</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">In view of the therapeutic importance of dopamine D3 and D2 receptors, there remains considerable interest in novel ligands.  Herein, we show that the tetrahydroisoquinoline 1H-indole-2-carboxylic acid {4-[2-(cyano-3,4-dihydro-1H-isoquinolin-2-yl)-ethyl]-cyclohexyl}-amide (SB269,652) behaves as an atypical, allosteric antagonist at D3 and D2 receptors.  Accordingly, SB269,652 potently (low nanomolar range) abolished specific binding of [3H]nemanopride and [3H]spiperone to Chinese hamster ovary-transfected D3 receptors when radioligands were used at 0.2 and 0.5 nM, resp.  However, even at high concns. (5 μM), SB269,652 only submaximally inhibited the specific binding of these radioligands when they were employed at 10-fold higher concns.  By analogy, although SB269,652 potently blocked D3 receptor-mediated activation of Gαi3 and phosphorylation of extracellular-signal-regulated kinase (ERK)1/2, when concns. of dopamine were increased by 10-fold, from 1 μM to 10 μM, SB269,652 only submaximally inhibited dopamine-induced stimulation of Gαi3.  SB269,652 (up to 10 μM) only weakly and partially (by approx. 20-30%) inhibited radioligand binding to D2 receptors.  Likewise, SB269,652 only submaximally suppressed D2 receptor-mediated stimulation of Gαi3 and Gαgi5 (detected with the aequorin assay) and phosphorylation of ERK1/2 and Akt.  Furthermore, SB269,652 only partially (35%) inhibited the dopamine-induced recruitment of β-arrestin2 to D2 receptors.  Finally, Schild anal. using Gαi3 assays, and studies of radioligand assocn. and dissocn. kinetics, supported allosteric actions of SB269,652 at D3 and D2 receptors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpxX6x9JWZ0VrVg90H21EOLACvtfcHk0li2XxEKiZBG7Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhsVajs7zP&md5=ab4b8119ecda7d1ad81b61ce9e5483c1</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1124%2Fmol.110.065755&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fmol.110.065755%26sid%3Dliteratum%253Aachs%26aulast%3DSilvano%26aufirst%3DE.%26aulast%3DMillan%26aufirst%3DM.%2BJ.%26aulast%3Dla%2BCour%26aufirst%3DC.%2BM.%26aulast%3DHan%26aufirst%3DY.%26aulast%3DDuan%26aufirst%3DL.%26aulast%3DGriffin%26aufirst%3DS.%2BA.%26aulast%3DLuedtke%26aufirst%3DR.%2BR.%26aulast%3DAloisi%26aufirst%3DG.%26aulast%3DRossi%26aufirst%3DM.%26aulast%3DZazzeroni%26aufirst%3DF.%26aulast%3DJavitch%26aufirst%3DJ.%2BA.%26aulast%3DMaggio%26aufirst%3DR.%26atitle%3DThe%2520Tetrahydroisoquinoline%2520Derivative%2520SB269%252C652%2520Is%2520an%2520Allosteric%2520Antagonist%2520at%2520Dopamine%2520D3%2520and%2520D2%2520Receptors%26jtitle%3DMol.%2520Pharmacol.%26date%3D2010%26volume%3D78%26spage%3D925%26epage%3D934%26doi%3D10.1124%2Fmol.110.065755" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Christopoulos, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kenakin, T.</span></span> <span> </span><span class="NLM_article-title">G Protein-Coupled Receptor Allosterism and Complexing</span>. <i>Pharmacol. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>54</i></span>,  <span class="NLM_fpage">323</span>– <span class="NLM_lpage">374</span>, <span class="refDoi"> DOI: 10.1124/pr.54.2.323</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00412&amp;key=10.1124%2Fpr.54.2.323" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00412&amp;key=12037145" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00412&amp;key=1%3ACAS%3A528%3ADC%252BD38XltVOhsrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2002&pages=323-374&author=A.+Christopoulosauthor=T.+Kenakin&title=G+Protein-Coupled+Receptor+Allosterism+and+Complexing&doi=10.1124%2Fpr.54.2.323"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">G protein-coupled receptor allosterism and complexing</span></div><div class="casAuthors">Christopoulos, Arthur; Kenakin, Terry</div><div class="citationInfo"><span class="NLM_cas:title">Pharmacological Reviews</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">323-374</span>CODEN:
                <span class="NLM_cas:coden">PAREAQ</span>;
        ISSN:<span class="NLM_cas:issn">0031-6997</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">A review.  G protein-coupled receptors (GPCRs) represent the largest family of cell-surface receptors.  These receptors are natural allosteric proteins because agonist-mediated signaling by GPCRs requires a conformational change in the receptor protein transmitted between two topog. distinct binding sites, one for the agonist and another for the G protein.  It is now becoming increasingly recognized, however, that the agonist-bound GPCR can also form ternary complexes with other ligands or "accessory" proteins and display altered binding and/or signaling properties in relation to the binary agonist-receptor complex.  Allosteric sites on GPCRs represent novel drug targets because allosteric modulators possess a no. of theor. advantages over classic orthosteric ligands, such as a ceiling level to the allosteric effect and a potential for greater GPCR subtype-selectivity.  Because of the noncompetitive nature of allosteric phenomena, the detection and quantification of such effects often relies on a combination of equil. binding, nonequil. kinetic, and functional signaling assays.  This review discusses the development and properties of allosteric receptor models for GPCRs and the detection and quantification of allosteric effects.  Moreover, we provide an overview of the current knowledge regarding,the location of possible allosteric sites on GPCRs and candidate endogenous allosteric modulators.  Finally, we discuss the potential for allosteric effects arising from the formation of GPCR oligomers or GPCRs complexed with accessory cellular proteins.  It is proposed that the study of allosteric phenomena will become of progressively, greater import to the drug discovery process due to the advent of newer and more sensitive GPCR screening-technologies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrnSA5pRRWTILVg90H21EOLACvtfcHk0li2XxEKiZBG7Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XltVOhsrs%253D&md5=6c4895bf66778eda4778ac409c7abb70</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1124%2Fpr.54.2.323&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fpr.54.2.323%26sid%3Dliteratum%253Aachs%26aulast%3DChristopoulos%26aufirst%3DA.%26aulast%3DKenakin%26aufirst%3DT.%26atitle%3DG%2520Protein-Coupled%2520Receptor%2520Allosterism%2520and%2520Complexing%26jtitle%3DPharmacol.%2520Rev.%26date%3D2002%26volume%3D54%26spage%3D323%26epage%3D374%26doi%3D10.1124%2Fpr.54.2.323" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gerald, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Friedrich, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Elisabeth, K.</span></span> <span> </span><span class="NLM_article-title">Construction of Antagonist Dose-Response Curves for Estimation of pA2-Values by Schild-Plot Analysis and Detection of Allosteric Interactions</span>. <i>Br. J. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">1992</span>,  <span class="NLM_volume"><i>106</i></span>,  <span class="NLM_fpage">710</span>– <span class="NLM_lpage">716</span>, <span class="refDoi"> DOI: 10.1111/j.1476-5381.1992.tb14399.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00412&amp;key=10.1111%2Fj.1476-5381.1992.tb14399.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00412&amp;key=1504755" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=106&publication_year=1992&pages=710-716&author=P.+Geraldauthor=B.+Friedrichauthor=K.+Elisabeth&title=Construction+of+Antagonist+Dose-Response+Curves+for+Estimation+of+pA2-Values+by+Schild-Plot+Analysis+and+Detection+of+Allosteric+Interactions&doi=10.1111%2Fj.1476-5381.1992.tb14399.x"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1111%2Fj.1476-5381.1992.tb14399.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1476-5381.1992.tb14399.x%26sid%3Dliteratum%253Aachs%26aulast%3DGerald%26aufirst%3DP.%26aulast%3DFriedrich%26aufirst%3DB.%26aulast%3DElisabeth%26aufirst%3DK.%26atitle%3DConstruction%2520of%2520Antagonist%2520Dose-Response%2520Curves%2520for%2520Estimation%2520of%2520pA2-Values%2520by%2520Schild-Plot%2520Analysis%2520and%2520Detection%2520of%2520Allosteric%2520Interactions%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D1992%26volume%3D106%26spage%3D710%26epage%3D716%26doi%3D10.1111%2Fj.1476-5381.1992.tb14399.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kumar, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moritz, A. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Keck, T. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bonifazi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ellenberger, M. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sibley, C. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Free, R. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shi, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lane, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sibley, D. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Newman, A. H.</span></span> <span> </span><span class="NLM_article-title">Synthesis and Pharmacological Characterization of Novel trans-Cyclopropylmethyl-Linked Bivalent Ligands That Exhibit Selectivity and Allosteric Pharmacology at the Dopamine D3 Receptor (D3R)</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>60</i></span>,  <span class="NLM_fpage">1478</span>– <span class="NLM_lpage">1494</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.6b01688</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.6b01688" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00412&amp;key=1%3ACAS%3A528%3ADC%252BC2sXitlyhsLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2017&pages=1478-1494&author=V.+Kumarauthor=A.+E.+Moritzauthor=T.+M.+Keckauthor=A.+Bonifaziauthor=M.+P.+Ellenbergerauthor=C.+D.+Sibleyauthor=R.+B.+Freeauthor=L.+Shiauthor=J.+R.+Laneauthor=D.+R.+Sibleyauthor=A.+H.+Newman&title=Synthesis+and+Pharmacological+Characterization+of+Novel+trans-Cyclopropylmethyl-Linked+Bivalent+Ligands+That+Exhibit+Selectivity+and+Allosteric+Pharmacology+at+the+Dopamine+D3+Receptor+%28D3R%29&doi=10.1021%2Facs.jmedchem.6b01688"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and Pharmacological Characterization of Novel trans-Cyclopropylmethyl-Linked Bivalent Ligands That Exhibit Selectivity and Allosteric Pharmacology at the Dopamine D3 Receptor (D3R)</span></div><div class="casAuthors">Kumar, Vivek; Moritz, Amy E.; Keck, Thomas M.; Bonifazi, Alessandro; Ellenberger, Michael P.; Sibley, Christopher D.; Free, R. Benjamin; Shi, Lei; Lane, J. Robert; Sibley, David R.; Newman, Amy Hauck</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1478-1494</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The development of bitopic ligands directed toward D2-like receptors has proven to be of particular interest to improve the selectivity and/or affinity of these ligands and as an approach to modulate and bias their efficacies.  The structural similarities between dopamine D3 receptor (D3R)-selective mols. that display bitopic or allosteric pharmacol. and those that are simply competitive antagonists are subtle and intriguing.  Herein the authors synthesized a series of mols. in which the primary and secondary pharmacophores were derived from the D3R-selective antagonists SB269,652 and SB277011A whose structural similarity and pharmacol. disparity provided the perfect templates for SAR investigation.  Incorporating a trans-cyclopropylmethyl linker between pharmacophores and manipulating linker length resulted in the identification of two bivalent noncompetitive D3R-selective antagonists, I and II, which further delineates SAR assocd. with allosterism at D3R and provides leads toward novel drug development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo_PUM_XBYBsLVg90H21EOLACvtfcHk0lip4U1LLqAVXw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXitlyhsLs%253D&md5=de385d8d9699e2d37a56974382989a19</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.6b01688&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.6b01688%26sid%3Dliteratum%253Aachs%26aulast%3DKumar%26aufirst%3DV.%26aulast%3DMoritz%26aufirst%3DA.%2BE.%26aulast%3DKeck%26aufirst%3DT.%2BM.%26aulast%3DBonifazi%26aufirst%3DA.%26aulast%3DEllenberger%26aufirst%3DM.%2BP.%26aulast%3DSibley%26aufirst%3DC.%2BD.%26aulast%3DFree%26aufirst%3DR.%2BB.%26aulast%3DShi%26aufirst%3DL.%26aulast%3DLane%26aufirst%3DJ.%2BR.%26aulast%3DSibley%26aufirst%3DD.%2BR.%26aulast%3DNewman%26aufirst%3DA.%2BH.%26atitle%3DSynthesis%2520and%2520Pharmacological%2520Characterization%2520of%2520Novel%2520trans-Cyclopropylmethyl-Linked%2520Bivalent%2520Ligands%2520That%2520Exhibit%2520Selectivity%2520and%2520Allosteric%2520Pharmacology%2520at%2520the%2520Dopamine%2520D3%2520Receptor%2520%2528D3R%2529%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2017%26volume%3D60%26spage%3D1478%26epage%3D1494%26doi%3D10.1021%2Facs.jmedchem.6b01688" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Shonberg, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Draper-Joyce, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mistry, S. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Christopoulos, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scammells, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lane, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Capuano, B.</span></span> <span> </span><span class="NLM_article-title">Structure–Activity Study of N-((trans)-4-(2-(7-Cyano-3,4-dihydroisoquinolin-2(1H)-yl)ethyl)cyclohexyl)-1<i>H</i>-indole-2-carboxamide (SB269652), a Bitopic Ligand That Acts as a Negative Allosteric Modulator of the Dopamine D2 Receptor</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>58</i></span>,  <span class="NLM_fpage">5287</span>– <span class="NLM_lpage">5307</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.5b00581</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.5b00581" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2015&pages=5287-5307&author=J.+Shonbergauthor=C.+Draper-Joyceauthor=S.+N.+Mistryauthor=A.+Christopoulosauthor=P.+J.+Scammellsauthor=J.+R.+Laneauthor=B.+Capuano&title=Structure%E2%80%93Activity+Study+of+N-%28%28trans%29-4-%282-%287-Cyano-3%2C4-dihydroisoquinolin-2%281H%29-yl%29ethyl%29cyclohexyl%29-1H-indole-2-carboxamide+%28SB269652%29%2C+a+Bitopic+Ligand+That+Acts+as+a+Negative+Allosteric+Modulator+of+the+Dopamine+D2+Receptor&doi=10.1021%2Facs.jmedchem.5b00581"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.5b00581&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.5b00581%26sid%3Dliteratum%253Aachs%26aulast%3DShonberg%26aufirst%3DJ.%26aulast%3DDraper-Joyce%26aufirst%3DC.%26aulast%3DMistry%26aufirst%3DS.%2BN.%26aulast%3DChristopoulos%26aufirst%3DA.%26aulast%3DScammells%26aufirst%3DP.%2BJ.%26aulast%3DLane%26aufirst%3DJ.%2BR.%26aulast%3DCapuano%26aufirst%3DB.%26atitle%3DStructure%25E2%2580%2593Activity%2520Study%2520of%2520N-%2528%2528trans%2529-4-%25282-%25287-Cyano-3%252C4-dihydroisoquinolin-2%25281H%2529-yl%2529ethyl%2529cyclohexyl%2529-1H-indole-2-carboxamide%2520%2528SB269652%2529%252C%2520a%2520Bitopic%2520Ligand%2520That%2520Acts%2520as%2520a%2520Negative%2520Allosteric%2520Modulator%2520of%2520the%2520Dopamine%2520D2%2520Receptor%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2015%26volume%3D58%26spage%3D5287%26epage%3D5307%26doi%3D10.1021%2Facs.jmedchem.5b00581" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-cit34"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mistry, S. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shonberg, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Draper-Joyce, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Klein Herenbrink, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Michino, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shi, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Christopoulos, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Capuano, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scammells, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lane, J. R.</span></span> <span> </span><span class="NLM_article-title">Discovery of a Novel Class of Negative Allosteric Modulator of the Dopamine D2 Receptor Through Fragmentation of a Bitopic Ligand</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>58</i></span>,  <span class="NLM_fpage">6819</span>– <span class="NLM_lpage">6843</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.5b00585</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.5b00585" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00412&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhtlSmtrjI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2015&pages=6819-6843&author=S.+N.+Mistryauthor=J.+Shonbergauthor=C.+J.+Draper-Joyceauthor=C.+Klein+Herenbrinkauthor=M.+Michinoauthor=L.+Shiauthor=A.+Christopoulosauthor=B.+Capuanoauthor=P.+J.+Scammellsauthor=J.+R.+Lane&title=Discovery+of+a+Novel+Class+of+Negative+Allosteric+Modulator+of+the+Dopamine+D2+Receptor+Through+Fragmentation+of+a+Bitopic+Ligand&doi=10.1021%2Facs.jmedchem.5b00585"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of a Novel Class of Negative Allosteric Modulator of the Dopamine D2 Receptor Through Fragmentation of a Bitopic Ligand</span></div><div class="casAuthors">Mistry, Shailesh N.; Shonberg, Jeremy; Draper-Joyce, Christopher J.; Klein Herenbrink, Carmen; Michino, Mayako; Shi, Lei; Christopoulos, Arthur; Capuano, Ben; Scammells, Peter J.; Lane, J. Robert</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">6819-6843</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Recently, the authors have demonstrated that N-((trans)-4-(2-(7-cyano-3,4-dihydroisoquinolin-2(1H)-yl)ethyl)cyclohexyl)-1H-indole-2-carboxamide (SB269652) (I) adopts a bitopic pose at one protomer of a dopamine D2 receptor (D2R) dimer to neg. modulate the binding of dopamine at the other protomer.  The 1H-indole-2-carboxamide moiety of I extends into a secondary pocket between the extracellular ends of TM2 and TM7 within the D2R protomer.  To target this putative allosteric site, the authors generated and characterized fragments that include and extend from the 1H-indole-2-carboxamide moiety of I.  N-Isopropyl-1H-indole-2-carboxamide (II) displayed allosteric pharmacol. and sensitivity to mutations of the same residues at the top of TM2 as was obsd. for I.  Using II as an "allosteric lead", the authors designed and synthesized an extensive fragment library to generate novel SAR and identify N-butyl-1H-indole-2-carboxamide, which displayed both increased neg. cooperativity and affinity for the D2R.  These data illustrate that fragmentation of extended compds. can expose fragments with purely allosteric pharmacol.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrEvPMqz8_m3bVg90H21EOLACvtfcHk0liM3V96FX5t0A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtlSmtrjI&md5=75991ee65b79a0131ca2e8a615694369</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.5b00585&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.5b00585%26sid%3Dliteratum%253Aachs%26aulast%3DMistry%26aufirst%3DS.%2BN.%26aulast%3DShonberg%26aufirst%3DJ.%26aulast%3DDraper-Joyce%26aufirst%3DC.%2BJ.%26aulast%3DKlein%2BHerenbrink%26aufirst%3DC.%26aulast%3DMichino%26aufirst%3DM.%26aulast%3DShi%26aufirst%3DL.%26aulast%3DChristopoulos%26aufirst%3DA.%26aulast%3DCapuano%26aufirst%3DB.%26aulast%3DScammells%26aufirst%3DP.%2BJ.%26aulast%3DLane%26aufirst%3DJ.%2BR.%26atitle%3DDiscovery%2520of%2520a%2520Novel%2520Class%2520of%2520Negative%2520Allosteric%2520Modulator%2520of%2520the%2520Dopamine%2520D2%2520Receptor%2520Through%2520Fragmentation%2520of%2520a%2520Bitopic%2520Ligand%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2015%26volume%3D58%26spage%3D6819%26epage%3D6843%26doi%3D10.1021%2Facs.jmedchem.5b00585" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref35"><div class="reference"><strong class="refLabel"><a href="#ref35" class="rightTabRefNumLink">35</a></strong><div class="NLM_citation" id="rightTab-cit35"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kroeze, W. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sassano, M. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, X.-P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lansu, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McCorvy, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Giguère, P. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sciaky, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roth, B. L.</span></span> <span> </span><span class="NLM_article-title">PRESTO-Tango as an Open-Source Resource for Interrogation of the Druggable Human GPCRome</span>. <i>Nat. Struct. Mol. Biol</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>22</i></span>, <span class="NLM_elocation-id">362</span> <span class="refDoi"> DOI: 10.1038/nsmb.3014</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00412&amp;key=10.1038%2Fnsmb.3014" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00412&amp;key=25895059" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00412&amp;key=1%3ACAS%3A528%3ADC%252BC2MXnslOgtLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2015&author=W.+K.+Kroezeauthor=M.+F.+Sassanoauthor=X.-P.+Huangauthor=K.+Lansuauthor=J.+D.+McCorvyauthor=P.+M.+Gigu%C3%A8reauthor=N.+Sciakyauthor=B.+L.+Roth&title=PRESTO-Tango+as+an+Open-Source+Resource+for+Interrogation+of+the+Druggable+Human+GPCRome&doi=10.1038%2Fnsmb.3014"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">PRESTO-Tango as an open-source resource for interrogation of the druggable human GPCRome</span></div><div class="casAuthors">Kroeze, Wesley K.; Sassano, Maria F.; Huang, Xi-Ping; Lansu, Katherine; McCorvy, John D.; Giguere, Patrick M.; Sciaky, Noah; Roth, Bryan L.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Structural & Molecular Biology</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">362-369</span>CODEN:
                <span class="NLM_cas:coden">NSMBCU</span>;
        ISSN:<span class="NLM_cas:issn">1545-9993</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">G protein-coupled receptors (GPCRs) are essential mediators of cellular signaling and are important targets of drug action.  Of the approx. 350 nonolfactory human GPCRs, more than 100 are still considered to be 'orphans' because their endogenous ligands remain unknown.  Here, we describe a unique open-source resource that allows interrogation of the druggable human GPCRome via a G protein-independent β-arrestin-recruitment assay.  We validate this unique platform at more than 120 nonorphan human GPCR targets, demonstrate its utility for discovering new ligands for orphan human GPCRs and describe a method (parallel receptorome expression and screening via transcriptional output, with transcriptional activation following arrestin translocation (PRESTO-Tango)) for the simultaneous and parallel interrogation of the entire human nonolfactory GPCRome.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoVbl7caV9gUrVg90H21EOLACvtfcHk0liM3V96FX5t0A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXnslOgtLg%253D&md5=2a78b74a5f1425fa9e8b79b730c16be6</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1038%2Fnsmb.3014&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnsmb.3014%26sid%3Dliteratum%253Aachs%26aulast%3DKroeze%26aufirst%3DW.%2BK.%26aulast%3DSassano%26aufirst%3DM.%2BF.%26aulast%3DHuang%26aufirst%3DX.-P.%26aulast%3DLansu%26aufirst%3DK.%26aulast%3DMcCorvy%26aufirst%3DJ.%2BD.%26aulast%3DGigu%25C3%25A8re%26aufirst%3DP.%2BM.%26aulast%3DSciaky%26aufirst%3DN.%26aulast%3DRoth%26aufirst%3DB.%2BL.%26atitle%3DPRESTO-Tango%2520as%2520an%2520Open-Source%2520Resource%2520for%2520Interrogation%2520of%2520the%2520Druggable%2520Human%2520GPCRome%26jtitle%3DNat.%2520Struct.%2520Mol.%2520Biol%26date%3D2015%26volume%3D22%26doi%3D10.1038%2Fnsmb.3014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref36"><div class="reference"><strong class="refLabel"><a href="#ref36" class="rightTabRefNumLink">36</a></strong><div class="NLM_citation" id="rightTab-cit36"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Besnard, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ruda, G. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Setola, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abecassis, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rodriguiz, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, X.-P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Norval, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sassano, M. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shin, A. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Webster, L. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Simeons, F. R. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stojanovski, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prat, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Seidah, N. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Constam, D. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bickerton, G. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Read, K. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wetsel, W. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gilbert, I. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roth, B. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hopkins, A. L.</span></span> <span> </span><span class="NLM_article-title">Automated Design of Ligands to Polypharmacological Profiles</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>492</i></span>, <span class="NLM_elocation-id">215</span> <span class="refDoi"> DOI: 10.1038/nature11691</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00412&amp;key=10.1038%2Fnature11691" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00412&amp;key=23235874" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00412&amp;key=1%3ACAS%3A528%3ADC%252BC38XhvVamurfN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=492&publication_year=2012&author=J.+Besnardauthor=G.+F.+Rudaauthor=V.+Setolaauthor=K.+Abecassisauthor=R.+M.+Rodriguizauthor=X.-P.+Huangauthor=S.+Norvalauthor=M.+F.+Sassanoauthor=A.+I.+Shinauthor=L.+A.+Websterauthor=F.+R.+C.+Simeonsauthor=L.+Stojanovskiauthor=A.+Pratauthor=N.+G.+Seidahauthor=D.+B.+Constamauthor=G.+R.+Bickertonauthor=K.+D.+Readauthor=W.+C.+Wetselauthor=I.+H.+Gilbertauthor=B.+L.+Rothauthor=A.+L.+Hopkins&title=Automated+Design+of+Ligands+to+Polypharmacological+Profiles&doi=10.1038%2Fnature11691"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">Automated design of ligands to polypharmacological profiles</span></div><div class="casAuthors">Besnard, Jeremy; Ruda, Gian Filippo; Setola, Vincent; Abecassis, Keren; Rodriguiz, Ramona M.; Huang, Xi-Ping; Norval, Suzanne; Sassano, Maria F.; Shin, Antony I.; Webster, Lauren A.; Simeons, Frederick R. C.; Stojanovski, Laste; Prat, Annik; Seidah, Nabil G.; Constam, Daniel B.; Bickerton, G. Richard; Read, Kevin D.; Wetsel, William C.; Gilbert, Ian H.; Roth, Bryan L.; Hopkins, Andrew L.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">492</span>
        (<span class="NLM_cas:issue">7428</span>),
    <span class="NLM_cas:pages">215-220</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The clin. efficacy and safety of a drug is detd. by its activity profile across many proteins in the proteome.  However, designing drugs with a specific multi-target profile is both complex and difficult.  Therefore methods to design drugs rationally a priori against profiles of several proteins would have immense value in drug discovery.  Here is described a new approach for the automated design of ligands against profiles of multiple drug targets.  The method is demonstrated by the evolution of an approved acetylcholinesterase inhibitor drug donepezil (I) into brain-penetrable ligands with either specific polypharmacol. or exquisite selectivity profiles for G-protein-coupled receptors.  Overall, 800 ligand-target predictions of prospectively designed ligands were tested exptl., of which 75% were confirmed to be correct.  Target engagement in vivo is also demonstrated.  The approach can be a useful source of drug leads when multi-target profiles are required to achieve either selectivity over other drug targets or a desired polypharmacol.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqNu5bwrBD3tbVg90H21EOLACvtfcHk0lhYMllerru6Ag"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhvVamurfN&md5=ace6cced250cf968d327b482a5bf1798</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1038%2Fnature11691&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature11691%26sid%3Dliteratum%253Aachs%26aulast%3DBesnard%26aufirst%3DJ.%26aulast%3DRuda%26aufirst%3DG.%2BF.%26aulast%3DSetola%26aufirst%3DV.%26aulast%3DAbecassis%26aufirst%3DK.%26aulast%3DRodriguiz%26aufirst%3DR.%2BM.%26aulast%3DHuang%26aufirst%3DX.-P.%26aulast%3DNorval%26aufirst%3DS.%26aulast%3DSassano%26aufirst%3DM.%2BF.%26aulast%3DShin%26aufirst%3DA.%2BI.%26aulast%3DWebster%26aufirst%3DL.%2BA.%26aulast%3DSimeons%26aufirst%3DF.%2BR.%2BC.%26aulast%3DStojanovski%26aufirst%3DL.%26aulast%3DPrat%26aufirst%3DA.%26aulast%3DSeidah%26aufirst%3DN.%2BG.%26aulast%3DConstam%26aufirst%3DD.%2BB.%26aulast%3DBickerton%26aufirst%3DG.%2BR.%26aulast%3DRead%26aufirst%3DK.%2BD.%26aulast%3DWetsel%26aufirst%3DW.%2BC.%26aulast%3DGilbert%26aufirst%3DI.%2BH.%26aulast%3DRoth%26aufirst%3DB.%2BL.%26aulast%3DHopkins%26aufirst%3DA.%2BL.%26atitle%3DAutomated%2520Design%2520of%2520Ligands%2520to%2520Polypharmacological%2520Profiles%26jtitle%3DNature%26date%3D2012%26volume%3D492%26doi%3D10.1038%2Fnature11691" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref37"><div class="reference"><strong class="refLabel"><a href="#ref37" class="rightTabRefNumLink">37</a></strong><div class="NLM_citation" id="rightTab-cit37"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Luedtke, R. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Freeman, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boundy, V. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martin, M. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mach, R. H.</span></span> <span> </span><span class="NLM_article-title">Characterization of 125I-IABN, A Novel Azabicyclononane Benzamide Selective for D2-Like Dopamine Receptors</span>. <i>Synapse</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>38</i></span>,  <span class="NLM_fpage">438</span>– <span class="NLM_lpage">449</span>, <span class="refDoi"> DOI: 10.1002/1098-2396(20001215)38:4<438::AID-SYN9>3.0.CO;2-5</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00412&amp;key=10.1002%2F1098-2396%2820001215%2938%3A4%3C438%3A%3AAID-SYN9%3E3.0.CO%3B2-5" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=38&publication_year=2000&pages=438-449&author=R.+R.+Luedtkeauthor=R.+A.+Freemanauthor=V.+A.+Boundyauthor=M.+W.+Martinauthor=Y.+Huangauthor=R.+H.+Mach&title=Characterization+of+125I-IABN%2C+A+Novel+Azabicyclononane+Benzamide+Selective+for+D2-Like+Dopamine+Receptors&doi=10.1002%2F1098-2396%2820001215%2938%3A4%3C438%3A%3AAID-SYN9%3E3.0.CO%3B2-5"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1002%2F1098-2396%2820001215%2938%3A4%3C438%3A%3AAID-SYN9%3E3.0.CO%3B2-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252F1098-2396%252820001215%252938%253A4%253C438%253A%253AAID-SYN9%253E3.0.CO%253B2-5%26sid%3Dliteratum%253Aachs%26aulast%3DLuedtke%26aufirst%3DR.%2BR.%26aulast%3DFreeman%26aufirst%3DR.%2BA.%26aulast%3DBoundy%26aufirst%3DV.%2BA.%26aulast%3DMartin%26aufirst%3DM.%2BW.%26aulast%3DHuang%26aufirst%3DY.%26aulast%3DMach%26aufirst%3DR.%2BH.%26atitle%3DCharacterization%2520of%2520125I-IABN%252C%2520A%2520Novel%2520Azabicyclononane%2520Benzamide%2520Selective%2520for%2520D2-Like%2520Dopamine%2520Receptors%26jtitle%3DSynapse%26date%3D2000%26volume%3D38%26spage%3D438%26epage%3D449%26doi%3D10.1002%2F1098-2396%2820001215%2938%3A4%3C438%3A%3AAID-SYN9%3E3.0.CO%3B2-5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref38"><div class="reference"><strong class="refLabel"><a href="#ref38" class="rightTabRefNumLink">38</a></strong><div class="NLM_citation" id="rightTab-cit38"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Baker, J. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hill, S. J.</span></span> <span> </span><span class="NLM_article-title">Multiple GPCR conformations and signalling pathways: implications for antagonist affinity estimates</span>. <i>Trends Pharmacol. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>28</i></span>,  <span class="NLM_fpage">374</span>– <span class="NLM_lpage">381</span>, <span class="refDoi"> DOI: 10.1016/j.tips.2007.06.011</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00412&amp;key=10.1016%2Fj.tips.2007.06.011" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00412&amp;key=17629959" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00412&amp;key=1%3ACAS%3A528%3ADC%252BD2sXotlWltLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=2007&pages=374-381&author=J.+G.+Bakerauthor=S.+J.+Hill&title=Multiple+GPCR+conformations+and+signalling+pathways%3A+implications+for+antagonist+affinity+estimates&doi=10.1016%2Fj.tips.2007.06.011"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">Multiple GPCR conformations and signaling pathways: implications for antagonist affinity estimates</span></div><div class="casAuthors">Baker, Jillian G.; Hill, Stephen J.</div><div class="citationInfo"><span class="NLM_cas:title">Trends in Pharmacological Sciences</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">28</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">374-381</span>CODEN:
                <span class="NLM_cas:coden">TPHSDY</span>;
        ISSN:<span class="NLM_cas:issn">0165-6147</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Antagonist affinity measurements have traditionally been considered important in characterizing the cell-surface receptors present in a particular cell or tissue.  A central assumption has been that antagonist affinity is const. for a given receptor-antagonist interaction, regardless of the agonist used to stimulate that receptor or the downstream response that is measured.  As a consequence, changes in antagonist affinity values have been taken as initial evidence for the presence of novel receptor subtypes.  Emerging evidence suggests, however, that receptors can possess multiple binding sites and the same receptor can show different antagonist affinity measurements under distinct exptl. conditions.  Here, we discuss several mechanisms by which antagonists have different affinities for the same receptor as a consequence of allosterism, coupling to different G proteins, multiple (but non-interacting) receptor sites, and signal-pathway-dependent pharmacol. (where the pharmacol. obsd. varies depending on the signaling pathway measured).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrcWqdG7J1LyLVg90H21EOLACvtfcHk0lhYMllerru6Ag"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXotlWltLo%253D&md5=ac0bbf5922dd08316f502a3e981b2444</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1016%2Fj.tips.2007.06.011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.tips.2007.06.011%26sid%3Dliteratum%253Aachs%26aulast%3DBaker%26aufirst%3DJ.%2BG.%26aulast%3DHill%26aufirst%3DS.%2BJ.%26atitle%3DMultiple%2520GPCR%2520conformations%2520and%2520signalling%2520pathways%253A%2520implications%2520for%2520antagonist%2520affinity%2520estimates%26jtitle%3DTrends%2520Pharmacol.%2520Sci.%26date%3D2007%26volume%3D28%26spage%3D374%26epage%3D381%26doi%3D10.1016%2Fj.tips.2007.06.011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref39"><div class="reference"><strong class="refLabel"><a href="#ref39" class="rightTabRefNumLink">39</a></strong><div class="NLM_citation" id="rightTab-cit39"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Boateng, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bakare, O. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhan, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Banala, A. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burzynski, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pommier, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Keck, T. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Donthamsetti, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Javitch, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rais, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Slusher, B. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xi, Z.-X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Newman, A. H.</span></span> <span> </span><span class="NLM_article-title">High Affinity Dopamine D3 Receptor (D3R)-Selective Antagonists Attenuate Heroin Self-Administration in Wild-Type but not D3R Knockout Mice</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>58</i></span>,  <span class="NLM_fpage">6195</span>– <span class="NLM_lpage">6213</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.5b00776</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.5b00776" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00412&amp;key=1%3ACAS%3A528%3ADC%252BC2MXht1alur%252FK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2015&pages=6195-6213&author=C.+A.+Boatengauthor=O.+M.+Bakareauthor=J.+Zhanauthor=A.+K.+Banalaauthor=C.+Burzynskiauthor=E.+Pommierauthor=T.+M.+Keckauthor=P.+Donthamsettiauthor=J.+A.+Javitchauthor=R.+Raisauthor=B.+S.+Slusherauthor=Z.-X.+Xiauthor=A.+H.+Newman&title=High+Affinity+Dopamine+D3+Receptor+%28D3R%29-Selective+Antagonists+Attenuate+Heroin+Self-Administration+in+Wild-Type+but+not+D3R+Knockout+Mice&doi=10.1021%2Facs.jmedchem.5b00776"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">High Affinity Dopamine D3 Receptor (D3R)-Selective Antagonists Attenuate Heroin Self-Administration in Wild-Type but not D3R Knockout Mice</span></div><div class="casAuthors">Boateng, Comfort A.; Bakare, Oluyomi M.; Zhan, Jia; Banala, Ashwini K.; Burzynski, Caitlin; Pommier, Elie; Keck, Thomas M.; Donthamsetti, Prashant; Javitch, Jonathan A.; Rais, Rana; Slusher, Barbara S.; Xi, Zheng-Xiong; Newman, Amy Hauck</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">6195-6213</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The dopamine D3 receptor (D3R) is a promising target for the development of pharmacotherapeutics to treat substance use disorders.  Several D3R-selective antagonists are effective in animal models of drug abuse, esp. in models of relapse.  Nevertheless, poor bioavailability, metabolic instability, and/or predicted toxicity have impeded success in translating these drug candidates to clin. use.  Herein, the authors report a series of D3R-selective 4-phenylpiperazines with improved metabolic stability.  A subset of these compds. was evaluated for D3R functional efficacy and off-target binding at selected 5-HT receptor subtypes, where significant overlap in SAR with D3R has been obsd.  Several high affinity D3R antagonists, including compds. I (Ki = 0.12 nM) and II (Ki = 0.35 nM), showed improved metabolic stability compared to the parent compd., PG648.  Notably, I and the classic D3R antagonist SB277011A were effective in reducing self-administration of heroin in wild-type but not D3R knockout mice.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoagzWQU_gPV7Vg90H21EOLACvtfcHk0lj7Y2BRHzEUSA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXht1alur%252FK&md5=1724065cac8ac51295cf4660a20ed734</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.5b00776&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.5b00776%26sid%3Dliteratum%253Aachs%26aulast%3DBoateng%26aufirst%3DC.%2BA.%26aulast%3DBakare%26aufirst%3DO.%2BM.%26aulast%3DZhan%26aufirst%3DJ.%26aulast%3DBanala%26aufirst%3DA.%2BK.%26aulast%3DBurzynski%26aufirst%3DC.%26aulast%3DPommier%26aufirst%3DE.%26aulast%3DKeck%26aufirst%3DT.%2BM.%26aulast%3DDonthamsetti%26aufirst%3DP.%26aulast%3DJavitch%26aufirst%3DJ.%2BA.%26aulast%3DRais%26aufirst%3DR.%26aulast%3DSlusher%26aufirst%3DB.%2BS.%26aulast%3DXi%26aufirst%3DZ.-X.%26aulast%3DNewman%26aufirst%3DA.%2BH.%26atitle%3DHigh%2520Affinity%2520Dopamine%2520D3%2520Receptor%2520%2528D3R%2529-Selective%2520Antagonists%2520Attenuate%2520Heroin%2520Self-Administration%2520in%2520Wild-Type%2520but%2520not%2520D3R%2520Knockout%2520Mice%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2015%26volume%3D58%26spage%3D6195%26epage%3D6213%26doi%3D10.1021%2Facs.jmedchem.5b00776" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref40"><div class="reference"><strong class="refLabel"><a href="#ref40" class="rightTabRefNumLink">40</a></strong><div class="NLM_citation" id="rightTab-cit40"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mach, R. H.</span></span> <span> </span><span class="NLM_article-title">Small Molecule Receptor Ligands for PET Studies of the Central Nervous System—Focus on G Protein Coupled Receptors</span>. <i>Semin. Nucl. Med.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>47</i></span>,  <span class="NLM_fpage">524</span>– <span class="NLM_lpage">535</span>, <span class="refDoi"> DOI: 10.1053/j.semnuclmed.2017.05.002</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00412&amp;key=10.1053%2Fj.semnuclmed.2017.05.002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00412&amp;key=28826524" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00412&amp;key=1%3ACAS%3A280%3ADC%252BC1cbgt1Siuw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2017&pages=524-535&author=R.+H.+Mach&title=Small+Molecule+Receptor+Ligands+for+PET+Studies+of+the+Central+Nervous+System%E2%80%94Focus+on+G+Protein+Coupled+Receptors&doi=10.1053%2Fj.semnuclmed.2017.05.002"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">Small Molecule Receptor Ligands for PET Studies of the Central Nervous System-Focus on G Protein Coupled Receptors</span></div><div class="casAuthors">Mach Robert H</div><div class="citationInfo"><span class="NLM_cas:title">Seminars in nuclear medicine</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">47</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">524-535</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">G protein-coupled receptors (GPRCs) are a class of proteins that are expressed in high abundance and are responsible for numerous signal transduction pathways in the central nervous system.  Consequently, alterations in GPRC function have been associated with a wide variety of neurologic and neuropsychiatric disorders.  The development of PET probes for imaging GPRCs has served as a major emphasis of PET radiotracer development and PET imaging studies over the past 30 years.  In this review, a basic description of the biology of G proteins and GPRCs is provided.  This includes recent evidence of the existence of dimeric and multimeric species of GPRCs that have been termed "receptor mosaics," with an emphasis on the different GPRCs that form complexes with the dopamine D2 receptor.  An overview of the different PET radiotracers for imaging the component GPRC within these different multimeric complexes of the D2 receptor is also provided.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTaZEK7fnupmfx2phytoz6_fW6udTcc2eZB_VsCD7NCjrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC1cbgt1Siuw%253D%253D&md5=a863ca1c89efd2f16a6a18b8a6c14314</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1053%2Fj.semnuclmed.2017.05.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1053%252Fj.semnuclmed.2017.05.002%26sid%3Dliteratum%253Aachs%26aulast%3DMach%26aufirst%3DR.%2BH.%26atitle%3DSmall%2520Molecule%2520Receptor%2520Ligands%2520for%2520PET%2520Studies%2520of%2520the%2520Central%2520Nervous%2520System%25E2%2580%2594Focus%2520on%2520G%2520Protein%2520Coupled%2520Receptors%26jtitle%3DSemin.%2520Nucl.%2520Med.%26date%3D2017%26volume%3D47%26spage%3D524%26epage%3D535%26doi%3D10.1053%2Fj.semnuclmed.2017.05.002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref41"><div class="reference"><strong class="refLabel"><a href="#ref41" class="rightTabRefNumLink">41</a></strong><div class="NLM_citation" id="rightTab-cit41"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mach, R. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luedtke, R. R.</span></span> <span> </span><span class="NLM_article-title">Challenges in the Development of Dopamine D2- and D3-Selective Radiotracers for PET Imaging Studies</span>. <i>J. Labelled Compd. Radiopharm.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>61</i></span>,  <span class="NLM_fpage">291</span>– <span class="NLM_lpage">298</span>, <span class="refDoi"> DOI: 10.1002/jlcr.3558</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00412&amp;key=10.1002%2Fjlcr.3558" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00412&amp;key=28857231" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00412&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhsFOitbjN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2018&pages=291-298&author=R.+H.+Machauthor=R.+R.+Luedtke&title=Challenges+in+the+Development+of+Dopamine+D2-+and+D3-Selective+Radiotracers+for+PET+Imaging+Studies&doi=10.1002%2Fjlcr.3558"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">Challenges in the development of dopamine D2- and D3-selective radiotracers for PET imaging studies</span></div><div class="casAuthors">Mach, Robert H.; Luedtke, Robert R.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Labelled Compounds and Radiopharmaceuticals</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">61</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">291-298</span>CODEN:
                <span class="NLM_cas:coden">JLCRD4</span>;
        ISSN:<span class="NLM_cas:issn">0362-4803</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons Ltd.</span>)
        </div><div class="casAbstract">The dopamine D2-like receptors (ie, D2/3 receptors) have been the most extensively studied CNS receptor with Positron Emission Tomog. (PET).  The 3 different radiotracers that have been used in these studies are [11C]raclopride, [18F]fallypride, and [11C]PHNO.  Because these radiotracers have a high affinity for both dopamine D2 and D3 receptors, the d. of dopamine receptors in the CNS is reported as the D2/3 binding potential, which reflects a measure of the d. of both receptor subtypes.  Although the development of D2- and D3-selective PET radiotracers has been an active area of research for many years, this by and large presents an unmet need in the area of translational PET imaging studies.  This article discusses some of the challenges that have inhibited progress in this area of research and the current status of the development of subtype selective radiotracers for imaging D3 and D2 dopamine receptors with PET.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr8JZoIikHgU7Vg90H21EOLACvtfcHk0lg926bv6wMlbA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhsFOitbjN&md5=4158425b26582cc514b994c264c5da04</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1002%2Fjlcr.3558&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjlcr.3558%26sid%3Dliteratum%253Aachs%26aulast%3DMach%26aufirst%3DR.%2BH.%26aulast%3DLuedtke%26aufirst%3DR.%2BR.%26atitle%3DChallenges%2520in%2520the%2520Development%2520of%2520Dopamine%2520D2-%2520and%2520D3-Selective%2520Radiotracers%2520for%2520PET%2520Imaging%2520Studies%26jtitle%3DJ.%2520Labelled%2520Compd.%2520Radiopharm.%26date%3D2018%26volume%3D61%26spage%3D291%26epage%3D298%26doi%3D10.1002%2Fjlcr.3558" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref42"><div class="reference"><strong class="refLabel"><a href="#ref42" class="rightTabRefNumLink">42</a></strong><div class="NLM_citation" id="rightTab-cit42"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sóvágó, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Farde, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Halldin, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Langer, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Laszlovszky, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kiss, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gulyás, B.</span></span> <span> </span><span class="NLM_article-title">Positron Emission Tomographic Evaluation of the Putative Dopamine-D3 Receptor Ligand, [11C]RGH-1756 in the Monkey Brain</span>. <i>Neurochem. Int.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>45</i></span>,  <span class="NLM_fpage">609</span>– <span class="NLM_lpage">617</span>, <span class="refDoi"> DOI: 10.1016/j.neuint.2004.04.004</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00412&amp;key=10.1016%2Fj.neuint.2004.04.004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00412&amp;key=15234102" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00412&amp;key=1%3ACAS%3A528%3ADC%252BD2cXlsVartr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=2004&pages=609-617&author=J.+S%C3%B3v%C3%A1g%C3%B3author=L.+Fardeauthor=C.+Halldinauthor=O.+Langerauthor=I.+Laszlovszkyauthor=B.+Kissauthor=B.+Guly%C3%A1s&title=Positron+Emission+Tomographic+Evaluation+of+the+Putative+Dopamine-D3+Receptor+Ligand%2C+%5B11C%5DRGH-1756+in+the+Monkey+Brain&doi=10.1016%2Fj.neuint.2004.04.004"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit42R"><div class="casContent"><span class="casTitleNuber">42</span><div class="casTitle"><span class="NLM_cas:atitle">Positron emission tomographic evaluation of the putative dopamine-D3 receptor ligand, [11C]RGH-1756 in the monkey brain</span></div><div class="casAuthors">Sovago, Judit; Farde, Lars; Halldin, Christer; Langer, Oliver; Laszlovszky, Istvan; Kiss, Bela; Gulyas, Balazs</div><div class="citationInfo"><span class="NLM_cas:title">Neurochemistry International</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">45</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">609-617</span>CODEN:
                <span class="NLM_cas:coden">NEUIDS</span>;
        ISSN:<span class="NLM_cas:issn">0197-0186</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science B.V.</span>)
        </div><div class="casAbstract">The dopamine-D3 receptor is of special interest due to its postulated role in the pathophysiol. and treatment of schizophrenia and Parkinson's Disease.  Increasing evidences support the assumption that the D3 receptors are occupied to a high degree by dopamine at physiol. conditions.  Research on the functional role of the D3 receptors in brain has however been hampered by the lack of D3 selective ligands.  In the present Positron Emission Tomog. (PET) study the binding of the novel, putative dopamine-D3 receptor ligand, [11C]RGH-1756 was characterized in the cynomolgus monkey brain.  [11C]RGH-1756 was rather homogenously distributed in brain and the regional binding potential (BP) values ranged between 0.17 and 0.48.  Pretreatment with unlabeled RGH-1756 decreased radioligand binding to the level of the cerebellum in most brain areas.  The regional BP values were lower after i.v. injection of a higher mass of RGH-1756, indicating saturable binding of [11C]RGH-1756.  The D2/D3 antagonist raclopride partly inhibited the binding of [11C]RGH-1756 in several brain areas, including the striatum, mesencephalon and neocortex, whereas the 5HT1A antagonist WAY-100635 had no evident effect on [11C]RGH-1756 binding.  Despite the promising binding characteristics of RGH-1756 in vitro the present PET-study indicates that [11C]RGH-1756 provides a low signal for specific binding to the D3 receptor in vivo.  One explanation is that the favorable binding characteristics of RGH-1756 in vitro are not manifested in vivo.  Alternatively, the results may support the hypothesis that the dopamine-D3 receptors are indeed occupied to a high extent by dopamine in vivo and thus not available for radioligand binding.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp1rtfx7fQFvrVg90H21EOLACvtfcHk0lg926bv6wMlbA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXlsVartr0%253D&md5=79472e54e607a024844afc5d606fe210</span></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1016%2Fj.neuint.2004.04.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.neuint.2004.04.004%26sid%3Dliteratum%253Aachs%26aulast%3DS%25C3%25B3v%25C3%25A1g%25C3%25B3%26aufirst%3DJ.%26aulast%3DFarde%26aufirst%3DL.%26aulast%3DHalldin%26aufirst%3DC.%26aulast%3DLanger%26aufirst%3DO.%26aulast%3DLaszlovszky%26aufirst%3DI.%26aulast%3DKiss%26aufirst%3DB.%26aulast%3DGuly%25C3%25A1s%26aufirst%3DB.%26atitle%3DPositron%2520Emission%2520Tomographic%2520Evaluation%2520of%2520the%2520Putative%2520Dopamine-D3%2520Receptor%2520Ligand%252C%2520%255B11C%255DRGH-1756%2520in%2520the%2520Monkey%2520Brain%26jtitle%3DNeurochem.%2520Int.%26date%3D2004%26volume%3D45%26spage%3D609%26epage%3D617%26doi%3D10.1016%2Fj.neuint.2004.04.004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref43"><div class="reference"><strong class="refLabel"><a href="#ref43" class="rightTabRefNumLink">43</a></strong><div class="NLM_citation" id="rightTab-cit43"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kuhnast, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Valette, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Besret, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Demphel, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Coulon, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ottaviani, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guillermier, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bottlaender, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dollé, F.</span></span> <span> </span><span class="NLM_article-title">Synthesis and Radiolabeling of N-[4-[4-(2-[11C]Methoxyphenyl)piperazin-1-yl]butyl]benzo[b]thiophene-2-carboxamide — a Potential Radiotracer for D3 Receptor Imaging with PET</span>. <i>Nucl. Med. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>33</i></span>,  <span class="NLM_fpage">785</span>– <span class="NLM_lpage">795</span>, <span class="refDoi"> DOI: 10.1016/j.nucmedbio.2006.05.007</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00412&amp;key=10.1016%2Fj.nucmedbio.2006.05.007" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00412&amp;key=16934697" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00412&amp;key=1%3ACAS%3A528%3ADC%252BD28Xoslyqurs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=2006&pages=785-795&author=B.+Kuhnastauthor=H.+Valetteauthor=L.+Besretauthor=S.+Demphelauthor=C.+Coulonauthor=M.+Ottavianiauthor=M.+Guillermierauthor=M.+Bottlaenderauthor=F.+Doll%C3%A9&title=Synthesis+and+Radiolabeling+of+N-%5B4-%5B4-%282-%5B11C%5DMethoxyphenyl%29piperazin-1-yl%5Dbutyl%5Dbenzo%5Bb%5Dthiophene-2-carboxamide+%E2%80%94+a+Potential+Radiotracer+for+D3+Receptor+Imaging+with+PET&doi=10.1016%2Fj.nucmedbio.2006.05.007"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit43R"><div class="casContent"><span class="casTitleNuber">43</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and radiolabeling of N-[4-[4-(2-[11C]methoxyphenyl)piperazin-1-yl]butyl]benzo[b]thiophene-2-carboxamide - a potential radiotracer for D3 receptor imaging with PET</span></div><div class="casAuthors">Kuhnast, Bertrand; Valette, Heric; Besret, Laurent; Demphel, Stephane; Coulon, Christine; Ottaviani, Michele; Guillermier, Martine; Bottlaender, Michel; Dolle, Frederic</div><div class="citationInfo"><span class="NLM_cas:title">Nuclear Medicine and Biology</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">33</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">785-795</span>CODEN:
                <span class="NLM_cas:coden">NMBIEO</span>;
        ISSN:<span class="NLM_cas:issn">0969-8051</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">FAUC346 (N-[4-[4-(2-methoxyphenyl)piperazin-1-yl]butyl]benzo[b]thiophene-2-carboxamide),an in vitro D3-selective ligand, and its normethyl deriv. have been synthesized from com. available 1-(2-substituted-phenyl)piperazines.  FAUC346 has been labeled using [11C]methyl triflate in acetone contg. aq. NaOH (5 Equiv) at -10 °C for 1 min, purified on semipreparative reverse-phase high-performance liq. chromatog. (HPLC) and formulated as an i.v. injectable soln. using a Sep-Pak Plus C18 device.  Up to 5.5 GBq of [11C]FAUC346 (N-[4-[4-(2-[methyl-11C]methoxyphenyl)piperazin-1-yl]butyl]benzo[b]thiophene-2-carboxamide), with a specific radioactivity of 45-75 GBq/μmol, could be obtained in 30-35 min, including HPLC purifn. and formulation starting from 44.4 GBq of [11C]carbon dioxide.  Preliminary pharmacol. evaluation of [11C]FAUC346 in rat brain clearly demonstrated in vivo selectivity for D3 receptors and the absence of radiolabeled metabolite within the brain.  These encouraging results, however, could not be confirmed in nonhuman primates; therefore, this radioligand does not appear to have the required pharmacol. profile for a positron emission tomog. probe for imaging D3 receptors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrx0NTdR3DKMrVg90H21EOLACvtfcHk0liBI0m9H_TD0A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xoslyqurs%253D&md5=4f3a8d6fce9e174298570fa0a7dd8c11</span></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1016%2Fj.nucmedbio.2006.05.007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.nucmedbio.2006.05.007%26sid%3Dliteratum%253Aachs%26aulast%3DKuhnast%26aufirst%3DB.%26aulast%3DValette%26aufirst%3DH.%26aulast%3DBesret%26aufirst%3DL.%26aulast%3DDemphel%26aufirst%3DS.%26aulast%3DCoulon%26aufirst%3DC.%26aulast%3DOttaviani%26aufirst%3DM.%26aulast%3DGuillermier%26aufirst%3DM.%26aulast%3DBottlaender%26aufirst%3DM.%26aulast%3DDoll%25C3%25A9%26aufirst%3DF.%26atitle%3DSynthesis%2520and%2520Radiolabeling%2520of%2520N-%255B4-%255B4-%25282-%255B11C%255DMethoxyphenyl%2529piperazin-1-yl%255Dbutyl%255Dbenzo%255Bb%255Dthiophene-2-carboxamide%2520%25E2%2580%2594%2520a%2520Potential%2520Radiotracer%2520for%2520D3%2520Receptor%2520Imaging%2520with%2520PET%26jtitle%3DNucl.%2520Med.%2520Biol.%26date%3D2006%26volume%3D33%26spage%3D785%26epage%3D795%26doi%3D10.1016%2Fj.nucmedbio.2006.05.007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref44"><div class="reference"><strong class="refLabel"><a href="#ref44" class="rightTabRefNumLink">44</a></strong><div class="NLM_citation" id="rightTab-cit44"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Reid, J. L.</span></span> <span> </span><span class="NLM_article-title">Alpha-Adrenergic Receptors and Blood Pressure Control</span>. <i>Am. J. Cardiol.</i> <span class="NLM_year" style="font-weight: bold;">1986</span>,  <span class="NLM_volume"><i>57</i></span>,  <span class="NLM_fpage">E6</span>– <span class="NLM_lpage">E12</span>, <span class="refDoi"> DOI: 10.1016/0002-9149(86)90716-2</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00412&amp;key=10.1016%2F0002-9149%2886%2990716-2" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=1986&pages=E6-E12&author=J.+L.+Reid&title=Alpha-Adrenergic+Receptors+and+Blood+Pressure+Control&doi=10.1016%2F0002-9149%2886%2990716-2"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1016%2F0002-9149%2886%2990716-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0002-9149%252886%252990716-2%26sid%3Dliteratum%253Aachs%26aulast%3DReid%26aufirst%3DJ.%2BL.%26atitle%3DAlpha-Adrenergic%2520Receptors%2520and%2520Blood%2520Pressure%2520Control%26jtitle%3DAm.%2520J.%2520Cardiol.%26date%3D1986%26volume%3D57%26spage%3DE6%26epage%3DE12%26doi%3D10.1016%2F0002-9149%2886%2990716-2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref45"><div class="reference"><strong class="refLabel"><a href="#ref45" class="rightTabRefNumLink">45</a></strong><div class="NLM_citation" id="rightTab-cit45"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Newman, A. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grundt, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nader, M. A.</span></span> <span> </span><span class="NLM_article-title">Dopamine D3 Receptor Partial Agonists and Antagonists as Potential Drug Abuse Therapeutic Agents</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>48</i></span>,  <span class="NLM_fpage">3663</span>– <span class="NLM_lpage">3679</span>, <span class="refDoi"> DOI: 10.1021/jm040190e</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm040190e" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00412&amp;key=1%3ACAS%3A528%3ADC%252BD2MXjtl2nur0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2005&pages=3663-3679&author=A.+H.+Newmanauthor=P.+Grundtauthor=M.+A.+Nader&title=Dopamine+D3+Receptor+Partial+Agonists+and+Antagonists+as+Potential+Drug+Abuse+Therapeutic+Agents&doi=10.1021%2Fjm040190e"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit45R"><div class="casContent"><span class="casTitleNuber">45</span><div class="casTitle"><span class="NLM_cas:atitle">Dopamine D3 Receptor Partial Agonists and Antagonists as Potential Drug Abuse Therapeutic Agents</span></div><div class="casAuthors">Newman, Amy Hauck; Grundt, Peter; Nader, Michael A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">48</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">3663-3679</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  This report is limited to discussions of potential dopamine D3 receptor agents, currently being developed as medications for drug abuse and other neuropsychiatric disorders, to partial agonists and antagonists.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrqHXSFV83KfLVg90H21EOLACvtfcHk0liBI0m9H_TD0A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXjtl2nur0%253D&md5=4244539d9e8038e2027dba1e21497cdd</span></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1021%2Fjm040190e&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm040190e%26sid%3Dliteratum%253Aachs%26aulast%3DNewman%26aufirst%3DA.%2BH.%26aulast%3DGrundt%26aufirst%3DP.%26aulast%3DNader%26aufirst%3DM.%2BA.%26atitle%3DDopamine%2520D3%2520Receptor%2520Partial%2520Agonists%2520and%2520Antagonists%2520as%2520Potential%2520Drug%2520Abuse%2520Therapeutic%2520Agents%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2005%26volume%3D48%26spage%3D3663%26epage%3D3679%26doi%3D10.1021%2Fjm040190e" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref46"><div class="reference"><strong class="refLabel"><a href="#ref46" class="rightTabRefNumLink">46</a></strong><div class="NLM_citation" id="rightTab-cit46"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pilla, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perachon, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sautel, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garrido, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mann, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wermuth, C. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schwartz, J.-C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Everitt, B. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sokoloff, P.</span></span> <span> </span><span class="NLM_article-title">Selective Inhibition of Cocaine-Seeking Behaviour by a Partial Dopamine D3 Receptor Agonist</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">1999</span>,  <span class="NLM_volume"><i>400</i></span>,  <span class="NLM_fpage">371</span>– <span class="NLM_lpage">375</span>, <span class="refDoi"> DOI: 10.1038/22560</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00412&amp;key=10.1038%2F22560" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00412&amp;key=10432116" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00412&amp;key=1%3ACAS%3A528%3ADyaK1MXkvFOntr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=400&publication_year=1999&pages=371-375&author=M.+Pillaauthor=S.+Perachonauthor=F.+Sautelauthor=F.+Garridoauthor=A.+Mannauthor=C.+G.+Wermuthauthor=J.-C.+Schwartzauthor=B.+J.+Everittauthor=P.+Sokoloff&title=Selective+Inhibition+of+Cocaine-Seeking+Behaviour+by+a+Partial+Dopamine+D3+Receptor+Agonist&doi=10.1038%2F22560"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit46R"><div class="casContent"><span class="casTitleNuber">46</span><div class="casTitle"><span class="NLM_cas:atitle">Selective inhibition of cocaine-seeking behavior by a partial dopamine D3 receptor agonist</span></div><div class="casAuthors">Pilla, Maria; Perachon, Sylvie; Sautel, Francois; Garrido, Fabrice; Mann, Andre; Wermuth, Camille G.; Schwartz, Jean-Charles; Everitt, Barry J.; Sokoloff, Pierre</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London)</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">400</span>
        (<span class="NLM_cas:issue">6742</span>),
    <span class="NLM_cas:pages">371-375</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Macmillan Magazines</span>)
        </div><div class="casAbstract">Environmental stimuli that are reliably assocd. with the effects of many abused drugs, esp. stimulants such as cocaine, can produce craving and relapse in abstinent human substance abusers.  In animals, such cues can induce and maintain drug-seeking behavior and also reinstate drug-seeking after extinction.  Reducing the motivational effects of drug-related cues might therefore be useful in the treatment of addiction.  Converging pharmacol., human post-mortem and genetic studies implicate the dopamine D3 receptor in drug addiction.  Here we have designed BP 897, the first D3-receptor-selective agonist, as assessed in vitro with recombinant receptors and in vivo with mice bearing disrupted D3-receptor genes.  BP 897 is a partial agonist in vitro and acts in vivo as either an agonist or an antagonist.  We show that BP 897 inhibits cocaine-seeking behavior that depends upon the presentation of drug-assocd. cues, without having any intrinsic, primary rewarding effects.  Our data indicate that compds. like BP 897 could be used for reducing the drug craving and vulnerability to relapse that are elicited by drug-assocd. environmental stimuli.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp6SwJsmcTSCLVg90H21EOLACvtfcHk0lg3CoL4BVrc-g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXkvFOntr0%253D&md5=3f4055a4cd1b6cee7e890ff1b96b21b6</span></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1038%2F22560&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F22560%26sid%3Dliteratum%253Aachs%26aulast%3DPilla%26aufirst%3DM.%26aulast%3DPerachon%26aufirst%3DS.%26aulast%3DSautel%26aufirst%3DF.%26aulast%3DGarrido%26aufirst%3DF.%26aulast%3DMann%26aufirst%3DA.%26aulast%3DWermuth%26aufirst%3DC.%2BG.%26aulast%3DSchwartz%26aufirst%3DJ.-C.%26aulast%3DEveritt%26aufirst%3DB.%2BJ.%26aulast%3DSokoloff%26aufirst%3DP.%26atitle%3DSelective%2520Inhibition%2520of%2520Cocaine-Seeking%2520Behaviour%2520by%2520a%2520Partial%2520Dopamine%2520D3%2520Receptor%2520Agonist%26jtitle%3DNature%26date%3D1999%26volume%3D400%26spage%3D371%26epage%3D375%26doi%3D10.1038%2F22560" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref47"><div class="reference"><strong class="refLabel"><a href="#ref47" class="rightTabRefNumLink">47</a></strong><div class="NLM_citation" id="rightTab-cit47"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sánchez-Soto, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Casadó-Anguera, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yano, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bender, B. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cai, N.-S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moreno, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Canela, E. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cortés, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meiler, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Casadó, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ferré, S.</span></span> <span> </span><span class="NLM_article-title">α2A- and α2C-Adrenoceptors as Potential Targets for Dopamine and Dopamine Receptor Ligands</span>. <i>Mol. Neurobiol.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>55</i></span>,  <span class="NLM_fpage">8438</span>– <span class="NLM_lpage">8454</span>, <span class="refDoi"> DOI: 10.1007/s12035-018-1004-1</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00412&amp;key=10.1007%2Fs12035-018-1004-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00412&amp;key=29552726" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00412&amp;key=1%3ACAS%3A528%3ADC%252BC1cXltVynsrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2018&pages=8438-8454&author=M.+S%C3%A1nchez-Sotoauthor=V.+Casad%C3%B3-Angueraauthor=H.+Yanoauthor=B.+J.+Benderauthor=N.-S.+Caiauthor=E.+Morenoauthor=E.+I.+Canelaauthor=A.+Cort%C3%A9sauthor=J.+Meilerauthor=V.+Casad%C3%B3author=S.+Ferr%C3%A9&title=%CE%B12A-+and+%CE%B12C-Adrenoceptors+as+Potential+Targets+for+Dopamine+and+Dopamine+Receptor+Ligands&doi=10.1007%2Fs12035-018-1004-1"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit47R"><div class="casContent"><span class="casTitleNuber">47</span><div class="casTitle"><span class="NLM_cas:atitle">α2A- and α2C-Adrenoceptors as Potential Targets for Dopamine and Dopamine Receptor Ligands</span></div><div class="casAuthors">Sanchez-Soto, Marta; Casado-Anguera, Veronica; Yano, Hideaki; Bender, Brian Joseph; Cai, Ning-Sheng; Moreno, Estefania; Canela, Enric I.; Cortes, Antoni; Meiler, Jens; Casado, Vicent; Ferre, Sergi</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Neurobiology</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">8438-8454</span>CODEN:
                <span class="NLM_cas:coden">MONBEW</span>;
        ISSN:<span class="NLM_cas:issn">0893-7648</span>.
    
            (<span class="NLM_cas:orgname">Humana Press Inc.</span>)
        </div><div class="casAbstract">The poor norepinephrine innervation and high d. of Gi/o-coupled α2A- and α2C-adrenoceptors in the striatum and the dense striatal dopamine innervation have prompted the possibility that dopamine could be an effective adrenoceptor ligand.  Nevertheless, the reported adrenoceptor agonistic properties of dopamine are still inconclusive.  In this study, we analyzed the binding of norepinephrine, dopamine, and several compds. reported as selective dopamine D2-like receptor ligands, such as the D3 receptor agonist 7-OH-PIPAT and the D4 receptor agonist RO-105824, to α2-adrenoceptors in cortical and striatal tissue, which express α2A-adrenoceptors and both α2A- and α2C-adrenoceptors, resp.  The affinity of dopamine for α2-adrenoceptors was found to be similar to that for D1-like and D2-like receptors.  Moreover, the exogenous dopamine receptor ligands also showed high affinity for α2A- and α2C-adrenoceptors.  Their ability to activate Gi/o proteins through α2A- and α2C-adrenoceptors was also analyzed in transfected cells with bioluminescent resonance energy transfer techniques.  The relative ligand potencies and efficacies were dependent on the Gi/o protein subtype.  Furthermore, dopamine binding to α2-adrenoceptors was functional, inducing changes in dynamic mass redistribution, adenylyl cyclase activity, and ERK1/2 phosphorylation.  Binding events were further studied with computer modeling of ligand docking.  Docking of dopamine at α2A- and α2C-adrenoceptors was nearly identical to its binding to the crystd. D3 receptor.  Therefore, we provide conclusive evidence that α2A- and α2C-adrenoceptors are functional receptors for norepinephrine, dopamine, and other previously assumed selective D2-like receptor ligands, which calls for revisiting previous studies with those ligands.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrGdXKvwK7HTLVg90H21EOLACvtfcHk0lg3CoL4BVrc-g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXltVynsrw%253D&md5=307c9e1dfa5a39a0bca6c137034c1216</span></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.1007%2Fs12035-018-1004-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs12035-018-1004-1%26sid%3Dliteratum%253Aachs%26aulast%3DS%25C3%25A1nchez-Soto%26aufirst%3DM.%26aulast%3DCasad%25C3%25B3-Anguera%26aufirst%3DV.%26aulast%3DYano%26aufirst%3DH.%26aulast%3DBender%26aufirst%3DB.%2BJ.%26aulast%3DCai%26aufirst%3DN.-S.%26aulast%3DMoreno%26aufirst%3DE.%26aulast%3DCanela%26aufirst%3DE.%2BI.%26aulast%3DCort%25C3%25A9s%26aufirst%3DA.%26aulast%3DMeiler%26aufirst%3DJ.%26aulast%3DCasad%25C3%25B3%26aufirst%3DV.%26aulast%3DFerr%25C3%25A9%26aufirst%3DS.%26atitle%3D%25CE%25B12A-%2520and%2520%25CE%25B12C-Adrenoceptors%2520as%2520Potential%2520Targets%2520for%2520Dopamine%2520and%2520Dopamine%2520Receptor%2520Ligands%26jtitle%3DMol.%2520Neurobiol.%26date%3D2018%26volume%3D55%26spage%3D8438%26epage%3D8454%26doi%3D10.1007%2Fs12035-018-1004-1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref48"><div class="reference"><strong class="refLabel"><a href="#ref48" class="rightTabRefNumLink">48</a></strong><div class="NLM_citation" id="rightTab-cit48"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Appel, N. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, S. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Holmes, T. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Acri, J. B.</span></span> <span> </span><span class="NLM_article-title">Dopamine D3 Receptor Antagonist (GSK598809) Potentiates the Hypertensive Effects of Cocaine in Conscious, Freely-Moving Dogs</span>. <i>J. Pharmacol. Exp. Ther.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>354</i></span>,  <span class="NLM_fpage">484</span>– <span class="NLM_lpage">492</span>, <span class="refDoi"> DOI: 10.1124/jpet.115.224121</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00412&amp;key=10.1124%2Fjpet.115.224121" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00412&amp;key=26177654" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00412&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhsV2rsbvJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=354&publication_year=2015&pages=484-492&author=N.+M.+Appelauthor=S.+H.+Liauthor=T.+H.+Holmesauthor=J.+B.+Acri&title=Dopamine+D3+Receptor+Antagonist+%28GSK598809%29+Potentiates+the+Hypertensive+Effects+of+Cocaine+in+Conscious%2C+Freely-Moving+Dogs&doi=10.1124%2Fjpet.115.224121"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit48R"><div class="casContent"><span class="casTitleNuber">48</span><div class="casTitle"><span class="NLM_cas:atitle">Dopamine D3 receptor antagonist (GSK598809) potentiates the hypertensive effects of cocaine in conscious, freely-moving dogs</span></div><div class="casAuthors">Appel, Nathan M.; Li, Shou-Hua; Holmes, Tyson H.; Acri, Jane B.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">354</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">484-492</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">1521-0103</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">The chronic and relapsing nature of addiction presents unique challenges for ensuring the safety of a potential medication.  A patient may use cocaine, for example, while taking the medication or take more medication than prescribed.  Thus, a potential medication must be safe and not exacerbate the effects of cocaine.  Multiple published studies support antagonism of brain dopamine D3 receptor function as a potential mechanism of action for an anti-addiction medication.  Dopamine D3 receptors are widely distributed outside the central nervous system, however; for example, dopamine D3 receptors in the kidneys are implicated in regulating blood pressure.  The selective dopamine D3 receptor antagonist GSK598809 [1-(2-fluoro-4- trifluoromethyl-phenyl)-3-{3-[4-methyl-5-(4-methyl-oxazol-5- yl)-4H-[1,2,4]triazol-3-ylsulfanyl]-propyl}-3-aza-bicyclo[3.1.0] hexane] has been proposed as a medication to treat cocaine and other substance use disorders.  The US Food and Drug Administration has established guidelines recommending safety studies to investigate potential undesirable pharmacodynamic effects of a substance in relation to exposure in the therapeutic range and above.  Hence, we assessed the interaction between this selective dopamine D3 receptor antagonist and cocaine on hemodynamics and cardiac function in freely-moving, telemetered dogs before conducting a clin. trial.  GSK598809 increased the hemodynamic effect of cocaine in this model.  Thus, the increase in blood pressure after i.v. cocaine was greater in animals that had been pretreated with GSK598809 compared with vehicle.  This finding suggests that GSK598809 in particular, and perhaps dopamine D3 receptor antagonists as a class, may produce unacceptable cardiovascular risks as medications to treat cocaine use disorder.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoWWq20sTq43bVg90H21EOLACvtfcHk0lgAh0QXj5rkrQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhsV2rsbvJ&md5=6fd994c95c5bee2dd486b4c340564c73</span></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.1124%2Fjpet.115.224121&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.115.224121%26sid%3Dliteratum%253Aachs%26aulast%3DAppel%26aufirst%3DN.%2BM.%26aulast%3DLi%26aufirst%3DS.%2BH.%26aulast%3DHolmes%26aufirst%3DT.%2BH.%26aulast%3DAcri%26aufirst%3DJ.%2BB.%26atitle%3DDopamine%2520D3%2520Receptor%2520Antagonist%2520%2528GSK598809%2529%2520Potentiates%2520the%2520Hypertensive%2520Effects%2520of%2520Cocaine%2520in%2520Conscious%252C%2520Freely-Moving%2520Dogs%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2015%26volume%3D354%26spage%3D484%26epage%3D492%26doi%3D10.1124%2Fjpet.115.224121" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref49"><div class="reference"><strong class="refLabel"><a href="#ref49" class="rightTabRefNumLink">49</a></strong><div class="NLM_citation" id="rightTab-cit49"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Galaj, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ewing, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ranaldi, R.</span></span> <span> </span><span class="NLM_article-title">Dopamine D1 and D3 Receptor Polypharmacology as a Potential Treatment Approach for Substance use Disorder</span>. <i>Neurosci. Biobehav. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>89</i></span>,  <span class="NLM_fpage">13</span>– <span class="NLM_lpage">28</span>, <span class="refDoi"> DOI: 10.1016/j.neubiorev.2018.03.020</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00412&amp;key=10.1016%2Fj.neubiorev.2018.03.020" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=89&publication_year=2018&pages=13-28&author=E.+Galajauthor=S.+Ewingauthor=R.+Ranaldi&title=Dopamine+D1+and+D3+Receptor+Polypharmacology+as+a+Potential+Treatment+Approach+for+Substance+use+Disorder&doi=10.1016%2Fj.neubiorev.2018.03.020"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=10.1016%2Fj.neubiorev.2018.03.020&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.neubiorev.2018.03.020%26sid%3Dliteratum%253Aachs%26aulast%3DGalaj%26aufirst%3DE.%26aulast%3DEwing%26aufirst%3DS.%26aulast%3DRanaldi%26aufirst%3DR.%26atitle%3DDopamine%2520D1%2520and%2520D3%2520Receptor%2520Polypharmacology%2520as%2520a%2520Potential%2520Treatment%2520Approach%2520for%2520Substance%2520use%2520Disorder%26jtitle%3DNeurosci.%2520Biobehav.%2520Rev.%26date%3D2018%26volume%3D89%26spage%3D13%26epage%3D28%26doi%3D10.1016%2Fj.neubiorev.2018.03.020" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref50"><div class="reference"><strong class="refLabel"><a href="#ref50" class="rightTabRefNumLink">50</a></strong><div class="NLM_citation" id="rightTab-cit50"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hayatshahi, H. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Griffin, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taylor, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mach, R. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luedtke, R. R.</span></span> <span> </span><span class="NLM_article-title">Analogues of Arylamide Phenylpiperazine Ligands To Investigate the Factors Influencing D3 Dopamine Receptor Bitropic Binding and Receptor Subtype Selectivity</span>. <i>ACS Chem. Neurosci.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">2972</span>– <span class="NLM_lpage">2983</span>, <span class="refDoi"> DOI: 10.1021/acschemneuro.8b00142</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acschemneuro.8b00142" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00412&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhtlWrt77J" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2018&pages=2972-2983&author=H.+S.+Hayatshahiauthor=K.+Xuauthor=S.+A.+Griffinauthor=M.+Taylorauthor=R.+H.+Machauthor=J.+Liuauthor=R.+R.+Luedtke&title=Analogues+of+Arylamide+Phenylpiperazine+Ligands+To+Investigate+the+Factors+Influencing+D3+Dopamine+Receptor+Bitropic+Binding+and+Receptor+Subtype+Selectivity&doi=10.1021%2Facschemneuro.8b00142"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit50R"><div class="casContent"><span class="casTitleNuber">50</span><div class="casTitle"><span class="NLM_cas:atitle">Analogues of Arylamide Phenylpiperazine Ligands To Investigate the Factors Influencing D3 Dopamine Receptor Bitropic Binding and Receptor Subtype Selectivity</span></div><div class="casAuthors">Hayatshahi, Hamed S.; Xu, Kuiying; Griffin, Suzy A.; Taylor, Michelle; Mach, Robert H.; Liu, Jin; Luedtke, Robert R.</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Neuroscience</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">2972-2983</span>CODEN:
                <span class="NLM_cas:coden">ACNCDM</span>;
        ISSN:<span class="NLM_cas:issn">1948-7193</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The authors have previously reported on the ability of arylamide phenylpiperazines to bind selectively to the D3 vs. the D2 dopamine receptor subtype.  For these studies, the authors used LS-3-134 as the prototypic arylamide phenylpiperazine ligand because it binds with high affinity at D3 dopamine receptor (0.17 nM) and exhibits >150-fold D3 vs. D2 receptor binding selectivity.  The authors' goal was to investigate how the compn. and size of the nonarom. ring structure at the piperazine position of substituted phenylpiperazine analogs might influence binding affinity at the human D2 and D3 dopamine receptors.  Two factors were identified as being important for detg. the binding affinity of bitropic arylamide phenylpiperazines at the dopamine D3 receptor subtype.  One factor was the strength of the salt bridge between the highly conserved residue Asp3.32 with the protonated nitrogen of the nonarom. ring at the piperazine position.  The second factor was the configuration of the unbound ligand in an aq. soln.  These two factors were found to be related to the logarithm of the affinities using a simple correlation model, which could be useful when designing high affinity subtype selective bitropic ligands.  While this model is based upon the interaction of arylamide phenylpiperazines with the D2 and D3 D2-like dopamine receptor subtypes, it provides insights into the complexity of the factors that define a bitropic mode of the binding at GPCRs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo2bY8O70GE2LVg90H21EOLACvtfcHk0lgAh0QXj5rkrQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhtlWrt77J&md5=1ed0ee59eef51b7e1c2e1b4b8fad8537</span></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=10.1021%2Facschemneuro.8b00142&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facschemneuro.8b00142%26sid%3Dliteratum%253Aachs%26aulast%3DHayatshahi%26aufirst%3DH.%2BS.%26aulast%3DXu%26aufirst%3DK.%26aulast%3DGriffin%26aufirst%3DS.%2BA.%26aulast%3DTaylor%26aufirst%3DM.%26aulast%3DMach%26aufirst%3DR.%2BH.%26aulast%3DLiu%26aufirst%3DJ.%26aulast%3DLuedtke%26aufirst%3DR.%2BR.%26atitle%3DAnalogues%2520of%2520Arylamide%2520Phenylpiperazine%2520Ligands%2520To%2520Investigate%2520the%2520Factors%2520Influencing%2520D3%2520Dopamine%2520Receptor%2520Bitropic%2520Binding%2520and%2520Receptor%2520Subtype%2520Selectivity%26jtitle%3DACS%2520Chem.%2520Neurosci.%26date%3D2018%26volume%3D9%26spage%3D2972%26epage%3D2983%26doi%3D10.1021%2Facschemneuro.8b00142" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref51"><div class="reference"><strong class="refLabel"><a href="#ref51" class="rightTabRefNumLink">51</a></strong><div class="NLM_citation" id="rightTab-cit51"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yung-Chi, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prusoff, W. H.</span></span> <span> </span><span class="NLM_article-title">Relationship Between the Inhibition Constant (KI) and the Concentration of Inhibitor Which Causes 50 Percent Inhibition (I50) of an Enzymatic Reaction</span>. <i>Biochem. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">1973</span>,  <span class="NLM_volume"><i>22</i></span>,  <span class="NLM_fpage">3099</span>– <span class="NLM_lpage">3108</span>, <span class="refDoi"> DOI: 10.1016/0006-2952(73)90196-2</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00412&amp;key=10.1016%2F0006-2952%2873%2990196-2" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00412&amp;key=4202581" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=1973&pages=3099-3108&author=C.+Yung-Chiauthor=W.+H.+Prusoff&title=Relationship+Between+the+Inhibition+Constant+%28KI%29+and+the+Concentration+of+Inhibitor+Which+Causes+50+Percent+Inhibition+%28I50%29+of+an+Enzymatic+Reaction&doi=10.1016%2F0006-2952%2873%2990196-2"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=10.1016%2F0006-2952%2873%2990196-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0006-2952%252873%252990196-2%26sid%3Dliteratum%253Aachs%26aulast%3DYung-Chi%26aufirst%3DC.%26aulast%3DPrusoff%26aufirst%3DW.%2BH.%26atitle%3DRelationship%2520Between%2520the%2520Inhibition%2520Constant%2520%2528KI%2529%2520and%2520the%2520Concentration%2520of%2520Inhibitor%2520Which%2520Causes%252050%2520Percent%2520Inhibition%2520%2528I50%2529%2520of%2520an%2520Enzymatic%2520Reaction%26jtitle%3DBiochem.%2520Pharmacol.%26date%3D1973%26volume%3D22%26spage%3D3099%26epage%3D3108%26doi%3D10.1016%2F0006-2952%2873%2990196-2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref52"><div class="reference"><strong class="refLabel"><a href="#ref52" class="rightTabRefNumLink">52</a></strong><div class="NLM_citation" id="rightTab-cit52"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Reilly, S. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Puentes, L. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wilson, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hsieh, C.-J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weng, C.-C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Makvandi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mach, R. H.</span></span> <span> </span><span class="NLM_article-title">Examination of Diazaspiro Cores as Piperazine Bioisosteres in the Olaparib Framework Shows Reduced DNA Damage and Cytotoxicity</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>61</i></span>,  <span class="NLM_fpage">5367</span>– <span class="NLM_lpage">5379</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.8b00576</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.8b00576" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00412&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhtVKktbzE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2018&pages=5367-5379&author=S.+W.+Reillyauthor=L.+N.+Puentesauthor=K.+Wilsonauthor=C.-J.+Hsiehauthor=C.-C.+Wengauthor=M.+Makvandiauthor=R.+H.+Mach&title=Examination+of+Diazaspiro+Cores+as+Piperazine+Bioisosteres+in+the+Olaparib+Framework+Shows+Reduced+DNA+Damage+and+Cytotoxicity&doi=10.1021%2Facs.jmedchem.8b00576"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit52R"><div class="casContent"><span class="casTitleNuber">52</span><div class="casTitle"><span class="NLM_cas:atitle">Examination of Diazaspiro Cores as Piperazine Bioisosteres in the Olaparib Framework Shows Reduced DNA Damage and Cytotoxicity</span></div><div class="casAuthors">Reilly, Sean W.; Puentes, Laura N.; Wilson, Khadija; Hsieh, Chia-Ju; Weng, Chi-Chang; Makvandi, Mehran; Mach, Robert H.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">61</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">5367-5379</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Development of poly(ADP-ribose) polymerase inhibitors (PARPi's) continues to be an attractive area of research due to synthetic lethality in DNA repair deficient cancers; however, PARPi's also have potential as therapeutics to prevent harmful inflammation.  We investigated the pharmacol. impact of incorporating spirodiamine motifs into the phthalazine architecture of FDA approved PARPi olaparib.  Synthesized analogs were screened for PARP-1 affinity, enzyme specificity, catalytic inhibition, DNA damage, and cytotoxicity.  This work led to the identification of 10e (12.6 ± 1.1 nM), which did not induce DNA damage at similar drug concns. as olaparib.  Interestingly, several worst in class compds. with low PARP-1 affinity, including 15b (4397 ± 1.1 nM), induced DNA damage at micromolar concns., which can explain the cytotoxicity obsd. in vitro.  This work provides further evidence that high affinity PARPi's can be developed without DNA damaging properties offering potential new drugs for treating inflammatory related diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrnTC4dTcUAdrVg90H21EOLACvtfcHk0liPFu8GX-rGHA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhtVKktbzE&md5=e352b0777c5f53f2c126288a1c5ff4c1</span></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.8b00576&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.8b00576%26sid%3Dliteratum%253Aachs%26aulast%3DReilly%26aufirst%3DS.%2BW.%26aulast%3DPuentes%26aufirst%3DL.%2BN.%26aulast%3DWilson%26aufirst%3DK.%26aulast%3DHsieh%26aufirst%3DC.-J.%26aulast%3DWeng%26aufirst%3DC.-C.%26aulast%3DMakvandi%26aufirst%3DM.%26aulast%3DMach%26aufirst%3DR.%2BH.%26atitle%3DExamination%2520of%2520Diazaspiro%2520Cores%2520as%2520Piperazine%2520Bioisosteres%2520in%2520the%2520Olaparib%2520Framework%2520Shows%2520Reduced%2520DNA%2520Damage%2520and%2520Cytotoxicity%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2018%26volume%3D61%26spage%3D5367%26epage%3D5379%26doi%3D10.1021%2Facs.jmedchem.8b00576" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref53"><div class="reference"><strong class="refLabel"><a href="#ref53" class="rightTabRefNumLink">53</a></strong><div class="NLM_citation" id="rightTab-cit53"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Morris, G. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huey, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lindstrom, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sanner, M. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Belew, R. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goodsell, D. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Olson, A. J.</span></span> <span> </span><span class="NLM_article-title">AutoDock4 and AutoDockTools4: Automated Docking with Selective Receptor Flexibility</span>. <i>J. Comput. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>30</i></span>,  <span class="NLM_fpage">2785</span>– <span class="NLM_lpage">2791</span>, <span class="refDoi"> DOI: 10.1002/jcc.21256</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00412&amp;key=10.1002%2Fjcc.21256" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00412&amp;key=19399780" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00412&amp;key=1%3ACAS%3A528%3ADC%252BD1MXht1GitrnK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=2009&pages=2785-2791&author=G.+M.+Morrisauthor=R.+Hueyauthor=W.+Lindstromauthor=M.+F.+Sannerauthor=R.+K.+Belewauthor=D.+S.+Goodsellauthor=A.+J.+Olson&title=AutoDock4+and+AutoDockTools4%3A+Automated+Docking+with+Selective+Receptor+Flexibility&doi=10.1002%2Fjcc.21256"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit53R"><div class="casContent"><span class="casTitleNuber">53</span><div class="casTitle"><span class="NLM_cas:atitle">AutoDock and AutoDockTools: Automated docking with selective receptor flexibility</span></div><div class="casAuthors">Morris, Garrett M.; Huey, Ruth; Lindstrom, William; Sanner, Michel F.; Belew, Richard K.; Goodsell, David S.; Olson, Arthur J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Computational Chemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">30</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">2785-2791</span>CODEN:
                <span class="NLM_cas:coden">JCCHDD</span>;
        ISSN:<span class="NLM_cas:issn">0192-8651</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">We describe the testing and release of AutoDock4 and the accompanying graphical user interface AutoDockTools.  AutoDock4 incorporates limited flexibility in the receptor.  Several tests are reported here, including a redocking expt. with 188 diverse ligand-protein complexes and a cross-docking expt. using flexible sidechains in 87 HIV protease complexes.  We also report its utility in anal. of covalently bound ligands, using both a grid-based docking method and a modification of the flexible sidechain technique. © 2009 Wiley Periodicals, Inc.  J Comput Chem, 2009.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqktE6WAo4GEbVg90H21EOLACvtfcHk0liPFu8GX-rGHA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXht1GitrnK&md5=679ce22fc50e9291c9aa16e7a1855845</span></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=10.1002%2Fjcc.21256&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjcc.21256%26sid%3Dliteratum%253Aachs%26aulast%3DMorris%26aufirst%3DG.%2BM.%26aulast%3DHuey%26aufirst%3DR.%26aulast%3DLindstrom%26aufirst%3DW.%26aulast%3DSanner%26aufirst%3DM.%2BF.%26aulast%3DBelew%26aufirst%3DR.%2BK.%26aulast%3DGoodsell%26aufirst%3DD.%2BS.%26aulast%3DOlson%26aufirst%3DA.%2BJ.%26atitle%3DAutoDock4%2520and%2520AutoDockTools4%253A%2520Automated%2520Docking%2520with%2520Selective%2520Receptor%2520Flexibility%26jtitle%3DJ.%2520Comput.%2520Chem.%26date%3D2009%26volume%3D30%26spage%3D2785%26epage%3D2791%26doi%3D10.1002%2Fjcc.21256" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><div class="accessionCode mb-5"><div class="toolbar-section accession-codes"><ul><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3PBL" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3PBL','PDB','3PBL'); return false;">PDB: 3PBL</a></li></ul></div></div><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i66"><a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.9b00412">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_36830"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge on the <a class="ext-link" href="/">ACS Publications website</a> at DOI: <a class="ext-link" href="/doi/abs/10.1021/acs.jmedchem.9b00412">10.1021/acs.jmedchem.9b00412</a>.<ul id="rightTab-silist" class="NLM_list-list_type-label"><li><p class="inline"><sup>1</sup>H and <sup>13</sup>C NMR spectra and mass spectral data of isolated compounds <b>E</b>, <b>F</b>, <b>4a</b>, <b>5a</b>–<b>c</b>, <b>6a</b>, <b>6c</b>–<b>f</b>, <b>6h</b>, <b>7</b>–<b>24</b>, <b>26</b>, <b>28</b>–<b>30</b>, <b>32</b>, <b>34</b>–<b>37</b>, and LC–MS traces of <b>1</b> and <b>31</b> (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.9b00412/suppl_file/jm9b00412_si_001.pdf">PDF</a>)</p></li><li><p class="inline">Molecular formula strings and some data (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.9b00412/suppl_file/jm9b00412_si_002.csv">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.9b00412/suppl_file/jm9b00412_si_001.pdf">jm9b00412_si_001.pdf (3.47 MB)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.9b00412/suppl_file/jm9b00412_si_002.csv">jm9b00412_si_002.csv (3.22 kb)</a></li></ul></div></div><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Facs.jmedchem.9b00412&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Barticle%3Aarticle%3A10.1021%2Facs.jmedchem.9b00412%3Bctype%3Astring%3AJournal+Content%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2019.62.issue-10%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/acs.jmedchem.9b00412" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                3MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"6799460ad92f24ad","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
